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A brief history about the importance of energy 
 
Energy is the ability to do work. Ever since the existence of mankind, humans have searched 
for ways of harvesting energy and putting it to work for them. The more we succeeded, the 
more time and power became available to us to alter the environment around us, eventually 
enabling growth and development into the complex society of today. In other words, there is 
a matching rise in energy use and cultural development or complexity (Figure 1.1), or as the 
anthropologist Leslie White once said: “Energy = civilization” [1]. For example, up until the 
discovery of fire, human civilization was very basic and the population was very small as the 
only source of energy available was human muscle (actually metabolism). The discovery of 
fire and the burning of wood, however, provided an extra source of available energy 
enabling things like cooking and the development of metal tools. With domestication, 
mankind also learned to harvest the power of animals to plough their fields and increase 
crop yields. Harvesting of wind and water energy, through the development of sails, 
windmills and water-wheels, allowed further population growth and cultural complexity [2].  
Together, these sources of energy remained the most powerful and reliable means to utilize 
energy for thousands of years. However, since the energy harvested by these methods is 
only relatively low, societies were restricted in size and complexity. For example, the 
development of the Roman Empire started with their ability to efficiently organize and 
process relatively big amounts of energy, which led to a surplus of available energy (such as 
food or man- and animal-power). Consumption of this surplus made it possible to develop 
into a complex society with a growing non-producing population and a complex system of 
social facilities. However, to sustain this complex society and ever growing population, huge 
amounts of energy were required. At first, these requirements could be met by expanding 
their Empire to obtain new farmland, natural resources and man- and animal-power. 
However, as energy requirements kept increasing, while expansion became ever more 
difficult, their energy reserves and systems slowly became insufficient. As no alternatives 
were available, this led to even more pressure on existing energy systems, which led to even 
faster exhaustion and eventually social unrest and the collapse of their society [3].  
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 Figure 1.1 Overview of historical energy sources and their effect on the world population 
 
The industrialized civilization of today has reached an unprecedented (global) complexity 
and the world population has grown far beyond numbers ever seen before. So how is this 
possible? The answer is: fossil fuels [4, 5]. For thousands of years energy use has been 
relatively low and the world population has only gradually increased to ~800 million in 1750 
(Figure 1.1). At the beginning of the industrial revolution, however, Europeans began to 
unlock the potential of fossil fuels (coal, natural gas and oil), providing a new source of 
available energy. This led to an energy surplus that absolutely dwarfed anything mankind 
had ever used before. Consumption of this surplus caused a wave of unprecedented 
innovation and advancement, as well as an almost unrestricted growth of population. 
However, like the Romans, sustaining this complex civilization and ever growing population 
requires huge amounts of energy. Unfortunately, the majority of this energy is still provided 
by fossil fuels and although large reserves still exist, it is generally accepted that the end of 
the cheap fossil energy era will be reached within the next few decades. This urges the 
search for alternative energy scenarios, in which the world ultimately becomes independent 
of fossil fuels. Growing concerns with respect to greenhouse gas emissions, economic 
dependence, and political stability will only speed up this development.  
 
Fossil fuels are a non-renewable primary energy source. Primary energy sources are sources 
of energy that occur naturally. They need to be transformed in energy conversion processes 
to more convenient forms of energy, called secondary energy sources or energy carriers, 
that can be used in everyday life to perform work. For example, coal and natural gas 
(primary energy) can be converted in a fossil fuel power station (energy conversion process) 
to electricity (energy carrier). Similarly, crude oil (primary energy) can be converted in an oil 
refinery (energy conversion process) to fuels such as gasoline and diesel (energy carrier). 
Future energy scenarios will mainly be based on a mix of renewable primary energy sources, 
such as solar-, wind-, water-, or geothermal energy, and biomass, in combination with 
energy carriers that are able to address environmental and security issues posed by current 
fuels. One of the promising future energy carriers in this respect is hydrogen gas (H2). 
Hydrogen 
What is it and where can it be used for? 
Hydrogen gas, or molecular hydrogen, was discovered in the 18th century [6]. Its 
monoatomic form is the most abundant element in the universe and molecular clouds of it 
are associated with the formation of stars [7]. Moreover, it is the main fuel that powers the 
sun (and many other stars), through a special chemical reaction called nuclear fusion. 
Nuclear fusion is special as it is the only process in which hydrogen is a primary energy 
source rather than an energy carrier. Through the sun, hydrogen is thus responsible for the 
majority of the available energy on earth [8]. Under ordinary conditions on earth, elemental 
hydrogen exists as the diatomic gas, H2. Although elemental hydrogen is the most abundant 
element in the universe, H2 is very scarce in the earth’s atmosphere. This is because of its 
light weight, which enables it to escape from earth’s gravity more easily than heavier gasses 
[9]. Moreover, contrary to natural gas (methane, CH4), no natural accumulation sites of H2 
exist. However, hydrogen is commonly present on the earth’s surface, but it is mostly bound 
in chemical compounds like hydrocarbons (CcHm), carbohydrates (Cn(H2O)m) or water (H2O).  
To produce H2, hydrogen must be freed from these compounds. This requires quite some 
work (energy), but some bacteria, archaea and algae are naturally able to do this (Table 1.1). 
In addition, H2 can be produced industrially via various methods such as electrolysis or 
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thermolysis [10-14]. Since its discovery, H2 has become an important chemical commodity. 
In 2013, its global demand was estimated to be 254.5 billion cubic meters, representing tens 
of billions of U.S. dollars, and is predicted to grow to an annual demand of ~300 billion cubic 
meters in 2018 [15]. H2 is commonly used in numerous industrial processes. Particularly, in 
the food, metal, electronics and glass-processing industries, where it is for instance used for 
welding, as coolant, O2-scavanger, or reactant in various hydrogenation processes. 
Moreover, it is used in petroleum refining and for the synthesis of other basic chemicals such 
methanol and ammonia. Since H2 is an energy carrier, it can also be implemented as an 
energy storage, transportation and delivery medium and has thus attracted widespread 
attention as a promising alternative to fossil fuels [16-22].  
 
Table 1.1 Overview of mesophilic, thermophilic and extreme/hyperthermophilic H2-fermenting bacteria (B) 
and archaea (A) 
Organism Domain Optimal growth 
temperature 
Substrate H2/hexose Reference
Mesophiles (~20-45°C)   
Enterobacter aerogenes  
HU-101 
B 37 glucose 0.7-1.1 [23]
Clostridium acetobutylicum
ATCC 4259 
B 34 glucose 1.0 [24]
Klebsiella oxytoca  
HP1 
B 38 glucose 1.0 [25]
   
Thermophiles (~45-65°C)   
Clostridium thermosaccharolyticum  
LMG 6564 
B 55 glucose/
fructose 
1.6 [26]
Clostridium thermocellum 
ATCC 27405 
B 60 cellulose 1.7 [27]
Thermoanaerobacterium 
thermosaccharolyticum PSU-2 
B 60 starch 2.8 [28]
   
Extreme/hyperthermophiles  
(~65-121°C) 
  
Pyrococcus furiosus  
DSM3638 
A 90 cellobiose 2.8 [29]
  maltose 3.5 [29]
Thermococcus kodakarensis  
KOD1 
A 85 starch 3.3 [30]
Caldicellulosiruptor saccharolyticus 
DSM8903 
B 72 glucose 3.6 [31]
Thermotoga maritima  
MSB8 
B 80 glucose 4.0 [32]
 
When used as a fuel, H2 can be oxidized in a combustion engine or in an H2-fueled fuel cell. 
Like conventional combustion engines, a H2-fueled one is powered by the energy (heat) 
released by the oxidation of the fuel, in this case H2 (Eq. 1.1). However, in contrast to 
conventional fuels, H2 oxidation with normal air is relatively clean, producing water (H2O), no 
carbon dioxide (CO2), and only a fraction of the normal levels of other environmental 
pollutants (NOx). Moreover, when pure oxygen (O2) is used instead of normal air, H2 
oxidation is completely emission free and produces only H2O. Similarly, the energy released 
by the oxidative conversion of H2 to water can relatively easily be converted to electricity 
using an H2-fuelled fuel cell. H2-fueled fuel cells are considered very promising as no 
pollutants are produced and the conversion of the chemical energy of H2 into electricity is 
far more efficient than combustion processes [16-22, 33].  
(Eq. 1.1) 2 H2 (g) + O2 (g) → 2 H2O (l)       
  -477.5 kJ/mole (∆r G°) [34-36] 
 
Biological hydrogen production 
Since H2 is an energy carrier, it must be produced from primary energy resources. 
Unfortunately, most of the current H2-generating techniques still rely on fossil fuels in one 
way or another and can hence not be considered sustainable. For example, the extraction of 
H2 by steam reforming of CH4 (Eq. 1.2), which is one of the most applied methods today, 
requires the direct input of natural gas. Moreover, even when methods are used that do not 
require the direct input of fossil fuels, such as electrolysis of water (Eq. 1.3), the energy 
(electricity) needed to extract H2 often is produced from fossil fuels. Therefore, to shift to a 
more sustainable production, H2 must be derived from renewable resources, like biomass 
[37-39]. This so-called biological hydrogen (BioH2) would achieve nearly zero carbon 
emissions in a whole life cycle and allows for easy combination with carbon sequestration 
(i.e. carbon capture at the site of production and long term storage in for example biomass). 
Subsequently using this captured CO2 for the autotrophic growth of microalgae, for instance, 
would even allow carbon-neutral production of other biofuels or value-added products [40, 
41]. 
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(Eq. 1.2) CH4 + 2 H2O → 4 H2 + CO2 
(Eq. 1.3) 2 H2O + electric energy → 2 H2 + O2 
BioH2 can be produced by a number of different processes including biophotolysis, microbial 
photo-fermentation, microbial electrolysis, or microbial dark fermentation [11, 16, 42]. 
Though the exact mechanism and energy source may differ, the principle reaction behind all 
of these methods is the same: two protons (H+) and two electrons (e-) are brought together 
to form H2 (Eq. 1.4). During microbial dark fermentation, biomass-derived carbohydrates, 
such as glucose, are anaerobically digested to organic acids and/or alcohols, CO2 and H2 [42]. 
Generating BioH2 by microbial dark fermentation has several advantages. It requires only 
relatively simple reactor technology, no direct energy input is needed, many (facultative) 
anaerobic bacteria and archaea are naturally able to perform it (Table 1.1), and the 
hydrogen evolution rate is higher in contrast to other methods [42, 43]. Moreover, it allows 
using (complex) organic wastes, such as agro-industrial residues, for BioH2 production, which 
are abundant, cheap, renewable and biodegradable [44-46]. Unfortunately, some major 
known drawbacks of this method are that large amounts of side products (acids, alcohols) 
are formed and that H2 production yields are still too low to make the process economically 
competitive [15, 43, 44, 47]. The latter is mainly due to the fact that BioH2 is a low-value 
product, for which costs of feedstock carbohydrates often account for the majority of the 
price of the products [47]. This implies that, to enhance the economy of the microbial dark 
fermentation it is required to improve the sugar-to-H2 yield. 
(Eq. 1.4) 2 H+ + 2 e- ⇄ H2 
 
Microbial dark fermentation 
Current sugar-to-H2 yields by microbial dark fermentation vary from less than 1 to almost 4 
mole of H2/mole of hexose consumed (Table 1.1) [13, 14, 43, 48, 49]. The differences in yield 
are mainly due to the types and relative proportions of the products generated by 
fermentation. Besides H2, hydrogen-fermenting microbes make other products to satisfy 
their metabolic needs and to allow growth to continue. For example, during the anaerobic 
 
digestion of biomass-derived carbohydrates, electrons are released which are typically 
transferred to electron carriers like NAD(P)+ or ferredoxin  (Fdox). The reduced electron 
carriers generated, NAD(P)H and Fdred, need to get re-oxidized (recycled) to keep sugar 
oxidation going and conserve energy for growth. Depending on their genome and 
environmental (culture) conditions, (facultative) anaerobic microorganisms may have 
different options to do this; these include the subsequent transfer of electrons to protons 
(H+), generating H2, or to catabolic intermediates, producing reduced products such as 
lactate, ethanol or butanol (at the expense of H2). Moreover, during anaerobic growth, 
electron transport phosphorylation (ETP), which acts as an electron sink and ATP source, is 
absent and cells mainly depend on substrate level phosphorylation (SLP) for their ATP 
(energy) production. Like reductant recycling, microbes may have different options for 
generating ATP by SLP, which may vary in efficiency or effect on H2 production. Overall, 
carbon flow, reductant recycling (including H2 production) and ATP generation are thus 
tightly coupled.  
To maximize H2 production, dark fermentation should only lead to fermentation end-
products that are coupled to H2 production. Ideally, the common biomass-derived 
carbohydrate glucose is completely oxidized to CO2 and H2 (Eq. 1.5). However, complete 
anaerobic oxidation of glucose is thermodynamically difficult, which is indicated by the 
positive value for the Gibbs energy (∆r G°) associated with this reaction, and is only possible 
at very low partial H2 pressures [48]. Moreover, since dark fermentation is performed by 
microorganisms, fermentations have been optimized by evolution to produce biomass (ATP) 
and not H2. According to the known metabolic pathways, complete anaerobic glucose 
oxidation generates no ATP by SLP and hence no single organism exists that is capable of 
catalyzing this conversion.  
(Eq. 1.5) glucose (C6H12O6) + 12 H2O → 6 HCO3- + 6 H+ + 12 H2    
  +0.72 kJ/mole (∆r G°) [34-36] 
In nature, anaerobic digestion of glucose generates the highest ATP and H2 yield (4 ATP and 
H2 per glucose) when two moles of acetate and bicarbonate (HCO3-) are concomitantly 
formed as fermentation end-products (Eq. 1.6) [50, 51]. Table 1.1 shows that 
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Microbial dark fermentation 
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are mainly due to the types and relative proportions of the products generated by 
fermentation. Besides H2, hydrogen-fermenting microbes make other products to satisfy 
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digestion of biomass-derived carbohydrates, electrons are released which are typically 
transferred to electron carriers like NAD(P)+ or ferredoxin  (Fdox). The reduced electron 
carriers generated, NAD(P)H and Fdred, need to get re-oxidized (recycled) to keep sugar 
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lactate, ethanol or butanol (at the expense of H2). Moreover, during anaerobic growth, 
electron transport phosphorylation (ETP), which acts as an electron sink and ATP source, is 
absent and cells mainly depend on substrate level phosphorylation (SLP) for their ATP 
(energy) production. Like reductant recycling, microbes may have different options for 
generating ATP by SLP, which may vary in efficiency or effect on H2 production. Overall, 
carbon flow, reductant recycling (including H2 production) and ATP generation are thus 
tightly coupled.  
To maximize H2 production, dark fermentation should only lead to fermentation end-
products that are coupled to H2 production. Ideally, the common biomass-derived 
carbohydrate glucose is completely oxidized to CO2 and H2 (Eq. 1.5). However, complete 
anaerobic oxidation of glucose is thermodynamically difficult, which is indicated by the 
positive value for the Gibbs energy (∆r G°) associated with this reaction, and is only possible 
at very low partial H2 pressures [48]. Moreover, since dark fermentation is performed by 
microorganisms, fermentations have been optimized by evolution to produce biomass (ATP) 
and not H2. According to the known metabolic pathways, complete anaerobic glucose 
oxidation generates no ATP by SLP and hence no single organism exists that is capable of 
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(Eq. 1.5) glucose (C6H12O6) + 12 H2O → 6 HCO3- + 6 H+ + 12 H2    
  +0.72 kJ/mole (∆r G°) [34-36] 
In nature, anaerobic digestion of glucose generates the highest ATP and H2 yield (4 ATP and 
H2 per glucose) when two moles of acetate and bicarbonate (HCO3-) are concomitantly 
formed as fermentation end-products (Eq. 1.6) [50, 51]. Table 1.1 shows that 
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hyperthermophilic bacteria and archaea, especially, appear to perform best in this respect. 
This is because the conversion of glucose to acetate, CO2 and H2 is thermodynamically 
difficult as sufficient Gibbs energy must be obtained to generate the 4 ATP coupled to this 
fermentation-pathway. Under physiological conditions, the Gibbs energy change needed 
for ATP synthesis must amount to a minimum of ~70 kJ/mole of ATP [52]. Thus, the 
minimum Gibbs energy quantum that can generate 4 mole of ATP would amount to ~280 
kJ/mole of glucose. However, under standard conditions, the Gibbs energy released by the 
acetate fermentation-pathway is only -207.72 kJ/mole (∆r G°) (Eq. 1.6), which means that 
the conversion of glucose to acetate, CO2 and H2 is not possible under these conditions. Even 
under physiological conditions (10 mM) and a low partial H2 pressure (10-1 atm), the  
conversion does not generate sufficient Gibbs energy to synthesize 4 mole ATP (Eq. 1.6, -
264.80 kJ/mole (∆r G’)). Only when the temperature is increased as well, the conversion of 
glucose to acetate, CO2 and H2 generates enough Gibbs energy to synthesize 4 mole of ATP 
(Eq. 1.6, -305.25 kJ/mole (∆r G’85°C)). 
(Eq. 1.6) glucose (C6H12O6) + 4 H2O → 2 acetate- (C2H3O2-) + 2 HCO3- + 4 H+ + 4 H2  
  -207.72 kJ/mole (∆r G°)       
  -264.80 kJ/mole (∆r G’)        
  -305.25 kJ/mole (∆r G’85°C) [34-36]  
However, the production of 4 mole H2/glucose that can be reached by some 
hyperthermophiles is still only a third of the theoretical maximal H2 yield of 12 mole 
H2/glucose. This means that about two thirds of the hydrogen and energy bound in glucose 
is excreted as acetate. Nevertheless, due to the metabolic and thermodynamic constraints 
explained above, the production of 4 mole H2/glucose is generally regarded as the upper 
limit that can be reached by microbial dark fermentation [51]. Especially, since a subsequent 
conversion of the fermentation end-product acetate to H2 and CO2 requires an input of 
additional energy (Eq. 1.7), and can hence not be performed by dark fermentation. 
(Eq. 1.7) 2 acetate- (C2H3O2-) + 2 H+ + 8 H2O → 4 HCO3- + 4 H+ + 8 H2   
  +216.4 kJ/mole (∆r G°) [34-36] 
 
Photo-fermentative organisms on the other hand, can overcome this energy barrier by 
utilizing the energy from solar light obtained via their light-driven proton pumps [11, 42]. 
Similarly, acetate can be converted to H2 and CO2 using microbial electrolysis, in which the 
additional energy required can be provided by an externally applied potential [53]. So the 
overall H2/glucose yield can be increased by using dark fermentation end-products as a 
substrate in a subsequent photo-fermentative or microbial electrolytic process [41]. 
However, such combined systems have lost the benefits associated with dark fermentation 
(i.e. relatively simple reactor technique, no energy input, high H2 evolution rate, etc.), and 
are therefore to expensive.   
Therefore, It would be desirable to combine the beneficial aspects of dark and photo-
fermentation in one easy to cultivate microorganism. However, as explained, it is very 
unlikely that such an organism has been created by evolution. Nevertheless, the increasing 
number of microbial genomes being sequenced, as well as the increasing availability and 
ever improving quality of genetic tools, might enable us to genetically engineer such an 
organism. Proof of principle that extra substrate oxidation steps can improve H2 yields from 
glucose, has already been shown in vitro. For example, near stoichiometric amounts were 
reached by using enzymatic, cell-free, synthetic pathways [54-56]. Although this so-called 
cell-free synthetic pathway biotransformation (SyPaB) definitely has its advantages [47], it is 
also heavily challenged by for example its constant and costly dependence on replenishment 
of labile enzymes and coenzymes, which would not be needed in an in vivo system. To 
engineer an organism that is able to convert glucose to higher H2 yields than currently 
obtained, it would make sense to start with a hyperthermophilic organism that is already 
able to produce H2 near the natural limit of 4 mole H2/glucose and that is genetically 
accessible, such as Thermococcus kodakarensis. 
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Thermococcus kodakarensis 
General information and description  
Thermococcus kodakarensis is a marine hyperthermophilic, heterotrophic, obligate 
anaerobic archaeon that can grow at temperatures ranging from 60°C to 100°C, with an 
optimum at 85°C. T. kodakarensis can grow on a variety of organic substrates in the 
presence of elemental sulfur, producing hydrogen sulfide (H2S), or when pyruvate or starch 
are present, in the absence of elemental sulfur producing hydrogen gas (H2). Under optimal 
conditions, T. kodakarensis grows rapidly to high cell densities, having an estimated doubling 
time of ~40 minutes. Moreover, it can be grown on solid media, forming defined but small 
colonies [57, 58]. With its genome being fully sequenced [59], its natural competence and 
the establishment of various genetic engineering techniques [60-63], T. kodakarensis rapidly 
became one of the model organisms for studying anaerobic Archaea. 
The type strain T. kodakarensis KOD1 was isolated from a sulfatara (a volcanic area that 
releases hot vapors and sulfurous gases into the environment, 102°C, pH 5.8) on the shore of 
Kodakara Island, Kagoshima, Japan [58]. Its cells are irregular cocci, having a diameter of 1-2 
µm, which are motile due to several polar flagella (Figure 1.2). T. kodakarensis has a single 
ether lipid membrane, consisting of both tetra-ether and di-ether type lipids, and has an 
outer glycoprotein coat which is also known as the S-layer. It has a circular chromosome 
containing a small 2.09 Mb genome, which is 
about half of the average size of microbial 
genomes (4 Mb), and is closely related to 
Pyrococcus spp. [59]. Originally, the strain was 
reported as Pyrococcus sp. KOD1 [58], but was 
later reclassified as a species of the euryarchaeal 
genus Thermococcus, based on its 16S rRNA 
sequence [57]. The members of the genus 
Thermococcus are ubiquitously present in natural 
high-temperature environments, and are 
therefore considered to play a major role in the Figure 1.2 Thermococcus kodakarensis KOD1
(Image by F. Fukuri, Kyoto University)   
 
ecology and metabolic activity of microbial consortia within hot-water ecosystems [64, 65]. 
After its reclassification, the strain was designated Thermococcus kodakar-a-ensis KOD1 sp. 
nov., which was later corrected on validation to Rule 61 of the Bacteriological Code to T. 
kodakarensis KOD1 [66]. 
Energy metabolism and H2 production 
T. kodakarensis is an anaerobic heterotroph that uses environmentally abundant polymers, 
such as peptides, chitin or starch, as its carbon and energy source. The strain grows 
optimally at 85°C, pH 6.5, using sulfur (S0) as a terminal electron acceptor (producing H2S) 
[57, 58]. When growing on proteins and (large) peptides, T. kodakarensis first converts these 
polymers extracellularly to smaller peptides and amino acids which can be taken up by the 
cell. Once inside, the peptides are further degraded to amino acids, which are subsequently 
catabolized via three steps: (i) oxidative deamination of amino acids by glutamate 
dehydrogenase (GDH: Figure 1.3) or aminotransferases, (ii) oxidative decarboxylation by 2-
oxoacid:ferredoxin oxidoreductases (POR, VOR, IOR and OGOR: Figure 1.3), and (iii) 
hydrolysis of acyl-coenzyme A (CoA) by ADP-forming acyl-CoA synthetases (ACS I-III, SCS and 
ICS: Figure 1.3). During this catabolic process, reductant (Fdred and NADPH), ATP and CO2 are 
produced. To keep amino acid oxidation going and to conserve additional energy for growth, 
the generated reductant needs to get re-oxidized, which ultimately results in H2S and some 
H2 (Figure 1.3, box D & F) [67-71]. 
In the absence of S0, T. kodakarensis can grow on pyruvate and starch, using protons (H+) as 
a terminal electron acceptor (producing hydrogen gas (H2)) [57, 58]. Before taken up by the 
cell, starch polymers have to be hydrolyzed extracellularly to malto-oligosaccharides like 
maltodextrin, maltotriose or cyclomaltodextrin, but preferably not to mono- and 
disaccharides as these cannot be taken up by the cell [30, 59, 72]. The extracellular 
hydrolysis of starch is realized by secreting various enzymes that degrade the available 
starch polymers synergistically, such as amylases, pullulanase, amylopullulanase and 
cyclomaltodextrin glucanotransferase [59, 72-76]. Once imported in the cell, these malto-
oligosaccharides are further hydrolyzed intracellularly to either glucose or, via glucose-1-
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phosphate, to glucose-6-phosphate were they enter a modified Embden-Meyerhof (EM) 
pathway (Figure 1.3, box A-C) [59, 76, 77].  
This modified EM pathway for glucose degradation is also present in other Thermococcales 
and differs from the classical EM pathway found in, for example, Escherichia coli in some key 
aspects. For instance, the phosphorylation reactions of glucose and fructose-6-phosphate 
are catalyzed by ADP-dependent glucokinase and phosphofructokinase, respectively, rather 
than by the usual ATP-dependent versions [78-80]. Moreover, the conversion of 
glyceraldehyde-3-phosphate (GAP) to 3-phosphoglycerate (3PGA), normally catalyzed by the 
consecutive action of NAD+-dependent GAP dehydrogenase (GAPDH) and the ATP-
generating phospoglycerate kinase (PGK), is catalyzed by both ferredoxin-dependent 
GAP:ferredoxin oxidoreductase (GAPOR) and NADP+-dependent non-phosphorylating 
glyceraldehyde 3-phosphate dehydrogenase (GAPN), in an irreversible, phosphate-
independent, one-step reaction [77]. This is an important difference as the direct oxidation 
of GAP to 3PGA by GAPOR/GAPN omits ATP production via substrate level phosphorylation 
by PGK. Finally, the last step of glycolysis (i.e. the ATP-generating conversion of 
phosphoenolpyruvate (PEP) to pyruvate), normally catalyzed by ADP-dependent pyruvate 
kinase (PYK), is additionally catalyzed by AMP-dependent phosphoenolpyruvate synthase, 
which in contrast to PYK has been proven to be essential in T. kodakarensis [81]. This PEP 
synthase catalyzed reaction enables the conservation of 2 energetic phosphate bonds 
instead of just 1 in the pyruvate kinase reaction. Thus the PEP synthase reaction 
compensates for the absence of ATP synthesis in GAP oxidation.  
Reduced ferredoxins (Fdred), generated by glycolysis, must be re-oxidized to keep sugar 
oxidation going and conserve energy for growth. Although T. kodakarensis has several 
different options for the regeneration of Fdox from Fdred, the main system used during sugar 
oxidation is the production of H2 by a membrane bound hydrogenase. Part of the generated 
H2 can subsequently be re-consumed by the cell and re-oxidized by a cytosolic or soluble 
hydrogenase to generate NADPH when required (Figure 1.3, box F) [68, 82, 83]. Any excess 
NADPH may be disposed of through alanine production, mediated by glutamate 
 
dehydrogenase and alanine aminotransferase, which has been shown to be a potential 
electron sink (Figure 1.3 box C) [30, 59, 68, 83, 84]. 
T. kodakarensis has previously been described to ferment starch to acetate, CO2 and H2, 
having a H2-production yield of 3.3 mole/mole of hexose [30]. Since this is already relatively 
close to the generally considered upper limit of 4 mole/mole of hexose, it is a good starting 
point for improvement. In addition, its relatively simple (energy) metabolism and the 
availability of a genetic toolbox, might allow for the introduction of additional substrate 
oxidation steps. 
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Thesis Outline  
 
Many substrate oxidation steps result in the generation of NADPH. However, H2 formation 
from reduced pyridine nucleotides (NAD(P)H) is unfavorable as the Gibbs energy under 
standard conditions is positive. Only at relatively high temperatures and at low H2 partial 
pressures, the reaction becomes exergonic [48]. Nevertheless, H2 formation from NAD(P)H is 
possible, which can also be concluded from the H2/hexose ratios found for certain 
(hyper)thermophiles. For instance, Thermoanaerobacter tengcongensis and 
Caldicellulosiruptor saccharolyticus both produce reducing equivalents as NADH and Fdred 
(50/50%), and based on the observed high H2/hexose ratios, both types of electron carrier 
are apparently able to transfer their reducing equivalents to H2 [97, 98]. 
For the direct production of H2 from NADPH, an NADPH-dependent hydrogenase is required. 
Although this sub-class of [NiFe]-hydrogenases is rare [99-101], T. kodakarensis does contain 
such a cytosolic hydrogenase (Figure 1.3, box F (TK2069-2072)). However, this hydrogenase 
is normally utilized for oxidizing H2 to generate NADPH when NADPH levels are low [82, 83], 
but various studies have shown that these [NiFe]-hydrogenases are readily reversible in vitro 
[56, 101-103]. Increasing intracellular NADPH levels by adding additional substrate oxidation 
steps could therefore shift the catalytic direction of the reaction towards H2 evolution. 
Chapter 2 provides an overview of the major canonical and non-canonical reactions involved 
in the production and regeneration of NADPH in prokaryotes and discusses their key 
enzymes. In addition, an overview of how different enzymes have been applied to increase 
NADPH availability and thereby enhance productivity of many biotechnological products is 
provided. 
Chapter 3 builds upon knowledge gained in chapter 2 and describes the introduction of the 
(bacterial) pentose phosphate pathway (PPP) in the hyperthermophilic archaeon T. 
kodakarensis. The PPP is a major NADPH source in many organisms and is able to provide 
additional glucose oxidation steps in T. kodakarensis. Especially, since the species does not 
normally contains a complete version of this pathway. Instead, it relies on the ribulose 
monophosphate pathway for the synthesis of its pentoses (Figure 1.3, box) [91]. Therefore, 
 
to make sure that sugars taken up by the cell are (partially) directed through the introduced 
PPP, the ribulose monophosphate pathway was disrupted simultaneously. Together, these 
metabolic changes may improve the sugar-to-H2 yield by microbial dark fermentation, while 
ensuring sufficient Gibbs energy for ATP synthesis by SLP. The effects of the metabolic 
changes on the growth performance, metabolism, and the fermentation profile of T. 
kodakarensis are evaluated. 
Genomic modifications are generally relatively easily obtained in T. kodakarensis, and are 
therefore routinely applied (e.g [60-62, 71, 81-83, 104-106]). However, while creating the 
strains discussed in chapter 3, some puzzling and contradicting results were observed; it 
appeared that different chromosome versions co-existed within one strain. Although such 
observations may potentially be explained by cross-contamination, the difficulty in obtaining 
homozygous recombinant cultures, as well as the repeated observation of this phenomenon 
among different engineering attempts, suggested that T. kodakarensis may possess multiple 
copies of its chromosome. This prompted us to investigate the chromosome copy number of 
T. kodakarensis KOD1, which is discussed in Chapter 4. 
In Chapter 5, a quest for a glycerol-dialkyl-glycerol tetraether (GDGT) synthase in T. 
kodakarensis is described. As shown in Table 1.1, hyperthermophilic bacteria and archaea 
are better H2 producers than thermophilic or mesophilic ones. In the introduction, it has 
already been explained that this is mainly due to thermodynamic constraints, favoring H2 
production at higher temperatures. Therefore, it is interesting to understand how these 
hyperthermophilic microbes are able to thrive at such high temperatures, so that these 
characteristics might be transferred to other H2 producers as well. Naturally, the main focus 
of how these microbes withstand the perturbations of cellular integrity has been on the 
plasma membrane. Hyperthermophilic archaea have ether lipid membranes (as opposed to 
the bacterial ester lipids ones), which consists of either di-ether type lipids (GDGD), tetra-
ether type lipids (GDGT), or a combination of both [107, 108]. GDGTs especially, are thought 
to confer enhanced thermal stability to the lipid membrane [109]. However, despite two 
alternative biochemical pathways have been proposed, it is currently unclear how GDGTs are 
synthesized and particularly which enzyme(s) catalyze the tail-to-tail condensations between 
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observations may potentially be explained by cross-contamination, the difficulty in obtaining 
homozygous recombinant cultures, as well as the repeated observation of this phenomenon 
among different engineering attempts, suggested that T. kodakarensis may possess multiple 
copies of its chromosome. This prompted us to investigate the chromosome copy number of 
T. kodakarensis KOD1, which is discussed in Chapter 4. 
In Chapter 5, a quest for a glycerol-dialkyl-glycerol tetraether (GDGT) synthase in T. 
kodakarensis is described. As shown in Table 1.1, hyperthermophilic bacteria and archaea 
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already been explained that this is mainly due to thermodynamic constraints, favoring H2 
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isoprenoids [110]. T. kodakarensis offers an unique opportunity to identify this missing link 
in archaeal lipid biosynthesis, as it meets a couple of important criteria; (i) it contains both 
GDGD and GDGT type lipids, (ii) its genome has been sequenced and contains only a 
relatively small number of genes, (iii) the strain can be cultured in a laboratory, and (iv) a 
genetic toolbox is available.     
Finally, Chapter 6 summarizes and discusses the research presented in this thesis and 
concludes with recommendations for future research. 
  
 
  
39949 Spaans, Bas.indd   26 20-05-16   10:55
 isoprenoids [110]. T. kodakarensis offers an unique opportunity to identify this missing link 
in archaeal lipid biosynthesis, as it meets a couple of important criteria; (i) it contains both 
GDGD and GDGT type lipids, (ii) its genome has been sequenced and contains only a 
relatively small number of genes, (iii) the strain can be cultured in a laboratory, and (iv) a 
genetic toolbox is available.     
Finally, Chapter 6 summarizes and discusses the research presented in this thesis and 
concludes with recommendations for future research. 
  
 
  
39949 Spaans, Bas.indd   27 20-05-16   10:55
   
 
Chapter 2 
 
NADPH-generating systems in bacteria 
and archaea 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been published as: 
Spaans, S.K., R.A. Weusthuis, J. van der Oost, S.W.M. Kengen. NADPH-generating systems in bacteria 
and archaea. Frontiers in Microbiology, 2015. 6(742) 
39949 Spaans, Bas.indd   28 20-05-16   10:55
   
 
Chapter 2 
 
NADPH-generating systems in bacteria 
and archaea 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been published as: 
Spaans, S.K., R.A. Weusthuis, J. van der Oost, S.W.M. Kengen. NADPH-generating systems in bacteria 
and archaea. Frontiers in Microbiology, 2015. 6(742) 
Chapter 2
NADPH-generati ng systems 
in bacteria and archaea
39949 Spaans, Bas.indd   29 20-05-16   10:55
30
Chapter 2
 
Abstract 
 
Reduced nicotinamide adenine dinucleotide phosphate (NADPH) is an essential electron 
donor in all organisms. It provides the reducing power that drives numerous anabolic 
reactions, including those responsible for the biosynthesis of all major cell components and 
many products in biotechnology. The efficient synthesis of many of these products, 
however, is limited by the rate of NADPH regeneration. Hence, a thorough understanding of 
the reactions involved in the generation of NADPH is required to increase its turnover 
through rational strain improvement. Traditionally, the main engineering targets for 
increasing NADPH availability have included the dehydrogenase reactions of the oxidative 
pentose phosphate pathway and the isocitrate dehydrogenase step of the tricarboxylic acid 
(TCA) cycle. However, the importance of alternative NADPH-generating reactions has 
recently become evident. In the current review, the major canonical and non-canonical 
reactions involved in the production and regeneration of NADPH in prokaryotes are 
described, and their key enzymes are discussed. In addition, an overview of how different 
enzymes have been applied to increase NADPH availability and thereby enhance productivity 
is provided. 
  
 
Introduction 
 
Reduced nicotinamide adenine dinucleotide phosphate (NADPH) is an essential electron 
donor in all eukaryotes, bacteria, and archaea. Not only is NADPH vital for the generation of 
reactive oxygen species (ROS) [111-114] and the anti-oxidative defense mechanisms of most 
organisms [115-117], most importantly, it is also the driving force of most biosynthetic 
enzymatic reactions, including those responsible for the biosynthesis of all major cell 
components, such as DNA and lipids [115-121]. Owing to this essential role in biosynthesis, 
NADPH availability has been of major interest to industry [122, 123]. Many natural products 
of industrial importance are complex secondary metabolites, the production of which often 
involves NADPH-dependent enzymes. To synthesize such products using purified enzyme 
systems in vitro would require the addition of huge amounts of NADPH in order to sustain 
production. From an industrial point of view, this would be too expensive. Hence, in situ 
NADPH regeneration from its oxidized counterpart (NADP+) is required [124-128].  
Regeneration of NADPH in situ can be achieved by various strategies, including chemical, 
electrochemical, photochemical, and enzyme-based methods [125, 127-131]. NADPH can be 
regenerated enzymatically by complementing the in vitro system with additional enzymatic 
reactions or by using substrate-coupled reaction systems. The latter system employs 
enzymes that use both NADP+ and NADPH and that are able to catalyze the synthesis of the 
desired product from one substrate and cofactor regeneration with another substrate [124, 
130, 132]. However, reduced productivity compared to systems without in situ regeneration 
and problems associated with enzyme stability make these options unattractive.  
Microbial in vivo production systems also provide in situ NADPH regeneration and have 
several advantages when compared to in vitro systems. For example, microbes are able to 
grow on inexpensive renewable feedstocks that provide the organisms with reductant for 
the regeneration of NADPH. They also contain numerous pathways, involving stable and 
highly specific enzymes, thus obviating the need for expensive enzyme purification. In 
addition, our knowledge of natural metabolic pathways is rapidly advancing, allowing for 
rational design towards product formation [122, 123, 133, 134]. Therefore, it is not 
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surprising that microbial conversion is the preferred method for the synthesis of a range of 
products.  
With the possibility of engineering microbial metabolism to facilitate product formation, it 
became clear that NADPH availability remains a major hurdle in the efficient generation of 
many products. These products range from medicinal compounds [133-135] and (essential) 
amino acids [123, 136] to molecules used as biofuels [137-139] and building-blocks for 
biodegradable plastic [140]. Given its involvement in a multitude of crucial biological 
functions and its importance in biosynthesis, NADPH is without question an essential 
molecule. Hence, a key question arises: what are the major NADPH-generating reactions and 
systems?  
Traditionally, the dehydrogenase reactions of the oxidative pentose phosphate pathway 
(oxPPP), the Entner-Doudoroff (ED) pathway, and the isocitrate dehydrogenase step of the 
tricarboxylic acid (TCA) cycle have been considered the major sources of NADPH. However, 
the importance of other NADPH-generating enzymes, such as transhydrogenases, glucose 
dehydrogenases, and non-phosphorylating glyceraldehyde 3-phosphate dehydrogenase 
(GAPN), is becoming clear, indicating that the traditional view is over-simplistic [77, 78, 141]. 
In this review, we describe the major canonical and noncanonical biochemical mechanisms 
that are involved in the production and regeneration of NADPH in prokaryotes and discuss 
the key enzymes involved. We have divided the mechanisms into those that are directly 
coupled to central carbon metabolism and those that are not (Table 2.1). In addition, we 
briefly address how different enzymes have been applied to increase NADPH availability and 
thereby enhance NADPH-dependent biotransformation processes. 
 Ta
bl
e 
2.
1 
O
ve
rv
ie
w
 o
f m
aj
or
 c
an
on
ic
al
 a
nd
 n
on
-c
an
on
ic
al
 N
AD
PH
-g
en
er
at
in
g 
en
zy
m
es
 
 
En
zy
m
e 
EC
:n
um
be
r
Pa
th
w
ay
Ba
ct
er
ia
* 
(%
) 
Ar
ch
ae
a*
 
(%
) 
Ad
di
tio
na
l 
co
fa
ct
or
s 
Ap
pl
ie
d*
*
Δ rG
′m
**
* 
(k
J/
m
ol
) 
N
AD
PH
-g
en
er
at
in
g 
en
zy
m
es
 c
ou
pl
ed
 
to
 c
en
tr
al
 c
ar
bo
n 
m
et
ab
ol
is
m
 
G6
PD
H 
EC
:1
.1
.1
.4
9
ox
PP
P,
 E
D
66
0
n.
a.
ye
s
-2
.3
 ±
 2
.6
6P
GD
H 
EC
:1
.1
.1
.4
4
ox
PP
P
62
27
n.
a.
ye
s
-6
.0
 ±
 6
.3
ID
H 
EC
:1
.1
.1
.4
2
TC
A 
cy
cl
e
82
59
n.
a.
ye
s
-1
0.
7 
± 
6.
3
M
E 
EC
:1
.1
.1
.4
0
An
ap
le
ro
tic
 n
od
e
47
25
n.
a.
no
-3
.1
 ±
 6
.2
GA
PN
 
EC
:1
.2
.1
.9
EM
P
12
31
n.
a.
ye
s
-3
6.
1 
± 
1.
1
N
AD
P+
-G
AP
DH
EC
:1
.2
.1
.1
3
EM
P
n.
d.
n.
d.
n.
a.
ye
s
25
.9
 ±
 1
.0
GD
Hs
 
EC
:1
.1
.1
.4
7,
EC
:1
.1
.1
.1
19
 
M
od
ifi
ed
 E
Ds
18 n.
d.
 
10 n.
d.
 
n.
a.
n.
a.
 
ye
s
-2
.4
 ±
 2
.2
N
AD
PH
-g
en
er
at
in
g 
en
zy
m
es
 n
ot
 
co
up
le
d 
to
 c
en
tr
al
 
ca
rb
on
 m
et
ab
ol
is
m
 
ST
H 
EC
:1
.6
.1
.1
n.
a.
19
0
N
AD
H,
 F
AD
ye
s
1.
0 
± 
0.
7
H+
-T
H 
EC
:1
.6
.1
.2
n.
a.
50
5
N
AD
H
ye
s
1.
0 
± 
0.
7
FN
R 
EC
:1
.1
8.
1.
2
n.
a.
63
29
FA
D 
or
 F
M
N
, F
d r
ed
no
-1
5.
6 
± 
11
.7
SH
 
EC
:1
.1
2.
1.
3
n.
a.
10
6
FA
D 
or
 F
M
N
no
-1
6.
5 
± 
5.
9
N
AD
K 
EC
:2
.7
.1
.2
3
n.
a.
96
98
N
TP
 o
r p
ol
y(
P)
, 
N
AD
+  o
r N
AD
H 
ye
s
n.
a.
 * 
Di
st
rib
ut
io
n 
of
 th
e 
en
zy
m
e 
in
 c
om
pl
et
el
y 
se
qu
en
ce
d 
pr
ok
ar
yo
tic
 g
en
om
es
. A
ll 
av
ai
la
bl
e 
pr
ok
ar
yo
tic
 g
en
om
es
 w
er
e 
do
w
nl
oa
de
d 
to
 E
xc
el
 fr
om
 th
e 
IM
G 
da
ta
ba
se
 o
n 
6/
16
/2
01
5.
 T
he
 a
na
ly
sis
 
in
cl
ud
ed
 o
nl
y 
fin
ish
ed
 g
en
om
es
 (1
98
 a
rc
ha
ea
l a
nd
 3
38
0 
ba
ct
er
ia
l g
en
om
es
) a
nd
 o
nl
y 
on
e 
re
pr
es
en
ta
tiv
e 
ge
no
m
e 
fr
om
 e
ac
h 
ge
nu
s (
83
 a
rc
ha
ea
l a
nd
 6
36
 b
ac
te
ria
l g
en
om
es
), 
to
 c
or
re
ct
 fo
r t
he
 
m
an
y 
dr
af
t g
en
om
es
 a
nd
 fo
r t
he
 m
an
y 
se
qu
en
ce
s i
n 
cl
os
el
y 
re
la
te
d 
ge
no
m
es
, r
es
pe
ct
iv
el
y.
 T
he
 o
bt
ai
ne
d 
di
st
rib
ut
io
n 
is 
m
er
el
y 
an
 in
di
ca
tio
n 
of
 th
e 
tr
ue
 d
ist
rib
ut
io
n 
of
 th
e 
re
sp
ec
tiv
e 
en
zy
m
es
 
am
on
g 
pr
ok
ar
yo
te
s b
ec
au
se
 th
e 
da
ta
ba
se
 is
 in
co
m
pl
et
e 
an
d 
ge
ne
 fu
nc
tio
ns
 a
re
 o
ft
en
 a
ut
om
at
ic
al
ly
 a
nn
ot
at
ed
.  
**
 U
se
 o
f t
he
 e
nz
ym
e 
in
 m
et
ab
ol
ic
 e
ng
in
ee
rin
g 
to
 in
cr
ea
se
 N
AD
PH
 a
va
ila
bi
lit
y 
an
d 
en
ha
nc
e 
bi
ot
ra
ns
fo
rm
at
io
n 
pr
oc
es
se
s.
  
**
* 
Gi
bb
s e
ne
rg
ie
s (
Δ rG
′m )
 c
al
cu
la
te
d 
us
in
g 
th
e 
bi
oc
he
m
ic
al
 th
er
m
od
yn
am
ic
s c
al
cu
la
to
r e
Q
ui
lib
ra
to
r 2
.0
 [3
4-
36
], 
w
hi
ch
 c
al
cu
la
te
s Δ
rG
′m .
 T
hi
s t
er
m
 d
es
cr
ib
es
 th
e 
ch
an
ge
 in
 G
ib
bs
 e
ne
rg
y 
du
e 
to
 
a 
ch
em
ic
al
 re
ac
tio
n 
at
 a
 p
ar
tic
ul
ar
 p
H 
an
d 
io
ni
c 
st
re
ng
th
 (s
ub
sc
rip
t r
), 
us
in
g 
1 
m
M
 c
on
ce
nt
ra
tio
ns
 fo
r a
ll 
re
ac
ta
nt
s (
su
pe
rs
cr
ip
t m
). 
De
fa
ul
t s
et
tin
gs
 (p
H 
7 
an
d 
io
ni
c 
st
re
ng
th
 0
.1
 M
) w
er
e 
us
ed
 
fo
r a
ll 
re
ac
tio
ns
.  
Ab
br
ev
ia
tio
ns
: n
.a
., 
no
t a
pp
lic
ab
le
; n
.d
., 
no
 d
at
a 
av
ai
la
bl
e 
in
 th
e 
IM
G 
da
ta
ba
se
; G
6P
DH
, g
lu
co
se
-6
-p
ho
sp
ha
te
 d
eh
yd
ro
ge
na
se
; 6
PG
DH
, 6
-p
ho
sp
ho
gl
uc
on
at
e 
de
hy
dr
og
en
as
e;
 ID
H,
 is
oc
itr
at
e 
de
hy
dr
og
en
as
e;
 M
E,
 m
al
ic
 e
nz
ym
e;
 G
AP
N
, n
on
-p
ho
sp
ho
ry
la
tin
g 
gl
yc
er
al
de
hy
de
 3
-p
ho
sp
ha
te
 d
eh
yd
ro
ge
na
se
; N
AD
P+
-G
AP
DH
, N
AD
P+
-d
ep
en
de
nt
 p
ho
sp
ho
ry
la
tin
g 
gl
yc
er
al
de
hy
de
 3
-p
ho
sp
ha
te
 
de
hy
dr
og
en
as
e;
 G
DH
, g
lu
co
se
 d
eh
yd
ro
ge
na
se
; S
TH
, e
ne
rg
y-
in
de
pe
nd
en
t s
ol
ub
le
 tr
an
sh
yd
ro
ge
na
se
; H
+ -
TH
, e
ne
rg
y-
de
pe
nd
en
t o
r p
ro
to
n-
tr
an
slo
ca
tin
g,
 m
em
br
an
e-
bo
un
d 
tr
an
sh
yd
ro
ge
na
se
; 
FN
R,
 fe
rr
ed
ox
in
:N
AD
P+
 o
xi
do
re
du
ct
as
e;
 S
H,
 c
yt
os
ol
ic
 N
AD
P+
-r
ed
uc
in
g 
hy
dr
og
en
as
e;
 N
AD
K,
 N
AD
+  k
in
as
e
39949 Spaans, Bas.indd   32 20-05-16   10:55
NADPH-generating systems in bacteria and archaea
33
2
 
surprising that microbial conversion is the preferred method for the synthesis of a range of 
products.  
With the possibility of engineering microbial metabolism to facilitate product formation, it 
became clear that NADPH availability remains a major hurdle in the efficient generation of 
many products. These products range from medicinal compounds [133-135] and (essential) 
amino acids [123, 136] to molecules used as biofuels [137-139] and building-blocks for 
biodegradable plastic [140]. Given its involvement in a multitude of crucial biological 
functions and its importance in biosynthesis, NADPH is without question an essential 
molecule. Hence, a key question arises: what are the major NADPH-generating reactions and 
systems?  
Traditionally, the dehydrogenase reactions of the oxidative pentose phosphate pathway 
(oxPPP), the Entner-Doudoroff (ED) pathway, and the isocitrate dehydrogenase step of the 
tricarboxylic acid (TCA) cycle have been considered the major sources of NADPH. However, 
the importance of other NADPH-generating enzymes, such as transhydrogenases, glucose 
dehydrogenases, and non-phosphorylating glyceraldehyde 3-phosphate dehydrogenase 
(GAPN), is becoming clear, indicating that the traditional view is over-simplistic [77, 78, 141]. 
In this review, we describe the major canonical and noncanonical biochemical mechanisms 
that are involved in the production and regeneration of NADPH in prokaryotes and discuss 
the key enzymes involved. We have divided the mechanisms into those that are directly 
coupled to central carbon metabolism and those that are not (Table 2.1). In addition, we 
briefly address how different enzymes have been applied to increase NADPH availability and 
thereby enhance NADPH-dependent biotransformation processes. 
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Biosynthesis of NADP+ 
 
To maintain a sufficient quantity of NADP+ for the generation of NADPH, NADP+ biosynthesis 
is essential. While the necessity for NADP+ synthesis during cell proliferation is clear, the 
requirement for NADP+ synthesis in non-dividing cells might not be obvious. NADP(H) is 
generally thought of solely as a redox carrier that facilitates the transfer of electrons 
between two redox couples, a role that does not account for the need for constant 
resynthesis. The constant need to resynthesize NADP+ arises from its participation in other 
crucial biological processes [142]. In eukaryotes, for example, NADP+ serves as the substrate 
in the synthesis of nicotinic acid-adenine dinucleotide phosphate (NAADP), an important 
intracellular Ca2+-mobilizing messenger [143-146]. Although NAADP has also been found in 
bacteria [143], its physiological relevance in these organisms remains to be established. 
The enzymes responsible for NADP+ resynthesis, best studied in eukaryotes, mainly include 
NAD(P)+ nucleosidase [147, 148], NADP+ phosphatase, and NADPH phosphatase. The 
enzymes in prokaryotes are less well studied, but similar activities and proteins have been 
found in this domain [149-155]. NADP+ phosphatase and NADPH phosphatase, together with 
NAD(H) kinase, regulate the intracellular balance of NAD(H) and NADP(H) [152]. Like NADPH, 
NADH mainly serves to transfer electrons from one molecule to another. However, unlike 
NADPH, NADH is primarily involved in catabolic reactions [148]. In addition to its redox 
function, NAD+ serves as a substrate for mono- and poly-ADP ribosylation, participates in 
histone deacetylation, and contributes to the production of the signaling molecule cyclic 
ADP-ribose. Most of these reactions have been characterized in eukaryotes, but the 
ribosylation reactions also play a role in toxin production by pathogenic bacteria [155, 156]. 
The consumption of NADP+ is thus connected to the consumption of NAD+ and to the 
regulation of various major biological activities such as DNA repair, gene expression, 
apoptosis, nitrogen fixation, and calcium homeostasis [142, 148, 152, 155, 156].  
Given that the intracellular balance between NAD(H) and NADP(H) is regulated via the 
addition or removal of a phosphate group by NAD(H) kinase or NADP(H) phosphatase, 
respectively, it is clear that the biosynthesis of NAD+ plays a crucial role in the metabolism of 
 
NADP+. Two principal NAD+ biosynthesis pathways have been characterized: 1) the de novo 
pathway and 2) the salvage pathway [157-159]. Both pathways have been reviewed recently 
[148, 155, 160, 161]. In the de novo pathway, NAD+ is generated from quinolinic acid, which 
in prokaryotes is produced from either L-aspartate or L-tryptophan [159, 162, 163]. In the 
salvage pathway, degradation products containing a pyridine ring, namely nicotinic acid and 
nicotinamide, are utilized to regenerate NAD+ (Figure 2.1(a)) [159, 160]. 
A portion of the synthesized NAD+ can be converted into NADP+ by NAD kinase (NADK) 
(Figure 2.1(b)). In the NAD+ synthesis pathways, several variations exist and multiple 
enzymes are involved [161, 164]. In contrast, NADK is the sole enzyme able to generate 
NADP+ de novo. NAD kinase is found in archaea [165], bacteria [166-168], and eukaryotes 
[169, 170]) and has been proven to be essential in prokaryotes [171, 172]. According to the 
literature, only one species not able to synthesize NADP+ from NAD+ has been identified: 
Chlamydia trachomatis [152, 173]. The intracellular parasite appears to lack NADK and hence 
relies completely on the metabolism of its host cell. 
According to Kawai and Murata [152], NADK orthologs can be classified into three types 
according to their substrate specificity: I) NADKs that utilize both ATP and inorganic 
polyphosphate (poly(P)) as a phosphoryl donor and phosphorylate both NAD+ and NADH. 
This type of NADK has been identified in gram-positive bacteria and archaea. II) NADKs that 
utilize ATP but not poly(P) and phosphorylate both NAD+ and NADH. This type has been 
identified in eukaryotes. III) NADKs that utilize ATP but not poly(P) and phosphorylate NAD+ 
but not NADH. The latter type of NADK has been identified in gram-negative bacteria. 
Because of its vital role in NADP+ synthesis, NADK has received much attention since its 
discovery in 1950 [174]. Hence, many papers about its structure, function, and application 
are available, including reviews by Kawai and Murata [152], Shi et al. [175], and Agledal et al. 
[142]. 
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function, NAD+ serves as a substrate for mono- and poly-ADP ribosylation, participates in 
histone deacetylation, and contributes to the production of the signaling molecule cyclic 
ADP-ribose. Most of these reactions have been characterized in eukaryotes, but the 
ribosylation reactions also play a role in toxin production by pathogenic bacteria [155, 156]. 
The consumption of NADP+ is thus connected to the consumption of NAD+ and to the 
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Given that the intracellular balance between NAD(H) and NADP(H) is regulated via the 
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NADP+. Two principal NAD+ biosynthesis pathways have been characterized: 1) the de novo 
pathway and 2) the salvage pathway [157-159]. Both pathways have been reviewed recently 
[148, 155, 160, 161]. In the de novo pathway, NAD+ is generated from quinolinic acid, which 
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A portion of the synthesized NAD+ can be converted into NADP+ by NAD kinase (NADK) 
(Figure 2.1(b)). In the NAD+ synthesis pathways, several variations exist and multiple 
enzymes are involved [161, 164]. In contrast, NADK is the sole enzyme able to generate 
NADP+ de novo. NAD kinase is found in archaea [165], bacteria [166-168], and eukaryotes 
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discovery in 1950 [174]. Hence, many papers about its structure, function, and application 
are available, including reviews by Kawai and Murata [152], Shi et al. [175], and Agledal et al. 
[142]. 
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Figure 2.1 NAD+ and NADP+ biosynthetic pathways in prokaryotes. (a) De novo and salvage pathways for NAD+ 
biosynthesis. (b) NADP+ biosynthesis by NAD kinase. Abbreviations: NaMN, nicotinic acid mononucleotide; 
NaAD, nicotinic acid adenine dinucleotide; NR, nicotinamide riboside; NMN, nicotinamide mononucleotide; 
NAD, nicotinamide adenine dinucleotide; NADP, nicotinamide adenine dinucleotide phosphate; NADK, NAD 
kinase. 
  
 
Redox potential of NADP+/NADPH 
 
The redox potential of NADP+/NADPH at standard physiological conditions is identical to that 
of NAD+/NADH (E0′: -320 mV). However, the function of the cofactors is different. 
NADP+/NADPH is used for anabolic redox reactions, whereas NAD+/NADH is used for 
oxidation reactions. This is possible because NADP+/NADPH is generally maintained in a 
reduced state and NAD+/NADH in an oxidized state [176]. The ratios for the electron carriers 
have been reported, and the values can differ by orders of magnitude, depending on the 
organism and growth conditions. For example, reported NAD+/NADH values range from 3.74 
to 31.3 for bacterial cells [52, 177-179] and reach 1820 for mammalian cells [180], whereas 
NADP+/NADPH values range from 0.017 to 0.95 [52, 177-179]. This indicates that the actual 
redox potential of both redox couples can deviate significantly from the standard potential 
(i.e., generally more negative/positive than -320 mV for (NADP+/NADPH)/(NAD+/NADH), 
respectively). Such deviation affects the Gibbs energy of the NADPH-generating reactions 
and the feasibility of converting NADH into NADPH. To assess the feasibility of various 
NADPH-generating reactions, we calculated the Gibbs energies (ΔrG′m) using the biochemical 
thermodynamics calculator eQuilibrator 2.0 [34-36], setting all reactants at a physiological 
concentration of 1 mM (Table 2.1). However, even under these conditions, several reactions 
appeared to be at equilibrium or slightly endergonic. At NADP+/NADPH ratios lower than 1, 
the reaction becomes even less feasible, indicating that the actual concentration of the 
reaction components must be substantially different for NADPH generation to proceed. 
Systems for NADPH generation 
 
NADP+ synthesized by NADK or generated by NADPH-oxidizing reactions is eventually 
reduced to NADPH. To ensure that the cellular redox balance is maintained in the absence of 
de novo NADP+ synthesis and NADP+ consumption, the catabolic fluxes through the NADPH-
regenerating reactions must be matched to the anabolic demand. However, this is generally 
not the case [181]. In addition, the precise NADPH formation rate depends on fluxes through 
the generating pathways, which in turn vary with different growth conditions [82, 182, 183]. 
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Therefore, prokaryotes must have other network-wide biochemical mechanisms that 
maintain the cellular redox balance [181]. The exact mechanisms are not fully understood 
and are beyond the scope of this review, but papers about the topic are available [117, 181].  
Although numerous reactions reduce NADP+ to NADPH (at least 143 reactions according to 
the MetaCyc database, accessed on 03/30/15), only a few have been thought to contribute 
significantly. However, new studies have demonstrated the importance of other NADPH-
generating reactions. The present review provides a general overview of the known major 
NADPH-generating reactions and discusses the key enzymes involved. We have divided the 
reactions into I) those that are directly coupled to central carbon metabolism and II) those 
that are not (Table 2.1). The enzymes that comprise the first group are the oxPPP enzymes 
glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase; isocitrate 
dehydrogenase of the TCA cycle; malic enzyme; and three enzymes involved in noncanonical 
NADPH-generating reactions: phosphorylating GAP dehydrogenase (NADP+-GAPDH), non-
phosphorylating GAP dehydrogenase (GAPN), and glucose dehydrogenase. The enzymes in 
the second group are transhydrogenases (NADH:NADP+), ferredoxin:NADP+ oxidoreductase, 
hydrogenases (H2:NADP+), and NAD(H) kinase, although the latter is a de novo 
NADP+/NADPH-synthesizing enzyme rather than an NADPH-regenerating enzyme. NAD(H) 
kinase is included because it plays an essential role in NADP+ biosynthesis and the regulation 
of the NAD(H)/NADP(H) balance offers a potential strategy for improving the biosynthesis of 
industrially valuable metabolites. 
NADPH-generating reactions coupled to central carbon metabolism 
Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase 
The oxidative pentose phosphate pathway (oxPPP) enzymes glucose-6-phosphate 
dehydrogenase (G6PDH, EC:1.1.1.49) and 6-phosphogluconate dehydrogenase (6PGDH, 
EC:1.1.1.44) have a central role in metabolism in many microbes (Table 2.1). The enzymes 
are involved in the conversion of glucose-6-phosphate into ribulose-5-phosphate (Figure 
2.2), a precursor of important molecules such as nucleic acids, and are generally considered 
a major source of NADPH. The importance of the oxPPP enzymes as a source of NADPH has 
been demonstrated in various organisms [141, 184, 185]. Flux through these enzymes 
 
reportedly increases when NADPH requirements are high [184, 186-188] and decreases 
when NADPH requirements are low [189, 190]. This is consistent with the anticipated 
anabolic role of the oxPPP as a supplier of pentoses and NADPH for biosynthesis. The key 
enzyme with regard to the control of PPP flux is thought to be G6PDH [191-193]. However, in 
addition to its role in the oxPPP, G6PDH can also participate in the classical phosphorylated 
version of the Entner-Doudoroff (ED) pathway (Figure 2.2). The ED pathway can be 
considered an alternative to the Embden-Meyerhof-Parnas (EMP) glycolytic pathway, 
because both catabolize glucose to pyruvate [94, 194]. The ED pathway is mainly present in 
prokaryotes, although some eukaryotes possess a functional ED pathway as well [195]. A 
generally held view is that the ED pathway is less important than the EMP pathway with 
respect to glucose catabolism. However, Fuhrer et al. have shown that this might be a 
misconception and that the ED pathway might be a major pathway for glucose catabolism 
even in species that possess both pathways [196]. 
 
 
Figure 2.2 NADPH generation by glucose-6-phosphate dehydrogenase (G6PDH) and 6-phosphogluconate 
dehydrogenase (6PGDH). Solid and dashed lines indicate single and lumped reactions, respectively. Pathway 
abbreviations: ED, Entner-Doudoroff pathway (in green); EMP, Embden-Meyerhof-Parnas pathway (in blue); 
PPP, pentose phosphate pathway (oxidative phase in red, non-oxidative phase in yellow).  
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G6PDHs and 6PGDHs have been widely studied with respect to cofactor specificity. Although 
some bacterial G6PDHs and 6PGDHs show dual cofactor specificity [181, 197, 198] or have a 
strong preference for NAD+ [197, 198] or other cofactors such as the flavin derivative F420 
[199], most are NADP+-dependent [181, 200, 201]. In addition, the dual cofactor specificity 
that some G6PDHs show is often observed in vitro under saturated conditions. However, 
physiological in vivo conditions often result in higher specificities for NADP+ [181]. Therefore, 
G6PDHs and 6PGDHs are generally considered to catalyze the following reactions: 
(Eq. 2.1) glucose-6-phosphate + NADP+ → 6-phospho-D-glucono-1,5-lactone + NADPH + 
H+ ΔrG′m = -2.3 ± 2.6 kJ/mol 
and 
(Eq. 2.2) 6-phosphogluconate + NADP+ → ribulose 5-phosphate + CO2 + NADPH + H+
   ΔrG′m = -6.0 ± 6.3 kJ/mol 
Like eukaryotes, some prokaryotes possess multiple G6PDH [198, 202, 203] or 6PGDH 
isozymes [204]. In general, these isozymes are similar, with the same cofactor preferences, 
but exceptions exist. Mycobacterium smegmatis, for example, has two G6PDH isozymes, one 
of which is NADP+-dependent. The other is F420-dependent and does not utilize NAD+ or 
NADP+ [205]. In addition, cell-free extracts of several other Mycobacterium and Nocardia 
species contain both F420-dependent and NADP+-dependent G6PDH activity [199], indicating 
that the genomes of these species likely encode both variants. Similarly, exceptions among 
6PGDH isozymes have been identified. The genome of Bacillus subtilis, for example, encodes 
three functional 6PGDH isozymes; two prefer NAD+, and one prefers NADP+ [204]. As 
discussed by Zamboni et al., the presence of isozymes with different cofactor preferences 
would, in principle, enable NADP+, NAD+, and F420 reduction in the oxPPP to adjust to the 
overall metabolic requirements of the cell [204]. However, the exact functional roles of 
these isozymes remains to be determined. 
The availability of NADPH is of principal importance for various industrially important classes 
of products, including amino acids, proteins, antibiotics, organic acids, and high-value 
metabolites. The apparent relationship between the rate of NADPH generation and actual 
carbon fluxes through the oxPPP suggests that the oxPPP can be a target for metabolic 
 
engineering for overproduction of NADPH. The oxPPP has been engineered to increase the 
NADPH/NADP+ ratio, through overexpression of oxPPP enzymes [136, 206-208] and through 
redirection of the carbon flux from glycolysis to the oxPPP, by disrupting phosphoglucose 
isomerase [133, 140, 209] or phosphofructokinase [210, 211], overexpressing fructose 1,6-
bisphosphatase [212], or introducing glucose dehydrogenase [213]. Both strategies have 
been applied successfully in various prokaryotes, but reduction in growth is a common side 
effect [208, 209, 214]. However, the opposite effect was observed with an archaeal strain 
recently developed in our lab: introduction of the oxPPP increased the hydrogen yield and 
significantly improved the growth rate (unpublished data). 
Although both strategies have been applied successfully in various prokaryotes, they are not 
effective in every organism [215, 216]. Moreover, as mentioned above, G6PDH is a key 
enzyme not only for control of the PPP flux but also for control of the ED pathway. 
Overexpressing G6PDH could therefore affect the flux of both pathways simultaneously. 
However, this is generally not observed. Cells apparently possess the ability to regulate 
fluxes to ensure a network-wide balancing of NADPH supply and demand [181, 217].  
The effects of G6PDH and 6PGDH disruption have also been investigated. The exact effects 
are strongly dependent on the organism, the genetic background of the parent strain, and 
the environmental growth conditions [185, 202, 204, 218-220]. However, in general, G6PDH-
deficient and 6PGDH-deficient prokaryotes exhibit remarkably mild phenotypes. Their 
growth rates are similar to or somewhat lower than those of the parent strain, and they are 
more sensitive to oxidative stress. Flux through the oxPPP and ED pathways is lower in 
G6PDH-deficient strains. To compensate for this and to ensure a sufficient supply of anabolic 
precursors and NADPH, flux rerouting via the EMP pathway and the non-oxPPP is generally 
observed (Figure 2.2). In addition, glucose-grown mutants generally display enhanced TCA 
cycle activity. In contrast, acetate- or pyruvate-grown cells generally display decreased TCA 
cycle activity [182, 220]. Like G6PDH-deficient strains, 6PGDH-deficient strains exhibit a 
strong reduction in oxPPP flux, but not in ED pathway flux. In contrast, prokaryotes with a 
functional ED pathway generally respond to 6PGDH knockout by rerouting through the ED 
pathway and by reversing the direction of the non-oxPPP, slightly increasing the flux through 
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precursors and NADPH, flux rerouting via the EMP pathway and the non-oxPPP is generally 
observed (Figure 2.2). In addition, glucose-grown mutants generally display enhanced TCA 
cycle activity. In contrast, acetate- or pyruvate-grown cells generally display decreased TCA 
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the EMP pathway, and activating malic enzyme [220, 221]. Prokaryotes that lack a functional 
ED pathway display a similar response, but instead of rerouting the flux through the ED 
pathway, they increase flux through the EMP pathway [204]. Thus, in general, prokaryotes 
can compensate for disruption of G6PDH or 6PGDH. 
Isocitrate dehydrogenase  
Isocitrate dehydrogenase (IDH, EC:1.1.1.42) is a component of the TCA cycle that catalyzes 
the decarboxylation of isocitrate to 2-oxoglutarate (also known as α-ketoglutarate), with the 
release of CO2 and NADPH (Figure 2.3). The IDH reaction is important for the generation of 
reducing power. Through the generation of 2-oxoglutarate, the reaction also links nitrogen 
and carbon metabolism and plays an important role in the cellular defense against oxidative 
damage and detoxification of ROS [222-224]. Together with isocitrate lyase, IDH is a 
branching point between the TCA cycle and the glyoxylate shunt (Figure 2.3), a pathway 
needed for growth on non-fermentative carbon sources such as acetate and ethanol. IDH 
activity is important in controlling the metabolic flux between both pathways and is affected 
by various regulatory factors, such as metal ions [225, 226], PEP concentration [227], and 
phosphorylation/dephosphorylation [228, 229]. In addition, IDH is a component of the 
reductive tricarboxylic acid (RTCA) cycle. The RTCA cycle is a CO2 fixation pathway, present in 
some bacteria and archaea, in which four molecules of CO2 are fixed to produce one 
molecule of oxaloacetate [230-232]. Obviously, IDH cannot act as a source of NADPH under 
these conditions. 
In contrast to eukaryotes, prokaryotes are generally thought to possess only NADP+-
dependent IDHs. Although this is true for most prokaryotes, a small but increasing number 
of reports have described bacterial and archaeal NAD+-dependent IDHs, such as the one 
found in Hydrogenobacter thermophilus [233-241]. Moreover, a survey of sequenced 
prokaryotic genomes by Zhu et al. identified nine additional species that likely contain NAD+-
dependent IDHs [242]. However, although the IDH of H. thermophilus was originally 
described as an NAD+-dependent IDH, Aoshima and Igarashi later showed it was not a 
conventional decarboxylating IDH but a novel non-decarboxylating enzyme that catalyzes 
 
the conversion between isocitrate and oxalosuccinate. They therefore proposed that the 
enzyme should not be categorized as an IDH [243]. 
 
 
Figure 2.3 General overview of the TCA cycle and 
anaplerotic node. Solid and dashed arrows represent 
single and lumped enzymatic reactions, respectively. 
Malic enzyme is able to catalyze the decarboxylation 
of malate and OAA. Abbreviations for metabolites 
(normal text) and enzymes (bold text): PEP, 
phosphoenolpyruvate; OAA, oxaloacetate; PEPCK, 
phosphoenolpyruvate carboxykinase; PEPCx, 
phosphoenolpyruvate carboxylase; PCx, pyruvate 
carboxylase; ODx, oxaloacetate decarboxylase; MDH, 
malate dehydrogenase; ME, malic enzyme; ICL, 
isocitrate lyase; IDH, isocitrate dehydrogenase.  
 
 
 
 
 
With the exception of the few NAD+-preferring IDHs, prokaryotic IDHs generally catalyze the 
following decarboxylating reaction: 
(Eq. 2.3) isocitrate + NADP+ → 2-oxoglutarate + CO2 + NADPH + H+   
  ΔrG′m = -10.7 ± 6.3 kJ/mol 
In addition to the cofactor NADP+, IDH also needs divalent cations, particularly Mg2+ or Mn2+. 
Although most IDHs have a strong requirement for either Mg2+ or Mn2+, substitution of other 
divalent cations, or even univalent ions such as Na+, is sometimes possible. However, in most 
cases, this leads to little or no activity [225, 226, 244, 245].  
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the EMP pathway, and activating malic enzyme [220, 221]. Prokaryotes that lack a functional 
ED pathway display a similar response, but instead of rerouting the flux through the ED 
pathway, they increase flux through the EMP pathway [204]. Thus, in general, prokaryotes 
can compensate for disruption of G6PDH or 6PGDH. 
Isocitrate dehydrogenase  
Isocitrate dehydrogenase (IDH, EC:1.1.1.42) is a component of the TCA cycle that catalyzes 
the decarboxylation of isocitrate to 2-oxoglutarate (also known as α-ketoglutarate), with the 
release of CO2 and NADPH (Figure 2.3). The IDH reaction is important for the generation of 
reducing power. Through the generation of 2-oxoglutarate, the reaction also links nitrogen 
and carbon metabolism and plays an important role in the cellular defense against oxidative 
damage and detoxification of ROS [222-224]. Together with isocitrate lyase, IDH is a 
branching point between the TCA cycle and the glyoxylate shunt (Figure 2.3), a pathway 
needed for growth on non-fermentative carbon sources such as acetate and ethanol. IDH 
activity is important in controlling the metabolic flux between both pathways and is affected 
by various regulatory factors, such as metal ions [225, 226], PEP concentration [227], and 
phosphorylation/dephosphorylation [228, 229]. In addition, IDH is a component of the 
reductive tricarboxylic acid (RTCA) cycle. The RTCA cycle is a CO2 fixation pathway, present in 
some bacteria and archaea, in which four molecules of CO2 are fixed to produce one 
molecule of oxaloacetate [230-232]. Obviously, IDH cannot act as a source of NADPH under 
these conditions. 
In contrast to eukaryotes, prokaryotes are generally thought to possess only NADP+-
dependent IDHs. Although this is true for most prokaryotes, a small but increasing number 
of reports have described bacterial and archaeal NAD+-dependent IDHs, such as the one 
found in Hydrogenobacter thermophilus [233-241]. Moreover, a survey of sequenced 
prokaryotic genomes by Zhu et al. identified nine additional species that likely contain NAD+-
dependent IDHs [242]. However, although the IDH of H. thermophilus was originally 
described as an NAD+-dependent IDH, Aoshima and Igarashi later showed it was not a 
conventional decarboxylating IDH but a novel non-decarboxylating enzyme that catalyzes 
 
the conversion between isocitrate and oxalosuccinate. They therefore proposed that the 
enzyme should not be categorized as an IDH [243]. 
 
 
Figure 2.3 General overview of the TCA cycle and 
anaplerotic node. Solid and dashed arrows represent 
single and lumped enzymatic reactions, respectively. 
Malic enzyme is able to catalyze the decarboxylation 
of malate and OAA. Abbreviations for metabolites 
(normal text) and enzymes (bold text): PEP, 
phosphoenolpyruvate; OAA, oxaloacetate; PEPCK, 
phosphoenolpyruvate carboxykinase; PEPCx, 
phosphoenolpyruvate carboxylase; PCx, pyruvate 
carboxylase; ODx, oxaloacetate decarboxylase; MDH, 
malate dehydrogenase; ME, malic enzyme; ICL, 
isocitrate lyase; IDH, isocitrate dehydrogenase.  
 
 
 
 
 
With the exception of the few NAD+-preferring IDHs, prokaryotic IDHs generally catalyze the 
following decarboxylating reaction: 
(Eq. 2.3) isocitrate + NADP+ → 2-oxoglutarate + CO2 + NADPH + H+   
  ΔrG′m = -10.7 ± 6.3 kJ/mol 
In addition to the cofactor NADP+, IDH also needs divalent cations, particularly Mg2+ or Mn2+. 
Although most IDHs have a strong requirement for either Mg2+ or Mn2+, substitution of other 
divalent cations, or even univalent ions such as Na+, is sometimes possible. However, in most 
cases, this leads to little or no activity [225, 226, 244, 245].  
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Like G6PDH and 6PGDH, IDH is an important source of NADPH [141, 218]. In wild-type 
Escherichia coli aerobically grown in chemostats under glucose- or ammonia-limited 
conditions, the IDH reaction was the major producer of NADPH, accounting for more than 
60% of the total NADPH production [218]. Accordingly, overexpression of IDH resulted in a 
31% increase in the production of GDP-L-fucose, whose formation is NADPH-dependent. 
While this is a significant improvement, the biosynthesis of GDP-L-fucose in the IDH 
overexpression strain was not better than that in a G6PDH overexpression strain [246]. This 
suggests that, under the applied conditions, IDH is not a better option than G6PDH for 
NADPH regeneration in biotransformation reactions [122]. The ability of IDH overexpression 
to enhance glutamate formation in Corynebacterium glutamicum has also been tested [247]. 
C. glutamicum secretes glutamate under certain conditions. Because IDH supplies 2-
oxoglutarate, the direct precursor of glutamate, overexpression of IDH was an obvious 
choice. However, overexpression of IDH, even in combination with glutamate 
dehydrogenase, did not enhance glutamate production. 
Disruption of IDH has also been investigated. The exact effects of IDH disruption were 
dependent on the specific conditions and species used, but some general trends were 
apparent [247-251]. First, all IDH mutants investigated were glutamate auxotrophs. Second, 
although glutamate-containing cultivation media sustained the growth of IDH mutants, their 
growth was slower than that of the parental strains. The reduced specific growth rate was 
most likely due to a lower ATP/ADP ratio and a lower NADPH/NADP+ ratio, as shown in an E. 
coli IDH disruption strain grown on glucose under aerobic conditions [249]. Moreover, other 
significant effects observed in the mutant E. coli strain included upregulation of oxPPP 
enzymes and the anaplerotic glyoxylate pathway. Similarly, redirection from the TCA cycle to 
anaplerosis has also been reported for an IDH knockdown of C. glutamicum [248]. However, 
with respect to citrate synthase, contradictory results have been obtained. Kabir and Shimizu 
[249] found upregulation of citrate synthase, but an earlier study of E. coli IDH mutants [252] 
and a study of Rhizobium meliloti [250] found that IDH mutants spontaneously gave rise to 
IDH-citrate synthase double mutants.  
 
Malic enzyme  
The TCA cycle-associated malic enzyme (ME, EC:1.1.1.40) catalyzes the NAD(P)+-dependent 
oxidative decarboxylation of malate to pyruvate (Figure 2.3). Confusingly, malic enzyme is 
also known as “malate dehydrogenase (oxaloacetate-decarboxylating),” while true malate 
dehydrogenases, enzymes that catalyze the non-decarboxylating reaction between malate 
and oxaloacetate (Figure 2.3), are sometimes referred to as malic enzyme. In addition, 
various classes of ME that differ in their preference for NAD+ or NADP+ and in their ability to 
decarboxylate oxaloacetate have also been characterized [253]. Enzymes in the first ME class 
(EC:1.1.1.38) use NAD+ and can decarboxylate oxaloacetate as wells as malate. Enzymes in 
the second class (EC:1.1.1.39) also prefer NAD+, but they are unable to decarboxylate 
oxaloacetate. Enzymes in the third class (EC:1.1.1.40) are NADP+-dependent; they can 
catalyze the decarboxylation of malate and oxaloacetate. Moreover, MEs that do not fit the 
general classification scheme exactly, such as those from the gram-negative bacterium 
Rhizobium meliloti and the hyperthermophilic archaeon Thermococcus kodakarensis, have 
been described as well [86, 254]. The latter, for example, prefers NADP+ but, unlike normal 
NADP+-dependent MEs, is not able to decarboxylate oxaloacetate.  
Although malic enzymes (MEs) are widely distributed amongst prokaryotes (Table 2.1), most 
ME-containing species possess an ME that belongs to the third class [255, 256] and catalyzes 
the following reaction: 
(Eq. 2.4) malate + NADP+ → pyruvate + CO2 + NADPH + H+    
  ΔrG′m = -3.1 ± 6.2 kJ/mol 
However, prokaryotes without an ME or with only an NAD+-dependent ME, such as lactic 
acid bacteria [257-260], or prokaryotes with both NAD+- and NADP+-dependent MEs have 
also been characterized [254-256, 261, 262]. Moreover, Morimoto et al. recently showed 
that directed evolution could easily alter the cofactor preference of an ME from T. 
kodakarensis[263]. Thus, NAD+/NADP+ specificity seems to depend only on a few specific, 
highly conserved residues [86, 255, 264-267].  
All MEs require a divalent cation as a cofactor. Maximum activity is generally observed in the 
presence of Mn2+, followed closely by Mg2+. Divalent cations such as Co2+ and Ni2+ are usually 
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Like G6PDH and 6PGDH, IDH is an important source of NADPH [141, 218]. In wild-type 
Escherichia coli aerobically grown in chemostats under glucose- or ammonia-limited 
conditions, the IDH reaction was the major producer of NADPH, accounting for more than 
60% of the total NADPH production [218]. Accordingly, overexpression of IDH resulted in a 
31% increase in the production of GDP-L-fucose, whose formation is NADPH-dependent. 
While this is a significant improvement, the biosynthesis of GDP-L-fucose in the IDH 
overexpression strain was not better than that in a G6PDH overexpression strain [246]. This 
suggests that, under the applied conditions, IDH is not a better option than G6PDH for 
NADPH regeneration in biotransformation reactions [122]. The ability of IDH overexpression 
to enhance glutamate formation in Corynebacterium glutamicum has also been tested [247]. 
C. glutamicum secretes glutamate under certain conditions. Because IDH supplies 2-
oxoglutarate, the direct precursor of glutamate, overexpression of IDH was an obvious 
choice. However, overexpression of IDH, even in combination with glutamate 
dehydrogenase, did not enhance glutamate production. 
Disruption of IDH has also been investigated. The exact effects of IDH disruption were 
dependent on the specific conditions and species used, but some general trends were 
apparent [247-251]. First, all IDH mutants investigated were glutamate auxotrophs. Second, 
although glutamate-containing cultivation media sustained the growth of IDH mutants, their 
growth was slower than that of the parental strains. The reduced specific growth rate was 
most likely due to a lower ATP/ADP ratio and a lower NADPH/NADP+ ratio, as shown in an E. 
coli IDH disruption strain grown on glucose under aerobic conditions [249]. Moreover, other 
significant effects observed in the mutant E. coli strain included upregulation of oxPPP 
enzymes and the anaplerotic glyoxylate pathway. Similarly, redirection from the TCA cycle to 
anaplerosis has also been reported for an IDH knockdown of C. glutamicum [248]. However, 
with respect to citrate synthase, contradictory results have been obtained. Kabir and Shimizu 
[249] found upregulation of citrate synthase, but an earlier study of E. coli IDH mutants [252] 
and a study of Rhizobium meliloti [250] found that IDH mutants spontaneously gave rise to 
IDH-citrate synthase double mutants.  
 
Malic enzyme  
The TCA cycle-associated malic enzyme (ME, EC:1.1.1.40) catalyzes the NAD(P)+-dependent 
oxidative decarboxylation of malate to pyruvate (Figure 2.3). Confusingly, malic enzyme is 
also known as “malate dehydrogenase (oxaloacetate-decarboxylating),” while true malate 
dehydrogenases, enzymes that catalyze the non-decarboxylating reaction between malate 
and oxaloacetate (Figure 2.3), are sometimes referred to as malic enzyme. In addition, 
various classes of ME that differ in their preference for NAD+ or NADP+ and in their ability to 
decarboxylate oxaloacetate have also been characterized [253]. Enzymes in the first ME class 
(EC:1.1.1.38) use NAD+ and can decarboxylate oxaloacetate as wells as malate. Enzymes in 
the second class (EC:1.1.1.39) also prefer NAD+, but they are unable to decarboxylate 
oxaloacetate. Enzymes in the third class (EC:1.1.1.40) are NADP+-dependent; they can 
catalyze the decarboxylation of malate and oxaloacetate. Moreover, MEs that do not fit the 
general classification scheme exactly, such as those from the gram-negative bacterium 
Rhizobium meliloti and the hyperthermophilic archaeon Thermococcus kodakarensis, have 
been described as well [86, 254]. The latter, for example, prefers NADP+ but, unlike normal 
NADP+-dependent MEs, is not able to decarboxylate oxaloacetate.  
Although malic enzymes (MEs) are widely distributed amongst prokaryotes (Table 2.1), most 
ME-containing species possess an ME that belongs to the third class [255, 256] and catalyzes 
the following reaction: 
(Eq. 2.4) malate + NADP+ → pyruvate + CO2 + NADPH + H+    
  ΔrG′m = -3.1 ± 6.2 kJ/mol 
However, prokaryotes without an ME or with only an NAD+-dependent ME, such as lactic 
acid bacteria [257-260], or prokaryotes with both NAD+- and NADP+-dependent MEs have 
also been characterized [254-256, 261, 262]. Moreover, Morimoto et al. recently showed 
that directed evolution could easily alter the cofactor preference of an ME from T. 
kodakarensis[263]. Thus, NAD+/NADP+ specificity seems to depend only on a few specific, 
highly conserved residues [86, 255, 264-267].  
All MEs require a divalent cation as a cofactor. Maximum activity is generally observed in the 
presence of Mn2+, followed closely by Mg2+. Divalent cations such as Co2+ and Ni2+ are usually 
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only partially able to replace Mn2+, while others such as Ca2+, Cu2+, or Sr2+ cannot replace 
Mn2+ at all [86, 268, 269]. In addition, the MEs of various prokaryotes also require a 
monovalent cation for activity, preferably NH4+ and K+ [258, 268, 270-272]. 
In many aerobic and facultative anaerobic organisms, the TCA cycle-associated ME is part of 
the PEP-pyruvate-oxaloacetate node, also referred to as the anaplerotic node (Figure 2.3). 
This node represents the metabolic link between glycolysis/gluconeogenesis and the TCA 
cycle [256, 273]. As such, ME is involved in the interconversion of C4 and C3 compounds, 
which is important for maintaining the levels of TCA cycle intermediates (anaplerotic 
reactions) and for growth on C4 and C3 compounds and substrates that enter central 
metabolism via acetyl-CoA, such as acetate, fatty acids, and ethanol. Although ME can 
catalyze C3-carboxylation and C4-decarboxylation reactions, it is generally involved in the 
latter (decarboxylation of malate to pyruvate with the concomitant formation of NADPH) 
[254-256, 268, 269]. However, examples of prokaryotic MEs without a preference for either 
[86] and MEs with a preference for the C3-carboxylation reaction have been identified [274]. 
To determine the exact contribution of ME to the cellular NADPH pool, the physiological 
direction and flux through the enzyme needs to be established. However, regulation of the 
carbon flux at the anaplerotic node involves a complex interplay between the enzymes 
involved and depends on the growth conditions and species [183, 275-277]. A detailed 
discussion of this complex regulation is beyond the scope of this review, but comprehensive 
reviews, such as those by Owen et al. [273] and Sauer and Eikmanns [256], are available. 
To understand the physiological role of ME in the metabolism of prokaryotes, the disruption 
of ME and alternative pathways has been studied. The significance of the latter is clearly 
demonstrated by the absence of a detectable phenotype in Campylobacter jejuni and E. coli 
ME disruption strains [278, 279]. The lack of a clear phenotype can be explained by the 
presence of alternative pathways and enzymes, such as the malate dehydrogenase-
phosphoenolpyruvate carboxykinase pathway (mdh-PEPCK) and isocitrate dehydrogenase, 
that can fulfill the pyruvate/PEP and NADPH requirements, respectively (Figure 2.3) [269, 
279-281]. Because of the wide distribution of such alternatives in prokaryotes, it is likely that 
ME gene disruption in other species will yield similar results. Nevertheless, species in which 
 
ME gene disruption yields a phenotype, such as Corynebacterium glutamicum, Bacillus 
subtilis, and various lactic acid bacteria, have been identified [255, 257, 259, 268]. 
Analysis of various disruption strains created to understand the physiological role of ME in 
prokaryotes has shown that it is crucial to take the genetic background of a strain into 
consideration because the exact physiological role of ME differs from species to species 
[259, 278, 279, 282, 283]. Analysis has also shown that the effect of ME disruption can be 
subtle and/or heavily dependent on the cultivation conditions [255, 268]. A C. glutamicum 
ME disruption strain, for example, showed no detectable phenotype during growth on either 
acetate or glucose, but showed significantly modified growth behavior during lactate 
metabolism [268]. Moreover, the physiological role of NAD+- and NADP+-dependent MEs 
appears to be different [255, 257, 259, 261, 269, 282]. Whereas NAD+-dependent MEs 
generally play a role in malate catabolism, NADP+-dependent MEs function either as 
gluconeogenic enzymes, by supplying pyruvate from C4-dicarboxylic acids, or as NADPH-
generating systems needed for various biosynthetic purposes. It is interesting in this respect 
that the concerted action of ME, MDH, and pyruvate carboxylase (PCx) can act as a kind of 
transhydrogenase. The combined action of these enzymes enables the ATP-dependent 
conversion of pyruvate to OAA and malate and back to pyruvate, while converting NADH 
into NADPH (Figure 2.3) [256]. A similar reaction sequence can involve PEP carboxylase 
(PEPCx) instead of pyruvate carboxylase, which also enables conversion of NADH into 
NADPH. This so-called malate shunt was recently described in Clostridium thermocellum 
[284]. 
NAD+- and NADP+-dependent MEs have also been used in metabolic engineering approaches 
to improve specific biotechnological applications. However, to our knowledge, no 
prokaryotic ME has been used to increase intracellular NADPH levels, as has been done in 
the yeast Saccharomyces cerevisiae [285, 286]. Instead, prokaryotic MEs have been 
overexpressed for the formation of C4-dicarboxylic acids from glucose or pyruvate [287-290]. 
These acids are important intermediates in the production of tetrapyrroles [288] and amino 
acids [291], for example, and they can be chemically converted into common intermediates 
in the petrochemical industry. Hence, C4-dicarboxylic acids are important intermediates in 
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only partially able to replace Mn2+, while others such as Ca2+, Cu2+, or Sr2+ cannot replace 
Mn2+ at all [86, 268, 269]. In addition, the MEs of various prokaryotes also require a 
monovalent cation for activity, preferably NH4+ and K+ [258, 268, 270-272]. 
In many aerobic and facultative anaerobic organisms, the TCA cycle-associated ME is part of 
the PEP-pyruvate-oxaloacetate node, also referred to as the anaplerotic node (Figure 2.3). 
This node represents the metabolic link between glycolysis/gluconeogenesis and the TCA 
cycle [256, 273]. As such, ME is involved in the interconversion of C4 and C3 compounds, 
which is important for maintaining the levels of TCA cycle intermediates (anaplerotic 
reactions) and for growth on C4 and C3 compounds and substrates that enter central 
metabolism via acetyl-CoA, such as acetate, fatty acids, and ethanol. Although ME can 
catalyze C3-carboxylation and C4-decarboxylation reactions, it is generally involved in the 
latter (decarboxylation of malate to pyruvate with the concomitant formation of NADPH) 
[254-256, 268, 269]. However, examples of prokaryotic MEs without a preference for either 
[86] and MEs with a preference for the C3-carboxylation reaction have been identified [274]. 
To determine the exact contribution of ME to the cellular NADPH pool, the physiological 
direction and flux through the enzyme needs to be established. However, regulation of the 
carbon flux at the anaplerotic node involves a complex interplay between the enzymes 
involved and depends on the growth conditions and species [183, 275-277]. A detailed 
discussion of this complex regulation is beyond the scope of this review, but comprehensive 
reviews, such as those by Owen et al. [273] and Sauer and Eikmanns [256], are available. 
To understand the physiological role of ME in the metabolism of prokaryotes, the disruption 
of ME and alternative pathways has been studied. The significance of the latter is clearly 
demonstrated by the absence of a detectable phenotype in Campylobacter jejuni and E. coli 
ME disruption strains [278, 279]. The lack of a clear phenotype can be explained by the 
presence of alternative pathways and enzymes, such as the malate dehydrogenase-
phosphoenolpyruvate carboxykinase pathway (mdh-PEPCK) and isocitrate dehydrogenase, 
that can fulfill the pyruvate/PEP and NADPH requirements, respectively (Figure 2.3) [269, 
279-281]. Because of the wide distribution of such alternatives in prokaryotes, it is likely that 
ME gene disruption in other species will yield similar results. Nevertheless, species in which 
 
ME gene disruption yields a phenotype, such as Corynebacterium glutamicum, Bacillus 
subtilis, and various lactic acid bacteria, have been identified [255, 257, 259, 268]. 
Analysis of various disruption strains created to understand the physiological role of ME in 
prokaryotes has shown that it is crucial to take the genetic background of a strain into 
consideration because the exact physiological role of ME differs from species to species 
[259, 278, 279, 282, 283]. Analysis has also shown that the effect of ME disruption can be 
subtle and/or heavily dependent on the cultivation conditions [255, 268]. A C. glutamicum 
ME disruption strain, for example, showed no detectable phenotype during growth on either 
acetate or glucose, but showed significantly modified growth behavior during lactate 
metabolism [268]. Moreover, the physiological role of NAD+- and NADP+-dependent MEs 
appears to be different [255, 257, 259, 261, 269, 282]. Whereas NAD+-dependent MEs 
generally play a role in malate catabolism, NADP+-dependent MEs function either as 
gluconeogenic enzymes, by supplying pyruvate from C4-dicarboxylic acids, or as NADPH-
generating systems needed for various biosynthetic purposes. It is interesting in this respect 
that the concerted action of ME, MDH, and pyruvate carboxylase (PCx) can act as a kind of 
transhydrogenase. The combined action of these enzymes enables the ATP-dependent 
conversion of pyruvate to OAA and malate and back to pyruvate, while converting NADH 
into NADPH (Figure 2.3) [256]. A similar reaction sequence can involve PEP carboxylase 
(PEPCx) instead of pyruvate carboxylase, which also enables conversion of NADH into 
NADPH. This so-called malate shunt was recently described in Clostridium thermocellum 
[284]. 
NAD+- and NADP+-dependent MEs have also been used in metabolic engineering approaches 
to improve specific biotechnological applications. However, to our knowledge, no 
prokaryotic ME has been used to increase intracellular NADPH levels, as has been done in 
the yeast Saccharomyces cerevisiae [285, 286]. Instead, prokaryotic MEs have been 
overexpressed for the formation of C4-dicarboxylic acids from glucose or pyruvate [287-290]. 
These acids are important intermediates in the production of tetrapyrroles [288] and amino 
acids [291], for example, and they can be chemically converted into common intermediates 
in the petrochemical industry. Hence, C4-dicarboxylic acids are important intermediates in 
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the production of commodity chemicals from renewable carbohydrate feedstocks [292, 
293]. However, to produce these acids from glucose or pyruvate, one has to reverse the 
physiological direction of ME. This has been accomplished in different ways [287, 289, 290]. 
NADP+-dependent glyceraldehyde-3-phosphate dehydrogenases  
NADP+-dependent glyceraldehyde-3-phosphate dehydrogenases belong to the aldehyde 
dehydrogenase (ALDH) superfamily, a divergently related group of enzymes widely 
distributed among all three domains of life [294, 295]. Enzymes in this group metabolize a 
broad spectrum of endogenous and exogenous aldehydes, which are oxidized to the 
corresponding carboxylic acid, using NAD+ or NADP+ as a cofactor [296, 297]: 
RCHO (aldehyde) + NADP+ + H2O → RCOOH (acid) + NADPH + H+ 
 
As such, the enzymes play essential roles in processes such as intermediary metabolism and 
detoxification [298, 299]. Although many ALDHs are NADP+-dependent, only the NADP+-
dependent glyceraldehyde-3-phosphate dehydrogenases will be addressed here, because 
these enzymes contribute significantly to NADPH levels in certain prokaryotes. Moreover, 
extensive reviews of the ALDH superfamily are available [294, 295, 300, 301].  
While most glyceraldehyde-3-phosphate dehydrogenases (GAPDH, EC:1.2.1.12) are NAD+-
dependent enzymes responsible for the reversible oxidation of GAP into 1,3-
bisphosphoglycerate (1,3-BPG) as part of the classical EMP pathway, NADP+-dependent 
variants exist as well. In fact, there are two different types of NADP+-dependent GAPDHs, a 
phosphorylating type (NADP+-GAPDH, EC:1.2.1.13), producing 1,3-BPG, and a non-
phosphorylating type (GAPN, EC:1.2.1.9), unidirectionally producing 3-phosphoglycerate (3-
PG) (Figure 2.4). However, the term NADP+-GAPDH is used inconsistently in different studies 
to denote either the phosphorylating or non-phosphorylating type or both types, thus 
generating confusion. 
 
 
Figure 2.4 NADPH generation by GAP 
dehydrogenases. Solid and dashed arrows 
represent single and lumped enzymatic reactions, 
respectively. Abbreviations for metabolites 
(normal text) and enzymes (bold text): GAP, 
glyceraldehyde 3-phosphate; 1,3-BPG, 1,3-
bisphosphoglycerate; 3-PG, 3-phosphoglycerate; 
GAPOR, GAP:ferredoxin oxidoreductase; GAPDH, 
glyceraldehyde-3-phosphate dehydrogenase; 
GAPN, non-phosphorylating GAPDH; PGK, 
phosphoglycerate kinase. 
 
 
 
 
GAPN was originally thought to be present only in photosynthetic eukaryotes [302, 303]. 
However, early reports of GAPN activity in Streptococcus mutans were later confirmed by 
the characterization of the first prokaryotic GAPN [304, 305]. Since then, GAPN has also been 
found in various (hyper)thermophilic archaea, such as Thermococcus kodakarensis, 
Thermoproteus tenax, and Sulfolobus solfataricus [77, 306, 307], and several gram-positive 
bacteria, such as Clostridium acetobutylicum, Streptococcus pyogenes, and Bacillus 
halodurans (Table 2.1) [142, 295, 308-310]. GAPN catalyzes the irreversible, non-
phosphorylating oxidation of GAP to 3-PG with the concurrent reduction of NADP+ to 
NADPH: 
(Eq 2.5)  GAP + NADP+ + H2O → 3-phosphoglycerate + NADPH + H+  
   ΔrG′m = -36.1 ± 1.1 kJ/mol 
In this reaction, 1,3-BPG is not formed, and the oxidation of GAP is not coupled to the 
generation of ATP (Figure 2.4). Such modifications of the classical EMP or ED pathway are 
regularly found in archaea [77, 78, 307, 311, 312]. Interestingly, GAPN has been reported to 
have a key function in the regulation of these modified pathways [306, 307, 313, 314]. 
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to denote either the phosphorylating or non-phosphorylating type or both types, thus 
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GAPN was originally thought to be present only in photosynthetic eukaryotes [302, 303]. 
However, early reports of GAPN activity in Streptococcus mutans were later confirmed by 
the characterization of the first prokaryotic GAPN [304, 305]. Since then, GAPN has also been 
found in various (hyper)thermophilic archaea, such as Thermococcus kodakarensis, 
Thermoproteus tenax, and Sulfolobus solfataricus [77, 306, 307], and several gram-positive 
bacteria, such as Clostridium acetobutylicum, Streptococcus pyogenes, and Bacillus 
halodurans (Table 2.1) [142, 295, 308-310]. GAPN catalyzes the irreversible, non-
phosphorylating oxidation of GAP to 3-PG with the concurrent reduction of NADP+ to 
NADPH: 
(Eq 2.5)  GAP + NADP+ + H2O → 3-phosphoglycerate + NADPH + H+  
   ΔrG′m = -36.1 ± 1.1 kJ/mol 
In this reaction, 1,3-BPG is not formed, and the oxidation of GAP is not coupled to the 
generation of ATP (Figure 2.4). Such modifications of the classical EMP or ED pathway are 
regularly found in archaea [77, 78, 307, 311, 312]. Interestingly, GAPN has been reported to 
have a key function in the regulation of these modified pathways [306, 307, 313, 314]. 
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With the exception of the GAPN in T. tenax, which has a preference for NAD+, prokaryotic 
GAPNs, in general, have a clear preference for NADP+. However, although the GAPN of T. 
tenax was shown to be NAD+-dependent, it was later shown to be allosterically regulated, 
shifting its cofactor preference from NAD+ to NADP+ in the presence of activators such as F6P 
and G1P [314]. Based on sequence similarity, similar allosteric regulation might also exist for 
GAPNs in a number of other hyperthermophiles [314, 315]. Aside from NADP+, GAPNs do not 
require other cofactors or metals.  
While the physiological significance of GAPN might vary between organisms, the enzyme is 
an important and essential source of NADPH in the bacterium S. mutans and the archaeon T. 
kodakarensis, respectively [77, 304, 316]. Moreover, the ability to use GAPN as a source of 
NADPH has been demonstrated in a mutant E. coli strain in which the endogenous NAD+-
dependent glyceraldehyde-3-phosphate dehydrogenase (NAD+-GAPDH) was replaced by the 
GAPN of S. mutans. Transcriptional analysis of this strain revealed upregulation of the 
transhydrogenase and downregulation of the PPP and TCA cycle, which together indicate a 
response to avoid NADPH excess [317]. In addition, GAPN has been used successfully in 
metabolic engineering efforts intended to improve the production of metabolites whose 
biosynthesis depends on NADPH, such as L-lysine or poly-3-hydroxybutyrate, or to decrease 
the formation of undesired by-products such as glycerol in industrial ethanol production 
strains [318-320]. 
In contrast to GAPN, NADP+-GAPDH produces 1,3-BPG. It is therefore more similar to NAD+-
GAPDH (Figure 2.4).  
(Eq. 2.6) GAP + NADP+ + Pi → 1,3-bisphosphoglycerate + NADPH + H+  
   ΔrG′m = 25.9 ± 1.0 kJ/mol  
The generation of 1,3-BPG is an important difference between the reactions catalyzed by 
NADP+-GAPDH and GAPN, because further oxidation of 1,3-BPG to 3-PG generates ATP. 
Moreover, while the oxidation of GAP by NADP+-GAPDH is reversible, the oxidation by GAPN 
is not. Hence, NADP+-GAPDH, in contrast to GAPN, is active in both glycolysis and 
gluconeogenesis. However, in prokaryotes that also contain alternative GAP oxidation 
enzymes, such as NAD+-GAPDH, GAPN, or GAP:ferredoxin oxidoreductase (GAPOR) (Figure 
 
2.4), NADP+-GAPDH is primarily involved in gluconeogenesis and does not appear to play a 
role in generating NADPH [77, 315, 321-324]. 
As with GAPN, the significance of NADP+-GAPDH as a source of NADPH has been 
demonstrated. Overexpression of NADP+-GAPDH or replacement of the native NAD+-GAPDH 
with the NADP-variant improved the yield of NADPH-dependent products such as lycopene, 
ɛ-caprolactone, L-ornithine, or coenzyme Q10 [325-328]. Moreover, metabolic flux analysis of 
the exchange mutant revealed that the oxPPP branch and TCA fluxes were significantly 
reduced, presumably to avoid NADPH excess [327]. In addition, an attempt in C. glutamicum 
to alter the cofactor specificity of native NAD+-GAPDH to NADP+ through protein engineering 
resulted in a 60% increase in lysine production [329]. 
NADP+-dependent glucose dehydrogenase  
Similar to GAPN and GAPDH, other non-canonical NADP+-dependent enzymes, such as 
NADP+-dependent glucose dehydrogenase (NADP+-GDH), might make a larger contribution 
to NADPH generation than previously thought. Glucose dehydrogenases (GDHs, EC:1.1.1.47 
and EC:1.1.1.119) are responsible for the first step of the modified ED pathways found in 
some archaea and bacteria (Table 2.1), i.e., the semiphosphorylated ED, the 
nonphosphorylated ED, and the branched ED pathways (Figure 2.5) [78]. GDHs are 
responsible for a main difference between modified ED pathways and the classical ED 
pathway. GDHs catalyze the direct oxidation of glucose into gluconolactone. In contrast, in 
the classical ED, glucose is phosphorylated before its oxidation into 6-P-gluconolactone [78]. 
(Eq. 2.7) D-glucose + NADP+ → D-glucono-1,5-lactone + NADPH + H+  
  ΔrG′m = -2.4 ± 2.2 kJ/mol 
Two different classes of GDHs are capable of using NADP+ as cofactor: EC:1.1.1.47, which 
shows dual cosubstrate specificity with a preference for NADP+, and EC:1.1.1.119, which is 
strictly dependent on NADP+. GDHs belonging to these groups have been found in extremely 
halophilic and thermoacidophilic archaea, as well as in bacteria such as Bacillus subtilis, 
Bacillus megaterium, and Gluconobacter oxydans [78, 330-332]. 
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pathway. GDHs catalyze the direct oxidation of glucose into gluconolactone. In contrast, in 
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shows dual cosubstrate specificity with a preference for NADP+, and EC:1.1.1.119, which is 
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Figure 2.5 Classical ED pathway compared to modified ED pathways. Solid and dashed arrows represent single 
and lumped enzymatic reactions, respectively. Shown are the classical ED pathway (in black), the 
semiphosphorylated ED pathway (in blue), the nonphosphorylated ED pathway (in red), and the branched ED 
pathway that includes the semi- and nonphosphorylated ED pathways. Only the glucose degradation directions 
are shown. Abbreviated enzymes (in bold text): G6PDH, glucose-6-phosphate dehydrogenase; GAPN, non-
phosphorylating glyceraldehyde-3-phosphate dehydrogenase; GDH, glucose dehydrogenase. 
 
NADP+-GDHs have been used for NADPH regeneration in various production systems, such as 
the in vitro synthesis of poly(3-hydroxybutyrate) or L-leucovorin [333, 334]. In addition, 
NADP+-GDHs are important components of many commercial glucose-sensing assays. As 
such, they have been utilized for blood glucose monitoring [335]. Moreover, NADP+-GDHs 
have also been used as NADPH regenerators in various whole-cell, or in vivo, production 
systems. The GDHs of B. megaterium and B. subtilis, for example, have been expressed in 
several E. coli strains for the synthesis of various products, including indigo, S-sulfoxide, and 
ethyl (R/S)-4-chloro-3-hydroxybutanoate [213, 336-342]. 
 
 
NADPH-generating reactions not coupled to carbon metabolism 
Transhydrogenases  
Pyridine nucleotide transhydrogenase (TH) directly catalyzes the reversible hydride transfer 
between NAD(H) and NADP(H). There are two different isoforms: the energy-independent 
soluble transhydrogenase (STH, EC:1.6.1.1) and the energy-dependent, or proton-
translocating, membrane-bound transhydrogenase (H+-TH, EC:1.6.1.2) (Figure 2.6). Soluble 
transhydrogenases from Gammaproteobacteria such as Escherichia coli, Azotobacter 
vinelandii, Pseudomonas fluorescens, and Pseudomonas aeruginosa have been studied in 
some detail [343-346]. In contrast, proton-translocating, membrane-bound 
transhydrogenases have been investigated extensively, reviewed in [122, 347-352]. They are 
widely distributed in the mitochondria of eukaryotes and in certain bacteria, but are very 
rare in archaea (Table 2.1) [350, 351]. Bacteria with multiple copies of the transhydrogenase 
genes are not uncommon, and some species, particularly among the Enterobacteriaceae, 
contain both isoforms [141].  
The two transhydrogenase isoforms transfer electrons between NAD(H) and NADP(H) in the 
following reaction: 
(Eq. 2.8) NADH + NADP+ ↔ NAD+ + NADPH      
  ΔrG′m = 1.0 ± 0.7 kJ/mol 
However, in contrast to STHs, H+-THs couple the electron transfer reaction to the 
translocation of a proton across the membrane, according to the reaction: 
(Eq. 2.9) H+out + NADH + NADP+ ↔ H+ in + NAD+ + NADPH  
Where “out” and “in” denote the periplasmic space and cytosol, respectively. Although the 
reaction is in principle reversible, the electrochemical proton gradient (Δp) across the 
membrane under most physiological conditions strongly favors NADPH formation [348, 349, 
352, 353]. 
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Figure 2.6 NADPH-generating reactions 
not coupled to carbon metabolism. 
Abbreviated enzymes (in bold): H2-H, 
hydrogen-evolving hydrogenase; SH, 
cytosolic NADP+-reducing hydrogenase; 
NfnAB, electron-bifurcating NADH-
dependent reduced ferredoxin:NADP+ 
oxidoreductase; FNR, ferredoxin:NADP+ 
oxidoreductase; STH, energy-independent 
soluble transhydrogenase; H+-TH, energy-
dependent or proton-translocating, 
membrane-bound transhydrogenase. 
 
 
 
 
Since the discovery of transhydrogenases, there has been much debate about their 
physiological role [176, 352-356]). Given the type of reaction they catalyze, 
transhydrogenases might play an important role in maintaining the redox balance within 
microorganisms. Various studies have shown that several bacterial species require STH for 
growth under metabolic conditions with excess NADPH formation [141, 181, 218, 357, 358]. 
Moreover, mutant bacteria suffering from a disturbed redox balance due to an increased 
NADPH concentration often benefit from the heterologous expression of STH [359-362]. 
These observations support the idea that the physiological role of STH is to convert NADPH 
into NADH to prevent an excess of NADPH [356], a notion that is generally accepted and is 
supported by actual NAD+/NADH and NADP+/NADPH ratios (see above), which indicate that 
the formation of NADPH from NADH will generally require energy input. 
However, Sanchez et al. have reported that the NADPH-requiring production of poly(3-
hydroxybutyrate) in E. coli benefitted from the overexpression of STH [363]. This result is 
contrary to the generally accepted physiological role of STH and suggests that the enzyme 
catalyzes the opposite reaction. Moreover, recent reports have shown that STH is able to 
catalyze the opposite reaction and that overexpression of the enzyme can improve NADPH-
 
dependent production yields [364-367]. Additionally, although STH disruption and 
overexpression mutants often have disturbed or improved redox balances, respectively, 
similar mutants that do not show any effect have also been described [368, 369]. Together, 
these examples show that we have yet to achieve a thorough understanding of the 
physiological role of STH and that its role is strongly dependent on species, culture 
conditions, and genotypes. 
Similarly, the physiological role of H+-TH has been debated in the literature. It has often been 
reported that the H+-TH isoform is a major source of NADPH, needed for the biosynthesis of 
amino acids, for example, or the reduction of glutathione (required to minimize oxidative 
damage caused by free radicals generated in the respiratory chain) [141, 181, 218, 353, 354, 
356, 365, 370, 371]. In E. coli, H+-TH has been shown to provide about 40% of the total 
NADPH during growth on glucose in batch cultures [141]. Moreover, its expression is induced 
when there is demand for NADPH, and it is required for optimal growth on carbon sources 
whose metabolism does not directly generate NADPH [141, 371]. Additionally, Fuhrer and 
Sauer calculated that it is very unlikely, from a thermodynamic point of view, that H+-THs 
catalyze NADPH oxidation. They concluded that the NADP+ reduction catalyzed by H+-THs is 
irreversible under physiological conditions in various bacterial species [181]. Reports such as 
these contribute to the general view that the physiological role of H+-TH is reduction of 
NADP+ at the expense of NADH. However, other reports suggest that H+-TH catalyzes the 
opposite reaction or show that disruption or overexpression has no measurable effect [366, 
368, 369]. 
THs require the cofactors NAD(H) and NADP(H) for activity. In addition, and in contrast to H+-
THs, STHs also require a flavin (flavin adenine dinucleotide, FAD) cofactor [343, 372, 373]. 
THs generally do no required other cofactors or metal ions. In fact, metal ions have even 
been reported to inhibit TH activity [372, 374, 375]. Nevertheless, submillimolar 
concentrations of Ca2+ and Mg2+ have been reported to stimulate the H+-THs of Rhodobacter 
capsulatus and E. coli [376-378]. Similarly, saturating concentrations of Ca2+ have been 
reported to release the phosphate-induced inhibition of the NADP+ reducing reaction and to 
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dependent production yields [364-367]. Additionally, although STH disruption and 
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these contribute to the general view that the physiological role of H+-TH is reduction of 
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THs generally do no required other cofactors or metal ions. In fact, metal ions have even 
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cause full activation of the enzyme in Azotobacter vinelandii and Pseudomonas aeruginosa, 
respectively [379, 380]. 
Because of their ability to generate NADPH, STHs and H+-THs have been overexpressed to 
improve the production yields of NADPH-dependent metabolites. For example, 
overexpression of STH increased NADPH-dependent poly(3-hydroxybutyrate) production by 
82% in an engineered E. coli strain [363]. Moreover, the overexpression of STH in two other 
engineered E. coli strains increased (S)-2-chloropropionate and thymidine production 150% 
and 100%, respectively [366, 367]. Similarly, overexpression of H+-TH has significantly 
improved the yields of various NADPH-dependent products, such as chiral alcohols, 
isobutanol, and 3-hydroxypropionic acid in E. coli [381-384] and L-valine and L-lysine in C. 
glutamicum [187, 385]. 
Ferredoxin:NADP+ oxidoreductase  
Ferredoxin:NADP+ oxidoreductases (FNRs, EC:1.18.1.2) are ubiquitous flavoenzymes (Table 
2.1) that catalyze the reversible transfer of reducing equivalents between the one-electron 
carrier ferredoxin (Fd) and the two-electron carrying NADP(H), according to the following 
reaction (Figure 2.6): 
(Eq. 2.10) 2 Fdred + NADP+ + H+ ↔ 2 Fdox + NADPH     
   ΔrG′m = -15.6 ± 11.7 kJ/mol  
FNRs are present in all three domains of life [83, 386-388]. They are mainly known for their 
essential role in photosynthetic organisms (plants, algae, and cyanobacteria), in which they 
connect the Fdred-generating reactions of photosynthesis to NADPH-requiring carbon 
assimilation [389, 390]. In addition to enabling the flux of electrons from the photosystem 
into other metabolic pathways, FNRs might also avert this efflux of electrons and mediate 
the return of Fd-bound electrons to the plastoquinone pool of the photosynthetic system. By 
doing so, FNRs contribute to the so-called cyclic electron flow, which is essential for 
balancing the ATP/NADPH ratio generated by the photosystems [389, 391-394]. 
In non-photosynthetic tissues and organisms, FNRs participate in the electron transfer chains 
of various other metabolic processes such as nitrogen fixation, sulfate assimilation, 
 
isoprenoid biosynthesis, osmotic and oxidative stress responses, and iron-sulfur cluster 
biogenesis [395-402]. However, in contrast to the FNRs involved in photosynthesis, the 
physiological direction of FNRs involved in these processes is toward the production of Fdred. 
As a result, FNRs are sometimes classified as autotrophic (all photosynthetic FNRs) and 
heterotrophic (all other FNRs) [395], which, from a protein-family point of view, is not 
entirely correct.  
FNRs are generally classified into two phylogenetically and structurally unrelated protein 
families that are subdivided into four subclasses: the plant-type FNRs comprising the 
plastidic-type and bacterial-type subclasses and the glutathione (GR)-type FNRs comprising 
the mitochondrial adrenodoxin reductases (AdR-like) and oxygenase-coupled 
NADH:ferredoxin reductases (ONFR-like) [386, 403-406]. In addition, a third type of FNR has 
been reported, the so-called thioredoxin reductase-like FNR (TRLF), which functions as an 
FNR but has structural homology to NADPH-dependent thioredoxin reductases [388, 407-
410]. Interestingly, a novel type of FNR has recently been reported, the electron-bifurcating 
NADH-dependent reduced ferredoxin:NADP+ oxidoreductase (NfnAB), which couples the 
exergonic reduction of NADP+ with Fdred and the endergonic reduction of NADP+ with NADH 
in a reversible reaction (Eq. 2.11 and Figure 2.6) [411-413]. Genome analyses have revealed 
the NfnAB genes are present in many anaerobic bacteria and archaea [411, 414], a finding 
that might reflect the importance of a postulated NfnAB function: NfnAB and other electron-
bifurcating reactions have been implicated as a third mode of energy conservation, in 
addition to substrate level phosphorylation and electron transport phosphorylation [414].  
(Eq. 2.11) Fdred + NADH + 2 NADP+ + H+ ↔ Fdox + NAD+ + 2 NADPH  
Despite what the names imply, both subdivisions of the plant-type FNRs (plastidic-type and 
bacterial-type) as well as FNRs of the GR-type, TRLF-type, and “NfnAB-type” are found in 
prokaryotes [386, 403, 407]. Unfortunately, the literature does not always make clear the 
class to which an FNR belongs, generating confusion and making it difficult to judge the true 
NADPH-generating potential of FNRs found in different prokaryotes. Nevertheless, under 
normal physiological conditions, it appears that only the plastidic-type FNRs, found in 
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cause full activation of the enzyme in Azotobacter vinelandii and Pseudomonas aeruginosa, 
respectively [379, 380]. 
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engineered E. coli strains increased (S)-2-chloropropionate and thymidine production 150% 
and 100%, respectively [366, 367]. Similarly, overexpression of H+-TH has significantly 
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NADH-dependent reduced ferredoxin:NADP+ oxidoreductase (NfnAB), which couples the 
exergonic reduction of NADP+ with Fdred and the endergonic reduction of NADP+ with NADH 
in a reversible reaction (Eq. 2.11 and Figure 2.6) [411-413]. Genome analyses have revealed 
the NfnAB genes are present in many anaerobic bacteria and archaea [411, 414], a finding 
that might reflect the importance of a postulated NfnAB function: NfnAB and other electron-
bifurcating reactions have been implicated as a third mode of energy conservation, in 
addition to substrate level phosphorylation and electron transport phosphorylation [414].  
(Eq. 2.11) Fdred + NADH + 2 NADP+ + H+ ↔ Fdox + NAD+ + 2 NADPH  
Despite what the names imply, both subdivisions of the plant-type FNRs (plastidic-type and 
bacterial-type) as well as FNRs of the GR-type, TRLF-type, and “NfnAB-type” are found in 
prokaryotes [386, 403, 407]. Unfortunately, the literature does not always make clear the 
class to which an FNR belongs, generating confusion and making it difficult to judge the true 
NADPH-generating potential of FNRs found in different prokaryotes. Nevertheless, under 
normal physiological conditions, it appears that only the plastidic-type FNRs, found in 
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cyanobacteria, for example, and the novel “NfnAB-type” have significant effects on NADPH 
availability in prokaryotes.  
The reaction catalyzed by the different FNR types is in principle reversible, as demonstrated 
by various in vitro studies, as well as by in vivo studies in cyanobacteria and the thermophilic 
bacterium Hydrogenobacter thermophilus TK-6. Cyanobacteria contain a single FNR that is 
responsible for NADP+ reduction in vegetative cells as well as for Fd reduction in heterocysts 
[415]. A similar situation exists in H. thermophilus TK-6, where a single FNR catalyzes either 
the forward or reverse reaction depending on the specific type of Fd involved in the 
reaction. A [4Fe-4S]-containing Fd is involved in the forward (NADP+ reducing) reaction, 
whereas a [2Fe-2S]-containing Fd is involved in the reverse reaction [416]. Such insights 
might facilitate the development of rational engineering approaches aimed at gaining 
directional control of the reaction. Elucidating the reaction mechanisms of various FNR-types 
is a topic of many studies and has been reviewed extensively [395, 403, 404, 406, 417-421]. 
FNRs, in general, contain a noncovalently bound flavin (FAD) cofactor as a prosthetic group, 
but a flavin mononucleotide (FMN)-containing FNR has also been characterized [416]. The 
FAD group can alternate between an oxidized, one-electron-reduced semiquinone and a 
fully reduced hydroquinone state, thereby mediating the reversible electron change 
between the one-electron carrier Fd and the two-electron carrying NADP(H) [404]. The iron-
sulfur-containing Fd can sometimes be substituted by the flavin mononucleotide (FMN)-
containing flavodoxin (under iron-depleted conditions in some bacteria) or, in the case of the 
GR-type FNRs, by the mitochondrial iron-sulfur-containing adrenodoxin [386, 422-424]. 
Moreover, a novel rubrerythrin-like protein, named ferriperoxin (Fpx), has been described 
that exhibits NADPH- and FNR-dependent peroxidase activity in the thermophilic hydrogen-
oxidizing bacterium H. thermophilus [425]. Whereas most FNRs are NADP(H)-dependent, an 
NAD(H)-dependent variant also exists, the ONFR-like subtype of the GR-type FNRs 
(EC:1.18.1.3) [403]. However, because this group of FNRs is not involved in NADPH 
availability, it will not be discussed further in this review. 
 
NADP+-dependent hydrogenase  
Hydrogenases (H2ases) are metalloenzymes that catalyze the reversible oxidation of 
hydrogen gas into two protons and two electrons: 
H2 ↔ 2H+ + 2e-  
H2ases enable organisms to utilize H2 as a source of reducing power or to use protons as 
terminal electron acceptors, generating H2. According to the metal atoms at their active site, 
H2ases can be classified into three types: [NiFe]-H2ases, [FeFe]-H2ases, and [Fe]-H2ases. The 
latter were formerly known as metal-free or iron-sulfur-free H2ases; they are involved in CO2 
reduction with H2 to methane and are only found in methanogenic archaea [101, 426-430]. 
[NiFe]-H2ases are generally responsible for H2 oxidation and are widely distributed among 
both aerobic and anaerobic bacteria and archaea; they have been identified in 28.9% and 
57.8% of the available complete bacterial and archaeal genomes, respectively. [FeFe]-
H2ases, in contrast, are generally responsible for H2 evolution and are only found in 
anaerobic bacteria; they have been identified in 9.8% of the available complete bacterial 
genomes [427]. Alignment of the sequence motifs that coordinate the active site separates 
[NiFe]-H2ases into at least four, and possibly five, functional groups that are, in general, 
consistent with the physiological roles of the enzymes [100, 101, 427, 431]. Thus, H2ases are 
a diverse group of enzymes. They are cytosolic or membrane bound, involved in H2 oxidation 
and/or evolution, and able to use a variety of electron acceptors and donors. It is beyond the 
scope of this review to address all of the different types of H2ases. We will focus on those 
involved in NADPH generation in prokaryotes. For more information about H2ases in general, 
the reader is referred to various excellent reviews, such as those by Vignais and Colbeau 
[101], Shima and Thauer [428] and Peters et al. [427]. 
H2ases that use the cofactor NADP+ as an electron acceptor are not common, but have been 
identified in some bacteria and archaea (Table 2.1). Cytosolic NADP+-reducing hydrogenases 
(EC:1.12.1.3, SH) are present in the sulfate-reducing bacterium Desulfovibrio fructosovorans 
and the hyperthermophilic archaea Pyrococcus furiosus and Thermococcus kodakarensis 
[102, 432-434]. Moreover, cytosolic bidirectional NAD(P)+-H2ases and a membrane-bound 
NAD(P)+-H2ase, known to use both NAD+ and NADP+ as substrates, have been found in 
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cyanobacteria, for example, and the novel “NfnAB-type” have significant effects on NADPH 
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by various in vitro studies, as well as by in vivo studies in cyanobacteria and the thermophilic 
bacterium Hydrogenobacter thermophilus TK-6. Cyanobacteria contain a single FNR that is 
responsible for NADP+ reduction in vegetative cells as well as for Fd reduction in heterocysts 
[415]. A similar situation exists in H. thermophilus TK-6, where a single FNR catalyzes either 
the forward or reverse reaction depending on the specific type of Fd involved in the 
reaction. A [4Fe-4S]-containing Fd is involved in the forward (NADP+ reducing) reaction, 
whereas a [2Fe-2S]-containing Fd is involved in the reverse reaction [416]. Such insights 
might facilitate the development of rational engineering approaches aimed at gaining 
directional control of the reaction. Elucidating the reaction mechanisms of various FNR-types 
is a topic of many studies and has been reviewed extensively [395, 403, 404, 406, 417-421]. 
FNRs, in general, contain a noncovalently bound flavin (FAD) cofactor as a prosthetic group, 
but a flavin mononucleotide (FMN)-containing FNR has also been characterized [416]. The 
FAD group can alternate between an oxidized, one-electron-reduced semiquinone and a 
fully reduced hydroquinone state, thereby mediating the reversible electron change 
between the one-electron carrier Fd and the two-electron carrying NADP(H) [404]. The iron-
sulfur-containing Fd can sometimes be substituted by the flavin mononucleotide (FMN)-
containing flavodoxin (under iron-depleted conditions in some bacteria) or, in the case of the 
GR-type FNRs, by the mitochondrial iron-sulfur-containing adrenodoxin [386, 422-424]. 
Moreover, a novel rubrerythrin-like protein, named ferriperoxin (Fpx), has been described 
that exhibits NADPH- and FNR-dependent peroxidase activity in the thermophilic hydrogen-
oxidizing bacterium H. thermophilus [425]. Whereas most FNRs are NADP(H)-dependent, an 
NAD(H)-dependent variant also exists, the ONFR-like subtype of the GR-type FNRs 
(EC:1.18.1.3) [403]. However, because this group of FNRs is not involved in NADPH 
availability, it will not be discussed further in this review. 
 
NADP+-dependent hydrogenase  
Hydrogenases (H2ases) are metalloenzymes that catalyze the reversible oxidation of 
hydrogen gas into two protons and two electrons: 
H2 ↔ 2H+ + 2e-  
H2ases enable organisms to utilize H2 as a source of reducing power or to use protons as 
terminal electron acceptors, generating H2. According to the metal atoms at their active site, 
H2ases can be classified into three types: [NiFe]-H2ases, [FeFe]-H2ases, and [Fe]-H2ases. The 
latter were formerly known as metal-free or iron-sulfur-free H2ases; they are involved in CO2 
reduction with H2 to methane and are only found in methanogenic archaea [101, 426-430]. 
[NiFe]-H2ases are generally responsible for H2 oxidation and are widely distributed among 
both aerobic and anaerobic bacteria and archaea; they have been identified in 28.9% and 
57.8% of the available complete bacterial and archaeal genomes, respectively. [FeFe]-
H2ases, in contrast, are generally responsible for H2 evolution and are only found in 
anaerobic bacteria; they have been identified in 9.8% of the available complete bacterial 
genomes [427]. Alignment of the sequence motifs that coordinate the active site separates 
[NiFe]-H2ases into at least four, and possibly five, functional groups that are, in general, 
consistent with the physiological roles of the enzymes [100, 101, 427, 431]. Thus, H2ases are 
a diverse group of enzymes. They are cytosolic or membrane bound, involved in H2 oxidation 
and/or evolution, and able to use a variety of electron acceptors and donors. It is beyond the 
scope of this review to address all of the different types of H2ases. We will focus on those 
involved in NADPH generation in prokaryotes. For more information about H2ases in general, 
the reader is referred to various excellent reviews, such as those by Vignais and Colbeau 
[101], Shima and Thauer [428] and Peters et al. [427]. 
H2ases that use the cofactor NADP+ as an electron acceptor are not common, but have been 
identified in some bacteria and archaea (Table 2.1). Cytosolic NADP+-reducing hydrogenases 
(EC:1.12.1.3, SH) are present in the sulfate-reducing bacterium Desulfovibrio fructosovorans 
and the hyperthermophilic archaea Pyrococcus furiosus and Thermococcus kodakarensis 
[102, 432-434]. Moreover, cytosolic bidirectional NAD(P)+-H2ases and a membrane-bound 
NAD(P)+-H2ase, known to use both NAD+ and NADP+ as substrates, have been found in 
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cyanobacteria and Klebsiella pneumonia, respectively [435-437]. Many of these H2ases 
recycle the H2 produced by H2-evolving H2ases by coupling the oxidation of H2 to the 
reduction of NADP+ (Figure 6) [82, 83, 434, 436, 438, 439], according to the following 
reaction: 
(Eq. 2.12) H2 + NADP+ ↔ H+ + NADPH       
  ΔrG′m = -16.5 ± 5.9 kJ/mol 
H2 recycling might have a distinct energetic advantage because the NADP+-reducing H2ase 
could provide reductant in the form of NADPH without interfering with the energy balance 
through electron transport phosphorylation [438]. However, various studies have shown 
that disruption of NADP+-reducing H2ases has minor effects, suggesting that the role of the 
enzymes is not that important for overall growth [82, 83, 438, 440-442].  
Like most H2ases, NADP+-reducing H2ases require metal ions and cofactors for their activity. 
They contain multiple iron-sulfur clusters ([Fe-S]), which are coordinated in the active site by 
carbon monoxide (CO) and cyanide (CN-) groups. Moreover, various H2ases capable of 
reducing NADP+ belong to the [NiFe]-H2ases, making the availability of Ni essential as well 
[102, 103, 427, 443]. In addition, the enzymes have been reported to contain flavin 
cofactors: FAD in the case of T. kodakarensis and P. furiosus [102, 103, 444] and FMN in the 
case of D. fructosovorans [432]. 
The requirement for these different ligands, metals, and cofactors makes the biosynthesis of 
multisubunit H2ases a complex and dynamic process, involving various maturation proteins 
[427, 445-447]. It is thus no surprise that reports about the practical applications of NADP+-
reducing H2ases for NADPH generation are limited. Nevertheless, the potential of these 
enzymes to improve the production yields of NADPH-dependent metabolites has been 
demonstrated. For example, two prochiral model substrates, acetophenone and (2S)-
hydroxy-1-phenyl-propanone, were quantitatively reduced to the corresponding (S)-alcohol 
and (1R,2S)-diol by an NADPH-dependent alcohol dehydrogenase in an in vitro system 
containing H2 and the partially purified NADP+-reducing H2ase of P. furiosus [448]. Although 
in vitro examples like this demonstrate the potential of NADP+-H2ases, expression of 
heterologous [NiFe]-H2ases outside of a closely related host is still challenging [449]. It often 
 
results in an inactive enzyme or activity that is detectable only in vitro [450-452]. 
Nevertheless, successful expression of heterologous [NiFe]-H2ase has been reported [437].  
NAD+ kinase and NADH kinase  
NAD+ kinase (NADK, EC:2.7.1.23) catalyzes the conversion of NAD+ to NADP+. It is the sole 
enzyme leading to de novo NADP+ biosynthesis (Figures 2.1 and 2.6). As such, NADK is 
essential for NADP+ and NADPH availability. Together with NADP+ phosphatase (NADPase), 
which is thought to catalyze the opposite reaction (the conversion of NADP+ to NAD+), NADK 
is crucial for the regulation of the intracellular balance of NAD(H) and NADP(H) [152, 175]. 
Although NADPase activity has been detected in various organisms [453, 454]), to our 
knowledge, no enzyme that functions solely as an NADPase has been isolated to date. 
However, some enzymes that exhibit NADPase activity in addition to another activity have 
been isolated, such as the bifunctional NADP+ phosphatase/NAD+ kinase, discovered in the 
archaeon Methanococcus jannaschii [455, 456]. 
NADK activity was enriched in extracts from the yeast Saccharomyces cerevisiae for the first 
time in 1950 [174] and has since been purified from various organisms [159, 457]. However, 
it was not until 2000 that the gene encoding NADK was identified by Kawai et al. in 
Micrococcus flavus and Mycobacterium tuberculosis H37Rv [167]. Since then, NADKs from 
various organisms have been studied in detail, and although the exact physiological 
functions, related pathways, and regulatory mechanisms have not always clearly been 
elucidated, some reviews of NADK structure, function, and potential applications are 
available [142, 152, 155, 175, 458]. 
NADKs are ubiquitous enzymes (Table 2.1). Homologs, according to literature, can be found 
in almost all eukaryotes and prokaryotes, with the exception of the intracellular parasite 
Chlamydia trachomatis [152, 173, 459]. The discrepancy between the distribution shown in 
Table 2.1 and that described in the literature might reflect the rapidly increasing availability 
of prokaryotic genomes and errors inherent to automated genome annotation [460]. 
Functionally and structurally, NADKs are weakly related to other kinases, suggesting that 
they belong to a kinase superfamily [461]. With the exception of the NADKs of gram-
negative bacteria, the enzymes accept NAD+ and its reduced form, NADH [152]. 
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case of D. fructosovorans [432]. 
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[427, 445-447]. It is thus no surprise that reports about the practical applications of NADP+-
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containing H2 and the partially purified NADP+-reducing H2ase of P. furiosus [448]. Although 
in vitro examples like this demonstrate the potential of NADP+-H2ases, expression of 
heterologous [NiFe]-H2ases outside of a closely related host is still challenging [449]. It often 
 
results in an inactive enzyme or activity that is detectable only in vitro [450-452]. 
Nevertheless, successful expression of heterologous [NiFe]-H2ase has been reported [437].  
NAD+ kinase and NADH kinase  
NAD+ kinase (NADK, EC:2.7.1.23) catalyzes the conversion of NAD+ to NADP+. It is the sole 
enzyme leading to de novo NADP+ biosynthesis (Figures 2.1 and 2.6). As such, NADK is 
essential for NADP+ and NADPH availability. Together with NADP+ phosphatase (NADPase), 
which is thought to catalyze the opposite reaction (the conversion of NADP+ to NAD+), NADK 
is crucial for the regulation of the intracellular balance of NAD(H) and NADP(H) [152, 175]. 
Although NADPase activity has been detected in various organisms [453, 454]), to our 
knowledge, no enzyme that functions solely as an NADPase has been isolated to date. 
However, some enzymes that exhibit NADPase activity in addition to another activity have 
been isolated, such as the bifunctional NADP+ phosphatase/NAD+ kinase, discovered in the 
archaeon Methanococcus jannaschii [455, 456]. 
NADK activity was enriched in extracts from the yeast Saccharomyces cerevisiae for the first 
time in 1950 [174] and has since been purified from various organisms [159, 457]. However, 
it was not until 2000 that the gene encoding NADK was identified by Kawai et al. in 
Micrococcus flavus and Mycobacterium tuberculosis H37Rv [167]. Since then, NADKs from 
various organisms have been studied in detail, and although the exact physiological 
functions, related pathways, and regulatory mechanisms have not always clearly been 
elucidated, some reviews of NADK structure, function, and potential applications are 
available [142, 152, 155, 175, 458]. 
NADKs are ubiquitous enzymes (Table 2.1). Homologs, according to literature, can be found 
in almost all eukaryotes and prokaryotes, with the exception of the intracellular parasite 
Chlamydia trachomatis [152, 173, 459]. The discrepancy between the distribution shown in 
Table 2.1 and that described in the literature might reflect the rapidly increasing availability 
of prokaryotic genomes and errors inherent to automated genome annotation [460]. 
Functionally and structurally, NADKs are weakly related to other kinases, suggesting that 
they belong to a kinase superfamily [461]. With the exception of the NADKs of gram-
negative bacteria, the enzymes accept NAD+ and its reduced form, NADH [152]. 
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Nevertheless, they are generally referred to as NAD+ kinases (EC:2.7.1.23) because they 
usually have a strong preference for the oxidized form. NADKs with a preference for the 
reduced form exist as well (EC:2.7.1.86) [462-464], but have not to our knowledge been 
found in prokaryotes. 
Aside from NAD(H), NADKs also need a phosphoryl donor for catalysis. The preferred 
phosphoryl donor often is a nucleoside triphosphate, particularly ATP, but many bacterial 
and archaeal NADKs can also utilize the ancient inorganic energy carrier poly(P) [165, 167, 
456, 465]. In addition, some bacterial enzymes can utilize ADP or glucose-6-phosphate [466, 
467]. However, the use of glucose-6-phosphate as a phosphoryl donor has not been 
investigated further. Finally, NADKs often also require divalent cations such as Mg2+, Mn2+, 
Zn2+, or Ca2+ for their activity [165-167, 465]. The NADK of Corynebacterium glutamicum, 
however, does not require divalent cations when using ATP as phosphoryl donor, but the 
enzyme is stimulated in their presence. When using poly(P) as phosphoryl donor, divalent 
cations are required for activity [467]. 
According the phosphoryl donor specificity, NADK orthologs are subdivided into several 
types. The classification typically applied divides the NADK orthologs into: I) poly(P)/ATP 
NADKs, which can use poly(P) and ATP as phosphoryl donors and II) ATP NADKs, which are 
specific for ATP [468, 469]. Poly(P)/ATP NADKs have been identified in gram-positive bacteria 
such as Mycobacterium tuberculosis, Micrococcus flatus, and Bacillus subtilis [167, 465] and 
in archaea such as Methanococcus jannaschii and Pyrococcus horikoshii [165, 456]. ATP 
NADKs have been found in gram-negative α- and γ-Proteobacteria such as Sphingomonas sp. 
A1, Salmonella enterica, and E. coli and in eukaryotes [166, 168, 459, 469]. A slightly 
different classification system is sometimes applied, dividing the NADK orthologs into: I) ATP 
NADKs, which are strictly dependent on ATP, II) NTP NADKs, which use ATP in addition to 
other nucleoside triphosphates, and III) poly(P)/NTP NADKs, which use nucleoside 
triphosphates and poly(P) [175]. The existence of these slightly different classification 
systems can make it difficult to ascertain the type of NADK being discussed. However, 
because no strict ATP NADKs (as defined in the latter system) have been identified in 
 
prokaryotes to date, it is not an issue in this review. The reaction catalyzed by NADKs can be 
described as either: 
(Eq. 2.13) NAD+ + nucleoside triphosphate (NTP, preferably ATP) → NADP+ + NDP 
or 
(Eq. 2.14) NAD+ + NTP/poly(P) → NADP+ + NDP/poly(P)n-1 
NADK is the sole enzyme leading to de novo NADP+ biosynthesis. It has a central role in the 
regulation of the NAD(H)/NADP(H) balance because it can directly phosphorylate NADH to 
form NADPH or cooperate with various NADP+ reducing enzymes to form NAD(H)/NADP(H) 
metabolic networks that ultimately convert NADH into NADPH [117, 175, 470]. In view of the 
importance of NADK, it is not surprising that disruption of NADK is lethal in various 
prokaryotes [171, 172, 459, 471-474]. 
Because of its essential role in NADP+ biosynthesis and the regulation of the 
NAD(H)/NADP(H) balance, NADKs have attracted attention as a potential strategy by which 
to improve the biosynthesis of industrially valuable metabolites. Several studies have shown 
that overexpression of NADK-encoding genes can increase the production yields of various 
NADPH-dependent biosynthetic pathways, such as poly(3-hydroxybutyrate) production and 
thymidine production in E. coli [367, 475, 476], lysine and isoleucine production in C. 
glutamicum [467, 477], and arginine production in Corynebacterium crenatum [478]. These 
results suggest that increased NADP+ availability, resulting from NADK overexpression, 
disturbs the intracellular redox balance, subsequently affecting the expression of NADP+-
reducing enzymes [367, 475, 476]. However, a comparable attempt to improve isobutanol 
production in E. coli showed that NADK overexpression alone is not always sufficient and 
that the co-(over)expression of an NADP+ reducing enzyme might be required to increase 
NADPH availability [383]. Similarly, combined overexpression of the NADK gene from E. coli 
and the NADP+-GAPDH gene from Bacillus subtilis in E. coli increased 2-chloropropionic acid 
production yield [328]. In addition to increasing NADPH availability indirectly by 
overexpressing NADK, a more direct approach has also been applied. For example, the 
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production yields of GDP-L-fucose and ε-caprolactone in E. coli were increased by 
introducing the NADH kinase (EC:2.7.1.86) gene from the yeast S. cerevisiae [479]. 
Final remarks and conclusion  
 
NADPH is an essential reducing agent in all organisms. It plays an important role in various 
biological processes and is the driving force behind numerous biosynthetic enzymatic 
reactions of importance to industry. However, efficient NADPH regeneration is often a 
bottleneck that limits the productivity of such biotransformation processes. A thorough 
understanding of the reactions involved in the generation of NADPH is thus essential to 
increase the availability of NADPH and enhance productivity in engineered production 
strains.  
This review has provided an overview of the major canonical NADPH-generating reactions as 
well as recently described NADPH-generating reactions (Table 2.1), and it has summarized 
how these different reactions have been applied to improve NADPH availability. However, 
additional NADPH-generating enzymes, such as gluconate 5-dehydrogenase or the recently 
discovered NADP+-specific electron-bifurcating [FeFe]-hydrogenase might also contribute to 
the overall NADPH supply [480, 481]. Similarly, enzymes generally considered to consume 
NADPH or enzymes newly developed to regenerate NADPH, such as glutamate 
dehydrogenase and F420-dependent NADP+ reductases or phosphite dehydrogenase, 
respectively, can occasionally become important NADPH suppliers [71, 122, 482]. 
Although various NADPH-generating enzymes have been overexpressed successfully, no 
general strategy that guarantees improved NADPH supply exists. Cells usually contain 
various integrated, network-wide, redox balancing systems, such that engineering of 
NADPH-generating pathways can result in unexpected metabolic perturbations. Thus, 
strategies often need to be optimized individually, taking the culture conditions and genetic 
background of the strains into consideration. Future research involving a systems biology 
approach is thus required to improve our understanding of the individual NADPH-generating 
 
enzymes and their effect on various metabolic backgrounds, in order to predict which 
approaches will increase NADPH availability in various biotransformation processes. 
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Abstract 
 
Background: Hydrogen (H2) production by microbial fermentation has attracted widespread 
attention as a promising alternative to fossil fuels. Unfortunately, however, H2 yields are not 
yet economically competitive. Herein, we set out to achieve a proof of principle that H2 
yields can be increased by introduction of heterologous enzymes providing additional 
substrate oxidation steps. In the absence of alternative reduced end products such as 
alanine, the PPP-generated additional reductant was predicted to lead to higher H2 levels. 
Herein, we introduced bacterial-derived Pentose Phosphate Pathway (PPP) genes into the 
genome of the hyperthermophilic archaeon Thermococcus kodakarensis in an attempt to 
add extra reductant-generating steps. To force glucose catabolism through the introduced 
PPP, the endogenous ribulose monophosphate pathway (RuMP) was disrupted 
simultaneously.  
Results: Strain SKS001 and SKS002 were complemented with only the oxidative-PPP (oxPPP) 
enzymes glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase or 
with the entire set of missing PPP enzymes, respectively. In-gel activity staining and 
proteomics confirmed the functional expression of the heterologous genes. Growth and 
fermentation profile analyses showed that introduction of merely the oxPPP enzymes is 
sufficient to replace RuMP as a source of pentose phosphates. H2 production levels were 
significantly higher in both strains, especially in the early exponential phase where a 96% 
and 50% increase in the H2/OD600, and 42% and 33% increase in the H2/acetate ratio was 
observed for strains SKS001 and SKS002, respectively. Moreover, the elevated H2/acetate 
ratios in the early exponential phase suggested that NADPH was responsible for (part of) the 
increase in H2 formation. Unexpectedly, significantly higher growth rates and final OD600-
values were observed for the mutant strains. This could be a result of an increased supply of 
NADPH, but improved growth of the parental strain upon addition of nucleosides and 
proteomics suggested that this could also be due to an enhanced supply of ribulose-5-
phosphate. 
 
Conclusions: Introduction of bacterial PPP genes into the archaeon T. kodakarensis was 
successful and resulted in higher H2 production levels during the early exponential phase. 
Surprisingly, introduction of the PPP also resulted in significantly higher growth rates and 
final OD600-values. Due to the effect on both growth rate and H2 yield, H2 productivity was 
substantially higher in the oxPPP-containing strains. 
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Introduction 
 
Hydrogen (H2) is a commodity chemical, commonly used in various industries as a coolant, 
O2-scavanger or reactant in hydrogenation processes. In addition, hydrogen gas has 
attracted widespread attention as a promising alternative to fossil fuels [16, 18-20, 22]. 
However, in contrast to fossil fuels, H2 is not a primary energy resource but an energy 
carrier, which implies that it must be produced from other energy sources. Unfortunately, 
most of the current techniques for H2 production still rely on fossil fuels in one way or 
another and can hence not be considered sustainable. Therefore, to shift to a more 
sustainable production, H2 must be derived from renewable resources, such as biomass [37-
39].  
Biological H2 (BioH2) can be produced by microbial dark fermentation. However, some major 
known drawbacks of this method are that large amounts of side products, such as acids or 
alcohols, are formed and that H2 production yields are still too low to make the process 
economically competitive [43, 44, 47]. This is primarily due to the fact that BioH2 is a low-
value product, for which costs of feedstock carbohydrates often account for the majority of 
the price of the products [44, 47]. To enhance the economy of the microbial dark 
fermentation, it is necessary to improve the sugar-to-H2 yield.   
Current sugar-to-H2 yields by microbial dark fermentation vary from less than 1 to almost 4 
moles of H2 /mole of hexose consumed [13, 14, 43, 48, 49], the latter corresponding to about 
a third of the theoretical yield of 12 moles. The production of 4 H2/hexose is regarded as the 
upper limit (“Thauer limit”, [51]), of standard metabolisms, and increased yields require 
further oxidation of substrates to CO2. Complete anaerobic oxidation of glucose, however, is 
thermodynamically difficult and is only possible at very low partial H2 pressures [48]. 
Furthermore, dark fermentation has to rely on substrate level phosphorylation (SLP) for its 
energy conservation, and thus requires sufficient free energy for the ATP coupled reactions 
(~70 kJ/mol) [50, 52, 97]. The consequence of the latter is twofold: i) evolution has 
optimized fermentation pathways to produce biomass (ATP) and not H2, i.e. evolution has 
optimized for incomplete anaerobic glucose oxidation, and ii) even if an organism containing 
 
the necessary machinery for complete oxidation of sugars was known, complete oxidation of 
glucose to CO2 would not be energetically valuable as, according to the known metabolic 
pathways, no ATP is obtained by SLP. Nevertheless, bioenergetic analyses show that a sugar-
to-H2 yield of 8 H2/hexose should be possible by microbial dark fermentation as sufficient 
ATP by SLP might be obtained under non-standard conditions, especially at elevated 
temperatures and when partial H2 pressures can be kept low (Table 3.1). 
In this study, we set out to achieve a proof of principle that H2 production yields, in vivo, can 
be increased above the current upper limit of 4 moles/mole of hexose in a single organism. 
To do this, we selected the previously well characterized and genetically accessible archaeon 
Thermococcus kodakarensis [59, 60, 62, 77, 81, 83, 91, 483]. This heterotrophic 
hyperthermophile has an optimal growth temperature of 85°C, and is able to degrade 
environmentally abundant polymers (i.e. starch) to sugars that are oxidized via a modified 
Embden-Meyerhof pathway (Figure 3.1). Reduced ferredoxins (Fdred), generated by 
glycolysis, must be re-oxidized to keep sugar oxidation going and conserve energy for 
growth. Although T. kodakarensis has several different options for the regeneration of Fdox 
from Fdred, the main system used during sugar oxidation is the production of H2 by a 
membrane-bound hydrogenase (MBH). Part of the generated H2 can subsequently be re-
consumed by the cell and re-oxidized by a cytosolic or soluble hydrogenase (Hyh) to 
generate NADPH when required [68, 82, 83]. Any excess NADPH may be disposed of through 
alanine production, mediated by glutamate dehydrogenase (GDH) and alanine amino 
transferase (ALT), which has been shown to be a potential electron sink [30, 59, 68, 83, 84]. 
T. kodakarensis has previously been described to ferment starch to acetate, CO2 and H2, 
having a H2-production yield of 3.3 moles/mole of hexose [30]. Since this is already relatively 
close to the generally considered upper limit of 4 moles/mole of hexose, it is a good starting 
point for improvement. In addition, its relatively simple (energy) metabolism and the 
availability of a genetic toolbox, allow for the introduction of additional oxidation steps 
which can be realized by complementing its incomplete Pentose Phosphate Pathway (PPP) 
[59, 91, 99, 484]. Introducing the missing PPP-enzymes will result in the production of extra 
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NADPH, which may subsequently be converted to Fdred by the action of ferredoxin:NADP 
oxidoreductase (FNR), or act as electron donor for direct H2 formation (Figure 3.1) [99].  
 
Table 3.1 Thermodynamic data of anaerobic glucose oxidation 
1) Glucose + 4 H2O  2 Acetate- + 2 HCO3- + 4 H+ + 4 H2 (H2/acetate = 2) 
2) Glucose + 8 H2O  1 Acetate +  4 HCO3- + 5 H+ + 8 H2 (H2/acetate = 8) 
3) Glucose + 12 H2O  6 HCO3- + 6 H+ + 12 H2   (H2/acetate = ∞) 
Reaction # n ATP by 
SLP* 
Energy required for 
ATP production (KJ) 
ΔG0’ 
(KJ) 
ΔG’ 
(KJ)*** 
ΔG’85°C 
(KJ)*** 
1 4 -280 -207.72 -264.80 -305.25 
2 2 -140 -103.50 -194.82 -264.77 
3 0 n.a.** +0.72 -124.85 -224.29 
 
*= conversion AMP to ATP (PEP to PYR) is counted as 2 ATP, ATP consumption for sugar uptake and ATP 
production as a result of MBH activity not included. **= this reaction is biologically not relevant as no ATP by 
SLP is formed. ***= concentration of substrates and products 10 mM and partial H2 pressure of 10
-1 atm. 
 
H2 formation from reduced pyridine nucleotides is, however, unfavorable as the Gibbs 
energy under standard conditions is positive. Only at relatively high temperatures and at low 
H2 partial pressures does the reaction becomes exergonic [48]. That H2 formation from 
NAD(P)H is possible, in vivo, can also be concluded from the H2/hexose ratios found for 
certain (hyper)thermophiles. For instance, Thermoanaerobacter tengcongensis and 
Caldicellulosiruptor saccharolyticus both produce reducing equivalents as NADH and Fdred 
(50/50%), and based on the observed high H2/hexose ratios, both types of electron carrier 
are apparently able to transfer their reducing equivalents to H2 [97, 98]. 
For the direct production of H2 from NADPH, an NADPH-dependent hydrogenase is required. 
Although this sub-class of [NiFe]-hydrogenases is rare [99-101], T. kodakarensis does contain 
such a cytosolic hydrogenase (Hyh). Although Hyh is normally utilized for oxidizing H2 to 
generate NADPH when NADPH levels are low [82, 83], various studies have shown that these 
[NiFe]-hydrogenases are readily reversible in vitro [56, 101-103]. Increasing the intracellular 
NADPH/NADP+ ratio of T. kodakarensis by introducing the PPP might, therefore, shift the 
catalytic direction of Hyh towards H2 evolution.  
 
Here we present the successful introduction of the PPP in the hyperthermophile T. 
kodakarensis and report the effects hereof on its growth performance, metabolism, 
fermentation profile and H2-yield. 
 
 
Figure 3.1 Simplified overview of metabolism of T. kodakarensis. Solid and dashed arrows represent single 
and lumped enzymatic reactions, respectively. Shown are enzymes naturally present in T. kodakarensis TS559 
(in black), enzymes introduced to create strain SKS001 (in green), and enzymes additionally introduced to 
create strain SKS002 (in orange). Abbreviations for metabolites (normal text) and enzymes (bold text): G6P, 
glucose 6-phosphate; F6P, fructose 6-phosphate; GAP, glyceraldehyde 3-phosphate; 3PGA, 3-
phosphoglycerate; Pyr, pyruvate; Ace, acetate; Ala, alanine; 6PGL, 6-phospho-gluconolactone; 6PG, 6-
phosphogluconate; Ru5P, ribulose 5-phosphate; HCHO, formaldehyde; R5P, ribose 5-phosphate; X5P, xylulose 
5-phosphate; S7P, sedoheptulose 7-phosphate; E4P, erythrose 4-phosphate; PGI, glucose-6-phosphate 
isomerase; GAPOR, glyceraldehyde-3-phosphate:ferredoxin oxidoreductase; GAPN, NADP-dependent 
glyceraldehyde-3-phosphate dehydrogenase; ALT, alanine amino transferase; GDH, glutamate dehydrogenase; 
ATs, amino acid aminotransferases; G6PDH, glucose-6-phosphate dehydrogenase; 6PGLase, 6-phospho-
gluconolactonase; 6PGDH, 6-phospho-gluconate dehydrogenase; HPS-PHI, 3-hexulose-6-phosphate synthase 
(hps) - 6-phospho-3-hexuloisomerase (phi) fusion enzyme; RPI, ribulose-5-phosphate isomerase; Ru5PE, 
ribulose-phosphate 3-epimerase; TK, transketolase; TAL, transaldolase; MBH, membrane-bound hydrogenase; 
Hyh, NADPH-dependent soluble hydrogenase; FNR, ferredoxin:NADP+ oxidoreductase  
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*= conversion AMP to ATP (PEP to PYR) is counted as 2 ATP, ATP consumption for sugar uptake and ATP 
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Here we present the successful introduction of the PPP in the hyperthermophile T. 
kodakarensis and report the effects hereof on its growth performance, metabolism, 
fermentation profile and H2-yield. 
 
 
Figure 3.1 Simplified overview of metabolism of T. kodakarensis. Solid and dashed arrows represent single 
and lumped enzymatic reactions, respectively. Shown are enzymes naturally present in T. kodakarensis TS559 
(in black), enzymes introduced to create strain SKS001 (in green), and enzymes additionally introduced to 
create strain SKS002 (in orange). Abbreviations for metabolites (normal text) and enzymes (bold text): G6P, 
glucose 6-phosphate; F6P, fructose 6-phosphate; GAP, glyceraldehyde 3-phosphate; 3PGA, 3-
phosphoglycerate; Pyr, pyruvate; Ace, acetate; Ala, alanine; 6PGL, 6-phospho-gluconolactone; 6PG, 6-
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gluconolactonase; 6PGDH, 6-phospho-gluconate dehydrogenase; HPS-PHI, 3-hexulose-6-phosphate synthase 
(hps) - 6-phospho-3-hexuloisomerase (phi) fusion enzyme; RPI, ribulose-5-phosphate isomerase; Ru5PE, 
ribulose-phosphate 3-epimerase; TK, transketolase; TAL, transaldolase; MBH, membrane-bound hydrogenase; 
Hyh, NADPH-dependent soluble hydrogenase; FNR, ferredoxin:NADP+ oxidoreductase  
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Results 
Construction of the mutant strains 
The genes needed to complement the missing PPP enzymes were derived from the 
thermophilic bacterium Thermotoga maritima (Table 3.2), which has a similar optimal 
growth temperature as T. kodakarensis [485]. To make sure that sugars taken up by the cell 
are directed through the desired H2-producing pathway, we made use of the capacity of the 
PPP to generate ribulose-5-phosphate (Ru5P). By simultaneously disrupting the Ribulose 
Monophosphate Pathway (RuMP) (Figure 3.2), normally responsible for the synthesis of 
pentoses in T. kodakarensis [91], we forced the organism to use the introduced, bacterial-
derived PPP as a source of pentoses. T. kodakarensis strain TS559 (ΔpyrF; ΔtrpE::pyrF; 
ΔTK0664; ΔTK0149) was chosen as a parent strain to exploit the previously developed 
selection and counter-selection procedure for use in rich media [60, 61, 486]. An important 
feature of this selection and counter-selection procedure is that each strain so constructed 
has not only the desired modification, but also retains the ΔpyrF; ΔtrpE::pyrF; ΔTK0664; 
ΔTK0149 genotype and can hence be used as a parental strain for another round of the 
procedure to construct strains having additional modifications.  
 
Table 3.2 Genes introduced and disrupted in this study 
 
*= JCVI gene annotation, release date 1999/06/01, modified 2014/12/22 
 
Enzyme EC-number Source/host Locus-
tag* 
Strain 
Gene knock-ins     
Glucose-6-phosphate dehydrogenase EC 1.1.1.49 T. maritima TM1155 SKS001 + 
SKS002 
6-phospho-gluconate dehydrogenase EC 1.1.1.44 T. maritima TM0438 SKS001 + 
SKS002 
6-phospho-gluconolactonase EC 3.1.1.31 T. maritima TM1154 SKS002 
Transaldolase EC 2.2.1.2 T. maritima TM0295 SKS002 
Ribulose-5-phosphate 3-epimerase EC 5.1.3.1 T. maritima TM1718 SKS002 
Gene knock-out     
Hexulose-6-phosphate synthase / 
 6-phospho-3-hexuloseisomerase 
EC 4.1.2.43 / 
5.3.1.27 
T. kodakarensis TK0475 SKS001 + 
SKS002 
 
The metabolism of T. kodakarensis (Figure 3.1) suggests that the introduction of only the 
oxidative PPP (oxPPP) enzymes may already be enough to complement the cell with all the 
intermediates associated with the PPP, two different mutant strains were created. The first 
strain, designated SKS001, was created by introducing glucose-6-phosphate dehydrogenase 
(G6PDH) and 6-phosphogluconate dehydrogenase (6PGDH), while simultaneously disrupting 
the RuMP. The oxPPP enzyme 6-phosphogluconolactonase (6PGLase) was not included as it 
was assumed that the labile intermediate 6-phosphogluconolactone, normally converted to 
6-phosphogluconate by 6PGLase, decomposes spontaneously because of the high 
temperature [487-489]. The second strain, designated SKS002, was created by using strain 
SKS001 as the parent and was additionally complemented with the lacking oxPPP enzyme, 
6PGLase, as well as the missing non-oxPPP enzymes ribulose-5-phosphate 3-epimerase 
(Ru5PE) and transaldolase (TAL) (Figure 3.2). This resulted in a T. kodakarensis strain 
containing a complete PPP; to the best of our knowledge, this is the first archaeal strain with 
this metabolic feature. 
Transformants were selected by colony growth on medium lacking agmatine [60, 486]. 
Diagnostic PCRs and sequencing of the PCR fragments were performed to discriminate 
between transformants that were the result of a single homologous recombination 
(resulting in the integration of the entire donor plasmid DNA integrated into the genome of 
T. kodakarensis) and transformants that were the result of two crossover events (resulting in 
the desired intermediate genomes as depicted in Figure 3.2). Representative intermediates, 
resulting from two cross-overs, were confirmed to be sensitive to 6-methyl purine (6MPs), a 
phenotype conferred by the expression of TK0664. Next, precise and markerless deletion of 
the selection and counter-selection cassette was stimulated by plating the transformants on 
plates containing 6MP and agmatine. Genomic DNA of spontaneous 6MP resistant (6MPR) 
clones growing on these plates was analyzed by diagnostic PCR, confirming that the selection 
and counter-selection cassette had been deleted by recombination in the flanking, 
duplicated chromosomal region. Representative clones, having the desired final genome 
orientations (Figure 3.2), were designated T. kodakarensis strain SKS001 (TS559 + 
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ΔTK0475::TM1155, TM0438) and T. kodakarensis strain SKS002 (SKS001 + 
ΔTK1765::TM0295, TM1718, TM1154), respectively. 
The diagnostic PCRs performed showed that during the procedure, most transformants 
growing on media lacking agmatine (designated intermediates) turned out to be the result of 
a single homologous recombination. Moreover, transformants generating desired PCR 
fragments for the first two reactions (see Materials and Methods), suggesting an 
intermediate genotype being the result of two cross-over events and hence the loss of the 
sequence that is normally present in between the two homologous recombinations (hps-phi 
and chiAΔ4 in strains SKS001 and SKS002, respectively), often also generated a 
representative PCR product in the third PCR (Figure S3.1). These confusing results can be 
explained by the recent finding that T. kodakarensis is polyploid (7-19 chromosomes/cell) 
(see chapter 4) [490], which entails that the desired strains are only obtained when the 
modifications are incorporated in all chromosome copies. Nevertheless, repetitive and 
intensive re-plating and screening, eventually led to the desired, homozygous, genotypes for 
both strain SKS001 and strain SKS002. 
As a final diagnostic test, total RNA of both strain SKS001 and SKS002 was isolated and used 
in a Reverse Transcriptase-PCR (RT-PCR) to confirm the presence or absence of transcription 
of the genes of interest. Primers used in PCR were developed so that transcription of a 
particular gene could be monitored by the production of a PCR product of ~300 bp. The 
results shown in Figure 3.2C confirm both the transcription of the introduced codon 
optimized PPP genes as well as the loss of transcription of the hps-phi-gene. The gene coding 
for the α-subunit of the elongation factor-1 complex, puf (TK0308), was used for 
normalization as it is considered (at least under the used conditions) a stably expressed 
housekeeping gene [491].   
 
 
 
 
 
A. 
 
B.               C. 
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Figure 3.2 Schematic diagram of PPP introduction and RuMP disruption in Thermococcus kodakarensis.  
(A) Plasmid pSKS019 was constructed for the simultaneous integration of the oxPPP enzymes glucose-6-
phosphate dehydrogenase (TM1155) and 6-phosphogluconate dehydrogenase (TM10438), and the disruption 
of the RuMP (TK0475). It was constructed, as illustrated, with the PCR-amplified regions of the T. kodakarensis 
genome flanking the [TM1155; TM0438-TK0664; TK0149] expression cassette and used to transform T. 
kodakarensis TS559 (ΔpyrF; ΔtrpE::pyrF; ΔTK0664; ΔTK0149). The genome organization of transformants 
(intermediate strain), selected by growth in the absence of agmatine, was confirmed by diagnostic PCR (data 
not shown). A verified intermediate strain was strain was plated on a medium containing 6MP, and 6MPR 
clones were isolated. A second round of diagnostic PCRs confirmed the deletion of the selection cassette 
(TK0664; TK0149) as well as the desired final genome organization (TS559 + ΔTK0475::TM1155, TM0438). The 
verified clone was designated T. kodakarensis SKS001.  
(B) Plasmid pSKS022 was constructed, as illustrated, with the PCR-amplified regions of the T. kodakarensis 
genome flanking the [TM0295; TM1718; TM1154 - TK0664; TK0149] expression cassette and used to transform 
T. kodakarensis SKS001. Selection and verification was performed as described above. A clone having the 
desired final genome organization (SKS001 + ΔTK1765::TM0295, TM1718, TM1154) was designated T. 
kodakarensis SKS002.  
(C) RT-PCR analysis on total RNA isolated from strain TS559, SKS001 and SKS002, confirming the desired 
integrations and disruption. Total RNA from the aforementioned strains was isolated and exposed to a DNase I 
treatment to remove any traces of isolated chromosomal DNA. cDNA was created via a reverse transcriptase 
reaction and subsequently used as template in a diagnostic PCR to confirm expression of the introduced TM-
genes as well as loss of expression of the RuMP. All RT-PCR products had the appropriate size on SYBR safe 
stained agarose gels. The housekeeping gene for elongation factor 1-α was used for normalization.  
Abbreviations: T8, synthetic transcription terminator; PhpyA1, histone gene hpyA1 promoter from Pyrococcus 
furiosus [492]; Pgdh, glutamate dehydrogenase promoter [493]; Pcsg, cell surface glycoprotein promoter [106]; 
KO, knockout; KI, knock-in; RT, Reverse transcriptase; HPS-PHI, 3-hexulose-6-phosphate synthase (hps)  -  6-
phospho-3-hexuloisomerase (phi) fusion enzyme; G6PDH, glucose-6-phosphate dehydrogenase; 6PGDH, 6-
phospho-gluconate dehydrogenase; 6PGLase, 6-phospho-gluconolactonase; TAL, transaldolase; Ru5PE, 
ribulose-phosphate 3-epimerase; EF-1α, elongation factor 1-α. “+”, RT present; “-“, RT absent 
 
  
 
Confirmation of enzyme activity  
To confirm that the genes introduced into T. kodakarensis to generate strains SKS001 and 
SKS002 are functionally expressed, various bulk assays were performed. We initially 
attempted to monitor enzyme activities using cell extracts of both the mutant strains, the 
parental strain TS559 (negative control) and Thermotoga maritima MSB8 (positive control). 
The activities of G6PDH and 6PGDH are traditionally monitored by following NADPH 
production spectrophotometrically, but our assays employing total cell extracts were then 
subject to the competing activities of the strong NADPH-oxidase activity observed in the 
controls [494]. In an attempt to circumvent these competing activities, the G6PDH and 
6PGDH activity assays were repeated anaerobically such that NADPH-oxidase activity was 
now severely hampered by the lack of oxygen. Unfortunately strong NADPH converting 
background activities also made these attempts inconclusive. Similarly, the coupled 
anaerobic enzyme assays used to test the functionality of the TAL and Ru5PE, were not 
successful.  
To minimize the interfering background activities, the cell extracts were analyzed by an in-
gel activity assay. The benefit of this method is that the soluble dehydrogenases are 
separated from interfering NADPH oxidases and that functional enzymes can be visualized 
very specifically by using nitro blue tetrazolium (NBT) as a final electron acceptor. Cell 
extracts of the mutant strain SKS001, the parental strain TS559 (negative control) and T. 
maritima MSB8 (positive control), were loaded and resolved on a native polyacrylamide gel, 
which was then used for the in-gel activity assay. The results obtained showed clear, single 
bands for the lanes containing cell extract of the mutant strain SKS001 or cell extract of T. 
maritima MSB8, but not for the lanes containing cell extract of the parental strain TS559. 
Moreover, control gels loaded with the same cell extracts placed in similar activity buffers, 
but without the addition of either glucose-6-phosphate (G6P) or 6-phospho-gluconate (6PG) 
showed no bands (Figure S3.2). Together, these results confirm the functionality of G6PDH 
and 6PGDH when introduced into T. kodakarensis. 
Finally, a growth assay on plates containing minimal medium, ASW-AA, supplemented with 
agmatine but without nucleosides, was performed. A previous study demonstrated that the 
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ribulose monophosphate pathway (RuMP) is the only relevant pathway for the biosynthesis 
of Ru5P in T. kodakarensis and that a hps-phi deletion mutant did not exhibit any growth in 
minimal medium, while growth could be recovered by the addition of nucleosides to the 
medium [91]. The hps-phi deletion mutants created in this study, however, were predicted 
to grow on minimal medium as the introduction of the oxPPP should provide an alternative 
route for Ru5P biosynthesis. Moreover, the presence of a complete PPP in the mutant strain 
SKS002 may even result in better growth results than those of SKS001. To test this, growth of 
the mutant strains, SKS001 and SKS002, on ASW-AA plates was compared to that of the 
previous constructed hps-phi deletion mutant, Δhps-phi 7A, as well as to that of the wild-
type strain KOD1. As expected, no colonies formed on the ASW-AA plates containing the 
Δhps-phi 7A strain, while the ones containing the wild-type strain KOD1 showed many. The 
plates containing the mutant strains SKS001 and SKS002 also showed many colonies, 
indicating that the oxPPP is functionally expressed in both strains and that the presence of 
6PGLase is indeed not required. Unfortunately, the functionality of TAL and Ru5PE remained 
unclear, as no difference in growth performance between the two mutant strains created in 
this study (SKS001 and SKS002) was observed. However, functional expression of TAL and 
Ru5PE may not necessarily result in better growth, as all intermediates for anabolism can 
already be synthesized by SKS001. 
Growth and fermentation data 
The consequences of the modifications made to generate strains SKS001 and SKS002 on 
growth and alanine, acetate, CO2 and H2 production were measured and compared to the 
parental strain TS559 for cells growing in media containing artificial seawater (ASW) salts, 
yeast extract and tryptone (YT), and modified potato starch (SA2) (Figure 3.3). For each 
strain, a series of pre-cultures was prepared to allow the strains to fully adapt to the carbon 
source. Data was collected from multiple independent cultures for each strain, and 
remarkably, growth of the mutant strains SKS001 and SKS002, measured by the increase in 
OD600 in time, was significantly faster than that of the parental strain TS559 (Figure 3.3A). 
Growth rates obtained were 0.24 ± 0.011 h-1, 0.19 ± 0.009 h-1 and 0.14 ± 0.008 h-1 for 
SKS001, SKS002 and TS559, respectively (Figure S3.3). Final OD600-values reached by the 
 
mutants were also significantly higher than those of the parental strain. Growth of both the 
mutant strains and the parental strain collapsed after ~18-20 h and ~33 h, respectively. 
Together, these observations show that the growth characteristics of the mutant strains 
were severely affected by the genetic modifications. To test whether the difference in 
growth rate was caused by a limited availability of nucleosides, growth of the parental strain 
TS559 in the absence and presence of nucleosides was compared. We applied nucleosides 
instead of nucleotides, since the phosphate group may hamper transport over the 
membrane [91]. Although growth of the cultures was initially very similar, the ones 
supplemented with nucleosides eventually approached the growth rates observed for the 
mutants, whereas the ones without nucleosides did not (Figure S3.4). 
The production of the fermentation end-products alanine, acetate, CO2 and H2 by the three 
strains was simultaneously monitored to investigate their fermentation characteristics. As 
for the OD600 measurements, samples were taken at regular intervals throughout the 
experiment for each of the  replicates for every strain. Average production values 
(concentration of the product at a certain time point minus the concentration of that 
product at time point zero) were determined for each time point (Figure 3.3B). Similar to the 
OD600 values, the results obtained show that the absolute production of acetate, alanine, 
CO2 and H2 was significantly higher in the mutant strains than in the parental strain (Figure 
3B). Although these higher product levels may be simply a result of the higher OD600 levels, 
calculation of the specific total reductant production (total reductant production/OD600) 
suggests they are not. For example, a 109% and 63% increase in the specific total reductant 
production was obtained in the early exponential phase for strains SKS001 and SKS002, 
respectively (Figure 3.4A). Similarly, a 96% and 50% increase in the specific H2 production 
(H2/OD600) was obtained (Figure 3.4B). For a complete time course of the H2/OD600 ratio see 
Figure S3.5A/B. 
To further investigate the differences in the fermentation characteristics of the strains, it 
was decided to compare the various fermentation end-product ratios. Preferably, the end-
products should have been normalized to the amount of hexose that is converted, but the 
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The production of the fermentation end-products alanine, acetate, CO2 and H2 by the three 
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product at time point zero) were determined for each time point (Figure 3.3B). Similar to the 
OD600 values, the results obtained show that the absolute production of acetate, alanine, 
CO2 and H2 was significantly higher in the mutant strains than in the parental strain (Figure 
3B). Although these higher product levels may be simply a result of the higher OD600 levels, 
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suggests they are not. For example, a 109% and 63% increase in the specific total reductant 
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outcome of the glucose consumption analysis (soluble starch as C-source) was not 
consistently accurate enough to allow precise calculation of such yields. 
 
 
  
 
Figure 3.3 Growth and fermentation profile of T. kodakarensis strains TS559 (dotted lines), SKS001 (solid 
lines) and SKS002 (dashed lines) in ASW-YT-SA2 media supplemented with 500 µM agmatine and 75 µM 
6MPs. (A) Increases in the optical density (OD600) were measured over time. The results shown for each strain 
is the average value from the data collected from three independent cultures. (B) Production of metabolites 
was measured over time. Production values were determined by subtracting the concentration of each 
metabolite at the time of inoculation from the measured concentration of the metabolite at the individual time 
points. The results shown are the average value from the data collected from three independent cultures. The 
metabolites analyzed in this study are Hydrogen (squares), CO2 (diamonds), Acetate (circles) and Alanine 
(triangles). 
 
Based on the metabolism of T. kodakarensis (Figure 3.1), certain results are to be expected 
when cells are grown on sugars. Oxidation of sugars to acetate and CO2 along the modified 
Embden-Meyerhof pathway generates Fdred that must be re-oxidized (Fdox) to maintain 
metabolic flux and conserve energy for growth. In the absence of S°, disposal of reductant is 
accomplished by a membrane-bound hydrogenase complex (Mbh) that combines the 
oxidation of Fdred with the reduction of protons, generating H2 (Figure 3.1) [68, 82, 83]. This 
implies that when T. kodakarensis (parent strain) is growing on sugars exclusively, a constant 
value of 2 is to be expected for both the H2/acetate and H2/CO2 ratios, irrespective of 
A. B. 
 
possible alanine formation. Moreover, a constant value of 1 is expected for the CO2/acetate 
ratio. In contrast, the alanine/acetate ratio may increase in time, as the partial H2-pressure 
also increases in time, which may force Fdred to transfer electrons, via NADPH, to alanine, or 
stimulate H2 uptake by Hyh, also resulting in more NADPH and hence alanine production [30, 
59, 68, 82-84]. However, if the oxPPP contributes to the glucose conversion, the H2/acetate 
and CO2/acetate ratios will increase, whereas the H2/CO2 will remain 2. Moreover, the 
alanine values for the mutant strains may increase, as these strains are expected to produce 
extra NADPH in the oxPPP, which may be used to produce more H2, but also more alanine.  
 
 
 
  
 
Figure 3.4 Relative reductant and hydrogen production after 11 h of growth. (A) Relative total reductant 
production per OD600, expressed as a percentage of TS559 (B) relative hydrogen production ratios, expressed as 
a percentage of TS559 
  
A. B.
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Figure 3.5 Fermentation results (product/product) of T. kodakarensis strain TS559 (black circles), SKS001 
(white circles) and SKS002 (grey circles) in ASW-YT-SA2. 
 
Figure 3.5A shows that the H2/acetate ratios obtained for the mutant strains SKS001 and 
SKS002 are very similar to each other and that the values obtained at early logarithmic phase 
are significantly higher than those obtained for the parental strain TS559. For example, after 
11 h of growth a 42% and 33% increase in the H2/acetate ratio was observed for SKS001 and 
SKS002, respectively (Figure 3.4B). Moreover, the ratios obtained for the mutants at early 
logarithmic phase are also well above the expected wildtype ratio of 2 (~2.3-2.7). 
Remarkably, while the H2/acetate ratio of both mutant strains remained rather constant in 
time or slightly decreased, the ratio for TS559 increased in time (from ~1.9 towards ~2.5; 
Figure 3.5A). Thus, all three strains eventually appear to level off around 2.5. The effect of 
the mutations on the CO2/acetate ratios appear to be somewhat similar to the effect 
observed on the H2/acetate ratios. Figure 3.5B shows that the CO2/acetate ratios obtained 
for the mutant strains at early logarithmic phase are significantly higher than those obtained 
for the parental strain TS559 and well above the expected wildtype ratio of 1, especially for 
A. B.
C. D.
 
strain SKS001, but that all eventually appear to level off around 1.3. Concerning the H2/CO2 
ratios, no significant changes were observed. Like TS559, the H2/CO2 ratios obtained for the 
mutants are relatively constant and show a value around the expected value of 2 (Figure 
3.4B and 3.5C). The alanine/acetate ratios of the mutant strains SKS001 and SKS002 are very 
comparable to each other and start significantly higher than the ratio obtained for TS559 
(Figure 3.5D). Interestingly, alanine/acetate ratios for the mutants show a fast decline in 
time, whereas TS559 shows the opposite and increases from ~0.05 towards ~0.13 (Figure 
3.5D).  
  
Differential proteome analyses 
Proteomic analysis was used to investigate the metabolic response of T. kodakarensis to the 
changes made in the strains SKS001 and SKS002. The analysis resulted in the identification of 
569 proteins (corresponding to 24.67% of the identified coding DNA sequences [59]), 403 of 
which were found in TS559, 460 of which were found in SKS001 and 412 of which were 
found in SKS002. The relative abundance of the differentially expressed proteins in T. 
kodakarensis TS559, SKS001, and SKS002 grown on starch, is shown in Table S3.1 and a short 
list of relevant proteins which show differential expression is shown in Table 3.3. The results 
confirm the loss of expression of TK0475 (HPS-PHI) in the mutants, as well as the expression 
of TM1155 (G6PDH), and additionally TM0295 (TAL), TM1154 (6PGLase) and TM1718 
(Ru5PE), in strains SKS001 and SKS002, respectively. Proteins associated with DNA 
replication (such as DNA-polymerases, DNA topoisomerases or DNA primases), transcription 
(RNA-polymerases), translation (aminoacyl-tRNA synthetases, tRNA/rRNA/mRNA 
modification and processing proteins) and protein folding (chaperonins) are all slightly 
upregulated in the mutants as compared to the parental strain TS559. This is likely related to 
the higher growth rate of strain SKS001 and SKS002. Contrary to these results, cell division 
proteins are generally slightly downregulated in the mutant strains. With respect to proteins 
involved in electron transfer or NADP(H) conversion, no big differences were observed. The 
alanine aminotransferase (TK1094) and the glutamate dehydrogenase (TK1431), which are 
responsible for the disposal of reductant as alanine, were both downregulated. A subunit of 
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strain SKS001, but that all eventually appear to level off around 1.3. Concerning the H2/CO2 
ratios, no significant changes were observed. Like TS559, the H2/CO2 ratios obtained for the 
mutants are relatively constant and show a value around the expected value of 2 (Figure 
3.4B and 3.5C). The alanine/acetate ratios of the mutant strains SKS001 and SKS002 are very 
comparable to each other and start significantly higher than the ratio obtained for TS559 
(Figure 3.5D). Interestingly, alanine/acetate ratios for the mutants show a fast decline in 
time, whereas TS559 shows the opposite and increases from ~0.05 towards ~0.13 (Figure 
3.5D).  
  
Differential proteome analyses 
Proteomic analysis was used to investigate the metabolic response of T. kodakarensis to the 
changes made in the strains SKS001 and SKS002. The analysis resulted in the identification of 
569 proteins (corresponding to 24.67% of the identified coding DNA sequences [59]), 403 of 
which were found in TS559, 460 of which were found in SKS001 and 412 of which were 
found in SKS002. The relative abundance of the differentially expressed proteins in T. 
kodakarensis TS559, SKS001, and SKS002 grown on starch, is shown in Table S3.1 and a short 
list of relevant proteins which show differential expression is shown in Table 3.3. The results 
confirm the loss of expression of TK0475 (HPS-PHI) in the mutants, as well as the expression 
of TM1155 (G6PDH), and additionally TM0295 (TAL), TM1154 (6PGLase) and TM1718 
(Ru5PE), in strains SKS001 and SKS002, respectively. Proteins associated with DNA 
replication (such as DNA-polymerases, DNA topoisomerases or DNA primases), transcription 
(RNA-polymerases), translation (aminoacyl-tRNA synthetases, tRNA/rRNA/mRNA 
modification and processing proteins) and protein folding (chaperonins) are all slightly 
upregulated in the mutants as compared to the parental strain TS559. This is likely related to 
the higher growth rate of strain SKS001 and SKS002. Contrary to these results, cell division 
proteins are generally slightly downregulated in the mutant strains. With respect to proteins 
involved in electron transfer or NADP(H) conversion, no big differences were observed. The 
alanine aminotransferase (TK1094) and the glutamate dehydrogenase (TK1431), which are 
responsible for the disposal of reductant as alanine, were both downregulated. A subunit of 
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the soluble hydrogenase Hyh (TK2072) also showed a 4-fold downregulation, whereas 
protein levels of the membrane bound hydrogenase (TK2080-2093) were unaltered. The 
enzyme responsible for the first oxidation step of the glycolysis, viz. glyceraldehyde-3-
phosphate:ferredoxin oxidoreductase (GAPOR; TK2163) is slightly upregulated, while its 
NADP-dependent counterpart (GAPN; TK0705) remained unaltered. Protein levels of the PPP 
enzyme ribose-5-phosphate isomerase (TK1426) are slightly higher or doubled in SKS001 and 
SKS002, respectively. The latter suggests that the function of 6PGLase, i.e. converting 6PGL 
into 6PG, is not completely redundant, as has previously also been reported by Miclet et al. 
[488]
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the soluble hydrogenase Hyh (TK2072) also showed a 4-fold downregulation, whereas 
protein levels of the membrane bound hydrogenase (TK2080-2093) were unaltered. The 
enzyme responsible for the first oxidation step of the glycolysis, viz. glyceraldehyde-3-
phosphate:ferredoxin oxidoreductase (GAPOR; TK2163) is slightly upregulated, while its 
NADP-dependent counterpart (GAPN; TK0705) remained unaltered. Protein levels of the PPP 
enzyme ribose-5-phosphate isomerase (TK1426) are slightly higher or doubled in SKS001 and 
SKS002, respectively. The latter suggests that the function of 6PGLase, i.e. converting 6PGL 
into 6PG, is not completely redundant, as has previously also been reported by Miclet et al. 
[488]
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Discussion 
 
In this study, we set out to achieve a proof of principle that the H2 production yield in the 
archaeon T. kodakarensis could be increased by introducing extra substrate oxidation (or 
reducing equivalent-generating) steps. To do this, bacterial PPP genes were successfully 
introduced, yielding strains SKS001 and SKS002, while simultaneously disrupting the 
endogenous RuMP to ensure partial rerouting of the sugar metabolism through the oxPPP. 
T. kodakarensis, or archaea in general, usually do not contain a functional PPP [59, 91, 99, 
484]. Instead, pentose phosphates (Ru5P and R5P) are generated by the RuMP [91, 484]. As 
expected, introduction of the oxPPP enzymes G6PDH and 6PGDH was sufficient to substitute 
for the loss of the RuMP and to provide the cell with all the intermediates normally 
associated with the PPP. This is clearly shown by the successful cultivation of both the 
SKS001 and SKS002 strain on ASW-AA plates and is also suggested by the similar growth 
behavior of these strains in ASW-YT-SA2 medium (Figure 3.3A).  
Introduction of oxPPP leads to higher hydrogen yields 
The introduction of extra substrate oxidation steps in the sugar metabolism of T. 
kodakarensis may lead to higher H2 yields if the generated NADPH can be used for proton 
reduction. Alternatively, NADPH can be used to produce alanine, at the expense of pyruvate. 
Thus, increased production of NADPH by introduction of the oxPPP enzymes, may lead to 
higher levels of H2 and/or alanine. Other reduced end-products are not produced by T. 
kodakarensis. If we compare the H2 and alanine levels of the mutant and the parental strains 
we see that reductant levels are indeed significantly higher for SKS001 and SKS002 (Figure 
3.3). Even when we normalize these data for the difference in growth (OD600), both PPP 
mutants show a significantly higher level of specific reductant, both hydrogen and alanine 
(Figure 3.4A).  
Although this is a considerable improvement, it does not necessarily mean that the H2 
production per hexose has increased as well. This is because the higher specific reductant 
level might, for example, also be due to an improved overall sugar oxidation rate. To 
determine whether the engineered strains actually produce H2 beyond the threshold of 4 
 
H2/hexose, we need to determine the exact amount of converted sugar. Unfortunately, the 
starch-based medium used in this study does not allow for the precise quantification of such 
yields. Another way to determine whether the oxPPP contributes to the generated H2, is by 
calculating the H2/acetate ratio. In the EM pathway that is naturally present in T. 
kodakarensis, the H2/acetate ratio is always predicted to be ~2. Even when part of the 
generated H2 is used for alanine formation (re-oxidation of H2 by Hyh), this does not affect 
the H2/acetate ratio; as for each alanine produced two H2 and one acetate (actually 
pyruvate) is needed. However, if part of the sugar is converted along the oxPPP, more 
reductant and less acetate is produced, leading to an increase in the H2/acetate ratio. If all 
sugar would be converted via the oxPPP the H2/acetate ratio would even become 8 (Table 
3.1).  
In the early exponential phase, the H2/acetate ratios obtained in this study are ~1.9 and 
~2.7/2.5 for the parental strain TS559 and the mutants SKS001/SKS002, respectively (Figure 
3.5A). This suggests that part of the sugar in the mutants is indeed metabolized via the 
oxPPP and that the extra reductant associated with this is (partially) converted to H2. 
However, when growth ceases, the parental strain also reaches a value of ~2.5 (Figure 3.5A), 
which is higher than expected based on the natural sugar fermentation pathway. A similar 
pattern is observed for the CO2/acetate ratios, i.e. lower values for the parent strain at the 
early exponential phase (~1), reaching similar values as the mutants (~1.3) when growth 
ceases (Figure 3.5B). These observations cannot easily be explained.  
Possibly, the contribution of amino acid fermentation increases. This is because the medium 
used contains a substantial amount of amino acids and it has been shown previously that 
under the conditions used, sugars and amino acids can be oxidized simultaneously [68]. Like 
sugar oxidation, amino acid oxidation in the absence of S° results in the production of acids 
(other than acetate), H2 and CO2. This implies that in the case of simultaneous sugar and 
amino acid oxidation a higher than expected H2/acetate- and CO2/acetate ratio might indeed 
be obtained, i.e. above the expected value of 2 and 1, respectively. However, amino acid 
oxidation in the absence of S° is thermodynamically difficult and seems to be only possible at 
very low H2 concentrations [495, 496]. Moreover, an increasing contribution of amino acid 
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archaeon T. kodakarensis could be increased by introducing extra substrate oxidation (or 
reducing equivalent-generating) steps. To do this, bacterial PPP genes were successfully 
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kodakarensis may lead to higher H2 yields if the generated NADPH can be used for proton 
reduction. Alternatively, NADPH can be used to produce alanine, at the expense of pyruvate. 
Thus, increased production of NADPH by introduction of the oxPPP enzymes, may lead to 
higher levels of H2 and/or alanine. Other reduced end-products are not produced by T. 
kodakarensis. If we compare the H2 and alanine levels of the mutant and the parental strains 
we see that reductant levels are indeed significantly higher for SKS001 and SKS002 (Figure 
3.3). Even when we normalize these data for the difference in growth (OD600), both PPP 
mutants show a significantly higher level of specific reductant, both hydrogen and alanine 
(Figure 3.4A).  
Although this is a considerable improvement, it does not necessarily mean that the H2 
production per hexose has increased as well. This is because the higher specific reductant 
level might, for example, also be due to an improved overall sugar oxidation rate. To 
determine whether the engineered strains actually produce H2 beyond the threshold of 4 
 
H2/hexose, we need to determine the exact amount of converted sugar. Unfortunately, the 
starch-based medium used in this study does not allow for the precise quantification of such 
yields. Another way to determine whether the oxPPP contributes to the generated H2, is by 
calculating the H2/acetate ratio. In the EM pathway that is naturally present in T. 
kodakarensis, the H2/acetate ratio is always predicted to be ~2. Even when part of the 
generated H2 is used for alanine formation (re-oxidation of H2 by Hyh), this does not affect 
the H2/acetate ratio; as for each alanine produced two H2 and one acetate (actually 
pyruvate) is needed. However, if part of the sugar is converted along the oxPPP, more 
reductant and less acetate is produced, leading to an increase in the H2/acetate ratio. If all 
sugar would be converted via the oxPPP the H2/acetate ratio would even become 8 (Table 
3.1).  
In the early exponential phase, the H2/acetate ratios obtained in this study are ~1.9 and 
~2.7/2.5 for the parental strain TS559 and the mutants SKS001/SKS002, respectively (Figure 
3.5A). This suggests that part of the sugar in the mutants is indeed metabolized via the 
oxPPP and that the extra reductant associated with this is (partially) converted to H2. 
However, when growth ceases, the parental strain also reaches a value of ~2.5 (Figure 3.5A), 
which is higher than expected based on the natural sugar fermentation pathway. A similar 
pattern is observed for the CO2/acetate ratios, i.e. lower values for the parent strain at the 
early exponential phase (~1), reaching similar values as the mutants (~1.3) when growth 
ceases (Figure 3.5B). These observations cannot easily be explained.  
Possibly, the contribution of amino acid fermentation increases. This is because the medium 
used contains a substantial amount of amino acids and it has been shown previously that 
under the conditions used, sugars and amino acids can be oxidized simultaneously [68]. Like 
sugar oxidation, amino acid oxidation in the absence of S° results in the production of acids 
(other than acetate), H2 and CO2. This implies that in the case of simultaneous sugar and 
amino acid oxidation a higher than expected H2/acetate- and CO2/acetate ratio might indeed 
be obtained, i.e. above the expected value of 2 and 1, respectively. However, amino acid 
oxidation in the absence of S° is thermodynamically difficult and seems to be only possible at 
very low H2 concentrations [495, 496]. Moreover, an increasing contribution of amino acid 
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fermentation would also imply a decreasing H2/CO2 ratio (exclusive sugar oxidation results in 
a H2/CO2 ratio of 2, exclusive amino acid oxidation results in a H2/CO2 ratio of  ~1 [68, 497]). 
The fact that the H2/CO2 ratios obtained are constant in time and show values around the 
expected value for sugar oxidation (~2), argues against any contribution of amino acid 
oxidation (Figure 3.5C). 
Interestingly, also the alanine/acetate ratio is significantly different in the early phase of 
growth, but reaches similar values when growth rates decline (Figure 3.5D). Higher alanine 
values for the mutant strains are plausible, as these strains are expected to produce extra 
NADPH in the oxPPP, which may be used to produce more H2, but also more alanine. Again, 
why these differences disappear near the end of growth is not clear. 
Altogether the results show that the introduction of the oxPPP genes results in a significantly 
different (hydrogen) metabolism during exponential growth, but that the mutant strains 
shift to a similar type of metabolism as observed in the parent strain near the stationary 
phase. 
Introduction of oxPPP leads to higher growth rates 
Surprisingly, substituting the RuMP with the PPP not only results in higher H2 levels, but, 
when growing in ASW-YT-SA2 medium, also results in a significant increase in both the 
growth rate and the final OD600-values reached (Figure 3.3A). These improved growth results 
were unexpected as the introduction of extra oxidation steps, to convert some of the 
substrate into CO2 at the expense of acetate, implies that less ATP is formed by substrate 
level phosphorylation (SLP) (Figure 3.1). It might be, however, that the loss of ATP 
production by SLP is compensated for by extra ATP production via the respiratory system in 
the following way. The introduction of the oxPPP enzymes G6PDH and 6PGDH is supposed to 
increase the NADPH supply, which, if successful, may allow an increase in the Fd-reducing 
GAPOR flux at the expense of NADP-reducing GAPN, which is no longer needed for NADPH 
generation (Figure 3.1). The extra Fdred generation that is associated with the increased 
GAPOR flux eventually also leads to an increased MBH activity and hence proton gradient. 
The proton gradient can then be used by the membrane-bound ATP synthase, to eventually 
produce extra ATP and hence conserve energy for growth. Interestingly, the proteome 
 
analysis indeed shows an 67% and 72% increase in the level of GAPOR, whereas the 
expression level of GAPN only increased 7% or even decreased by 6% in strains SKS001 and 
SKS002, respectively (Table 3.3 and S3.1). Moreover, the proteome analysis also showed a 
decrease in the levels of several ATP consuming enzymes, such as flagella related proteins or 
various ABC transporters (Table S3.1). Though the rationale behind this is unclear, these 
results suggests that the improved growth performance might also be due to a decreased 
ATP demand. 
Another possible explanation for the improved growth might be that the extra NADPH 
generation associated with the oxPPP has a positive effect on biosynthesis. T. kodakarensis 
does not contain many sites for NADPH generation, especially not under glycolytic growth 
conditions [77, 99]. Extra NADPH generation by the oxPPP might therefore be beneficial for 
various biosynthetic pathways in the cell. Confirmation that the introduction of the oxPPP 
indeed led to higher NADPH availability seems to be provided by the higher specific alanine 
production in the early exponential phase (Figure 3.4A), as well as by the lower Hyh levels 
and the relative increase in the GAPOR/GAPN levels observed in the proteome analysis 
(Table 3.3). Similarly, introduction of the oxPPP might have a positive effect on the 
availability of pentose phosphates (Ru5P and R5P), which are used to build the pentose 
moiety of nucleotides (Figure 3.1) [91]. We could confirm this hypothesis, by showing that 
addition of nucleosides indeed caused an increase in the growth rate of the parental strain 
TS559 (Figure S3.4). These remarkable results suggest that pentose phosphate availability is 
limiting in TS559 under glycolytic conditions, which may be resolved by substituting the 
RuMP for the oxPPP. Moreover, an increased availability of Ru5P also seems to be suggested 
by the proteome analysis, where an 30% and 110% increase in the level of ribose-5-
phosphate isomerase was observed for strains SKS001 and SKS002, respectively. 
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SKS002, respectively (Table 3.3 and S3.1). Moreover, the proteome analysis also showed a 
decrease in the levels of several ATP consuming enzymes, such as flagella related proteins or 
various ABC transporters (Table S3.1). Though the rationale behind this is unclear, these 
results suggests that the improved growth performance might also be due to a decreased 
ATP demand. 
Another possible explanation for the improved growth might be that the extra NADPH 
generation associated with the oxPPP has a positive effect on biosynthesis. T. kodakarensis 
does not contain many sites for NADPH generation, especially not under glycolytic growth 
conditions [77, 99]. Extra NADPH generation by the oxPPP might therefore be beneficial for 
various biosynthetic pathways in the cell. Confirmation that the introduction of the oxPPP 
indeed led to higher NADPH availability seems to be provided by the higher specific alanine 
production in the early exponential phase (Figure 3.4A), as well as by the lower Hyh levels 
and the relative increase in the GAPOR/GAPN levels observed in the proteome analysis 
(Table 3.3). Similarly, introduction of the oxPPP might have a positive effect on the 
availability of pentose phosphates (Ru5P and R5P), which are used to build the pentose 
moiety of nucleotides (Figure 3.1) [91]. We could confirm this hypothesis, by showing that 
addition of nucleosides indeed caused an increase in the growth rate of the parental strain 
TS559 (Figure S3.4). These remarkable results suggest that pentose phosphate availability is 
limiting in TS559 under glycolytic conditions, which may be resolved by substituting the 
RuMP for the oxPPP. Moreover, an increased availability of Ru5P also seems to be suggested 
by the proteome analysis, where an 30% and 110% increase in the level of ribose-5-
phosphate isomerase was observed for strains SKS001 and SKS002, respectively. 
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Conclusions 
 
The results presented demonstrate that bacterial PPP genes were successfully introduced 
into the archaeon T. kodakarensis and that introduction of just the oxPPP enzymes G6PDH 
and 6PGDH is sufficient to replace the RuMP. Introduction of the PPP resulted in significantly 
higher H2 production levels, and the elevated H2/acetate ratios in the early exponential 
phase suggested that increased NADPH production may ultimately be responsible for the 
increase in H2 formation. Further research using quantifiable sugars is needed to obtain 
H2/hexose data and to exclude the contribution of amino acid fermentation to increased H2 
production. Surprisingly, introduction of the PPP also resulted in significantly higher growth 
rates and final OD600-values, which, together with the higher specific H2 production values 
(H2/OD600), results in a substantially higher overall H2 productivity. The proteome analysis 
suggested that the higher growth rate could be due to an improved supply of ribulose-5-
phosphate, which was later confirmed by the improved growth characteristics of the 
parental strain in ASW-YT medium supplemented with nucleosides. In addition, an increase 
in NADPH availability, and possibly a decrease in ATP consumption might be responsible. 
Finally, the data presented suggests that some oxidation of amino acids may occur as well 
and that its relative contribution may increase in time. Although a proof of principle was 
obtained that introduction of extra oxidation steps can lead to higher H2 levels, this is only 
the beginning. Even higher yields are necessary to make biohydrogen production by dark 
fermentation economically competitive. Thermodynamics predict that H2/acetate ratios of 8 
should be thermodynamically possible. Future research will, therefore, focus on further 
improvement of the H2 yield, among others by blocking the competing glycolytic pathway.  
        
  
 
Materials and Methods 
Microorganisms and culture conditions 
E. coli DH5α was used for general DNA manipulation, and E. coli strains were cultivated at 
37°C in Luria-Bertani (LB) medium supplemented with either 100 µg/ml ampicillin or 50 
µg/ml kanamycin. T. maritima MSB8, used as a positive control in enzyme activity assays, 
was cultivated anaerobically at 80°C in M3-medium containing 5 g/L glucose as described 
previously [498]. T. kodakarensis strains and plasmids used in this study are listed in Table 
3.4. T. kodakarensis strains were cultivated anaerobically in stoppered serum bottles at 85°C 
in a nutrient-rich medium (ASW-YT), composed of 0.8x artificial seawater (0.8x ASW) [62], 
5.0 g/L yeast extract, 5.0 g/L tryptone, 1 ml/L KOD vitamin mixture (1000x) and 0.8 mg/L 
resazurine. The headspace of all cultures was exchanged for N2 or, when an internal gas 
standard was required, for N2 and CH4 (see below). Before inoculation, either 2.0 g/L S0 
(ASW-YT-S0) or 5.0 g/L of the modified potato starch “Paselli SA2” (ASW-YT-SA2) was added 
to the medium, as well as Na2S.9H2O to reduce the dissolved oxygen, until the medium 
became colorless. The modified potato starch “Paselli SA2” has a degree of polymerization of 
~60 and was a gift of AVEBE FOOD, Veendam, The Netherlands. When required, the media 
were furthermore supplemented with 500 µM agmatine and/or 75 µM 6-methyl purine 
(6MP) [60, 61], and in the case of the ASW-YT-SA2 medium with 10 mM PIPES buffer (the pH 
was adjusted to pH 7 at RT). For the growth experiment with supplemented nucleosides, 
0.25% of adenosine and uridine was added to the ASW-YT-SA2 medium. Cultures were 
continuously shaken (120 rpm) during growth. The minimal medium (ASW-AA) used in the 
growth assay on plates was prepared as described previously [62]. In the case of plate 
culture, 1% (wt/vol) Gelrite was added to solidify the medium together with 2 ml/L 
polysulfide solution [62] instead of S0. Cells inoculated on plates were incubated at 85°C in 
an air-tight anaerobic jar containing an Anaerocult A mini (Merck Millipore, Darmstadt, 
Germany) to ensure anaerobic conditions. 
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Conclusions 
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H2/hexose data and to exclude the contribution of amino acid fermentation to increased H2 
production. Surprisingly, introduction of the PPP also resulted in significantly higher growth 
rates and final OD600-values, which, together with the higher specific H2 production values 
(H2/OD600), results in a substantially higher overall H2 productivity. The proteome analysis 
suggested that the higher growth rate could be due to an improved supply of ribulose-5-
phosphate, which was later confirmed by the improved growth characteristics of the 
parental strain in ASW-YT medium supplemented with nucleosides. In addition, an increase 
in NADPH availability, and possibly a decrease in ATP consumption might be responsible. 
Finally, the data presented suggests that some oxidation of amino acids may occur as well 
and that its relative contribution may increase in time. Although a proof of principle was 
obtained that introduction of extra oxidation steps can lead to higher H2 levels, this is only 
the beginning. Even higher yields are necessary to make biohydrogen production by dark 
fermentation economically competitive. Thermodynamics predict that H2/acetate ratios of 8 
should be thermodynamically possible. Future research will, therefore, focus on further 
improvement of the H2 yield, among others by blocking the competing glycolytic pathway.  
        
  
 
Materials and Methods 
Microorganisms and culture conditions 
E. coli DH5α was used for general DNA manipulation, and E. coli strains were cultivated at 
37°C in Luria-Bertani (LB) medium supplemented with either 100 µg/ml ampicillin or 50 
µg/ml kanamycin. T. maritima MSB8, used as a positive control in enzyme activity assays, 
was cultivated anaerobically at 80°C in M3-medium containing 5 g/L glucose as described 
previously [498]. T. kodakarensis strains and plasmids used in this study are listed in Table 
3.4. T. kodakarensis strains were cultivated anaerobically in stoppered serum bottles at 85°C 
in a nutrient-rich medium (ASW-YT), composed of 0.8x artificial seawater (0.8x ASW) [62], 
5.0 g/L yeast extract, 5.0 g/L tryptone, 1 ml/L KOD vitamin mixture (1000x) and 0.8 mg/L 
resazurine. The headspace of all cultures was exchanged for N2 or, when an internal gas 
standard was required, for N2 and CH4 (see below). Before inoculation, either 2.0 g/L S0 
(ASW-YT-S0) or 5.0 g/L of the modified potato starch “Paselli SA2” (ASW-YT-SA2) was added 
to the medium, as well as Na2S.9H2O to reduce the dissolved oxygen, until the medium 
became colorless. The modified potato starch “Paselli SA2” has a degree of polymerization of 
~60 and was a gift of AVEBE FOOD, Veendam, The Netherlands. When required, the media 
were furthermore supplemented with 500 µM agmatine and/or 75 µM 6-methyl purine 
(6MP) [60, 61], and in the case of the ASW-YT-SA2 medium with 10 mM PIPES buffer (the pH 
was adjusted to pH 7 at RT). For the growth experiment with supplemented nucleosides, 
0.25% of adenosine and uridine was added to the ASW-YT-SA2 medium. Cultures were 
continuously shaken (120 rpm) during growth. The minimal medium (ASW-AA) used in the 
growth assay on plates was prepared as described previously [62]. In the case of plate 
culture, 1% (wt/vol) Gelrite was added to solidify the medium together with 2 ml/L 
polysulfide solution [62] instead of S0. Cells inoculated on plates were incubated at 85°C in 
an air-tight anaerobic jar containing an Anaerocult A mini (Merck Millipore, Darmstadt, 
Germany) to ensure anaerobic conditions. 
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Table 3.4 Strains and plasmids used in this study 
Strain or plasmid Relevant characteristics Source or reference
T. kodakarensis strains   
KOD1 Wild type [57] 
TS559 ΔpyrF; ΔtrpE::pyrF; ΔTK0664; ΔTK0149 [486] 
Δhps-phi 7A ΔpyrF; ΔtrpE::pyrF; Δhps-phi:: trpE [91] 
SKS001 TS559 derivative, 
ΔTK0475 (hps-phi)::TM1155, TM0438 
This study 
SKS002 SKS001 derivative,
ΔTK1765::TM0295, TM1718, TM1154 
This study 
   
Plasmids   
pUDhps-phi pUC118 derivative,
∆hps-phi::trpE 
[91] 
pSKS019 TK0664; TK0149; ΔTK0475 (hps-phi)::TM1155, 
TM0438 
This study 
pSecPyrF PyrF overexpression and secretion system, 
integration at TK1765 locus  
(ΔTK1765::trpE, PyrF) 
[106] 
pSKS022 TK0664; TK0149; ΔTK1765::TM0295, TM1718, 
TM1154 
This study 
 
Construction of plasmids and mutant strains 
Plasmids incapable of autonomous replication in T. kodakarensis were constructed and 
amplified in Escherichia coli, carrying the desired genes adjacent to the previous developed 
selection and counter-selection cassette (TK0149; TK0664). The PPP genes and selection and 
counter-selection cassette were flanked by a ~1-kb region homologous to T. kodakarensis 
genomic sequences that naturally were located immediately up- and downstream of the 
target locus (Figure 3.2). Standard molecular biology procedures were used for PCR 
amplifications, plasmid construction, E. coli DH5α transformation, transformants selection, 
and plasmid isolation. The sequences of oligonucleotide primers used in this study are listed 
in Table S3.2.  
Two different vectors, designated pSKS019 and pSKS022, were constructed to create strain 
SKS001 and SKS002, respectively. Plasmid pSKS019, designed to introduce the oxPPP 
enzymes G6PDH and 6PGDH while simultaneously disrupting the HPS-PHI fusion enzyme and 
hence the RuMP, was constructed as follows. DNA fragments containing either the genes of 
interest, TM1155; TM0438, codon optimized for expression in T. kodakarensis, or the 
selection and counter-selection cassette, TK0664; TK0149 [60, 61], were synthesized by 
 
GeneArt (Life technologies, Regensburg, Germany), ligated together and digested from the 
resulting plasmid using PvuII and EcoRI, to create a linear blunt ended DNA fragment 
containing both the TM-genes and the selection and counter-selection cassette. Next, an 
inverse-PCR was carried out using the previously constructed hps-phi disruption vector 
pUDhps-phi [91], as template with the primer-pair BG3884-BG3885, to amplify the hps-phi 
flanking regions and the pUC118 backbone, thereby removing the trpE marker. Finally, the 
created vector backbone containing the hps-phi flanking regions, and the linear DNA 
fragment containing the TM-genes and selection and counter-selection cassette (TM1155-
TK0149), were ligated together to form pSKS019 as shown in Figure 3.2. Similarly, plasmid 
pSKS022, designed to introduce the remaining missing PPP enzymes into SKS001, was 
constructed by carrying out an inverse PCR using the previously constructed overexpression 
and secretion vector pSecPyrF [106], as template with the primer-pair BG4718-BG4720, to 
amplify the desired flanking regions and backbone, thereby removing the csg-promoter, the 
TK1675 secretion signal, the PyrF coding sequence, the STREP-tag sequence, and the gdh-
terminator. pSecPyrF was chosen as template as integration in the genome at the ChiA locus 
targeted by this plasmid has shown to be efficient and non-disturbing. The linear vector 
backbone created by this PCR was flanked by BamHI and EcoRI restriction sites, which were 
incorporated in the primers used. A linear DNA fragment containing a synthetic operon 
composed of TM0295, TM1718 and TM1154 codon optimized for expression in T. 
kodakarensis, as well as the TK0664; TK0149 cassette was synthesized by GeneArt (Life 
technologies, Regensburg, Germany). The entire fragment was flanked by BamHI and EcoRI 
restriction sites, allowing for easy ligation with the amplified vector backbone, creating 
pSKS022 as shown in Figure 3.2. Transcription of the synthetic operon was designed to be 
driven by the strong constitutive cell surface glycoprotein (csg) promoter [106] and to be 
inhibited by the presence of a synthetic transcription terminator (T8) [499]. 
T. kodakarensis SKS001 was generated by transforming pSKS019 into T. kodakarensis TS559, 
and following the previously described selection and counter-selection procedure (Figure 
3.2) [60, 61]. T. kodakarensis SKS002 was generated by transforming pSKS022 into the newly 
created strain SKS001, and repeating the selection and counter-selection procedure. 
39949 Spaans, Bas.indd   94 20-05-16   10:55
Pentose phosphate pathway introduction
95
3
 
Table 3.4 Strains and plasmids used in this study 
Strain or plasmid Relevant characteristics Source or reference
T. kodakarensis strains   
KOD1 Wild type [57] 
TS559 ΔpyrF; ΔtrpE::pyrF; ΔTK0664; ΔTK0149 [486] 
Δhps-phi 7A ΔpyrF; ΔtrpE::pyrF; Δhps-phi:: trpE [91] 
SKS001 TS559 derivative, 
ΔTK0475 (hps-phi)::TM1155, TM0438 
This study 
SKS002 SKS001 derivative,
ΔTK1765::TM0295, TM1718, TM1154 
This study 
   
Plasmids   
pUDhps-phi pUC118 derivative,
∆hps-phi::trpE 
[91] 
pSKS019 TK0664; TK0149; ΔTK0475 (hps-phi)::TM1155, 
TM0438 
This study 
pSecPyrF PyrF overexpression and secretion system, 
integration at TK1765 locus  
(ΔTK1765::trpE, PyrF) 
[106] 
pSKS022 TK0664; TK0149; ΔTK1765::TM0295, TM1718, 
TM1154 
This study 
 
Construction of plasmids and mutant strains 
Plasmids incapable of autonomous replication in T. kodakarensis were constructed and 
amplified in Escherichia coli, carrying the desired genes adjacent to the previous developed 
selection and counter-selection cassette (TK0149; TK0664). The PPP genes and selection and 
counter-selection cassette were flanked by a ~1-kb region homologous to T. kodakarensis 
genomic sequences that naturally were located immediately up- and downstream of the 
target locus (Figure 3.2). Standard molecular biology procedures were used for PCR 
amplifications, plasmid construction, E. coli DH5α transformation, transformants selection, 
and plasmid isolation. The sequences of oligonucleotide primers used in this study are listed 
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hence the RuMP, was constructed as follows. DNA fragments containing either the genes of 
interest, TM1155; TM0438, codon optimized for expression in T. kodakarensis, or the 
selection and counter-selection cassette, TK0664; TK0149 [60, 61], were synthesized by 
 
GeneArt (Life technologies, Regensburg, Germany), ligated together and digested from the 
resulting plasmid using PvuII and EcoRI, to create a linear blunt ended DNA fragment 
containing both the TM-genes and the selection and counter-selection cassette. Next, an 
inverse-PCR was carried out using the previously constructed hps-phi disruption vector 
pUDhps-phi [91], as template with the primer-pair BG3884-BG3885, to amplify the hps-phi 
flanking regions and the pUC118 backbone, thereby removing the trpE marker. Finally, the 
created vector backbone containing the hps-phi flanking regions, and the linear DNA 
fragment containing the TM-genes and selection and counter-selection cassette (TM1155-
TK0149), were ligated together to form pSKS019 as shown in Figure 3.2. Similarly, plasmid 
pSKS022, designed to introduce the remaining missing PPP enzymes into SKS001, was 
constructed by carrying out an inverse PCR using the previously constructed overexpression 
and secretion vector pSecPyrF [106], as template with the primer-pair BG4718-BG4720, to 
amplify the desired flanking regions and backbone, thereby removing the csg-promoter, the 
TK1675 secretion signal, the PyrF coding sequence, the STREP-tag sequence, and the gdh-
terminator. pSecPyrF was chosen as template as integration in the genome at the ChiA locus 
targeted by this plasmid has shown to be efficient and non-disturbing. The linear vector 
backbone created by this PCR was flanked by BamHI and EcoRI restriction sites, which were 
incorporated in the primers used. A linear DNA fragment containing a synthetic operon 
composed of TM0295, TM1718 and TM1154 codon optimized for expression in T. 
kodakarensis, as well as the TK0664; TK0149 cassette was synthesized by GeneArt (Life 
technologies, Regensburg, Germany). The entire fragment was flanked by BamHI and EcoRI 
restriction sites, allowing for easy ligation with the amplified vector backbone, creating 
pSKS022 as shown in Figure 3.2. Transcription of the synthetic operon was designed to be 
driven by the strong constitutive cell surface glycoprotein (csg) promoter [106] and to be 
inhibited by the presence of a synthetic transcription terminator (T8) [499]. 
T. kodakarensis SKS001 was generated by transforming pSKS019 into T. kodakarensis TS559, 
and following the previously described selection and counter-selection procedure (Figure 
3.2) [60, 61]. T. kodakarensis SKS002 was generated by transforming pSKS022 into the newly 
created strain SKS001, and repeating the selection and counter-selection procedure. 
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Diagnostic PCRs were performed to select and confirm genotypes of both intermediate and 
final strains. For the selection of intermediates, at least three diagnostic PCRs were 
performed. In one PCR, the primers used were complementary to the sequence upstream of 
the desired integration locus as well as to the sequence inside one of the codon optimized 
PPP-genes (primer-pair BG4131-BG4133 and BG4871-BG4872, illustrated by A-B and H-I in 
Figure 3.2, for SKS001 and SKS002 respectively). Similarly, a second PCR was included using 
primers that were complementary to the sequence inside the selection and counter-
selection cassette as well as to the sequence downstream of the desired integration locus 
(primer-pair BG4126-BG4129 (C-D) and BG4126-BG4873 (C-J) for SKS001 and SKS002, 
respectively). A third PCR was performed to confirm the loss of hps-phi (primer-pair BG4658-
4659 (E-F)) or chiAΔ4 (BG5059-BG5060 (K-L)) in strain SKS001i and SKS002i, respectively. A 
generated PCR product having the correct size for the first two reactions, in combination 
with a failure to generate a PCR product for the third reaction, suggested the desired 
intermediate genotype. To discriminate between final strains and intermediate strains, an 
additional fourth PCR was performed using the genomic DNA of spontaneous 6MP resistant 
(6MPR) clones as template and primers that were complementary to the sequence 
downstream of the desired integration locus as well as to the sequence inside one of the 
codon optimized genes (BG4129-3952 (D-G) and BG4873-BG4874 (J-M)). A generated PCR 
product having the correct size for the first and fourth reaction, in combination with a failure 
to generate a PCR product for the second and third reaction, suggested the desired final 
genotype. Sequences of the primers are listed in Table S3.2. 
 
RNA isolation and RT-PCR 
To confirm transcription of the introduced PPP-genes as well as the loss of transcription of 
the hps-phi gene, Reverse Transcriptase PCR (RT-PCR) was performed. To do this, the 
parental strain TS559 and the mutant strains SKS001 and SKS002 were cultivated in 120-ml 
serum bottles containing 40 ml ASW-YT-SA2 medium, supplemented with 500 µM agmatine 
and 75 µM 6MP. Samples of 10 ml were taken and cells were harvested by centrifugation 
(4700 g, 30 min, 4°C). Total RNA was isolated by the following method. Cell pellets were 
resuspended in 1 ml Trizol and 200 µl chloroform was added. The mixtures were shaken by 
 
hand for 15 seconds, followed by an incubation at RT for 3 min. Next, the samples were 
centrifuged (13,000 g, 15 min, 4°C) and the supernatants were transferred to fresh 
Eppendorf tubes. 5 µg glycogen and 500 µl isopropanol were added and the mixtures were 
incubated at RT for 10 min. The samples were centrifuged (13,000 g, 15 min, 4°C) and the 
pellets were washed in 75% ethanol, air-dried for 10 min and resuspended in MQ water. 
RNA concentrations were determined with a Nanodrop ND-1000 and the total RNA samples 
were stored at -20°C until further processing. 
Before RT-PCR, the total RNA samples (1 µg each) were treated with DNaseI, to remove 
residual genomic DNA. cDNA was prepared by following the protocol for first strand cDNA 
synthesis of the Thermo Scientific RevertAid RT kit (20 µl reactions), using random hexamers 
as primers. Gene-specific cDNA fragments were amplified by conventional PCR using the 
freshly prepared cDNA as template and primer pairs developed to specifically target the 
genes of interest (Table S3.2). The genes of interest were: TK0475 (hps-phi), TM0295 (TAL), 
TM0438 (6PGDH), TM1154 (6PGLase), TM1155 (G6PDH), TM1718 (Ru5PE). The 
housekeeping gene TK0308 (puf), encoding the α-subunit of the elongation factor-1 complex 
(EF-1-α), was included for normalization. All primer pairs were designed to produce a specific 
product of ~300 bp. All reactions were run for 35 cycles with the exception of the reaction 
analyzing TK0308, which was run for only 18 cycles. PCR amplification products were 
analyzed by agarose gel electrophoresis. Control experiments were included by following the 
same procedure, but without addition of RevertAid Reverse Transcriptase enzyme to the RT 
reaction mix. 
Cell lysis and enzyme activity assays  
To test if the introduced PPP-genes are functionally expressed, various assays were 
performed. For the enzyme activity assays, including the in-gel activity assay, cell-free 
extracts were prepared. To do this, both the mutant strains SKS001 and SKS002, and the 
parental strain TS559 (negative control) were cultivated anaerobically in 200 ml ASW-YT-SA2 
(500-ml anaerobic bottles) as described above. In addition, a 40-ml culture of T. maritima 
MSB8 (positive control) in M3 medium containing glucose was prepared. Cells were 
harvested by centrifugation (5000 g, 30 min, 4°C) and the pellets were resuspended in 2 ml 
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as primers. Gene-specific cDNA fragments were amplified by conventional PCR using the 
freshly prepared cDNA as template and primer pairs developed to specifically target the 
genes of interest (Table S3.2). The genes of interest were: TK0475 (hps-phi), TM0295 (TAL), 
TM0438 (6PGDH), TM1154 (6PGLase), TM1155 (G6PDH), TM1718 (Ru5PE). The 
housekeeping gene TK0308 (puf), encoding the α-subunit of the elongation factor-1 complex 
(EF-1-α), was included for normalization. All primer pairs were designed to produce a specific 
product of ~300 bp. All reactions were run for 35 cycles with the exception of the reaction 
analyzing TK0308, which was run for only 18 cycles. PCR amplification products were 
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Cell lysis and enzyme activity assays  
To test if the introduced PPP-genes are functionally expressed, various assays were 
performed. For the enzyme activity assays, including the in-gel activity assay, cell-free 
extracts were prepared. To do this, both the mutant strains SKS001 and SKS002, and the 
parental strain TS559 (negative control) were cultivated anaerobically in 200 ml ASW-YT-SA2 
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and 1 ml lysis buffer, for T. kodakarensis and T. maritima cultures respectively. The lysis 
buffer was composed of 50 mM Tris-HCl buffer (pH adjusted to pH 8.0 by adding HCl), 1 mM 
EDTA, 150 mM NaCl, 1 mM DTT and 0.1 mM PMSF. The cells were lysed by sonication, and 
the cellular debris was removed by centrifugation (13,000 g, 30 min, 4°C). The protein 
concentration was determined using a Pierce BCA Protein Assay Kit (Thermo Scientific). The 
cell-free extracts were stored at -20°C until further processing.  
The enzyme assays were performed in pre-heated 1-ml quartz cuvettes. The cuvettes 
containing the assay mixture were allowed to reach the desired temperature inside a 
temperature controlled Hitachi U-2001 spectrophotometer. The reaction was started by 
either adding cell-free extract or an essential substrate. In case of the anaerobic assays, 
stoppered 1-ml quartz cuvettes were used, that were flushed with N2. In addition, all cell-
free extracts, stock solutions and the buffer were flushed with N2.  
Glucose-6-phosphate dehydrogenase (EC 1.1.1.49) and 6-phospho-gluconate dehydrogenase 
(EC 1.1.1.44) were assayed by measuring the formation of NADPH at 334 nm. The assays 
were performed at 80°C, at which both the T. kodakarensis and T. maritima enzymes are 
active. The assay mixtures contained: 100 mM Tris-HCl (pH 7.8), 10 mM MgCl2, 0.5 mM 
NADP+, 2 mM of either glucose-6-phosphate or 6-phospho-gluconate, and at least 20 µl 
extract (60-120 µg protein). Transaldolase (EC 2.2.1.2) and Ribulose-5-phosphate 3-
epimerase (EC 5.1.3.1) were assayed spectrophotometrically at 80°C in a coupled enzyme 
assay with GAPOR of T. kodakarensis, using benzyl viologen as artificial electron acceptor. 
The reaction mixtures in stoppered anaerobic quartz cuvettes contained 50 mM Tris-HCl (pH 
8.0) and 1 mM benzyl viologen. In the cuvette, the buffer was slightly prereduced with 
sodium dithionite until a light blue color was maintained, before addition of the extracts. 
The reactions were started by either adding 2 mM of fructose-6-phosphate and erythrose-4-
phosphate, or 2 mM of ribulose-5-phosphate for the TAL and Ru5PE-assay, respectively. The 
reduction of benzyl viologen was followed at 560 nm. In addition, a positive control reaction 
was included using 2 mM of GAP to start the reaction.    
 
Glucose-6-phosphate dehydrogenase (EC 1.1.1.49) and 6-phospho-gluconate dehydrogenase 
(EC 1.1.1.44) were also assayed by an in-gel activity assay. Using this method, soluble 
dehydrogenases can be visualized very specifically. The assay was performed by loading 100 
µg of cell-free extracts of the mutant strain SKS001, the parental strain TS559 (negative 
control), and T. maritima MSB8 (positive control) on a native polyacrylamide gel (5% stacking 
gel, pH 6.8 and 10% resolving gel, pH 8.8). The gels were resolved by running them at RT at 
15 mA per gel for ~1.5 h. Following electrophoresis, the gels were stained for dehydrogenase 
activity with phenazine methosulfate (PMS) and nitro blue tetrazolium chloride (NBT) 
according to the method of Benoist and Schwencke (1990) [500]. PMS acts as an 
intermediate electron carrier for coupling the production of NADPH to the reduction of NBT 
to insoluble precipitates. When the indicated dehydrogenases are actively expressed 
precipitates will be formed at their position in the gel. The assay was performed by placing 
the gels in 20 ml activity staining buffer, composed of 100 mM NaH2PO4 (pH 8.0), 200 mM 
NaCl, 5 mM MgCl2, 0.03% NBT and 0.001% PMS. NADP+ (1 mM) and either glucose-6-
phosphate or 6-phospho-gluconate (100 mM each) were used as substrates. The activity 
staining was performed by incubating the gels for 10-30 minutes in an anaerobic container 
at 60°C and 37°C, for the glucose-6-phosphate and 6-phospho-gluconate containing gel 
respectively. The gas phase of the anaerobic container consisted of 96% N2 and 4% H2. A 
palladium catalyst (BASF, Arnhem, The Netherlands) was used to remove traces of oxygen. 
Control experiments were done under the same conditions in the absence of either glucose-
6-phosphate or 6-phospho-gluconate. 
Growth assay on ASW-AA plates 
In addition to the activity assays, a growth assay on ASW-AA plates was performed. Plates 
were prepared by adding 1% (wt/vol) Gelrite to ASW-AA medium, supplemented with 2 ml/L 
polysulfide solution [62] instead of S0, 500 µM agmatine and in the case of SKS001 and 
SKS002, 10 µM 6MP. Cells inoculated on plates were incubated at 85°C for at least 3 days in 
an air-tight anaerobic jar containing a N2/H2 gas mixture and an Anaerocult A mini (Merck 
Millipore, Darmstadt, Germany) to ensure anaerobic conditions. T. kodakarensis strains used 
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were prepared by adding 1% (wt/vol) Gelrite to ASW-AA medium, supplemented with 2 ml/L 
polysulfide solution [62] instead of S0, 500 µM agmatine and in the case of SKS001 and 
SKS002, 10 µM 6MP. Cells inoculated on plates were incubated at 85°C for at least 3 days in 
an air-tight anaerobic jar containing a N2/H2 gas mixture and an Anaerocult A mini (Merck 
Millipore, Darmstadt, Germany) to ensure anaerobic conditions. T. kodakarensis strains used 
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for inoculation were: SKS001, SKS002, KOD1 (positive control), and Δhps-phi 7A (negative 
control). 
Determination of growth properties 
T. kodakarensis strains were pre-cultured in 120-ml serum bottles containing 40 ml ASW-YT-
S0 with N2 as headspace, at 85°C for 15 h (o/n). Next, the cells (1% vol/vol) were transferred 
to similar bottles containing ASW-YT-SA2 and the cultures were incubated at 85°C until 
growth was clearly visible. A final round of pre-culturing was performed by inoculating fresh 
ASW-YT-SA2 containing 120-ml serum bottles until the optical density at 600 nm (OD600) 
reached 0.3 and 0.4, for TS559 and the mutant strains SKS001 and SKS002 respectively. The 
OD600 was measured using an U-1500 spectrophotometer (Hitachi). Final cultures were 
inoculated with a 1% (vol/vol) inoculum for the mutant strains (OD600 = 0.4), and the 
equivalent of that (assuming a linear relationship between OD600 and absolute cell count) for 
TS559. The growth properties of the mutant strains were compared to that of the parental 
strain by following the increase in OD600 in time in 500-ml anaerobic bottles (average of 
three independent cultures for each strain) containing 150-ml ASW-YT-SA2 with 10 mM 
PIPES buffer (pH 7.0 at RT). For the growth experiment with added nucleosides, 120-ml 
serum bottles (average of 5 independent cultures for each strain) containing 40 ml ASW-YT-
SA2 with 10 mM PIPES buffer (pH 7.0 at RT) were used. The gas phase in all bottles was a 
mixture of N2 and a fixed amount of CH4 that was used as an internal standard for the gas 
measurements described below. Sigma plot application software version 12.3 was used for 
fitting the growth data and a modified Gompertz equation (Figure S3.3) was used to 
estimate the maximum growth rate of each strain [501]. The samples for the OD 
measurements, 1 ml and 1.5 ml for the 120-ml and 500-ml bottles respectively, were taken 
by syringe. After the OD measurements, the 1.5 ml samples were immediately centrifuged 
(13,000 g, 15 min, 4°C), and the supernatant was stored at -20°C for further processing (see 
section product analysis). 
Analysis of substrates and fermentation end products 
Gas samples to analyze H2 and CO2 production were taken at the same time points as the 
culture medium samples. Gas samples (500 µl) were taken using a 2.5-ml air-tight syringe, 
 
and the concentration of both gasses was determined by a gas chromatograph (G·A·S 
CompactGC), using CH4 as internal standard. Final gas concentrations are expressed per 
volume culture medium, and are corrected for sample withdrawal. The GC was equipped 
with a capillary column (15 m x 0.32 mm; carboxen 1010; Sigma Aldrich; carrier gas, helium) 
and a TCD detector.  
The 1.5-ml supernatant samples stored at -20°C (see above) were used to determine the 
concentrations of the fermentation products alanine and acetate, as well as the substrate 
glucose. The concentration of alanine in the supernatant was determined by HPLC after a 
pre-column derivatization with dabsyl chloride. The derivatization was performed by adding 
100 µl NaHCO3 (0.1 M, pH 9.0), 5 µl internal standard (4 mM norleucine in 200 mM HCl), 5 µl 
supernatant and 200 µl freshly prepared derivatization reagent (saturated solution of dabsyl 
chloride in acetonitrile) to glass 1.5-ml HPLC screwcap vials. The mixtures were heated for 20 
min at 70°C in an oven. Next, the mixtures were cooled down and 690 µl dilution buffer (25 
mM H3PO4 in water/acetonitrile 90:10 (v/v), pH 7.0) was added. The derivatives were 
analyzed using a HPLC apparatus (Thermo) equipped with a Polaris C18-A column (200 x 2.0 
mm; Agilent). The column was thermostated at 45°C. Mobile phase A consisted of 24 mM 
sodium acetate (pH 6.6) – acetonitrile (82:18 v/v). Mobile phase B consisted of isopropanol – 
acetonitrile (60:40 v/v). The elution was performed as follows: from 0 to 3 min, 30% B; from 
3 min to 19 min, a linear gradient from 30 to 45 % B; from 19 min to 21 min, a linear gradient 
form 45 to 95 % B; from 21 to 25.5 min, 95% B; from 25.5 min to 26 min, a linear gradient 
from 95 to 20 % B. The flow-rate 0.6 ml/min. The UV-absorbance was measured at 436 nm.  
The concentration of acetate was determined using a HPLC (Thermo Scientific, Dionex, 
ICS5000) apparatus equipped with a metacarb 67H column (300 x 6.5 mm; Agilent) and a 
refractive index detector. The column was thermostated at 60°C. The mobile phase was 5 
mM H2SO4, with a flow-rate of 0.8 ml/min. HPLC-samples were prepared by adding 0.5 ml 
supernatant and 0.5 ml H2SO4 (50 mM) containing 10 mM crotonate as internal standard, to 
1.5-ml HPLC screwcap vials.      
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The concentration of glucose consumed was determined by subtracting the glucose 
concentration in the supernatant of the samples (tx), from the glucose concentration present 
at the start of cultivation (t0). The glucose concentration present in the supernatant was 
determined by HPLC after a pre-column enzymatic digestion of the added substrate starch. 
The enzymatic digestion of starch into glucose was performed by mixing 0.5 ml supernatant 
and 0.5 ml acetic acid (200 mM, pH 5.5) containing 5 mM CaCl2 in a 1.5-ml Eppendorf tube, 
and adding ~50 Units of heat-stable versions of both α-amyloglucosidase and α-amylase. The 
reaction mixtures were incubated at 55°C for 4 h, while shaking (750 rpm). The Eppendorf 
tubes containing the reaction mixtures were weighed before and after the incubation, so 
that the increase in concentrations due to water evaporation could be corrected for. Control 
reactions with similar reaction mixtures containing only one of the enzymes, or control 
reactions in which the addition of supernatant was replaced by water, were included as well.  
Differential proteome analyses 
T. kodakarensis strains TS559, SKS001 and SKS002 were cultivated anaerobically in duplicate, 
in 120-ml stoppered serum bottles containing 40 ml ASW-YT-SA2 as described above. Cells 
were harvested (OD600 of 0.45 and 0.3 for the mutants and TS559, respectively) by 
centrifugation (5000 g, 30 min, 4°C) and the pellets were resuspended in 500 µl 20 mM Tris-
HCl (pH 7.8). The cells were lysed by sonication, and the cellular debris was removed by 
centrifugation (13,000 g, 30 min, 4°C). Proteome analyses was performed by the Radboud 
Proteomics Centre of the Radboud University Nijmegen Medical Centre, Nijmegen, the 
Netherlands. 5 μg of each of the provided samples (protein concentration determination by 
use of the 2D-Quant kit, GE Healthcare) was in-solution digested including reduction and 
alkylation. After digestion the samples were loaded on Omix C18 tips (Agilent) for desalting 
and concentration and analyzed by nanoflow C18 reversed phase liquid chromatography 
coupled online to a Maxis 4G +ETD QTOF (Bruker Daltonics). The samples were measured 
with CID (Collision Induced Dissociation) as fragmentation technique and chromatographic 
separation was achieved via a linear 90 minutes gradient of 5 to 32% acetonitrile using 0.1% 
formic acid as ion pair reagent. For data analysis a T. kodakarensis KOD1 database, 
downloaded from NCBI, with added sequences for TM0295, TM0438, TM1154, TM1155 and 
 
TM1718 was used. For database searches, validation and relative quantification the 
MaxQuant software package was used (version 1.5.0.0).  
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Supplementary figures and tables  
 
 
Figure S3.1 Example of diagnostic PCR results of a transformant. Results of diagnostic PCR analysis on isolated 
genomic DNA of an SKS002 transformant, i.e. an agmatine prototroph. Three different PCR analyses were 
performed, the results of which are visible in the gels above. On top of each gel, the primer-pair used in the 
specific reaction is indicated (BG-numbers). As described in the material and methods section, the BG-numbers 
correspond to the primers that are illustrated in Figure 3.2B by the letters H-I, C-J, and K-L. Below each gel, the 
expected product size (in bp) of the specific PCR reaction is shown. Besides the isolated genomic DNA of one of 
the agmatine prototrophs, each analysis also included isolated genomic DNA of the host strain, the original 
modification vector, and a No Template Control (NTC). The only exception to this is reaction number 3, in which 
no NTC was included. However, the absence of a product in the reaction containing the modification vector as 
template DNA, confirms that none of the other ingredients of the reaction was contaminated by genomic DNA. 
The solid lines visible in some of the gels indicate non-adjacent lanes of the same gel. Gel image #1 confirms 
integration of the vector (either by single or double recombination) downstream of TK1764. Gel image #2 
confirms integration of the vector upstream of TK1765. Together these results suggest that the desired 
“intermediate recombinant genome” as shown Figure 3.2B, was obtained. Contrary, gel image #3 suggest that 
the isolated genomic DNA is either that of the host strain or that of a transformant that is the result of a single 
crossover event (leading to the integration of the entire modification vector). Together, gel images #1-3 
suggest that there is a mixture of chromosomes in the preparation labeled "intermediate". 
 
 
 
Figure S3.2 In-gel G6PDH and 6PGDH activity assays. cell extracts of the mutant strain SKS001, the parental 
strain TS559 (negative control) and T. maritima MSB8 (positive control), were loaded and resolved on a native 
polyacrylamide gel. Next, the gel was placed in an activity staining buffer containing NADP+, NBT and phenazine 
methosulfate (PMS) and was analyzed for G6PDH and 6PGDH activity by adding either glucose-6-phosphate 
(G6P) or 6-phospho-gluconate (6PG), respectively. PMS acts as an intermediate electron carrier for coupling the 
production of NADPH to the reduction of NBT to insoluble precipitates. When the indicated dehydrogenases 
are actively expressed precipitates will be formed at their position in the gel 
 
 
Figure S3.3 Logarithmic plot of growth data and 
curve fitting of SKS001 (circles), SKS002 
(triangles) and TS559 (squares). Data were fitted 
using a modified Gompertz equation: y = A EXP{-
EXP[µmax.e/A(λ-t) + 1]} where y = ln(N/N0), A = 
maximum OD, µ = maximum growth rate, λ= lag 
phase [501] 
 
 
 
Figure S3.4 Growth properties of T. kodakarensis 
strains TS559 (black circles), SKS001 (white 
squares) and SKS002 (grey triangles) in ASW-YT-
SA2, or of TS559 (light grey circles) in ASW-YT-
SA2 supplemented with the nucleosides A 
(purine) and U (pyrimidine) 
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Figure S3.5 Normalized H2 production by T. kodakarensis TS559 (black), SKS001 (white) and SKS002 (grey) in 
ASW-YT-SA2 (A) Specific H2 production (H2/OD600) in time (B) Specific H2 production (H2/OD600) per OD. The 
data presented in this graph is corrected for the different growth rates of the various strains 
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Figure S3.5 Normalized H2 production by T. kodakarensis TS559 (black), SKS001 (white) and SKS002 (grey) in 
ASW-YT-SA2 (A) Specific H2 production (H2/OD600) in time (B) Specific H2 production (H2/OD600) per OD. The 
data presented in this graph is corrected for the different growth rates of the various strains 
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Table S3.2 sequences of oligonucleotide primers used in this study 
Oligonucleotide Sequence (5’-3’) Application 
BG3884 GACACGACCTCCGGAGATTTTTCAGTTGAAGGTTT Creation pSKS019: inverse PCR on 
pUDhps-phi (R) 
BG3885 TGAGTGAGGGTCGCGATGTTCTCCTTTACCCATATT Creation pSKS019: inverse PCR on 
pUDhps-phi (F) 
BG3952 TGAAGAGCCACATAGGCC Diagnostic PCR: binds TM0438
sequence (F) 
BG4126 GCATATGAGCTGGACAACCC Diagnostic PCR: binds TK0149
sequence (F) 
BG4129 GTATCCAGATCCTTTAAGCC Diagnostic PCR: binds TK0477
sequence (R) 
BG4131 CTCAAGTTCTTCAATGTCCTCTGG
 
Diagnostic PCR: binds TK0473
sequence (F) 
BG4133 ACCCTCTTCATGAGGAG Diagnostic PCR: binds TM1155
sequence (R) 
BG4654 ACGCCAACCCGGACTTCCTC RT-PCR: TM1155 (F) 
BG4655 GCCGAGGTAGTGGTCTATCC RT-PCR: TM1155 (R) 
BG4656 CGCCAGGAAGGGCTACAAGG RT-PCR: TM0438 (F) 
BG4657 CTAACGCCCATGCCGAGG RT-PCR: TM0438 (R) 
BG4658 CCCACTGGCTTGAAGTAGGC Diagnostic PCR: binds TK0475
sequence (F); 
RT-PCR: TK0475 (F) 
BG4659 TGTGGACGAGGATGTAGTGG
 
Diagnostic PCR: binds TK0475
sequence (R); 
RT-PCR: TK0475 (R) 
BG4662 GCTTGGGTCATGGACAGGCTC RT-PCR: TK0308 (F) 
BG4663 TCTTAACCTGCTCGGCGACC RT-PCR: TK0308 (R) 
BG4718 GCGCGGATCCCTTCCCGAGCACTTCTTCGC Creation pSKS022: inverse PCR on 
pSecPyrF (F) 
BG4720 CCGGAATTCCGGACAACACCCCTTGAGCTTTG Creation pSKS022: inverse PCR on 
pSecPyrF (R) 
BG4869 CCCGACCCTCATAAGCAAAG RT-PCR: TM0295 (F) 
BG4871 CATCCTCACAGGGACGTTTG Diagnostic PCR: binds TK1763
sequence (F) 
BG4872 TGAACTCGGCACCCTCTTTG Diagnostic PCR: binds TM0295
sequence (R) 
BG4873 ACAGACTTGAGGTGGAAAGG
 
Diagnostic PCR: binds TK1766
sequence (R) 
BG4874 ACCTTCAGGGCACTCAACAC Diagnostic PCR: binds TM1154
sequence (F) 
BG4982 GTTGCTGAGGTCGTCCATCC RT-PCR: TM0295 (R) 
BG4983 CCCGAGGACTACATAGACAG RT-PCR: TM1718 (F) 
BG4984 CTCCGCCATCAACCATTATC RT-PCR: TM1718 (R) 
BG4985 AGCGACCAGAGCAACTTTAG RT-PCR: TM1154 (F) 
BG4986 TTGAGTGCCCTGAAGGTGAG RT-PCR: TM1154 (R) 
BG5059 AAGCTACCTCGACCAGTATC Diagnostic PCR: binds TK1765
sequence (F) 
BG5060 GTCCCAGTAGTCCATAACTC Diagnostic PCR: binds TK1765
sequence (R) 
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pUDhps-phi (R) 
BG3885 TGAGTGAGGGTCGCGATGTTCTCCTTTACCCATATT Creation pSKS019: inverse PCR on 
pUDhps-phi (F) 
BG3952 TGAAGAGCCACATAGGCC Diagnostic PCR: binds TM0438
sequence (F) 
BG4126 GCATATGAGCTGGACAACCC Diagnostic PCR: binds TK0149
sequence (F) 
BG4129 GTATCCAGATCCTTTAAGCC Diagnostic PCR: binds TK0477
sequence (R) 
BG4131 CTCAAGTTCTTCAATGTCCTCTGG
 
Diagnostic PCR: binds TK0473
sequence (F) 
BG4133 ACCCTCTTCATGAGGAG Diagnostic PCR: binds TM1155
sequence (R) 
BG4654 ACGCCAACCCGGACTTCCTC RT-PCR: TM1155 (F) 
BG4655 GCCGAGGTAGTGGTCTATCC RT-PCR: TM1155 (R) 
BG4656 CGCCAGGAAGGGCTACAAGG RT-PCR: TM0438 (F) 
BG4657 CTAACGCCCATGCCGAGG RT-PCR: TM0438 (R) 
BG4658 CCCACTGGCTTGAAGTAGGC Diagnostic PCR: binds TK0475
sequence (F); 
RT-PCR: TK0475 (F) 
BG4659 TGTGGACGAGGATGTAGTGG
 
Diagnostic PCR: binds TK0475
sequence (R); 
RT-PCR: TK0475 (R) 
BG4662 GCTTGGGTCATGGACAGGCTC RT-PCR: TK0308 (F) 
BG4663 TCTTAACCTGCTCGGCGACC RT-PCR: TK0308 (R) 
BG4718 GCGCGGATCCCTTCCCGAGCACTTCTTCGC Creation pSKS022: inverse PCR on 
pSecPyrF (F) 
BG4720 CCGGAATTCCGGACAACACCCCTTGAGCTTTG Creation pSKS022: inverse PCR on 
pSecPyrF (R) 
BG4869 CCCGACCCTCATAAGCAAAG RT-PCR: TM0295 (F) 
BG4871 CATCCTCACAGGGACGTTTG Diagnostic PCR: binds TK1763
sequence (F) 
BG4872 TGAACTCGGCACCCTCTTTG Diagnostic PCR: binds TM0295
sequence (R) 
BG4873 ACAGACTTGAGGTGGAAAGG
 
Diagnostic PCR: binds TK1766
sequence (R) 
BG4874 ACCTTCAGGGCACTCAACAC Diagnostic PCR: binds TM1154
sequence (F) 
BG4982 GTTGCTGAGGTCGTCCATCC RT-PCR: TM0295 (R) 
BG4983 CCCGAGGACTACATAGACAG RT-PCR: TM1718 (F) 
BG4984 CTCCGCCATCAACCATTATC RT-PCR: TM1718 (R) 
BG4985 AGCGACCAGAGCAACTTTAG RT-PCR: TM1154 (F) 
BG4986 TTGAGTGCCCTGAAGGTGAG RT-PCR: TM1154 (R) 
BG5059 AAGCTACCTCGACCAGTATC Diagnostic PCR: binds TK1765
sequence (F) 
BG5060 GTCCCAGTAGTCCATAACTC Diagnostic PCR: binds TK1765
sequence (R) 
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Abstract 
 
The euryarchaeon Thermococcus kodakarensis is a well characterized anaerobic 
hyperthermophilic heterotroph and due to the availability of genetic engineering systems it 
has become one of the model organisms for studying Archaea. Despite this prominent role 
among the Euryarchaeota, no data about the ploidy level of this species is available. While 
polyploidy has been shown to exist in various Euryarchaeota, especially Halobacteria, the 
chromosome copy number of species belonging to one of the major orders within that 
phylum, i.e. the Thermococcales (including Thermococcus spp. and Pyrococcus spp.), has 
never been determined. This prompted us to investigate the chromosome copy number of T. 
kodakarensis. In this study, we demonstrate that T. kodakarensis is polyploid with a 
chromosome copy number that varies between 7 to 19 copies, depending on the growth 
phase. An apparent correlation between the presence of histones and polyploidy in Archaea 
is observed. 
  
 
Introduction 
 
Thermococcus kodakarensis is a marine hyperthermophilic, heterotrophic, obligate 
anaerobic euryarchaeon that can grow at temperatures ranging from 60°C to 100°C, with an 
optimum at 85°C. T. kodakarensis can grow on a variety of organic substrates in the 
presence of elemental sulfur, producing hydrogen sulfide, or when pyruvate or starch are 
present, in the absence of elemental sulfur producing hydrogen. Under optimal conditions, 
T. kodakarensis grows rapidly to high cell densities, having an estimated doubling time of 
~40 minutes. Moreover, it can be grown on solid media, forming defined but small colonies 
[57, 58]. With its genome being fully sequenced [59], its natural competence and the 
establishment of various genetic engineering techniques [60-63], T. kodakarensis rapidly 
became one of the model organisms for studying anaerobic Archaea.  
While genome modifications are generally relatively easily obtained in this organism, and 
thus routinely applied (e.g. [62, 71, 81-83, 104-106]), occasionally, we experienced 
difficulties in obtaining transformants with two homologous recombinations. Without going 
into too much detail, those data suggested that the desired double crossover modification 
co-existed with single crossover insertions, as well as with the wild type chromosome. The 
difficulty in obtaining homozygous recombinant cultures by repetitive cycles of re-streaking 
and screening, as well as the repeated observation of this phenomenon among different 
transformation attempts, suggested that T. kodakarensis may possess multiple copies of its 
chromosome.  
In contrast to the general idea of prokaryotes being monoploid, polyploidy has in recent 
years been demonstrated for various species including many Euryarchaeota (Table 4.1), the 
phylum that  T. kodakarensis belongs to. Although monoploid and polyploid species can co-
exist within one phylum [503], none of the Euryarchaeota investigated so far was 
monoploid. It has therefore been suggested that polyploidy might be a common feature in 
Euryarchaeota [504]. In this study, we determined the chromosome copy number of the 
euryarchaeon T. kodakarensis. The copy number was determined for three different growth-
phases; the early exponential phase, the late exponential / linear phase and the early 
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stationary phase. Our results confirm that T. kodakarensis is truly polyploid and that the 
exact ploidy level is dependent on the growth phase. In addition, a potential correlation 
between the presence of histones and polyploidy in Archaea is suggested. 
 
Results 
Growth analysis and preliminary quantification by “agarose gel method” 
To make growth curves, five independent cultures of T. kodakarensis were grown on 
pyruvate, and their average OD600 values and their variances were used to construct Figure 
4.1. The results show that growth is highly reproducible, which is a prerequisite for reliable 
chromosome copy number quantification methods. Before an exact chromosome copy 
number quantification was performed, however, a preliminary in-gel quantification was 
applied first to determine the probability of polyploidy in T. kodakarensis, and hence if a 
more exact quantification method was worth applying. This was done by preparing cell 
lysate samples, in duplicate, of three independent cultures having an OD600 of ~0.76. 
Corresponding cell densities were determined and aliquots of the 6 samples obtained were 
loaded on an agarose gel flanked by a known amount of an 1 kb GeneRuler DNA ladder 
(Thermo Scientific) as shown in Figure 4.2A. The DNA concentration and chromosome copy 
number of each sample was quantified by measuring the fluorescence intensity of the 
corresponding gel bands and comparing it to the ladder containing known concentrations of 
DNA. Together with the original cell density of each sample, the number of chromosome 
copies per cell was calculated (supplementary file). The results are shown in Figure 4.2B. 
These results clearly indicate polyploidy in T. kodakarensis, suggesting an average 
chromosome copy number of 17.8 ± 3.8. It was therefore decided to determine the 
chromosome copy number by a more exact quantification method as well. 
 
 
 
 
Table 4.1 Chromosome copy number of archaeal species and the distribution of archaeal histones 
PHYLUM 
Order 
Species 
Doubling 
time (h) 
Genome copy 
number Ploidy Histones Reference 
 Exp. 
phase 
Stat. 
phase 
  
EURYARCHAEOTA   
Halobacteriales   
Halobacterium cutirubrum 6.7 10.6 Polyploid yesa [505] 
Halobacterium cutirubrum 13.3 6.3 Polyploid yesa [505] 
Halobacterium salinarum 4 25 1 Polyploid yes [506] 
Halobacterium salinarum 8 25 15 Polyploid yes [506] 
Haloferax volcanii 4 17 10 Polyploid yes [506] 
Haloferax mediterranei 30-55 20-30 Polyploid yes [507] 
Methanosarcinales   
Methanosarcina acetivorans 6 18 16 Polyploid yes [504] 
Methanosarcina acetivorans 49 3 5 Polyploid yes [504] 
Methanobacteriales   
Methanothermobacter 
thermautotrophicus 
2 1-2 Diploidb yes [508] 
Methanomicrobiales   
Methanoculleus marisnigri yes  
Thermococcales   
Thermococcus kodakarensis 1.25 19.4 7.5 Polyploid yes This study 
Pyrococcus furiosus multiple yes [509] 
Pyrococcus abyssi multiple yes [510] 
Methanococcales   
Methanocaldococcus jannaschii 0.5 10-15 1-5 Polyploid yes [509] 
Methanococcus maripaludis 2 55 30 Polyploid yes [504] 
Thermoplasmatales   
Thermoplasma acidophilum noc  
Thermoplasma volcanium noc  
Ferroplasma acidarmanus noc  
Archaeoglobales   
Archaeoglobus fulgidus multiple yes [509] 
Methanopyrales   
Methanopyrus kandleri yes  
Methanocellales   
Methanocella paludicola Yes  
CRENARCHAEOTA   
Acidilobales   
Acidianus hospitalis 1-2 2 Monoploid no [511] 
Desulfurococcales   
Aeropyrum pernix 3.3 1-2 2 Monoploid no [511] 
Fervidicoccales   
Fervidicoccus fontis no  
Sulfolobales   
Sulfolobus acidocaldarius 3.5 1-2 2 Monoploid no [512] 
Sulfolobus tokodaii 8 1-2 2 Monoploid no [511] 
Sulfolobus solfataricus 7 1-2 2 Monoploid no [512] 
Thermoproteales   
Pyrobaculum aerophilum 1-2 2 Monoploid no [511] 
39949 Spaans, Bas.indd   138 20-05-16   10:55
Chromosome copy number
139
4
 
stationary phase. Our results confirm that T. kodakarensis is truly polyploid and that the 
exact ploidy level is dependent on the growth phase. In addition, a potential correlation 
between the presence of histones and polyploidy in Archaea is suggested. 
 
Results 
Growth analysis and preliminary quantification by “agarose gel method” 
To make growth curves, five independent cultures of T. kodakarensis were grown on 
pyruvate, and their average OD600 values and their variances were used to construct Figure 
4.1. The results show that growth is highly reproducible, which is a prerequisite for reliable 
chromosome copy number quantification methods. Before an exact chromosome copy 
number quantification was performed, however, a preliminary in-gel quantification was 
applied first to determine the probability of polyploidy in T. kodakarensis, and hence if a 
more exact quantification method was worth applying. This was done by preparing cell 
lysate samples, in duplicate, of three independent cultures having an OD600 of ~0.76. 
Corresponding cell densities were determined and aliquots of the 6 samples obtained were 
loaded on an agarose gel flanked by a known amount of an 1 kb GeneRuler DNA ladder 
(Thermo Scientific) as shown in Figure 4.2A. The DNA concentration and chromosome copy 
number of each sample was quantified by measuring the fluorescence intensity of the 
corresponding gel bands and comparing it to the ladder containing known concentrations of 
DNA. Together with the original cell density of each sample, the number of chromosome 
copies per cell was calculated (supplementary file). The results are shown in Figure 4.2B. 
These results clearly indicate polyploidy in T. kodakarensis, suggesting an average 
chromosome copy number of 17.8 ± 3.8. It was therefore decided to determine the 
chromosome copy number by a more exact quantification method as well. 
 
 
 
 
Table 4.1 Chromosome copy number of archaeal species and the distribution of archaeal histones 
PHYLUM 
Order 
Species 
Doubling 
time (h) 
Genome copy 
number Ploidy Histones Reference 
 Exp. 
phase 
Stat. 
phase 
  
EURYARCHAEOTA   
Halobacteriales   
Halobacterium cutirubrum 6.7 10.6 Polyploid yesa [505] 
Halobacterium cutirubrum 13.3 6.3 Polyploid yesa [505] 
Halobacterium salinarum 4 25 1 Polyploid yes [506] 
Halobacterium salinarum 8 25 15 Polyploid yes [506] 
Haloferax volcanii 4 17 10 Polyploid yes [506] 
Haloferax mediterranei 30-55 20-30 Polyploid yes [507] 
Methanosarcinales   
Methanosarcina acetivorans 6 18 16 Polyploid yes [504] 
Methanosarcina acetivorans 49 3 5 Polyploid yes [504] 
Methanobacteriales   
Methanothermobacter 
thermautotrophicus 
2 1-2 Diploidb yes [508] 
Methanomicrobiales   
Methanoculleus marisnigri yes  
Thermococcales   
Thermococcus kodakarensis 1.25 19.4 7.5 Polyploid yes This study 
Pyrococcus furiosus multiple yes [509] 
Pyrococcus abyssi multiple yes [510] 
Methanococcales   
Methanocaldococcus jannaschii 0.5 10-15 1-5 Polyploid yes [509] 
Methanococcus maripaludis 2 55 30 Polyploid yes [504] 
Thermoplasmatales   
Thermoplasma acidophilum noc  
Thermoplasma volcanium noc  
Ferroplasma acidarmanus noc  
Archaeoglobales   
Archaeoglobus fulgidus multiple yes [509] 
Methanopyrales   
Methanopyrus kandleri yes  
Methanocellales   
Methanocella paludicola Yes  
CRENARCHAEOTA   
Acidilobales   
Acidianus hospitalis 1-2 2 Monoploid no [511] 
Desulfurococcales   
Aeropyrum pernix 3.3 1-2 2 Monoploid no [511] 
Fervidicoccales   
Fervidicoccus fontis no  
Sulfolobales   
Sulfolobus acidocaldarius 3.5 1-2 2 Monoploid no [512] 
Sulfolobus tokodaii 8 1-2 2 Monoploid no [511] 
Sulfolobus solfataricus 7 1-2 2 Monoploid no [512] 
Thermoproteales   
Pyrobaculum aerophilum 1-2 2 Monoploid no [511] 
39949 Spaans, Bas.indd   139 20-05-16   10:55
140
Chapter 4
 
Pyrobaculum calidifontis 3.4 1-2 2 Monoploid no [511] 
Thermofilum pendens yes  
Caldivirga maquilingensis yes  
Vulcanisaeta distributa Yes  
THAUMARCHAEOTA   
Cenarchaeales   
Cenarchaeum symbiosum yes  
Nitrosopumilales   
Nitrosopumilus maritimus yes  
Nitrososphaerales   
Nitrososphaera viennensis Yes  
KORARCHAEOTA   
Candidatus Korarchaeum 
cryptofilum 
Yes 
 
 
NANOARCHAEOTA   
Nanoarchaeum equitans  yes  
 
Table 1. Chromosome copy number of archaeal species and the distribution of archaeal histones The table 
gives an overview of all studies in which chromosome copy numbers of archaeal species have been 
determined. The table was adapted from a table presented by Hillenbrand et al. [504], by including 
chromosome copy numbers of several additional species, grouping the results per order and including an extra 
column showing the presence or absence of archaeal histone homologs. The organisms that were not present 
in the histone database were additionally checked by BLAST for histone homologs. For the orders for which no 
ploidy level data is available, representative species, whose genome is available and could be screened for the 
presence of archaeal histone homologs, were randomly picked. 
aThe species Halobacterium salinarum, Halobacterium halobium, and Halobacterium cutirubrum are so similar 
that they should be regarded as strains of one species named Halobacterium salinarum. H. cutirubrum is 
therefore, as such, not present in the histone database [513].  
bThe cells grow in filaments; the numbers given are thus genome copies per cell, not per filament 
cThe Thermoplasmatales do not encode archaeal histones, however, they do encode homologs of HU-proteins 
(bacterial histone-like proteins) 
 
 
 
 
 
 
 
 
Figure 4.1. Growth curve. Increase in optical 
density of Thermococcus kodakarensis KOD1 (WT) 
in time on ASW-YT-Pyr medium. The graph 
represents the average optical density at 600 nm 
(OD600) of five independent cultures  
 
 
 
 
 
 
 
Quantification by “real-time PCR method” 
To certify polyploidy in T. kodakarensis and to quantify chromosome copy numbers more 
accurately, a previously developed real-time PCR method for quantification of chromosome 
copy numbers was optimized for T. kodakarensis. This chromosome quantification method 
has been established for haloarchaea in 2006 [506], and has since then been applied to 
various other prokaryotes. The method has been validated against several independent 
techniques and has shown to be very reliable [503, 504, 514]. A schematic overview of the 
method can be found in the previous report [504].  
To give a short overview, a fragment of about 1 kb is amplified first, using standard PCR with 
genomic DNA as template. A dilution series of this fragment is made and used to generate a 
standard curve in a real-time PCR analysis. This is done by amplifying a fragment of about 
300 bp, internal to the standard fragment, and by plotting the threshold value (Cq) against 
the corresponding template concentration (in copies / µl). To quantify the chromosome copy 
number of the species of interest, cells are lysed and a dilution series of the resulting cell 
lysates is analysed by real-time PCR in parallel to the standards. By comparing the Cq values 
of the cell lysate samples to the standard curve, the number of chromosome copies per 
sample can be determined, which in combination with the cell density of the corresponding 
culture, allows for calculating the ploidy level. 
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Figure 4.2. Chromosome copy number quantification by “agarose gel method” (A) Agarose gel containing cell 
lysate samples of three independent cultures, in duplicate, flanked by a 1 kb GeneRuler DNA ladder. The white 
line indicates non-adjacent lanes of the same gel. The DNA concentration and chromosome copy number of 
each sample was quantified by comparing the fluorescence intensity of the gel bands to that of the left and 
right ladder. (B) The number of chromosome copies per cell. This was calculated by dividing the chromosome 
copy number of the lysate by the original cell density of each replicate 
 
Cultures for chromosome copy number determination were grown to the optical densities as 
shown in Figure 4.3, representing the early exponential phase, late exponential / linear 
phase and early stationary phase. For each growth phase, samples were taken from three 
independent cultures. When the cultures reached the desired optical density, 1.5-ml 
samples were taken and cells were harvested by centrifugation and the supernatant was 
checked microscopically to verify that it was free of cells; which was the case. The cell 
numbers of the cultures at the moment of sampling were determined (see Figure 4.3C) and 
cells were lysed by adding SDS, which was found to be the most effective (see material and 
methods).  
A. 
B. 
 
A tenfold dilution series of the cell lysates was prepared and used for real-time PCR analysis 
in parallel with the standard fragment. To verify that the added SDS or other components 
present in the cell lysate did not negatively influence the reaction itself, the standard 
dilution series was also added to 4 selected dilutions of the cell lysate sample as an internal 
control. No inhibiting effects were observed for any of the selected samples. The final real-
time PCR was performed by including technical duplicates, in addition to the biological 
triplicates, and had an efficiency of 90.3%, an R2 of 0.999 and a slope of -3.5. The results of 
the real-time PCR are shown in Figure 4.3. It was found that cells in the early exponential 
phase contain about 19.4 ± 4.9 copies of their chromosome, and that this value drops to 7.5 
± 2.8 copies in early stationary phase. The two independent quantification methods thus 
both confirm polyploidy in T. kodakarensis.  
Discussion 
 
The results obtained in this study show that the euryarchaeon T. kodakarensis contains 
multiple chromosomes, with numbers varying from ~7 to 19 copies per cell. Although 
polyploidy has been demonstrated for several Euryarchaeota, the chromosome copy 
number of species belonging to one of the major orders within that phylum, i.e. the 
Thermococcales (including Thermococcus spp. and Pyrococcus spp.), has never been 
determined. The existence of polyploidy in T. kodakarensis supports the suggestion of 
Hildenbrand, et al. (2011) that polyploidy might be a common trait of all Euryarchaeota 
[504]. The only exception known so far is Methanothermobacter thermautotrophicus, which 
was reported to be diploid instead [508]. T. kodakarensis was found to have a growth-phase-
dependent ploidy level having as many as 19.4 ± 4.9 chromosome copies at the early 
exponential phase, which is strongly decreasing towards the stationary phase. The 
observation of a growth-phase-dependent ploidy level has been reported for many other 
prokaryotes as well, including the majority of the investigated euryarchaeal species [503, 
504, 506, 514]. Unfortunately, no common pattern has emerged from the characterized 
prokaryotic species [506]. Where some species have a higher chromosomal copy number in 
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A tenfold dilution series of the cell lysates was prepared and used for real-time PCR analysis 
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the exponential phase (e.g. T. kodakarensis or some halophillic Archaea [506]), others have a 
higher chromosomal copy number in the stationary phase (e.g. Azotobacter vinelandii [515]). 
Although a chromosome copy number of around 19 might seem to be rather high, this result 
is comparable to copy numbers (2-55) found in many other Euryarchaeota (see Table 4.1). 
The euryarchaea Methanococcus maripaludis and Haloferax mediterranei were even found 
to have up to 55 chromosome copies per cell, which is the highest copy number for Archaea 
described so far. While this is more than double the number found for T. kodakarensis, it is 
still low compared to the copy numbers reported for the cyanobacterium Synechocystis sp. 
PCC 6803 or the firmicute Epulopiscium spp., having up to 218 or even tens of thousands of 
copies, respectively [514, 516]. The bacterium Epulopiscium spp., however, is quite 
extraordinary in that it is one of the largest known bacteria (200-700 µm), having sufficient 
intracellular space to contain an exceptionally high number of chromosomes [517]. 
Synechocystis sp. PCC 6803, in contrast, is similar in size (2 µm) to T. kodakarensis, and one 
may wonder how it is able to accommodate up to 10 times more chromosomes [57, 518]. 
The finding that T. kodakarensis is polyploid is also in good agreement with results obtained 
in chromosome quantification studies of the genetically accessible extremophiles D. 
radiodurans and T. thermophilus [519, 520]. Both bacteria were reported to have similar 
engineering difficulties as the ones occasionally observed for T. kodakarensis and were 
subsequently found to have multiple copies (6-10 and 4-5, respectively) of their 
chromosome. The existence of multiple chromosome copies can readily explain the 
occasionally observed difficulty in obtaining homozygous recombinant cultures, as it entails 
that the desired strain is only obtained when the modification is incorporated in all 
chromosome copies 
 
 
 
 
 
 
     
 
 
Figure 4.3. Chromosome copy number quantification by real time PCR method a. Selected real time PCR 
results. The fluorescent intensity curves from four standard dilutions (in red), three sample dilutions (in green), 
and a No Template Control (NTC, in blue) are shown. The reactions containing the standard dilutions were 
performed in triplicate and the ones containing the samples in duplicate (these technical duplicates were in 
addition to the biological triplicates). The curves shown are the result of serial tenfold dilutions of the 
templates. In addition to the selected reactions shown here, each experiment included more standard and 
more sample dilutions. b. Standard curve. The standard curve was created by plotting the threshold values (Cq) 
of the individual reactions against the corresponding template concentration. c. Average chromosome copy 
number values and their standard variations of T. kodakarensis in three different growth phases. The third 
sample of the early stationary phase (in parentheses) could be argued not to be in the early stationary phase. 
Therefore, the average chromosome copy number and its standard deviation in this phase was calculated by 
both including (in parentheses) and excluding the third biological replicate 
 
Physical implications of polyploidy 
Based on the results obtained, several questions arise: (1) how are polyploid prokaryotes 
able to fit that many copies of its chromosome in a cell, and related to that, how is 
spontaneous aggregation due to the high DNA concentrations prevented, and (2) what 
possible evolutionary advantages could polyploidy have? Since the latter aspect has been 
thoroughly covered in recent papers [521-523], describing potential advantages such as 
conferring resistance to DNA damage or allowing heterozygosity to occur (both of which 
A. B.
C. 
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might be beneficial for survival in extreme conditions), only the former question will be 
briefly addressed here. 
It is well known that all living things have to extensively condense their genomic DNA to fit it 
in the physically small space of a cell. In addition, this so-called DNA packaging also prevents 
spontaneous aggregation due to the high concentration imposed by the confinement [524]. 
The key mechanisms employed for DNA packaging are DNA supercoiling, macromolecular 
crowding and the association of DNA-binding proteins that fold the genome into a more 
condensed structure. The interactions between DNA-binding proteins and the genomic DNA 
can have different structural effects on DNA, such as bending, bridging or wrapping, each of 
which mediates DNA-packaging in a different way (reviewed in e.g. [525, 526]).  
DNA-binding proteins are generally small basic proteins that are abundantly present. The 
best examples are the eukaryotic histones that wrap genomic DNA by folding it around their 
surface forming so-called nucleosomes, the primary unit of DNA compaction. Archaeal 
homologs of histone proteins have been found in almost all Euryarchaeota (including T. 
kodakarensis), Nanoarchaeota and Thaumarchaeota, but are generally not encoded by 
Crenarchaeota [527-532]. Interestingly, a similar dichotomy between Euryarchaeota and 
Crenarchaeota can be observed regarding their ploidy levels: almost all tested Euryarchaeal 
species have been found to be polyploid, while, all the Crenarchaeal species tested to date 
were found to be monoploid [504] (Table 4.1). Whether there is any correlation between 
these observations is currently unknown, however it is tempting to speculate that histones 
play an important role in enabling polyploidy in Archaea. 
While DNA packaging explains how a single genome is sufficiently condensed to fit the 
physically small space of a cell, it does not clarify how many chromosome copies actually fit 
in. To answer this question we compared the situation in T. kodakarensis with the situation 
in E. coli, for which it is known that on average two chromosome copies (~9.2 Mbp in total, 
~0.136-0.16 µm3 [533]) occupy about a quarter of the total cell volume (total cell volume of 
E. coli: 0.58-0.69 µm3 [534]) [535]. Assuming that DNA packaging in T. kodakarensis is as 
efficient as in E. coli and that the irregular cocci of T. kodakarensis are perfect spheres 
 
(having a cell diameter of 1-2 µm and hence a cell volume of ~0.52-4.18 µm3), fitting up to 
~19 copies of its chromosome (~39.7 Mbp in total, ~0.587-0.690 µm3), should physically, 
thus, be possible.       
Conclusion 
 
We clearly showed that T. kodakarensis has multiple chromosome copies and that this result 
supports earlier reports on the presence of polyploidy in Euryarchaeota. The existence of 
multiple chromosome copies can also readily explain the occasionally observed difficulty in 
obtaining homozygous recombinant cultures, as it entails that the desired strain is only 
acquired when the modification is incorporated in all chromosome copies. Moreover, an 
apparent correlation between the presence of histones and polyploidy in Archaea is 
observed. The histones may assist in the efficient DNA packaging which is required for fitting 
multiple chromosomes in a single cell.  
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Materials and Methods  
Culture conditions and growth analysis  
The hyperthermophillic archaeon Thermococcus kodakarensis KOD1 wild-type strain was 
grown anaerobically at 85°C in ASW-YT-Pyr medium. The ASW-YT medium was composed of 
0.8x artificial seawater (0.8x ASW), 5.0 g/L yeast extract, 5.0 g/L tryptone and 0.8 mg/L 
resazurine. Before inoculation, 5.0 g/L sodium pyruvate (ASW-YT-Pyr medium) was added to 
the medium, as well as Na2S.9H2O, until it became colorless. For all cultivations, 120-ml 
serum bottles containing 40 ml culture with N2 as headspace were used. Cultures were 
continuously shaken (120 rpm) during growth. Growth was monitored by measuring the 
optical density at 600 nm (OD600) using an U-1500 spectrophotometer (Hitachi). Five 
independent cultures were grown, and their average OD600 value and their variances were 
calculated (Figure 4.1).  
 
Sample extraction, cell lysis and determination of cell number  
Cultures for chromosome copy number determination were inoculated from fresh pre-
cultures in the late exponential growth phase (1% inoculum) and grown to the desired 
optical density. For each growth phase, samples were taken from three independent 
cultures. When the cultures reached the desired optical density, 1.0 ml and 1.5 ml-samples 
were taken by syringe and cells were harvested by centrifugation (5000 g, 30 min, RT), for 
the “agarose gel method” and “real time PCR method” respectively. The supernatant was 
checked microscopically to verify that it was free of cells. Cell pellets were stored at -20°C 
until further processing. The cell number of the cultures at the moment of sampling was 
determined by directly counting the cells using a Neubauer counting chamber. The pellets 
were resuspended in 100 µl TE buffer (10 mM Tris; 0.1 mM EDTA, pH8.5). Cell lysis was 
performed by adding SDS to a final concentration of 0.3%. Complete cell lysis was verified 
microscopically and the integrity of genomic DNA was verified by agarose gel 
electrophoresis.  
  
 
Preliminary quantification of chromosome copy number by “agarose gel method” 
To determine if T. kodakarensis could indeed possess multiple chromosomes per cell, and 
hence if it would be worth pursuing quantification by a more accurate method, a preliminary 
quantification experiment was performed first. This was done by preparing cell lysates of 
three independent cultures having an OD600 of ~0.76 (see above). To minimize the disturbing 
effect of SDS during agarose gel electrophoresis, the cell lysate was diluted 10-fold by adding 
TE buffer to a final volume of 1 ml. Aliquots of 5 µl of each sample were loaded, in duplicate, 
on a 1% agarose gel containing the SYBR Safe DNA gel stain (Life technologies), flanked by a 
known amount of a 1 kb GeneRuler DNA ladder (Thermo scientific). Since the SYBR Safe DNA 
gel stain moves away from the migrating DNA, the stain was also added to the running 
buffer to ensure an equal concentration of the stain in the entire gel. After electrophoresis, 
the DNA concentration of each sample was quantified by measuring the fluorescence 
intensity of the corresponding bands using a G:box imager and GeneSys analysis software 
(Syngene) and comparing it to the ladder with known concentrations of DNA. The molecular 
weight (in Daltons) of one chromosome copy was computed with the “DNA molecular 
weight calculator” (http://www.currentprotocols.com/WileyCDA), which was then 
converted to its mass (in grams) by using a “Dalton to grams conversion calculator” 
(http://www.unitconversion.org). Next, the chromosome copy number in the cell lysate was 
calculated by dividing the DNA concentration of the lysate by the mass of one chromosome. 
Finally, the number of chromosome copies per cell was calculated by combining this with the 
original cell density of the sample (an overview of these calculations is available online: DOI 
10.1007/s00792-015-0750-5; supplementary file). 
Quantification of chromosome copy number by “real-time PCR method” 
To determine chromosome copy numbers, a previously developed real-time PCR approach 
was used [506]. A schematic overview of the method can be found in Hildenbrand, et al. 
[504]. First, to make a standard curve, a 1 kb fragment was amplified using conventional PCR 
with genomic DNA as template. The genomic DNA was isolated by using a genomic DNA 
purification kit (Thermo scientific, protocol for Gram positive bacteria). The 1 kb fragment 
generated in this study was internal to the chitinase gene (TK1765) as the amplification of 
this fragment had previously been shown to be successful, resulting in a clear, single 
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product-band on gel. The primers used are shown in Table S4.1. The fragment was purified 
by using preparative agarose gel electrophoresis (0.8%) and an GeneJET Gel extraction kit 
(Thermo Scientific), and concentrated by an DNA Clean and Concentrator kit (ZYMO 
RESEARCH). The DNA concentration was determined with a Nanodrop ND-1000, and the 
number of DNA molecules was calculated using the molecular weight computed with “oligo 
calc” (www.basic.northwestern.edu/biotools/oligocalc.html). A serial tenfold dilution 
containing defined numbers of standard molecules was generated in triplicate, and used for 
real-time PCR analysis in parallel with a dilution series of cell lysate samples. 
To minimize the inhibiting effect of SDS on real-time PCR, the cell lysate (see above) was first 
diluted to a final SDS concentration of 0.03% by adding TE buffer to a final volume of 1 ml. 
This diluted cell lysate sample was used for making the dilution series that was used for real-
time PCR. A 5-µl aliquot of the dilution series was used as template in the real-time PCR 
analyses for quantification of chromosome copy numbers (see below). To ensure that the 
PCR efficiency of the cell lysate dilution series and the standard dilutions series was identical, 
the standard dilution series was also added to 4 selected dilutions of the cell lysate sample 
as an internal control, yielding 6 different dilution series in total. The fragment targeted in 
the real-time PCR analysis was 293 bp and was internal to the standard fragment.  
Real-time PCR was performed in 25-µl reactions containing 5 µl of template (cell lysate, 
standard, or cell lysate with added standard), 100 mM of primer BG5331 and BG5332 each 
and 2x qPCR Master Mix (iQ SYBR Green Supermix, BIO RAD). The master mix contained 
antibody-mediated hot start iTaq DNA polymerase, dNTPs, SYBR GREEN I, MgCl2, enhancers, 
stabilizers and fluorescein (concentrations not released by BIO RAD). The PCR reaction 
conditions were 10 min at 95°C, 40 cycles of amplification (30 sec at 95°C, 30 sec at 59°C, 30 
sec at 72°C), and an final incubation of 5 min at 72°C. The real-time PCRs were performed in 
a CFX96 thermal cycler (BioRad). At the end of the PCR, a melting curve was generated using 
the following settings: 65°C to 95°C with increments of 0.5°C per 5 sec. For each sample the 
numbers of cycles was determined until its fluorescence intensity reached the threshold (Cq 
value). By comparison of the threshold cycle (Cq) differences of the different dilutions it was 
verified that the PCR was exponential at least up to the threshold DNA concentration used 
 
for the analysis (i.e. a 10-fold dilution corresponds to a Cq difference of 3.6> Cq >3.1, having 
an efficiency of 90%-110%) The Cq values of the standards were used to construct a 
standard curve (Figure 4.3) that was used to determine the chromosome copy number in the 
cell lysates and to check the PCR efficiency in the cell lysates including internal standards. In 
combination with the cell density, the number of chromosome copies per cell was 
calculated. 
Method Optimization  
The protocol as outlined above was established by optimizing different steps individually. 
First, various genomic DNA isolation methods, such as sonication, French press, osmotic 
shock, CTAB/NaCl, lysozyme, SDS or repetitive freeze-thaw cycles were tested for their 
effectiveness (extent of cell lysis and gDNA recovery) and ability to leave the genomic DNA 
intact. The only method meeting both standards, and yielding reproducible results, was the 
addition of SDS to the cell suspensions. Since SDS is known to have disturbing effects on 
both PCR and agarose gel electrophoresis, a series of SDS concentrations was tested to 
determine the minimal concentration needed for complete lysis and yielding reproducible 
results. This was found to be 0.3%. chromosome copy number quantification by the “agarose 
gel method” was improved by addition of the SYBR Safe DNA gel stain to the running buffer 
to ensure an equal concentration of the stain in the entire gel. Real-time PCR was optimized 
by testing three different primer sets for the amplification of a small internal fragment (all 
~300 bp). For each primer set, the optimal annealing temperature was determined by 
gradient PCR. The primer set BG5331-BG5332 (see Table S4.1), resulting in the amplification 
of a 293 bp fragment, turned out to be the most reproducible, without any artificial by-
products. The latter was confirmed by visualizing the amplified fragments on a 1% agarose 
gel as well as by including a melting curve in the real-time PCR protocol.  
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To minimize the inhibiting effect of SDS on real-time PCR, the cell lysate (see above) was first 
diluted to a final SDS concentration of 0.03% by adding TE buffer to a final volume of 1 ml. 
This diluted cell lysate sample was used for making the dilution series that was used for real-
time PCR. A 5-µl aliquot of the dilution series was used as template in the real-time PCR 
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for the analysis (i.e. a 10-fold dilution corresponds to a Cq difference of 3.6> Cq >3.1, having 
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Method Optimization  
The protocol as outlined above was established by optimizing different steps individually. 
First, various genomic DNA isolation methods, such as sonication, French press, osmotic 
shock, CTAB/NaCl, lysozyme, SDS or repetitive freeze-thaw cycles were tested for their 
effectiveness (extent of cell lysis and gDNA recovery) and ability to leave the genomic DNA 
intact. The only method meeting both standards, and yielding reproducible results, was the 
addition of SDS to the cell suspensions. Since SDS is known to have disturbing effects on 
both PCR and agarose gel electrophoresis, a series of SDS concentrations was tested to 
determine the minimal concentration needed for complete lysis and yielding reproducible 
results. This was found to be 0.3%. chromosome copy number quantification by the “agarose 
gel method” was improved by addition of the SYBR Safe DNA gel stain to the running buffer 
to ensure an equal concentration of the stain in the entire gel. Real-time PCR was optimized 
by testing three different primer sets for the amplification of a small internal fragment (all 
~300 bp). For each primer set, the optimal annealing temperature was determined by 
gradient PCR. The primer set BG5331-BG5332 (see Table S4.1), resulting in the amplification 
of a 293 bp fragment, turned out to be the most reproducible, without any artificial by-
products. The latter was confirmed by visualizing the amplified fragments on a 1% agarose 
gel as well as by including a melting curve in the real-time PCR protocol.  
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Abstract 
 
In this study, we set out to identify the enzyme(s) involved in the synthesis of tetraether 
lipids in Thermococcus kodakarensis, more specifically the one(s) responsible for the 
condensation of two C20 isoprenyl chains, i.e. the putative tetraether synthase(s). To do this, 
a list of genes that are potentially involved in tetraether lipid synthesis was composed, and 
prioritized based on a couple of characteristics assumed to be important for a tetraether 
synthase. This resulted in the selection of 12 genes, which were targeted for overexpression 
and disruption. Subsequent diether/tetraether lipid analysis of the mutant strains showed 
that at least three of these genes, i.e. TK1548, TK1836 and TK1957 play a role in controlling 
the amount of GDGTs in the archaeal membrane. Whereas TK1548, annotated as serine-
pyruvate aminotransferase, has no obvious link with lipid biosynthesis, both TK1836 and 
TK1957 have putative roles as geranylgeranyl hydrogenase and polyprenyltransferase, 
respectively. Their role in GDGT synthesis is discussed. Disruption of various other candidate 
genes turned out to be non-viable, which is an interesting result as disruption of a tetraether 
synthase may very well be lethal. However, the data do not allow us to identify the key 
tetraether synthase, and more research is needed to get a better understanding of the 
tetraether synthesis pathway and to identify the tetraether synthase(s).  
 
Introduction 
 
Micro-organisms are able to colonize and survive an extraordinary range of environments. 
Most strikingly, some not only survive, but even thrive under extreme conditions such as 
very high temperatures (thermophiles), salinities (halophiles), or extreme pH levels (acido- 
and alkaliphiles). Though the majority of these so-called extremophiles belong to the 
archaea, they have also been found among the bacterial domain. Since their discovery, 
extremophiles have attracted much attention because of both their biotechnological 
potential and their remarkable physiological capabilities. Obviously, the main focus of how 
these microbes withstand the perturbations of cellular integrity has been on the plasma 
membrane, as the membrane shields the inner homeostatic conditions of the cell from the 
hostile environment. Before the discovery of extremophiles, the membrane composition and 
adaptation strategies of mesophilic bacteria were well described [536-539].  
The cell membrane generally consists primarily of a phospholipid bilayer. In bacteria, the 
framework molecule of these phospholipids is phosphatidic acid. Phosphatidic acid is 
composed of two acyl-chains which are esterified to the backbone sn-glycerol-3-phosphate. 
Phosphatidic acid serves as a basis for a high variety of phospholipids, which are adjusted to 
the needs of the membrane. The main membrane parameters which are subject to change 
in response to varying physicochemical conditions are fluidity and permeability [540, 541]. In 
response to physicochemical stressors, bacteria regulate the saturation and length of the 
acyl chains to keep the membrane parameters within acceptable boundaries.  
Archaea have a different lipid architecture and thus also differ in their homeoviscous 
adaptation strategies [108]. Instead of phosphatidic acid, archaea are generally thought to 
use archaetidic acid as the framework molecule of their phospholipids. Archaetidic acid, 
which is also known as (S)-2,3-di-O-geranylgeranyl-sn-1-glyceryl phosphate (DGGGP), differs 
from phosphatidic acid in several key aspects. For example, the hydrophobic moiety is 
composed of highly branched C20-isoprenoid chains, rather than the bacterial acyl chains. 
Moreover, these chains are bound by ether bonds (as opposed to the bacterial ester bonds) 
to sn-glycerol-1-phosphate, the stereochemical opposite of the bacterial sn-glycerol-3-
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phosphate [542, 543]. These key differences are unique to both domains and have therefore 
been termed “the lipid divide” [544]. Hence, phosphatidic acid and archaetidic acid are 
regarded as marker molecules between prokaryotic lineages.  
Archaetidic acid is generally considered to be the framework molecule of a broad range of 
archaeal membrane lipids [545]. Nevertheless, archaeal membranes typically consist of a 
variation of two main core structures: sn-2,3-diphytanyl glycerol diether, which in this study 
will simply be referred to as diether (and is also known as archaeol), and sn-2,3-dibiphytanyl 
diglycerol tetraether, which in this study will simply be referred to as tetraether (and is also 
known as glycerol-dialkyl-glycerol tetraether (GDGT), or caldarchaeol). The diether lipids are 
generated from archaetidic acid by reducing the unsaturated isoprenoid chains, forming C20-
phytanyl chains, and by subsequent addition of a polar headgroup to the glycerol moiety. 
Tetraether lipids are bipolar, consisting of saturated C40-biphytanyl chains (a molecule that is 
composed of two condensed C20-phytanyl units) and a polar head group at each end of that 
chain. Tetraether lipids form a monolayer membrane, whereas the diether lipids form a 
bilayer structure that closely resembles the traditional double leaflet bilayer of bacteria 
[110, 542, 543].  
The variation observed in tetraether lipids involves the incorporation of one or more 
pentacycles, the incorporation of a single hexamer, the addition of methyl groups, or the 
incorporation of bridges between the isoprenoids [108, 546-548]. Tetraether lipids are 
believed to contribute considerably to an increased stability, permeability and resistance of 
the membrane [540, 549]. Moreover, though the diether:tetraether ratio appears to vary 
substantially between archaea at comparable conditions, for some hyperthermophilic 
archaea the amount of tetraethers has been shown to increase steadily as the growth 
temperature rises [546, 550, 551]. This suggests that the diether:tetraether ratio might be 
regulated to adapt membrane fluidity and permeability. Additionally, for some 
hyperthermophilic archaea it has been shown that in response to increasing temperatures, 
the number of incorporated pentacycles also increases [540, 551, 552]. However, as thermal 
adaptation has frequently been studied in archaea, it soon became clear that not all archaea 
 
form tetraethers and that different archaeal species respond to temperature fluctuations in 
different ways.  
In general, tetraethers have been shown to be the dominant lipid species in Crenarchaeota 
and Thaumarchaeota, whereas members of the Euryarchaeota synthesize diethers, 
tetraethers, or both [110]. However, the exact route leading to tetraether synthesis is still 
unknown. Nevertheless, two different pathways have been postulated (Figure 5.1) [110, 
542, 543]. In the first pathway (to which we will refer to as the traditional route), archaetidic 
acid is first converted to diether lipids, after which two of these molecules are coupled via a 
yet unknown route by a tail-to-tail condensation of the isoprenoid chains to form one 
tetraether molecule [542, 543, 553-555]. Evidence for this traditional route comes from 
pulse chase and labelling experiments using cell extracts of the euryarchaeon Thermoplasma 
acidophilum incubated with 14C-mevalonate, which is a precursor molecule for the synthesis 
of the isoprenoid building blocks IPP and DMAPP [542, 553]. These experiments showed that 
the label first incorporates into diethers until saturation and only then into tetraethers. 
Moreover, when an inhibitor of squalene epoxidase (known as terbinafine) is used, an 
inhibition of tetraether formation was observed. In addition, pulse labelling in the presence 
of terbinafine showed an accumulation of radioactivity in the diether fraction and a decrease 
in radioactivity in the tetraether fraction, which was reversible by removal of the inhibitor 
[553, 554]. These observations are interesting as, in the traditional route, the putative 
tetraether synthase is predicted to be an analog of squalene or phytoene epoxidase [553].     
However, no incorporation of radiolabelled diether lipids (i.e. archaeol) into tetraether lipids 
(i.e. GDGT-0) was observed in vivo in the euryarchaeon Methanospirillum hungatei [556]. 
Moreover, from a chemical point of view, the reaction required for the formation of 
tetraethers from diethers (i.e. the condensation of two saturated phytanyl chains of 
archaeol) is considered quite unusual and some studies indeed suggest that the presence of 
double bonds is a prerequisite for the formation of tetraethers [110, 557, 558]. These 
observations are contradicting the ones described above and suggest that diether lipids (i.e. 
archaeol) are not the precursor of tetraether lipids (i.e. GDGT). This discrepancy might, for 
example, be explained by the possibility that the diether accumulation upon terbinafine 
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exposure is the result of growth retention by toxicity rather than the selective inhibition of 
an enzyme. Especially, as it has been demonstrated several times that the ratio of diether-
to-tetraether is highly dependent on growth phase as well [546, 547, 559, 560]. 
Recently, an alternative route for the formation of tetraether lipids has been proposed in 
which the tail-to-tail condensation is thought to take place directly after the synthesis of 
various forms of isoprenoid chains (i.e. with or without ring moieties) [110]. Thus, the tail-to-
tail condensation of two C20 isoprenyl molecules is suggested to occur before attachment to 
the glycerol-1-phosphate unit and the subsequent reduction of the unsaturated isoprenoid 
chains (Figure 5.1). The advantage of this is that the proposed pathway eliminates the need 
for the unusual condensation of the two saturated phytanyl chains present in diether lipids 
(i.e. archaeol). This alternative route implies that diether lipids are not the precursor of 
tetraether lipids and that the ether-bond forming enzymes, GGGP synthase and DGGGP 
synthase (responsible for the coupling of the isoprenyl chains to the glycerol unit), can utilize 
not one but various prenyl species as substrate. These substrates include both C20 and C40 
isoprenoid chains (for the formation of diether lipids and tetraether lipids, respectively) with 
or without ring moieties. Thus, in this alternative pathway, tetraether lipids are formed by 
creating C40 isoprenoid chains first, which are subsequently used as a substrate for the GGGP 
synthase and DGGGP synthase to attach both the first and second glycerol units. However, 
like the traditional route, the enzyme(s) responsible for the condensation of the C20 
isoprenyl chains are still unknown.  
Despite the high interest in the biochemical mechanism, nothing is known about the 
enzymes involved in the tail-to-tail condensation. This might be due to the lack of archaeal 
genetic toolboxes. Here, the anaerobic, sulphur reducing, hyperthermophilic Euryarchaeon 
Thermococcus kodakarensis was used as a model organism that meets a couple of important 
criteria that enable such a study: i) T. kodakarensis has previously been confirmed to have 
both diether lipids and tetraether lipids in its cytoplasmic membrane [58]  ii) T. kodakarensis 
has a genetic toolbox available [60-63] iii) It has a relatively small and fully sequenced 
genome of an estimated 2306 coding DNA sequences [59], many of which have been 
functionally characterized already, and iv) T. kodakarensis is fairly easily grown in a 
 
laboratory setting. By performing comparative bioinformatics analyses we selected several 
candidate genes that might code for enzyme(s) involved in the tail-to-tail condensation 
reaction, i.e. the putative tetraether synthase. Moreover, we composed a list of 
characteristics likely to encounter in a putative tetraether synthase. By scoring the candidate 
genes according to these characteristics, we ultimately selected 12 candidate genes that 
were targeted for overexpression and deletion. The generated mutant strains were analysed 
for their diether/tetraether lipid composition.  
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Figure 5.1. Two proposed pathways for tetraether synthesis. The first pathway is represented by the 
“traditional route”. This pathway proposes a substrate product relationship between archaeol and glycerol-
dialkyl-glycerol-tetraethers (GDGT). Initial steps are completed by full synthesis of DGGGP. From this stage, 
DGGGP can either bifurcate towards full synthesis of saturated diethers or towards synthesis of GDGT’s by the 
successive condensation of the two tail ends of the aligned archaeols. This reaction is here represented by two 
fully saturated diphytanylglycerol-CDP (DPhG-CDP) and the accompanying release of two electrons and two 
protons. Although the saturated diether was the first proposed substrate (as depicted here), some studies 
suggest the unsaturated DGGGP as a more likely substrate. The second pathway that has been proposed is 
represented  by the “alternative route”. In this pathway a C40 hydrocarbon chain is synthesized first by 
condensation of two molecules of GGPP. The two subsequent reactions are considered similar to the formation 
of GGGP and DGGGP except for the chain length of the substrates. The GDGT is finalized by the attachment of 
the glycerol moiety to the tail ends of the C40 chains by ether bond formations by either GGGP or DGGGP 
synthesis. 
 
Results 
Selection of candidate genes 
To select gene(s) that are potentially involved in tetraether synthesis, two independent 
bioinformatics approaches were performed. Both analyses were resting on the assumption 
that the gene(s) involved and the presence of tetraether lipids exhibit a genotype-phenotype 
correlation. In addition to archaea producing both diether and tetraether lipids, there are 
also a number of archaea within the phylum of Euryarchaeota that completely lack 
tetraethers [108]. In the first analysis, we made use of these phenotypes by selecting a set of 
reference species that are phylogenetically closely related to T. kodakarensis and that have a 
confirmed presence or absence of tetraethers in their membranes. The selected reference 
genomes belonging to the first group (i.e. confirmed presence of tetraethers) were those of 
the hyperthermophiles Pyrococcus furiosus and Thermoplasma acidophilum [553, 561-565] 
and those of the second group (i.e. confirmed absence) were those of the haloalkaliphilic 
Natronomonas pharaonis and the hyperthermophilic Methanopyrus kandleri [566-568]. The 
genome of T. kodakarensis was screened for homologs present in the first two, but absent in 
the latter two, by performing a phylogenetic profiler single gene search (using the IMG 
system of JGI). This resulted in the identification of 57 T. kodakarensis genes that may 
potentially be involved in tetraether synthesis (Table S5.1a). 
In the second comparative genome analysis we attempted to correlate the presence of 
specific arCOGs (archaeal Clusters of Orthologous Genes [569] in 149 sequenced archaeal 
genomes to species with a confirmed tetraether lipid membrane. The arCOGs included in the 
analysis (Table S5.2) were related to the following categories: phospholipid biosynthesis, 
isoprenoid mevalonate biosynthesis, uncharacterized proteins associated with mevalonate 
biosynthesis, terpene cyclases, fatty acid synthesis, and phytoene/squalene synthesis or 
saturases. However, none of the arCOGs analysed showed a strong correlation with species 
having a confirmed tetraether lipid membrane. Assuming correct membrane profiling, this 
analysis suggests that tetraether synthesis is either catalysed by different enzymes over 
different archaeal lineages or that a single enzyme is present in all archaea whose synthesis 
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or activity is tightly regulated (e.g. by post-translational modification, temperature 
activation, etc.).  
Since no correlation was observed, it was decided to select all uncharacterized T. 
kodakarensis genes that are present in the mentioned arCOGs categories instead. This led to 
the selection of 32 additional genes. To exclude other members of the archaeal lipid 
biosynthetic pathway (e.g. IPP synthase, GGPP synthase, GGGP synthase, etc.), 
experimentally characterized genes, that have shown to be responsible for the reactions 
leading to isoprenoid and CDP-archaeol synthesis in various archaea, were BLASTed against 
the genome of T. kodakarensis [570-577]. T. kodakarensis genes that showed a high 
sequence similarity to these characterized genes were excluded from the list of 32 genes 
(Figure S5.1). However, the candidate genes TK1324 and TK1957 both showed sequence 
similarity to known DGGGP synthases, making it, based on this information only, impossible 
to decide if both or only one (and if the latter, which one) encode for a DGGGP synthase. 
Moreover, both are annotated as 4-hydroxybenzoate polyprenyltransferase belonging to the 
UbiA-like prenyltransferase COG0382, and it was therefore decided to retain and prioritize 
both of them. This ultimately led to the selection of 26 additional genes that may be 
involved in tetraether lipid biosynthesis (Table S5.1b).  
Subsequently, it was decided to prioritize the resulting 81 genes based on a couple of 
characteristics assumed to be important for a putative tetraether synthase. These 
characteristics were (in a non-specific order): i) predicted prenyl binding. ii) the presence of 
an FAD or Flavin mononucleotide (FMN) binding domain, which is potentially important for 
tetraether synthases because carbon-carbon bond formations are occasionally aided by FAD 
cofactors as dual electron acceptor [578]. iii) the presence of aspartic acid rich DDxxD motifs. 
These motifs contribute to the substrate binding of prenyltransferases, which are 
responsible for the transfer of prenyl groups and chain elongation of isoprenoids [579-581]. 
iv) Homology to squalene epoxidase. This has been suggested by Kon et al. (2002), who, 
upon addition of a squalene epoxidase inhibiter (i.e. terbinafine) to the growth medium of 
Thermoplasma acidophilum, observed an accumulation of diether lipids at the expense of 
tetraether lipid biosynthesis. [553]. v) Transcriptional regulation by the Thermococcales heat 
 
shock protein Phr. Phr is a transcriptional regulator that represses transcription under 
normal growth conditions by binding to the promoters of certain genes and that is released 
from them upon heat shock [582-584]. Since previous studies showed an increase in 
tetraether lipid content upon thermal treatment, transcription of the putative tetraether 
synthase may also be Phr-dependent [546, 550, 551]. Altogether, this scoring resulted in a 
ranking of the candidate genes (Table S5.1). In case the candidate genes had an equal score, 
priority was given to the presence of prenyl binding or -transferase domains. By doing this, 
we selected 10 priority genes (in addition to TK1324 & TK1957) that were targeted for 
overexpression and disruption (Table 5.1). These genes were: TK1088, TK0929, TK2159, 
TK1836, TK0509, TK0513, TK1173, TK1477, TK1548 & TK1732.   
Moreover, an additional column was included to Table 5.1 showing the presence or absence 
of transmembrane spanning helices. This information may become valuable as it can 
demonstrate the validity of either the classical or alternative synthesis pathway. This is 
because in the classical biosynthesis pathway, the tetraether lipid biosynthesis is proposed 
to occur by condensing two diether lipids, the synthesis of which already takes place in the 
membrane [542]. In contrast, however, in the alternative pathway, the condensation 
reaction leading to the C40 isoprenoid chains takes place in the early steps of the ether lipid 
biosynthesis and is therefore more likely to be catalyzed by a cytosolic enzyme [110]. 
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Table 5.1. Top-10 ranking candidate genes 
Gene 
locus 
Gene annotation Predicted 
Prenyl 
binding 
FAD/FMN 
binding 
domain 
DDxxD 
motif 
SQE 
homology 
Phr-
regulation 
TMH Total 
score 
TK1088 Geranygeranyl hydrogenase + + + + + 0 5 
TK0929 
3-octaprenyl-4-
hydroxybenzoate 
decarboxylase 
+ + +  + 0 4 
TK2159 Predicted oxidoreductase  +  + + 1 3 
TK1836 Geranygeranyl hydrogenase + + +   0 3 
TK0509 
3-octaprenyl-4-
hydroxybenzoate 
decarboxylase UbiX 
+ +    0 2 
TK0513 Hypotheticalprotein +    + 0 2 
TK1173 
Undecaprenyl 
diphosphate 
synthase 
+    + 0 2 
TK1477 Hypotheticalprotein   +  + 0 2 
TK1548 
Probable serine—
glyoxylate 
aminotransferase 
  +  + 0 2 
TK1732 Dolichol-phosphate mannosyltransferase +  +   4 2 
 
Abbreviations: b/t, binding or transferase; FAD, Flavin adenine dinucleotide; FMN, Flavin mononucleotide; SQE, 
squalene epoxidase; Phr, the Phr-transcriptional regulator; TMH, transmembrane spanning helices  
 
Construction of mutant strains 
To screen for enzymes involved in tetraether lipid formation, 12 genes of interest (GOIs) 
were selected. For each of these genes, we attempted to create a disruption strain and a 
strain overexpressing the GOI. T. kodakarensis strain TS559 was chosen as a parent strain to 
utilize the previously developed selection and counter-selection procedure for use in rich 
media (Figure S5.2a) [60, 61, 486]. Disruption strains were created as described previously 
[60]. Transformation of the disruption vectors (Table 5.2) resulted in agmatine prototrophs 
for 11 out of the 12 GOIs. TK2159 is the only GOI for which no transformants were obtained, 
even not after 3 independent transformation attempts. Transformants of the remaining 11 
GOIs were confirmed to be 6-methyl purine sensitive (6MPs), a phenotype conferred by the 
 
expression of TK0664. Next, disruption of the GOIs as well as precise and markerless deletion 
of the selection and counter-selection cassette was stimulated by plating the transformants 
on plates containing 6MP and agmatine. For each of the remaining GOIs, genomic DNA of 30 
spontaneous 6MP resistant (6MPR) colonies was analyzed by diagnostic PCR. In this analysis, 
we screened for the deletion of both the GOIs and of the selection and counter-selection 
cassette. Ultimately, 6 of the 12 selected GOIs were successfully deleted. For the remaining 5 
(TK2159 did not result in transformants), only host strains were obtained. For the 6 
successful GOI disruptions, representative clones having the desired final genome 
configurations were designated T. kodakarensis strain ∆TK0513, ∆TK1324, ∆TK1477, 
∆TK1548, ∆TK1732, and ∆TK1836, in which the ∆ denotes disruption and the number 
indicates which TK-locus has been deleted (Table 5.2).  
Overexpression strains were obtained in the following way. First, a universal vector 
backbone was created suitable for integration of an additional copy of the GOIs into the 
chromosome of T. kodakarensis. Next, the 12 selected GOIs were individually cloned into 
this vector backbone, placing them under control of the strong constitutive hmtB-promoter 
[486], resulting in 12 unique overexpression vectors (Table 5.2). Subsequent transformation 
of these vectors in T. kodakarensis TS559 ultimately resulted in agmatine prototrophs for all 
GOIs. For each GOI, genomic DNA of 5 agmatine prototrophic clones was analyzed by 
diagnostic PCR to confirm integration of the various overexpression vectors. Moreover, the 
diagnostic PCR was also used to discriminate between transformants that were the result of 
a single homologous recombination (resulting in the integration of the entire donor plasmid 
DNA integrated into the genome of T. kodakarensis) and transformants that were the result 
of two crossover events (resulting in the integration of only the GOI and selection marker 
(TK0149)). The latter was done since only the transformants resulting from two crossover 
events can be considered stable (and are thus preferred), while the transformants resulting 
from a single homologous recombination may ultimately revert to the original genome. 
Nevertheless, both variants are considered sufficient for this study as long as the agmatine 
prototrophy selection pressure is maintained. The diagnostic PCRs showed that preferred 
double crossover mutants were obtained for TK1324, TK1477, TK1548, TK1732, TK1088, 
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TK1957 and TK2159, but not for TK0509, TK0513, TK1836, TK1173 and TK0929. Next, the 
entire integration locus was PCR amplified and subsequent sequencing confirmed that the 
integrated additional copy of the GOIs did not contain any undesired mutations. 
Representative clones, containing correct sequences of the additional copies of the GOIs 
were designated T. kodakarensis strains: OE0509, OE0513, OE0929, OE1088, OE1173, 
OE1324, OE1468, OE1477, OE1548, OE1732, OE1836, OE1957 and OE2159, in which the OE 
denotes ‘overexpression’ and the number specifies the introduced TK gene (Table 5.2). 
As a final check, total RNA of all OE- and ∆-strains was isolated and used in a semi 
quantitative Reverse Transcriptase-PCR (RT-PCR) to confirm increased transcription or loss of 
transcription of the GOIs, respectively. The primers used for the diagnostic PCRs were 
designed such that expression of a particular gene ultimately resulted in a PCR product of 
~250 bp. The results shown in Figure 5.2 confirm increased transcription levels of the GOIs in 
their corresponding OE-strain and the absence of transcription in their corresponding ∆-
strains. The housekeeping gene puf (TK0308) [491], encoding the α-subunit of the elongation 
factor-1 complex, was used for normalization and as positive control in the RT-PCRs for the 
OE- and ∆-strains, respectively. 
 
  
 
Table 5.2. T. kodakarensis strains and plasmids used in this study 
Strain or plasmid Relevant characteristics Source or reference
Strains   
TS559 ΔpyrF; ΔtrpE::pyrF; ΔTK0664; ΔTK0149 [486] 
Disruption strains   
ΔTK0513 TS559 derivative, ΔTK0513 This study 
ΔTK1324 TS559 derivative, ΔTK1324 This study 
ΔTK1477 TS559 derivative, ΔTK1477 This study 
ΔTK1548 TS559 derivative, ΔTK1548 This study 
ΔTK1732 TS559 derivative, ΔTK1732 This study 
ΔTK1836 TS559 derivative, ΔTK1836 This study 
Overexpression strains   
OE0509 TS559 derivative, ΔTK1765::TK0509, TK0149 This study 
OE0513 TS559 derivative, ΔTK1765::TK0513, TK0149 This study 
OE0929 TS559 derivative, ΔTK1765::TK0929, TK0149 This study 
OE1088 TS559 derivative, ΔTK1765::TK1088, TK0149 This study 
OE1173 TS559 derivative, ΔTK1765::TK1173, TK0149 This study 
OE1324 TS559 derivative, ΔTK1765::TK1324, TK0149 This study 
OE1477 TS559 derivative, ΔTK1765::TK1477, TK0149 This study 
OE1548 TS559 derivative, ΔTK1765::TK1548, TK0149 This study 
OE1732 TS559 derivative, ΔTK1765::TK1732, TK0149 This study 
OE1836 TS559 derivative, ΔTK1765::TK1836, TK0149 This study 
OE1957 TS559 derivative, ΔTK1765::TK1957, TK0149 This study 
OE2159 TS559 derivative, ΔTK1765::TK2159, TK0149 This study 
   
Plasmids   
pTS700 Basis for the creation of “A”-plasmids,
Harboring TK0664; TK0149 
[60] 
pSKS022 Derivative of pSecPyrF [106], enabling integration at 
TK1765 locus. Basis for the creation of vector backbone 
of OE plasmids, harboring TK0149 
Chapter 3 and [106]
Disruption vectors*   
p∆”GOI” (12x) TK0664; TK0149; Δ”GOI” This study 
Integration vectors*   
pOE”GOI” (12x) TK0149; ΔTK1765::”GOI” This study 
 
* = for each gene of interest (GOI) a disruption (∆) vector and integration (or overexpression; OE) vector was 
created. The GOIs were TK0509, TK0513, TK0929, TK1088, TK1173, TK1324, TK1477, TK1548, TK1732, TK1836, 
TK1957, and TK2159.  
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OE0513 TS559 derivative, ΔTK1765::TK0513, TK0149 This study 
OE0929 TS559 derivative, ΔTK1765::TK0929, TK0149 This study 
OE1088 TS559 derivative, ΔTK1765::TK1088, TK0149 This study 
OE1173 TS559 derivative, ΔTK1765::TK1173, TK0149 This study 
OE1324 TS559 derivative, ΔTK1765::TK1324, TK0149 This study 
OE1477 TS559 derivative, ΔTK1765::TK1477, TK0149 This study 
OE1548 TS559 derivative, ΔTK1765::TK1548, TK0149 This study 
OE1732 TS559 derivative, ΔTK1765::TK1732, TK0149 This study 
OE1836 TS559 derivative, ΔTK1765::TK1836, TK0149 This study 
OE1957 TS559 derivative, ΔTK1765::TK1957, TK0149 This study 
OE2159 TS559 derivative, ΔTK1765::TK2159, TK0149 This study 
   
Plasmids   
pTS700 Basis for the creation of “A”-plasmids,
Harboring TK0664; TK0149 
[60] 
pSKS022 Derivative of pSecPyrF [106], enabling integration at 
TK1765 locus. Basis for the creation of vector backbone 
of OE plasmids, harboring TK0149 
Chapter 3 and [106]
Disruption vectors*   
p∆”GOI” (12x) TK0664; TK0149; Δ”GOI” This study 
Integration vectors*   
pOE”GOI” (12x) TK0149; ΔTK1765::”GOI” This study 
 
* = for each gene of interest (GOI) a disruption (∆) vector and integration (or overexpression; OE) vector was 
created. The GOIs were TK0509, TK0513, TK0929, TK1088, TK1173, TK1324, TK1477, TK1548, TK1732, TK1836, 
TK1957, and TK2159.  
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Figure 5.2. Semi quantitative Reverse Transcriptase-PCR (RT-PCR) analysis. Total RNA was isolated from the 
parental and mutant strains and subjected to a DNase I treatment to degrade any traces of isolated 
chromosomal DNA. cDNA was created via a reverse transcriptase reaction and subsequently used as template 
in a diagnostic PCR to confirm (A) loss of expression or (B) overexpression of the genes of interest in the 
disruption- and overexpression strains, respectively. All RT-PCR products had the appropriate size on SYBR safe 
stained agarose gels. The housekeeping gene elongation factor 1-α was used for normalization. Abbreviations: 
D-strain, disruption strain; P, parent strain TS559; M, marker; EF1a, elongation factor 1-α; GOI, gene of interest; 
NTC, no template control; RT, Reverse transcriptase; TS559, parent strain; OES, overexpression strain; TK#, 
gene locus of GOI. “+”, RT present; “-“, RT absent 
 
Phenotypical changes elicited by the OE- and ∆-strains 
To assess the involvement of the corresponding GOIs in tetraether lipid biosynthesis, the 
total diether and tetraether lipid content of the OE- and ∆-strains was determined and 
compared to that of the parental strain TS559. To do this, overnight cultures were prepared 
in triplicate and the cells harvested. The membrane lipids were then hydrolysed to cleave off 
polar head groups and subjected to a total lipid extraction to isolate core lipids. These 
isolates were subsequently characterized for their diether and tetraether lipid content by 
UHPLC-API/MS by monitoring ions at m/z 652.6 and 1301.3. However, the total amounts of 
diether and tetraether lipids (in µg) turned out to be highly variable between the different 
strains, even after normalization per mg dry cell weight (DCW) (Figure 5.3, in w/w%). For 
example, the total amount of diether and tetraether lipids obtained for strain OE0929 was 
nearly twice as high as that obtained for the parental strain TS559, while hardly any diether 
and tetraether lipids were obtained from strain OE1324. 
 
To allow comparison of the membrane composition of the different strains, the average 
diether and tetraether lipid content per strain was expressed as a percentage of their 
cumulative amount (Figure 5.4). This showed that the parental strain TS559 has a tetraether 
lipid content of 93.6 ± 0.9 %, which roughly agrees with the results obtained by Matsuno Y. 
et al. (2009) [546]. Concerning the possible involvement of the GOIs in tetraether lipid 
biosynthesis, the most striking effects were observed for the strains OE1957 and ∆TK1548, 
for which a tetraether lipid content of 98.3 ± 0.5 % and 23.8 ± 3.9 % was observed, 
respectively. Moreover, an increased tetraether lipid content was also observed for the OE-
strains of TK0509, TK1088, and TK1732, having a tetraether lipid content of 96.3 ± 1.1 %, 
95.5 ± 0.6 %, and 96.4 ± 0.4 %, respectively. In addition, a significant decrease in the 
tetraether lipid content of the OE-strain of TK1836 was observed. Interestingly, though 
disruption of TK1548 led to a significant decrease in the tetraether lipid content, no notable 
increase was observed upon its overexpression. With the exception of the disruption of 
TK1548, no significant changes in the tetraether lipid content of the obtained disruption 
strains was observed.  
 
 
Figure 5.3. Average diether and tetraether lipid content per strain. Light grey: average tetraether lipid content 
(i.e. GDGT-0), black: average diether lipid content (i.e. archaeol). 
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Figure 5.3. Average diether and tetraether lipid content per strain. Light grey: average tetraether lipid content 
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Figure 5.4. Average % of tetraether and diether lipids per strain. The tetraether lipid contents (in black) and 
diether lipid contents (in light grey) of three biological replicates were normalized to the total amount of lipids 
measured per strain (i.e. to the sum of GDGT-0 and archaeol). The vertical numbers (in white) show the 
average fraction (in %) of tetraether lipids per strain. 
 
To investigate if the membrane composition (i.e. the diether:tetraether lipid ratio) has an 
effect on the physical appearance of T. kodakarensis, samples of the parental strain and 
mutant strains showing the biggest extremes in their membrane lipid composition (i.e. strain 
OE1957 and ∆TK1548) were studied by transmission electron microscopy (TEM). In addition, 
samples of the mutant strain OE1324 were included to check its cellular integrity as this 
strain showed a very low overall lipid content (Figure 5.3). The images obtained showed no 
clear effect of the membrane lipid composition on the physical appearance of the cell nor 
the membrane of T. kodakarensis Figure 5.5. 
 
 
 
 
 
 
Figure 5.5. Thin cross-sections of T. kodakarensis strains TS559, OE1957, ∆TK1548 & OE1324 observed by 
Transmission Electron Microscopy (TEM). Strain OE1957 and ∆TK1548 were selected for TEM as these strains 
showed the highest and lowest tetraether lipid content (TE), respectively. Strain OE1324 was included to check 
its cellular integrity as hardly any diether or tetraether lipids were obtained for this strain in the membrane 
characterization experiment. The upper micrographs show multiple cells of each strain (bars 1 µm). The lower 
micrographs show the cytoplasmic membrane (CM) and S-layer (SL) of individual cells (bar TS559 50 nm, bars 
OE1957, ∆TK1548 & OE1324 100 nm). The tetraether lipid content (TE) of each strain is shown in brackets. 
 
Discussion 
 
In this study, we set out to identify the enzyme(s) responsible for the synthesis of tetraether 
lipids. Especially, the one(s) responsible for the condensation of two C20 isoprenyl chains, i.e. 
the putative tetraether synthase(s). To do this, a list of genes that are potentially involved in 
tetraether synthesis was created, that was prioritized based on a couple of characteristics 
assumed to be important for a tetraether synthase. This resulted in the selection of 12 
genes, which were targeted for overexpression and disruption. Interestingly, subsequent 
lipid analysis of the mutant strains, strongly suggests that at least three of these genes 
indeed play a role in the synthesis of tetraether lipids. These genes are TK1548, TK1836 and 
TK1957. In addition, the genes that appear to be non-viable upon disruption may be 
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interesting in this respect as well. Especially, the ones for which no disruption strain was 
obtained, but a slight increase in the tetraether lipid content was observed upon its 
overexpression, such as TK0509 and TK1088. This is because the membrane of the parental 
strain primarily exists of tetraether lipids (i.e. 93.6% ± 0.93). Losing the ability to synthesize 
tetraether lipids due to the disruption of the tetraether synthase may thus very well be 
lethal. 
One of the genes that seems play a role in the synthesis of tetraether lipids is TK1548, which 
is annotated as a serine-glyoxylate aminotransferase. This gene was selected from the list of 
candidate genes as a priority gene since it contains a DDxxD motif, which is associated with 
substrate binding of prenyltransferases, and it has been shown to be slightly upregulated 
upon heat shock (Table 5.1). Disruption of TK1548 resulted in a strain with a significantly 
lower tetraether lipid content (Figure 5.4), which is a strong indication that the enzyme 
encoded by this gene plays an important role in tetraether synthesis. However, despite the 
disruption of TK1548, a considerable amount of tetraethers could still be detected (i.e. 
23.8% ± 3.9). This either suggests it is not the sole tetraether synthase encoding gene, and 
hence that there might be multiple isozymes, or that TK1548 is encoding a different enzyme 
of importance to tetraether synthesis. Moreover, since this gene has been annotated as an 
aminotransferase it is possible that the enzyme it encodes shows a broad substrate 
specificity, meaning that it could be involved in many pathways and that the observed effect 
may be indirect. To obtain clarity about its involvement in tetraether lipid synthesis more 
experimental data is needed. Unfortunately, overexpression of TK1548 did not result in a 
significant effect (Figure 5.4), which may suggest it is indeed not a tetraether synthase, but 
might also simply imply it is not a rate limiting step in the pathway.    
A second gene that has an influence on the tetraether lipid content is TK1836. This gene has 
been annotated as a geranylgeranyl hydrogenase and was selected as a priority gene for its 
predicted prenyl binding, and the presence of a FAD/FMN binding domain and DDxxD motif 
(Table 5.1). Though disruption of TK1836 does not seem to have a detrimental effect on the 
tetraether lipid content of the membrane, overexpression surprisingly does (Figure 5.4). 
These results imply that TK1836 is involved in lipid biosynthesis, but that it is very unlikely to 
 
be a tetraether synthase. Instead, subsequent phylogenetic analysis suggests that TK1836 
probably belongs to a dehydrogenase family that has been shown to be prenyl reductases 
(data not shown) [585, 586]. If true, the results obtained for this mutant suggest that the 
presence of double bonds in the precursor molecule of tetraether lipids is a prerequisite to 
the formation of tetraether lipids. This would be an interesting finding as the absence or 
presence of double bonds in the C20 isoprenyl chains (i.e. before the condensation reaction) 
is a major difference between the classical and alternative tetraether biosynthesis pathway, 
respectively [110].      
A third gene that seems to be involved in tetraether lipid synthesis is TK1957, which has 
been annotated as a 4-hydroxybenzoate polyprenyltransferase. Though this gene shows 
sequence similarity to experimentally characterized DGGGP synthases [570, 572] (which 
should lead to the exclusion of this gene from the list of candidate genes), it was decided to 
retain it and to select it as a priority gene for further analysis. The reason for this was that 
another candidate gene also annotated as a 4-hydroxybenzoate polyprenyltransferase, i.e. 
TK1324, showed sequence similarity to DGGGP synthases as well, making it difficult to 
decide which one is a DGGGP synthase and which one may potentially be a tetraether 
synthase. It was therefore decided to retain both and to select them as priority genes for 
further analysis. Interestingly, overexpression of TK1957 resulted in a strain that has a 
membrane that almost exclusively exists of tetraether lipids (i.e. 98.3% ± 5; figure 5.4). This 
is a strong indication that TK1957 is involved in the tetraether lipid synthesis and may 
perhaps even imply it is the tetraether synthase. Moreover, the observation that disruption 
of TK1957 appears to be non-viable is quite interesting in this respect as well. However, 
though these results may imply that TK1957 is a tetraether synthase, a similar reasoning as 
described above would also apply to a DGGGP synthase. This is because, in both the classical 
and alternative biosynthesis pathways proposed, DGGGP synthases are key enzymes in the 
formation of archaeal membrane lipids (Figure 5.1). It therefore seems likely that the 
annotation of TK1957 is correct and that TK1957 is not a tetraether synthase, but a DGGGP 
synthase.  
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Contrary to TK1957, overexpression and disruption of TK1324 (the other gene annotated as 
a DGGGP synthase) did not result in a significant change in the diether/tetraether lipid ratio 
(Figure 5.4). This implies that TK1324 is most likely neither a DGGGP nor a tetraether 
synthase. However, the significant decrease in the total amount of diether and tetraether 
lipids obtained upon its overexpression (Figure 5.3), combined with the observation that the 
physical appearance of these cells nevertheless appears to be normal (figure 5.5), suggests 
that TK1324 is involved in the biosynthesis of lipids other than the ones measured in this 
study. The analysis performed in this study encompasses a selected ion monitoring rather 
than a total ion monitoring, and as such was aimed to detect only the most prevalent lipids 
in the membrane which are represented by the core lipid species archaeol and GDGT-0. 
Therefore, before any conclusions can be drawn, more research is needed in which effects 
on lipid species other than archaeol and GDGT-0 are also investigated.  
In conclusion, though interesting results have been obtained future research is needed to 
get a better understanding of the tetraether synthesis pathway and to identify the 
tetraether synthase(s). With respect to the latter, TK1548 especially seems to be an 
interesting candidate, though the observed effects may be indirect. Moreover, the candidate 
genes for which no disruption strains were obtained might be worth investigating further as 
disruption of a tetraether synthase may very well be lethal. In addition, more of the genes 
present on the candidate list (Table S5.1) may be targeted for overexpression and 
disruption, after which the subsequent analysis of the membrane composition should 
include multiple lipid species.  All together, these analyses could provide a better 
understanding of the tetraether lipid biosynthesis pathway and may ultimately lead to the 
identification of the tetraether synthase(s). 
Materials and Methods 
Selection of candidate genes 
Two independent bioinformatics approaches were performed. In the first analysis, a set of 
reference species that are phylogenetically closely related to T. kodakarensis and that have a 
confirmed presence (Pyrococcus furiosus and Thermoplasma acidophilum) or absence 
(Natronomonas pharaonis and Methanopyrus kandleri) of tetraethers in their membranes 
 
was selected [553, 564-568]. The genome of T. kodakarensis was screened for homologs 
present in the first two, but which are absent in the latter two by performing a phylogenetic 
profiler single gene search using the IMG system of JGI (https://img.jgi.doe.gov/cgi-
bin/m/main.cgi). In the second analysis, it was attempted to correlate the presence of 
specific arCOGs (archaeal Clusters of Orthologous Genes [569] in 149 sequenced archaeal 
genomes to species with a confirmed tetraether lipid membrane.  
The list of genes resulting from two bioinformatics approaches was prioritized based on the 
following characteristics: i) predicted prenyl binding, ii) the presence of a FAD or Flavin 
mononucleotide (FMN) binding domain or Rosmann Fold [587], iii) the presence of aspartic 
acid rich DDxxD motifs, iv) homology to squalene epoxidase, and v) transcriptional regulation 
by the Thermococcales heat shock protein Phr. Screening for i and ii was done by scanning 
the protein sequences against the InterPro collection of protein signature databases 
(http://www.ebi.ac.uk/Tools/pfa/iprscan5/). The screening for iii was done by manually 
checking the protein sequences for presence of a DDxxD motif. To identify possible 
homologs of squalene epoxidase (iv), the selected genes were included in a BLAST search 
using the Saccharomyces cerevisiae ERG1 squalene epoxidase sequence (EC1.14.99.7) as a 
query. The S. cerevisiae squalene epoxidase was selected, as a recently created three-
dimensional model of this protein allowed for the identification of crucial residues [588]. To 
determine if the transcription of the candidate genes may be influenced by Phr (v), we made 
use of the results of a previously published microarray experiment that was performed to 
identify the Phr-dependent heat shock regulon in T. kodakarensis [582]. The presence or 
absence of transmembrane spanning helices was determined by constructing hydrophobicity 
plots using the online Transmembrane Hidden Markov Model (TMHMM 
http://www.cbs.dtu.dk/services/TMHMM-2.0/) tool to predict probability of 
transmembrane spanning segments. From this analysis it was shown that the following gene 
products (TK1324, TK1732, TK1957 and TK2159) are integral membrane proteins or 
membrane associated. 
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Microorganisms and culture conditions 
E. coli DH5α was used for general DNA manipulation, and E. coli strains were cultivated at 
37°C in LB medium supplemented with 100 µg/ml ampicillin. T. kodakarensis strains and 
plasmids used in this study are listed in Table 5.2. T. kodakarensis strains were cultivated 
anaerobically in stoppered serum bottles at 85°C in a nutrient-rich medium (ASW-YT) [62], 
composed of 0.8x artificial seawater (0.8x ASW), 5.0 g/L yeast extract, 5.0 g/L tryptone, 1 
ml/L KOD vitamin mixture (1000x) and 0.8 mg/L resazurine. The headspace of all cultures 
was exchanged for N2. Before inoculation, either 2.0 g/L sulfur (ASW-YT-S0) or 5.0 g/L 
pyruvate (ASW-YT-Pyr) was added to the medium, as well as Na2S.9H2O to reduce the 
dissolved oxygen, until the resazurin became colorless. When required, the media were 
supplemented with 500 µM agmatine and/or 75 µM 6-methyl purine (6MP) [60, 61]. 
Cultures were continuously shaken (50 rpm) during growth. In the case of plate culture, 1% 
(wt/vol) Gelrite was added to solidify the medium together with 2 ml/L polysulfide solution 
[62] instead of S0. Cells inoculated on plates were incubated at 85°C for at least 48 h in an 
air-tight anaerobic jar containing an Anaerocult A mini (Merck Millipore, Darmstadt, 
Germany) to maintain anaerobic conditions.  
Construction of plasmids and mutant strains 
Plasmids incapable of autonomous replication in T. kodakarensis were constructed and 
amplified in Escherichia coli, carrying the genes of interest (GOIs) or knockout constructs 
adjacent to the previous developed selection and, in the case of the disruption vectors, 
counter-selection cassette (TK0149; TK0664) [60, 61]. The GOIs and selection cassette (in 
case of the OE vectors) and the selection/counter-selection cassette (in case of the 
disruption vectors) were flanked by a ~500-1000 bp region homologous to T. kodakarensis 
genome that naturally was located immediately up- and downstream of the target locus 
(Figure S5.2). Standard molecular biology procedures were used for PCR amplifications, 
plasmid construction, E. coli DH5α transformation, transformants selection, plasmid 
isolation, and sequence verification. The sequences of oligonucleotide primers used in this 
study are listed in Table S5.3. 
 
The vectors created to disrupt or overexpress the GOIs are shown in Table 5.2. The 
disruption vectors were constructed as described before [60]; first, so-called “A”-plasmids 
were created by amplifying each GOI along with ~500-700 bp of flanking DNA and cloning 
the corresponding amplicon into pTS700 in a ligation-independent mechanism. Next, the 
“A”-plasmids served as a foundation plasmid from which so-called “B”-plasmids, or 
disruption vectors, were generated. This was done by a single-step PCR-based procedure 
wherein the original GOI was deleted from the plasmid, while leaving the flanking DNA that 
will target integration of the entire B-plasmid to the TS559 genome. Two separate initial 
integration events are possible for incorporation of the entire B-plasmid to the genome, and 
each generates an intermediate strain that, when 6MP-based counter-selective pressure is 
applied, can undergo an internal recombination event to either restore the original genome 
or produce a strain containing a genome with the desired, targeted deletion (Figure S5.2a). 
The overexpression vectors were constructed as follows. First an inverse PCR using the 
primer-pair BG4881-BG4882 and the previously constructed integration vector pSKS022 
(Chapter 3) as template was performed. pSKS022 is a derivative of pSecPyrF [106] and was 
chosen as template, as integration in the genome at the ChiA locus targeted by this plasmid 
has shown to be efficient and non-disturbing. The PCR resulted in the amplification of a 
vector backbone for the overexpression vectors, that contained the flanking regions needed 
for integration as well as the strong constitutive hmtB-promoter. The PCR thus removed the 
csg-promoter, the TM-gene expression cassette, the synthetic transcription terminator (T8), 
the 500-bp pop-out homology, and the counter-selection marker TK0664 from pSKS022. The 
linear vector backbone created by this PCR was extended with an unique AgeI restriction 
site, which was incorporated in the primer BG4882. Next, the GOIs were amplified by 
Phusion polymerase PCR (Thermo Fisher Scientific) using the corresponding primers listed in 
Table S5.3. The reverse primers were extended with a unique AgeI restriction site, allowing 
for easy and directional ligation in the amplified vector backbone, creating the desired 
vectors as shown in Figure S5.2b. Transcription of the GOIs was designed to be controlled by 
the strong constitutive hmtB-promoter [486]. 
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The T. kodakarensis ∆- and OE-strains shown in Table 5.2 were generated by transforming 
the corresponding vectors into T. kodakarensis TS559 (ΔpyrF; ΔtrpE::pyrF; ΔTK0664; 
ΔTK0149) [60, 61, 486]. Disruption strains were created as described previously [60]. 
Overexpression strains were created by a slightly adapted approach in which the counter-
selection marker (TK0664) was not involved and desired mutants were thus simply selected 
by growing colonies on medium lacking agmatine. An important difference between these 
two methods is that, as a result of excluding TK0664, the selection marker (TK0149) cannot 
be removed from the genome after obtaining initial transformants. This means that, in 
contrast to the disruption strains, the created overexpression strains do not allow another 
round of the procedure to make additional genome modifications. Diagnostic PCRs were 
performed to select and confirm genotypes of desired strains. To do this, 6MP-resistant 
colonies growing on ASW-YT plates supplemented with agmatine (in the case of the 
disruption strains) or agmatine-prototrophic colonies growing on ASW-YT plates without 
agmatine (in the case of the overexpression strains) were picked and used to inoculate liquid 
ASW-YT- S0 cultures (with and without agmatine, respectively), which were incubated o/n at 
85°C. Next, 1.5-ml culture was sampled using a syringe and genomic DNA was isolated 
according to the protocol for Gram-positive bacteria of the GeneJET genomic DNA 
purification kit (Thermo Scientific). Purified DNA was then used as template in three 
diagnostic PCRs. In the first PCR, the primers used were complementary to the sequence 
upstream of the desired integration locus as well as to the C-terminus of the integrated GOI 
(illustrated by primers A and B in Figure S5.2). Similarly, a second PCR was included using 
primers that were complementary to the sequence downstream of the desired integration 
locus as well as to the N-terminus of the integrated GOI (illustrated by primers C and D). A 
third PCR was performed to identify double crossover mutants, using primers that were 
complementary to the sequence downstream and upstream of the integration locus 
(illustrated by primers A and D). A generated PCR product having the correct size for all three 
reactions suggested the desired double crossover genotype. In addition, fragments 
containing the additional copy of the GOI were PCR amplified from the genome of the 
desired clones and sent for sequencing to confirm the absence of undesired mutations. 
Sequences of the primers are listed in Table S5.3. 
 
RNA isolation and RT-PCR 
To confirm loss of transcription or increased mRNA levels of the GOIs in the disruption 
strains or overexpression strains, respectively, reverse transcriptase PCR (RT-PCR) was 
performed. To do this, the parental strain TS559 and the various mutant strains created in 
this study were cultivated in 120-ml serum bottles containing 40 ml ASW-YT-S0 medium, 
which in the case of the disruption strains were also supplemented with 500 µM agmatine 
and 75 µM 6MP. Samples of 10 ml were removed and cells were harvested by centrifugation 
(4700x g, 30 min, 4°C). Total RNA was isolated by the following method. Cell pellets were 
resuspended in 1 ml Trizol and 200 µl chloroform was added. The mixtures were shaken by 
hand for 15 seconds, followed by an incubation at RT for 3 min. Next, the samples were 
centrifuged (13,000x g, 15 min, 4°C) and the supernatants were transferred to fresh 
Eppendorf tubes. 5 µg glycogen and 500 µl isopropanol were added and the mixtures were 
incubated at RT for 10 min. The samples were centrifuged (13,000x g, 15 min, 4°C) and the 
pellets were washed in 75% ethanol, air-dried for 10 min and resuspended in 20 µl MQ 
water. RNA concentrations were determined with a Nanodrop ND-1000 and the total RNA 
samples were stored at -20°C until further processing. 
Before RT-PCR, the total RNA samples (1 µg each) were treated with DNaseI, to remove 
residual genomic DNA. cDNA was prepared by following the protocol for first strand cDNA 
synthesis of the Thermo Scientific RevertAid RT kit (20 µl reactions), using random hexamers 
as primers. Gene-specific cDNA fragments were amplified by conventional PCR using the 
freshly prepared cDNA as template and primer pairs developed to specifically target the 
genes of interest (Table S5.3). The housekeeping gene TK0308 (puf), encoding the α-subunit 
of the elongation factor-1 complex (EF-1-α), was included for normalization [491]. All primer 
pairs were designed to produce a specific product of ~250 bp. All reactions were run for the 
amount of cycles needed to make the respective product in the reactions containing cDNA of 
the parental strain TS559 just visible. The only exception to this are the reactions used for 
normalization (TK0308), which were run for 18 cycles. PCR amplification products were 
analyzed by agarose gel electrophoresis. Control experiments were included by following the 
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same procedure, but without addition of RevertAid Reverse Transcriptase enzyme to the RT 
reaction mixture. 
Core lipid extraction and analysis by UHP-APCI/MS 
Triplicate cultures of the various mutant strains and parental strain TS559 were cultured on 
ASW-YT-Pyr. When the cultures reached the stationary phase, cells were harvested by 10 
min centrifugation at 4700x g and lyophilized overnight. To extract the core lipids of the 
various strains, lyophilized cells were hydrolysed with 1 N 5%HCl in methanol by reflux at 
130 °C for 3 h. The hydrolysate was adjusted to pH 7 with 2 N KOH-methanol (MeOH) (1:1, 
vol/vol) and, after addition of water to a final 1:1 ratio of H2O-MeOH, extracted three times 
with dichloromethane (DCM). The DCM fractions were collected and dried over sodium 
sulfate. The resulting extract was dried under nitrogen and dissolved in hexane–2-propanol 
(99:1, vol/vol), filtered over a 0.45-µm polytetrafluoroethylene filter, and analysed by high-
performance liquid chromatography (HPLC)–atmospheric pressure chemical ionization (APCI) 
mass spectrometry (MS) for archaeol and GDGTs. The UHPLC-APCI/MS analysis was done 
according to Hopmans et al. [589], with some modifications. Briefly, analysis was performed 
on an Agilent 1260 UHPLC coupled to a 6130 quadrupole MSD in selected ion monitoring 
(SIM) mode. Separation was achieved on two UHPLC silica columns (BEH HILIC columns, 2.1 x 
150 mm, 1.7 µm; Waters) in series, fitted with a 2.1 x 5 mm pre-column of the same material 
(Waters) and maintained at 30C. Archaeol and GDGTs were eluted isocratically for 10 min 
with 10% B, followed by a linear gradient to 18% B in 20 min, then a linear gradient to 100% 
B in 20 min, where A is hexane and B is hexane: isopropanol (9:1). Flow rate was 0.2 ml/min. 
Total run time is 60 min with a 20 min re-equilibration. Source settings were identical to 
Schouten et al. (2007) [590]. Typical injection volume was 5 µl of a 1 mg/ml solution. M/z of 
the protonated molecules of archaeol and isoprenoid GDGTs were monitored.  Archaeol and 
GDGTs were quantified by comparing  the response in the appropriate mass chromatogram 
to the response of known amounts of standards (archaeol obtained from Avanti Polar Lipids, 
Inc. Alabaster, Alabama, USA; GDGT-0 prepared according to Sinninghe Damste et al., 2002 
[591])  
 
 
Transmission electron microscopy (TEM) of thin sections.  
Cells of T. kodakarensis strains TS559, OE1324, OE1957 and Δ1548 cultured in ASW-YT-Pyr 
and harvested in the stationary phase were fixed by incubation in 3% glutaraldehyde in 0.1 
M sodium cacodylate buffer pH 7.2 for 1.5 h at room temperature. After three washes in the 
same buffer, a post fixation was done in 1% (w/v) OsO4 and 1.5% (w/v) potassium 
ferricyanide in the same buffer for 1 h at room temperature and subsequently rinsed three 
times in water. One volume of the sample suspensions were mixed with equal volumes of 
3% low melting point agarose. Between each step the samples were centrifuged for 5 min at 
8,000 rpm (5220x g) and the pellets were suspended again in the next liquid. After 
centrifugation the agarose was solidified at 0°C and the parts containing the pelleted sample 
were cut in very small pieces. The sample pieces were dehydrated in a graded ethanol series 
(10, 30, 50, 70, 90, 100, 100%), infiltrated with modified Spurr resin mixture (Serva) and 
polymerized for 8 h at 70°C. The samples were ultra-thin (70-80 nm) sectioned with an ultra-
microtome (Reichert, Ultracut S), post-stained with 5 times diluted Reynold’s lead citrate for 
5 minutes and analyzed with a transmission electron microscope (JEOL, JEM 1011). 
Micrographs were made with a digital camera (Olympus, Veleta). Sample preparation and 
imaging were performed by the Wageningen Electron Microscopy Centre (WEMC) facility. 
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Figure S5.1 Hypothetical pathway responsible for the biosynthesis of CDP-archaeol in T. kodakarensis. CDP-
archaeol is a CDP-activated precursor of the final diether lipid (i.e. archaeol). The pathway was constructed by 
BLASTing the sequences of experimentally characterized genes, that have shown to be responsible for the 
reactions leading to isoprenoid and CDP-archaeol synthesis in various archaea, against the genome of T. 
kodakarensis [570-577]. TK1957 was analysed in this study and has shown to be involved in GDGT 
formation. 
 
A. 
 
B. 
Figure S5.2 Schematic diagram of 
disruption and overexpression 
procedure in T. kodakarensis. a) Use 
of disruption vectors (B-plasmids) to 
generate markerless knockouts in the 
genome of T. kodakarensis TS559. The 
image has been reused from Hileman, 
T.H., and Santangelo, T.J. (2012) [60].  
A hypothetical region of the genome 
of T. kodakarensis strain TS559 is 
shown at top, with the left and right 
panels depicting the two possible 
integration events yielding agmatine-
prototrophic intermediate strains 
from the diagramed B-plasmid. Both intermediate strains #1 and #2 contain direct repeats flanking the target 
locus, and dependent on recombination responsible for excision upon counter-selection with 6MP, either the 
original TS559 genome can be restored or the desired deletion genome generated. b) Use of overexpression 
vectors (OE-vector) to generate T. kodakarensis strains overexpressing the gene of interest (GOI). The GOI is 
integrated at the ChiA-locus of T. kodakarensis strain TS559 via a double homologous recombination event 
yielding agmatine-prototrophic OE-strains. The letters A-D represent the binding sites of the primers used in 
the diagnostic PCRs. The letters E & F represent the binding sites of the primers used to amplify the vector 
backbone using pSKS022 as a template. Abbreviations: TK0149, agmatine selection marker; TK0664, counter-
selection marker; Phmtb, strong constitutive promoter  
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Table S5.2. arCOGs included in the second comparative genome analysis. 
COG0020 Undecaprenyl pyrophosphate synthase
COG0039 Malate/lactate dehydrogenases
COG0043 3-polyprenyl-4-hydroxybenzoate decarboxylase and related decarboxylases 
COG0075 Serine-pyruvate aminotransferase/archaeal aspartate aminotransferase
COG0083 Homoserine kinase 
COG0119 Isopropylmalate/homocitrate/citramalate synthases
COG0142 Geranylgeranyl pyrophosphate synthase
COG0153 Galactokinase
COG0163 3-polyprenyl-4-hydroxybenzoate decarboxylase
COG0167 Dihydroorotate dehydrogenase
COG0183 Acetyl-CoA acetyltransferase 
COG0210 Superfamily I DNA and RNA helicases
COG0214 Pyridoxine biosynthesis enzyme
COG0240 Glycerol-3-phosphate dehydrogenase
COG0280 Phosphotransacetylase 
COG0282 Acetate kinase 
COG0318 Acyl-CoA synthetases (AMP-forming)/AMP-acid ligases II
COG0331 (acyl-carrier-protein) S-malonyltransferase
COG0371 Glycerol dehydrogenase and related enzymes
COG0382 4-hydroxybenzoate polyprenyltransferase and related prenyltransferases 
COG0407 Uroporphyrinogen-III decarboxylase
COG0417 DNA polymerase elongation subunit (family B)
COG0439 Biotin carboxylase 
COG0469 Pyruvate kinase 
COG0558 Phosphatidylglycerophosphate synthase
COG0575 CDP-diglyceride synthetase 
COG0578 Glycerol-3-phosphate dehydrogenase 
COG0644 Dehydrogenases (flavoproteins)
COG0688 Phosphatidylserine decarboxylase
COG0761 Penicillin tolerance protein 
COG1022 Long-chain acyl-CoA synthetases (AMP-forming)
COG1024 Enoyl-CoA hydratase/carnithine racemase
COG1052 Lactate dehydrogenase and related dehydrogenases
COG1154 Deoxyxylulose-5-phosphate synthase
COG1183 Phosphatidylserine synthase 
COG1233 Phytoene dehydrogenase-related protein
COG1239 Mg-chelatase subunit ChII 
COG1250 3-hydroxyacyl-CoA dehydrogenase
COG1257 Hydroxymethylglutaryl-CoA reductase
COG1267 Phosphatidylglycerophosphatase A and related proteins
COG1304 L-lactate dehydrogenase (FMN-dependent) and related alpha-hydroxyl acid dehydrogenases
COG1331 Highly conserved protein containing a thioredoxin domain
COG1348 Nitrogenase subunit NifH (ATPase)
COG1355 Predicted dioxygenase 
COG1429 Cobalamin biosynthesis protein CoBN and related Mg-chelatases
COG1443 Isopentenyldiphosphate isomerase
COG1502 Phosphatidylserine/Phosphatidylglycerophosphate/cardiolipin synthases and related enzymes
COG1545 Predicted nucleic-acid-binding protein containing a Zn-ribbon
COG1562 Phytoene/squalene synthetase
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COG0167 Dihydroorotate dehydrogenase
COG0183 Acetyl-CoA acetyltransferase 
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COG0240 Glycerol-3-phosphate dehydrogenase
COG0280 Phosphotransacetylase 
COG0282 Acetate kinase 
COG0318 Acyl-CoA synthetases (AMP-forming)/AMP-acid ligases II
COG0331 (acyl-carrier-protein) S-malonyltransferase
COG0371 Glycerol dehydrogenase and related enzymes
COG0382 4-hydroxybenzoate polyprenyltransferase and related prenyltransferases 
COG0407 Uroporphyrinogen-III decarboxylase
COG0417 DNA polymerase elongation subunit (family B)
COG0439 Biotin carboxylase 
COG0469 Pyruvate kinase 
COG0558 Phosphatidylglycerophosphate synthase
COG0575 CDP-diglyceride synthetase 
COG0578 Glycerol-3-phosphate dehydrogenase 
COG0644 Dehydrogenases (flavoproteins)
COG0688 Phosphatidylserine decarboxylase
COG0761 Penicillin tolerance protein 
COG1022 Long-chain acyl-CoA synthetases (AMP-forming)
COG1024 Enoyl-CoA hydratase/carnithine racemase
COG1052 Lactate dehydrogenase and related dehydrogenases
COG1154 Deoxyxylulose-5-phosphate synthase
COG1183 Phosphatidylserine synthase 
COG1233 Phytoene dehydrogenase-related protein
COG1239 Mg-chelatase subunit ChII 
COG1250 3-hydroxyacyl-CoA dehydrogenase
COG1257 Hydroxymethylglutaryl-CoA reductase
COG1267 Phosphatidylglycerophosphatase A and related proteins
COG1304 L-lactate dehydrogenase (FMN-dependent) and related alpha-hydroxyl acid dehydrogenases
COG1331 Highly conserved protein containing a thioredoxin domain
COG1348 Nitrogenase subunit NifH (ATPase)
COG1355 Predicted dioxygenase 
COG1429 Cobalamin biosynthesis protein CoBN and related Mg-chelatases
COG1443 Isopentenyldiphosphate isomerase
COG1502 Phosphatidylserine/Phosphatidylglycerophosphate/cardiolipin synthases and related enzymes
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COG1577 Mevalonate kinase 
COG1608 Predicted archaeal kinase 
COG1646 Predicted phosphate-binding enzymes, TIM-barrel fold
COG1657 Squalene cyclase 
COG1689 Uncharacterized protein conserved in archaea
COG1960 Acyl-CoA dehydrogenases 
COG2025 Electron transfer flavoprotein, alpha subunit
COG2057 Acyl-CoA acetate/3-ketoacid CoA transferase, beta subunit
COG2086 Electron transfer flavoprotein, beta subunit
COG2098 Uncharacterized protein conserved in archaea
COG2227 2-polyprenyl-3-methyl-5-hydroxy-6-metoxy-1,4-benzoquinol methylase
COG2324 Predicted membrane protein 
COG2440 Ferredoxin-like protein 
COG2710 Nitrogenase molybdenum-iron protein, alpha and beta chains
COG3407 Mevalonate pyrophopsphate decarboxylase 
COG3425 3-hydroxy-3-methylglutaryl CoA synthase
COG3890 Phosphomevalonate kinase 
COG4072 Uncharacterized protein conserved in archaea
COG4851 Protein involved in sex pheromone biosynthesis
COG5190 TFIIF-interacting CTD phosphatases, including NLI-interacting factor
COG5243 HRD ubiquitin ligase complex, ER membrane component
COG5272 Ubiquitin 
 
  
 
Table S5.3. Sequences of oligonucleotide primers used in this study 
Oligonucleotide Sequence (5’-3’) Application 
Disruption vectors 
0010509 GGAGGTGAATTTCGTATGGACTTATACGTCAGAAAAGC TK0509 initial amplification
0020509 GGTGAAGGATTTCCTCCTTTATTATTTCCTTGCTCTCC TK0509 initial amplification
  
0160509 AGCCCTATCAAGGTCGTCCAGCTGTACCATCCAATCACC
TAACGTTCGCTAGGGACGCTT 
TK0509 inverse PCR to construct 
B plasmids 
0170509 AAGCGTCCCTAGCGAACGTTAGGTGATTGGATGGTACA
GCTGGACGACCTTGATAGGGCT 
TK0509 inverse PCR to construct 
B plasmids 
0010513 GGAGGTGAATTTCAGGGGATTATCGAGTATCTTCAGG TK0513 initial amplification
0020513 GGTGAAGGATTTCCTTCTCTATCTTATGCCCCCTATCC TK0513 initial amplification
0160513 CGCCTGTTCTACTCCATAGGAGGCGGTAGAATCTTTTAA
ACAATCCATCCTTTCGAAAGC 
TK0513 inverse PCR to construct 
B plasmids 
0170513 GCTTTCGAAAGGATGGATTGTTTAAAAGATTCTACCGCC
TCCTATGGAGTAGAACAGGCG 
TK0513 inverse PCR to construct 
B plasmids 
0010929 GGAGGTGAATTTCGGCATTCATCGAAGAGGACTATCG TK0929 initial amplification
0020929 GGTGAAGGATTTCCATGTCGTTTAAAGAAAGTGTGACC TK0929 initial amplification
0160929 AGACCTTTTGGAAGTTGGTATGGTGATAGCTCACTCCCC
CATTTCCCTAATCTTCCTGAC 
TK0929 inverse PCR to construct 
B plasmids 
0170929 GTCAGGAAGATTAGGGAAATGGGGGAGTGAGCTATCA
CCATACCAACTTCCAAAAGGTCT 
TK0929 inverse PCR to construct 
B plasmids 
0011088 GGAGGTGAATTTCCAGCGAGGAAGTACTATAACATCG TK1088 initial amplification
0021088 GGTGAAGGATTTCACCCTGATCTTGATCTTCAGTTAGG TK1088 initial amplification
0161088 AGCGCTAAACCCCTGGAGGTGAGCGAATGATCAAGGA
GCTTCTTTAACCAGTCTGAACCC 
TK1088 inverse PCR to construct 
B plasmids 
0171088 GGGTTCAGACTGGTTAAAGAAGCTCCTTGATCATTCGCT
CACCTCCAGGGGTTTAGCGCT 
TK1088 inverse PCR to construct 
B plasmids 
0011173 GGAGGTGAATTTCAGCTCAAAGACCTCATAGTGTTCC TK1173 initial amplification
0021173 GGTGAAGGATTTCAGGACTGCGAATCCTTTACTTTCG TK1173 initial amplification
0161173 TTAATAAGCTTTAGCGGAAAAATTTAAAAATTGCCCTCA
CTCTATCTTCTTCCTCTTGAG 
TK1173 inverse PCR to construct 
B plasmids 
0171173 CTCAAGAGGAAGAAGATAGAGTGAGGGCAATTTTTAA
ATTTTTCCGCTAAAGCTTATTAA 
TK1173 inverse PCR to construct 
B plasmids 
0011324 GGAGGTGAATTTCCTCACCAGTTCTCTCTCTTTATTGC TK1324 initial amplification
0021324 GGTGAAGGATTTCAATACGACACACCGGTTTACGTTGG TK1324 initial amplification
0161324 CTATTTTCATTTTCCTGCACCCCTAAGACAGGTATCACTC
AATAGCTCCCAAAATAGGAC 
TK1324 inverse PCR to construct 
B plasmids 
0171324 GTCCTATTTTGGGAGCTATTGAGTGATACCTGTCTTAGG
GGTGCAGGAAAATGAAAATAG 
TK1324 inverse PCR to construct 
B plasmids 
0011477 GGAGGTGAATTTCCCTCTAACAAGTCCTTCAAATACG TK1477 initial amplification
0021477 GGTGAAGGATTTCGTTCACAAAGAGGCTATAGAGTTCG TK1477 initial amplification
0161477 AAATATGGAAAAGGGCTTATCACACTTTCGCATCTCCAT
CACCCCCAATGGATTTTAGCT 
TK1477 inverse PCR to construct 
B plasmids 
0171477 AGCTAAAATCCATTGGGGGTGATGGAGATGCGAAAGT
GTGATAAGCCCTTTTCCATATTT 
TK1477 inverse PCR to construct 
B plasmids 
0011548 GGAGGTGAATTTCGAAAGTCCCAAATCTATTGTGTAGG TK1548 initial amplification
0021548 GGTGAAGGATTTCTATCATGGGAGTCTACATCTTTACC TK1548 initial amplification
0161548 CCTTGAGCAACTAAGGGCGAGGTGATAACTTTCCAATT
CTCCCTCTTTTCCCCTTCTTAT 
TK1548 inverse PCR to construct 
B plasmids 
0171548 ATAAGAAGGGGAAAAGAGGGAGAATTGGAAAGTTATC
ACCTCGCCCTTAGTTGCTCAAGG 
TK1548 inverse PCR to construct 
B plasmids 
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COG1577 Mevalonate kinase 
COG1608 Predicted archaeal kinase 
COG1646 Predicted phosphate-binding enzymes, TIM-barrel fold
COG1657 Squalene cyclase 
COG1689 Uncharacterized protein conserved in archaea
COG1960 Acyl-CoA dehydrogenases 
COG2025 Electron transfer flavoprotein, alpha subunit
COG2057 Acyl-CoA acetate/3-ketoacid CoA transferase, beta subunit
COG2086 Electron transfer flavoprotein, beta subunit
COG2098 Uncharacterized protein conserved in archaea
COG2227 2-polyprenyl-3-methyl-5-hydroxy-6-metoxy-1,4-benzoquinol methylase
COG2324 Predicted membrane protein 
COG2440 Ferredoxin-like protein 
COG2710 Nitrogenase molybdenum-iron protein, alpha and beta chains
COG3407 Mevalonate pyrophopsphate decarboxylase 
COG3425 3-hydroxy-3-methylglutaryl CoA synthase
COG3890 Phosphomevalonate kinase 
COG4072 Uncharacterized protein conserved in archaea
COG4851 Protein involved in sex pheromone biosynthesis
COG5190 TFIIF-interacting CTD phosphatases, including NLI-interacting factor
COG5243 HRD ubiquitin ligase complex, ER membrane component
COG5272 Ubiquitin 
 
  
 
Table S5.3. Sequences of oligonucleotide primers used in this study 
Oligonucleotide Sequence (5’-3’) Application 
Disruption vectors 
0010509 GGAGGTGAATTTCGTATGGACTTATACGTCAGAAAAGC TK0509 initial amplification
0020509 GGTGAAGGATTTCCTCCTTTATTATTTCCTTGCTCTCC TK0509 initial amplification
  
0160509 AGCCCTATCAAGGTCGTCCAGCTGTACCATCCAATCACC
TAACGTTCGCTAGGGACGCTT 
TK0509 inverse PCR to construct 
B plasmids 
0170509 AAGCGTCCCTAGCGAACGTTAGGTGATTGGATGGTACA
GCTGGACGACCTTGATAGGGCT 
TK0509 inverse PCR to construct 
B plasmids 
0010513 GGAGGTGAATTTCAGGGGATTATCGAGTATCTTCAGG TK0513 initial amplification
0020513 GGTGAAGGATTTCCTTCTCTATCTTATGCCCCCTATCC TK0513 initial amplification
0160513 CGCCTGTTCTACTCCATAGGAGGCGGTAGAATCTTTTAA
ACAATCCATCCTTTCGAAAGC 
TK0513 inverse PCR to construct 
B plasmids 
0170513 GCTTTCGAAAGGATGGATTGTTTAAAAGATTCTACCGCC
TCCTATGGAGTAGAACAGGCG 
TK0513 inverse PCR to construct 
B plasmids 
0010929 GGAGGTGAATTTCGGCATTCATCGAAGAGGACTATCG TK0929 initial amplification
0020929 GGTGAAGGATTTCCATGTCGTTTAAAGAAAGTGTGACC TK0929 initial amplification
0160929 AGACCTTTTGGAAGTTGGTATGGTGATAGCTCACTCCCC
CATTTCCCTAATCTTCCTGAC 
TK0929 inverse PCR to construct 
B plasmids 
0170929 GTCAGGAAGATTAGGGAAATGGGGGAGTGAGCTATCA
CCATACCAACTTCCAAAAGGTCT 
TK0929 inverse PCR to construct 
B plasmids 
0011088 GGAGGTGAATTTCCAGCGAGGAAGTACTATAACATCG TK1088 initial amplification
0021088 GGTGAAGGATTTCACCCTGATCTTGATCTTCAGTTAGG TK1088 initial amplification
0161088 AGCGCTAAACCCCTGGAGGTGAGCGAATGATCAAGGA
GCTTCTTTAACCAGTCTGAACCC 
TK1088 inverse PCR to construct 
B plasmids 
0171088 GGGTTCAGACTGGTTAAAGAAGCTCCTTGATCATTCGCT
CACCTCCAGGGGTTTAGCGCT 
TK1088 inverse PCR to construct 
B plasmids 
0011173 GGAGGTGAATTTCAGCTCAAAGACCTCATAGTGTTCC TK1173 initial amplification
0021173 GGTGAAGGATTTCAGGACTGCGAATCCTTTACTTTCG TK1173 initial amplification
0161173 TTAATAAGCTTTAGCGGAAAAATTTAAAAATTGCCCTCA
CTCTATCTTCTTCCTCTTGAG 
TK1173 inverse PCR to construct 
B plasmids 
0171173 CTCAAGAGGAAGAAGATAGAGTGAGGGCAATTTTTAA
ATTTTTCCGCTAAAGCTTATTAA 
TK1173 inverse PCR to construct 
B plasmids 
0011324 GGAGGTGAATTTCCTCACCAGTTCTCTCTCTTTATTGC TK1324 initial amplification
0021324 GGTGAAGGATTTCAATACGACACACCGGTTTACGTTGG TK1324 initial amplification
0161324 CTATTTTCATTTTCCTGCACCCCTAAGACAGGTATCACTC
AATAGCTCCCAAAATAGGAC 
TK1324 inverse PCR to construct 
B plasmids 
0171324 GTCCTATTTTGGGAGCTATTGAGTGATACCTGTCTTAGG
GGTGCAGGAAAATGAAAATAG 
TK1324 inverse PCR to construct 
B plasmids 
0011477 GGAGGTGAATTTCCCTCTAACAAGTCCTTCAAATACG TK1477 initial amplification
0021477 GGTGAAGGATTTCGTTCACAAAGAGGCTATAGAGTTCG TK1477 initial amplification
0161477 AAATATGGAAAAGGGCTTATCACACTTTCGCATCTCCAT
CACCCCCAATGGATTTTAGCT 
TK1477 inverse PCR to construct 
B plasmids 
0171477 AGCTAAAATCCATTGGGGGTGATGGAGATGCGAAAGT
GTGATAAGCCCTTTTCCATATTT 
TK1477 inverse PCR to construct 
B plasmids 
0011548 GGAGGTGAATTTCGAAAGTCCCAAATCTATTGTGTAGG TK1548 initial amplification
0021548 GGTGAAGGATTTCTATCATGGGAGTCTACATCTTTACC TK1548 initial amplification
0161548 CCTTGAGCAACTAAGGGCGAGGTGATAACTTTCCAATT
CTCCCTCTTTTCCCCTTCTTAT 
TK1548 inverse PCR to construct 
B plasmids 
0171548 ATAAGAAGGGGAAAAGAGGGAGAATTGGAAAGTTATC
ACCTCGCCCTTAGTTGCTCAAGG 
TK1548 inverse PCR to construct 
B plasmids 
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0011732 GGAGGTGAATTTCAAAGAGAACAGTATTCCCATCACC TK1732 initial amplification
0021732 GGTGAAGGATTTCGGAAGGAGAGTTGAGAGACTGACC TK1732 initial amplification
0161732 AAAATAGGGAGCAACGAGCAGAACCCTCATTCAACTGT
CATCTGCGACCCTCTCGTAGAA 
TK1732 inverse PCR to construct 
B plasmids 
0171732 TTCTACGAGAGGGTCGCAGATGACAGTTGAATGAGGG
TTCTGCTCGTTGCTCCCTATTTT 
TK1732 inverse PCR to construct 
B plasmids 
0011836 GGAGGTGAATTTCCAACGAGCTTTAATAACCTTCTCG TK1836 initial amplification
0021836 GGTGAAGGATTTCGCCAAGTAAAAGCTCTCGTTGTCC TK1836 initial amplification
0161836 TTTTAAAACCACCCCATCCGAGGGGTGAAGGGTGAGAA
GATGGCCAGATGGAAGATGGGC 
TK1836 inverse PCR to construct 
B plasmids 
0171836 GCCCATCTTCCATCTGGCCATCTTCTCACCCTTCACCCCT
CGGATGGGGTGGTTTTAAAA 
TK1836 inverse PCR to construct 
B plasmids 
0011957 GGAGGTGAATTTCAGCTGGTAAAACCTGACATTATTGC TK1957 initial amplification
0021957 GGTGAAGGATTTCAAGAAGAGGAGGAGAAAACTGAG
G 
TK1957 initial amplification
0161957 CTTCCGACAGAATTTAGTTAGGTGCCCCTATGGATATGG
ATTTTGAGAAAGAACTGATTA 
TK1957 inverse PCR to construct 
B plasmids 
0171957 TAATCAGTTCTTTCTCAAAATCCATATCCATAGGGGCAC
CTAACTAAATTCTGTCGGAAG 
TK1957 inverse PCR to construct 
B plasmids 
0012159 GGAGGTGAATTTCGTCAACTATGACCGGAGCCTCTACG TK2159 initial amplification
0022159 GGTGAAGGATTTCGAAGGTATCAAAAATCCCAAAGTGG TK2159 initial amplification
0162159 CCACTCTACAAATGTAAAGAAAAGTGCCGCTCTACCACC
TGAAATGCCAAGGGTGAGGAA 
TK2159 inverse PCR to construct
B plasmids 
0172159 TTCCTCACCCTTGGCATTTCAGGTGGTAGAGCGGCACTT
TTCTTTACATTTGTAGAGTGG 
TK2159 inverse PCR to construct 
B plasmids 
 
Overexpression vectors 
BG4881 
BG4882 
 
CACCTCCGTGATATTATCTATTAC 
CGCACCGGTCCGGACAACACCCCTTGAGCTTTG 
vbb amplification (pSKS022) 
vbb amplification (pSKS022) 
BG4934 
BG4935 
ATGCTATACAGATTGGTCTCCCACATCCC
CGCACCGGTCTACCTTCCAAAGCGCCGCTGTCTC 
TK1173 amplification 
TK1173 amplification 
BG4936 
BG4937 
ATGCTGAGGGAGATACTCTCAC
CGCACCGGTTCACACCCTCGCCCTCTCAAAC 
TK0929 amplification 
TK0929 amplification 
BG4938 
BG4939 
ATGAAGTACGATGTCCTCATAATCGGCGGC
GCGACCGGTTACTCCTCCTGGAGGCCCATCTTCCAT 
TK1836 amplification 
TK1836 amplification 
BG4940 
BG4941 
ATGAAAGTCATTGTCGCAATAACGGGGGC
GCGACCGGTTCAAGGTCGTCCAGCTGTAC 
TK0509 amplification 
TK0509 amplification 
BG4942 
BG4943 
ATGGCATCTGTTTCAGCTGTTATAAGG
GCGACCGGTCGCTGACGAGGGCTATTTTCAT 
TK1324 amplification 
TK1324 amplification 
BG5196 
BG5197 
ATGACCTGGAAGTACGACGTCGTTG
GCGACCGGTGAAGAAGGGGTTCAGACTGGTT 
TK1088 amplification 
TK1088 amplification 
BG5200 
BG5201 
ATGGAATTCAAGGCATTCATCGAG
GCGACCGGTGGCGTCTTGAACGTTATGACAG 
TK1957 amplification 
TK1957 amplification 
BG5202 
BG5203 
ATGGGCTCGAAGCTTGATGAG
GCGACCGGTTCCCGCACGTTAGTCCTACAC 
TK0513 amplification 
TK0513 amplification 
BG5204 
BG5205 
ATGGAGCTCCACTTTGACATGACC
GCGACCGGTGGGGAAAAGAGGGAGAATTG 
TK1548 amplification 
TK1548 amplification 
BG5584 
BG5585 
ATGACAGTTGAAGTCTCCGTG
GCGACCGGTAACGAGCAGAACCCTCATTC 
TK1732 amplification 
TK1732 amplification 
BG5586 
BG5587 
ATGGAGATGGTGGTAAGGTATCCC
GCGACCGGTCTAGCGCCTGAAGACTATG 
TK1477 amplification 
TK1477 amplification 
BG5588 
BG5589 
ATGAGTAAAGGAGTTGTACATCC 
GCGACCGGTGCCGCTCAGAGGTACCATTCGG 
TK2159 amplification 
TK2159 amplification 
 
  
Diagnostic primers  
BG4871 CATCCTCACAGGGACGTTTG OExxxx diagnosis & sequencing 
(primer A in Figure S2b) 
BG4873 ACAGACTTGAGGTGGAAAGG OExxxx diagnosis & sequencing 
(primer D in Figure S2b) 
BG4662 GCTTGGGTCATGGACAGGCTC RT-PCR: TK0308 (F) 
BG4663 TCTTAACCTGCTCGGCGACC RT-PCR: TK0308 (R) 
BG5570 TAGAAGGATAACCGCAGGTG RT-PCR: TK1477 (F) 
BG5571 CGATGGAGTGCTCGTATTTG RT-PCR: TK1477 (R) 
BG5572 TGGAAACTACCTGGCGTCTC RT-PCR: TK1836 (F) 
BG5573 AGTCGGCTCCCTTCTTTACC RT-PCR: TK1836 (R) 
BG5574 CTCACTGAACCCAGATAAGG RT-PCR: TK1324 (F) 
BG5575 GATTCTCCCGTCCATTGAAG RT-PCR: TK1324 (R) 
BG5576 AAGACGGCGGCTACTGCTTC RT-PCR: TK0513 (F) 
BG5577 CGCCAAGACCAACGGCAAAC RT-PCR: TK0513 (R) 
BG5578 TGGTGAAGCCGAAGTACAAG RT-PCR: TK1548 (F) 
BG5579 AACGCTCCAATAACCGTGAC RT-PCR: TK1548 (R) 
BG5580 GGTTGGGCGTTTCCTATGAG RT-PCR: TK1732 (F) 
BG5581 TGCACCGGGTTCGATCATTC RT-PCR: TK1732 (R) 
BG5723 GCTATCTCCAGCTCGCTAAC RT-PCR: TK0929 (F) 
BG5724 CTCAAGAAGCTCCCGATTCC RT-PCR: TK0929 (R) 
BG5725 GGATGCGGGCATAATCACAG RT-PCR: TK0509 (F) 
BG5726 GCTTGGGCATGAGGTTGTTG RT-PCR: TK0509 (R) 
BG5727 CGCTGTAGGCGATCTGATAG RT-PCR: TK1173 (F) 
BG5728 AACATAGCCCTCGCATACGG RT-PCR: TK1173 (R) 
BG5729 GCGGAGCGTAGGTGTTTATG RT-PCR: TK1088 (F) 
BG5730 ACAAGGAAGTCAGCGGAGTG RT-PCR: TK1088 (R) 
BG5733 ATGAGGAACGCAGAGTACAG RT-PCR: TK1957 (F) 
BG5734 ATAGCCGTTGGTGAGATTGG RT-PCR: TK1957 (R) 
BG5737 TCTCCTTGATGCCGATGTTC RT-PCR: TK2159 (F) 
BG5738 AGATAGGCGACAACGAGTTC RT-PCR: TK2159 (R) 
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0011732 GGAGGTGAATTTCAAAGAGAACAGTATTCCCATCACC TK1732 initial amplification
0021732 GGTGAAGGATTTCGGAAGGAGAGTTGAGAGACTGACC TK1732 initial amplification
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B plasmids 
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GATGGCCAGATGGAAGATGGGC 
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0171836 GCCCATCTTCCATCTGGCCATCTTCTCACCCTTCACCCCT
CGGATGGGGTGGTTTTAAAA 
TK1836 inverse PCR to construct 
B plasmids 
0011957 GGAGGTGAATTTCAGCTGGTAAAACCTGACATTATTGC TK1957 initial amplification
0021957 GGTGAAGGATTTCAAGAAGAGGAGGAGAAAACTGAG
G 
TK1957 initial amplification
0161957 CTTCCGACAGAATTTAGTTAGGTGCCCCTATGGATATGG
ATTTTGAGAAAGAACTGATTA 
TK1957 inverse PCR to construct 
B plasmids 
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CTAACTAAATTCTGTCGGAAG 
TK1957 inverse PCR to construct 
B plasmids 
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0022159 GGTGAAGGATTTCGAAGGTATCAAAAATCCCAAAGTGG TK2159 initial amplification
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B plasmids 
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TK2159 inverse PCR to construct 
B plasmids 
 
Overexpression vectors 
BG4881 
BG4882 
 
CACCTCCGTGATATTATCTATTAC 
CGCACCGGTCCGGACAACACCCCTTGAGCTTTG 
vbb amplification (pSKS022) 
vbb amplification (pSKS022) 
BG4934 
BG4935 
ATGCTATACAGATTGGTCTCCCACATCCC
CGCACCGGTCTACCTTCCAAAGCGCCGCTGTCTC 
TK1173 amplification 
TK1173 amplification 
BG4936 
BG4937 
ATGCTGAGGGAGATACTCTCAC
CGCACCGGTTCACACCCTCGCCCTCTCAAAC 
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GCGACCGGTGGCGTCTTGAACGTTATGACAG 
TK1957 amplification 
TK1957 amplification 
BG5202 
BG5203 
ATGGGCTCGAAGCTTGATGAG
GCGACCGGTTCCCGCACGTTAGTCCTACAC 
TK0513 amplification 
TK0513 amplification 
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TK2159 amplification 
 
  
Diagnostic primers  
BG4871 CATCCTCACAGGGACGTTTG OExxxx diagnosis & sequencing 
(primer A in Figure S2b) 
BG4873 ACAGACTTGAGGTGGAAAGG OExxxx diagnosis & sequencing 
(primer D in Figure S2b) 
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BG4663 TCTTAACCTGCTCGGCGACC RT-PCR: TK0308 (R) 
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BG5577 CGCCAAGACCAACGGCAAAC RT-PCR: TK0513 (R) 
BG5578 TGGTGAAGCCGAAGTACAAG RT-PCR: TK1548 (F) 
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BG5725 GGATGCGGGCATAATCACAG RT-PCR: TK0509 (F) 
BG5726 GCTTGGGCATGAGGTTGTTG RT-PCR: TK0509 (R) 
BG5727 CGCTGTAGGCGATCTGATAG RT-PCR: TK1173 (F) 
BG5728 AACATAGCCCTCGCATACGG RT-PCR: TK1173 (R) 
BG5729 GCGGAGCGTAGGTGTTTATG RT-PCR: TK1088 (F) 
BG5730 ACAAGGAAGTCAGCGGAGTG RT-PCR: TK1088 (R) 
BG5733 ATGAGGAACGCAGAGTACAG RT-PCR: TK1957 (F) 
BG5734 ATAGCCGTTGGTGAGATTGG RT-PCR: TK1957 (R) 
BG5737 TCTCCTTGATGCCGATGTTC RT-PCR: TK2159 (F) 
BG5738 AGATAGGCGACAACGAGTTC RT-PCR: TK2159 (R) 
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Summary 
 
Hydrogen (H2) production by microbial dark fermentation has attracted widespread 
attention as a promising alternative to fossil fuels. However, a major known drawback of this 
method is that H2 production yields are still too low to make the process economically 
competitive. Therefore, to enhance the economics of the microbial dark fermentation it is 
necessary to improve the sugar-to-H2 yield. Current sugar-to-H2 yields by microbial dark 
fermentation vary from less than 1 to almost 4 mole of H2/mole of hexose consumed, the 
latter corresponding to only about a third of the theoretical yield of 12 mole. Nevertheless, 
the production of 4 H2/hexose is generally regarded as the upper limit that can be reached 
naturally by dark fermentation. This is due to both thermodynamic constraints and the fact 
that evolution has optimized fermentations to produce biomass (ATP) and not H2. To reach 
H2 production yields beyond current limits, extra substrate oxidation steps need to be 
introduced into the catabolism of current top H2 producers via genetic engineering 
approaches, while maintaining sufficient ATP synthesis by SLP for microbial survival. To show 
that this is possible, we selected the hyperthermophilic archaeon Thermococcus 
kodakarensis, which is genetically accessible and has been reported to ferment starch to 
acetate, CO2 and H2, having a H2-production yield of 3.3 mole/mole of hexose (chapter 1). 
Many substrate oxidation steps that can potentially be added to T. kodakarensis result in the 
generation of NADPH (e.g. TCA cycle or Wood-Ljungdahl pathway). Although H2 formation 
from NADPH is thermodynamically difficult, the high optimal growth temperature of T. 
kodakarensis (85°C) should allow the conversion to proceed under physiological conditions. 
Moreover, in contrast to most organisms, T. kodakarensis naturally possesses an NADPH-
dependent hydrogenase. However, this cytosolic hydrogenase is normally utilized for 
oxidizing H2 rather than for H2 production, but various studies have shown that these [NiFe]-
hydrogenases are readily reversible in vitro. Increasing intracellular NADPH levels by adding 
additional substrate oxidation steps could therefore shift the catalytic direction of the 
reaction towards H2 evolution.  
 
Chapter 2 provides an overview of the major canonical and non-canonical reactions involved 
in the production and regeneration of NADPH in prokaryotes and discusses their key 
enzymes. In addition, an overview of how different enzymes have been applied to increase 
NADPH availability and thereby enhance productivity of many biotechnological products is 
provided. The reactions discussed were divided into I) those that are directly coupled to 
central carbon metabolism and II) those that are not. The enzymes that comprise the first 
group are the oxPPP enzymes glucose-6-phosphate dehydrogenase and 6-phospogluconate  
dehydrogenase; isocitrate dehydrogenase of the TCA cycle; malic enzyme; and three 
enzymes involved in non-canonical NADPH-generating reactions, namely phosphorylating 
GAP dehydrogenase (NADP+-GAPDH), non-phosphorylating GAP dehydrogenase (GAPN), and 
glucose dehydrogenase. The enzymes in the second group are transhydrogenases 
(NADH:NADP+), ferredoxin:NADP+ oxidoreductase, hydrogenases (H2:NADP+), and NAD(H) 
kinase, although the latter is a de novo NADP+/NADPH-synthesizing enzyme rather than an 
NADPH-regenerating enzyme. The overview showed that although various NADPH-
generating enzymes have been successfully overexpressed to increase NADPH availability, 
no general strategy that guarantees improved NADPH supply exists. Cells usually contain 
various integrated, network-wide, redox balancing systems, such that engineering of 
NADPH-generating pathways can result in unexpected metabolic perturbations. Thus, 
strategies often need to be optimized individually, taking the culture conditions and genetic 
background of the strains into consideration. 
Chapter 3 builts upon knowledge provided in chapter 2 and describes the successful 
introduction of bacterial-derived Pentose Phosphate Pathway (PPP) genes into the genome 
of the hyperthermophilic archaeon Thermococcus kodakarensis in an attempt to add extra 
reductant-generating steps. To force glucose catabolism through the introduced PPP, the 
endogenous ribulose monophosphate pathway (RuMP) was disrupted simultaneously. Two 
different strains were created and their growth- and fermentation profile and proteome, 
when cultured in starch containing medium, were compared to that of the parental strain. 
The two strains created, designated strain SKS001 and SKS002, were complemented with 
only the oxidative-PPP (oxPPP) enzymes glucose-6-phosphate dehydrogenase and 6-
39949 Spaans, Bas.indd   196 20-05-16   10:56
Thesis summary and general discussion
197
6
 
Summary 
 
Hydrogen (H2) production by microbial dark fermentation has attracted widespread 
attention as a promising alternative to fossil fuels. However, a major known drawback of this 
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latter corresponding to only about a third of the theoretical yield of 12 mole. Nevertheless, 
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naturally by dark fermentation. This is due to both thermodynamic constraints and the fact 
that evolution has optimized fermentations to produce biomass (ATP) and not H2. To reach 
H2 production yields beyond current limits, extra substrate oxidation steps need to be 
introduced into the catabolism of current top H2 producers via genetic engineering 
approaches, while maintaining sufficient ATP synthesis by SLP for microbial survival. To show 
that this is possible, we selected the hyperthermophilic archaeon Thermococcus 
kodakarensis, which is genetically accessible and has been reported to ferment starch to 
acetate, CO2 and H2, having a H2-production yield of 3.3 mole/mole of hexose (chapter 1). 
Many substrate oxidation steps that can potentially be added to T. kodakarensis result in the 
generation of NADPH (e.g. TCA cycle or Wood-Ljungdahl pathway). Although H2 formation 
from NADPH is thermodynamically difficult, the high optimal growth temperature of T. 
kodakarensis (85°C) should allow the conversion to proceed under physiological conditions. 
Moreover, in contrast to most organisms, T. kodakarensis naturally possesses an NADPH-
dependent hydrogenase. However, this cytosolic hydrogenase is normally utilized for 
oxidizing H2 rather than for H2 production, but various studies have shown that these [NiFe]-
hydrogenases are readily reversible in vitro. Increasing intracellular NADPH levels by adding 
additional substrate oxidation steps could therefore shift the catalytic direction of the 
reaction towards H2 evolution.  
 
Chapter 2 provides an overview of the major canonical and non-canonical reactions involved 
in the production and regeneration of NADPH in prokaryotes and discusses their key 
enzymes. In addition, an overview of how different enzymes have been applied to increase 
NADPH availability and thereby enhance productivity of many biotechnological products is 
provided. The reactions discussed were divided into I) those that are directly coupled to 
central carbon metabolism and II) those that are not. The enzymes that comprise the first 
group are the oxPPP enzymes glucose-6-phosphate dehydrogenase and 6-phospogluconate  
dehydrogenase; isocitrate dehydrogenase of the TCA cycle; malic enzyme; and three 
enzymes involved in non-canonical NADPH-generating reactions, namely phosphorylating 
GAP dehydrogenase (NADP+-GAPDH), non-phosphorylating GAP dehydrogenase (GAPN), and 
glucose dehydrogenase. The enzymes in the second group are transhydrogenases 
(NADH:NADP+), ferredoxin:NADP+ oxidoreductase, hydrogenases (H2:NADP+), and NAD(H) 
kinase, although the latter is a de novo NADP+/NADPH-synthesizing enzyme rather than an 
NADPH-regenerating enzyme. The overview showed that although various NADPH-
generating enzymes have been successfully overexpressed to increase NADPH availability, 
no general strategy that guarantees improved NADPH supply exists. Cells usually contain 
various integrated, network-wide, redox balancing systems, such that engineering of 
NADPH-generating pathways can result in unexpected metabolic perturbations. Thus, 
strategies often need to be optimized individually, taking the culture conditions and genetic 
background of the strains into consideration. 
Chapter 3 builts upon knowledge provided in chapter 2 and describes the successful 
introduction of bacterial-derived Pentose Phosphate Pathway (PPP) genes into the genome 
of the hyperthermophilic archaeon Thermococcus kodakarensis in an attempt to add extra 
reductant-generating steps. To force glucose catabolism through the introduced PPP, the 
endogenous ribulose monophosphate pathway (RuMP) was disrupted simultaneously. Two 
different strains were created and their growth- and fermentation profile and proteome, 
when cultured in starch containing medium, were compared to that of the parental strain. 
The two strains created, designated strain SKS001 and SKS002, were complemented with 
only the oxidative-PPP (oxPPP) enzymes glucose-6-phosphate dehydrogenase and 6-
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phosphogluconate dehydrogenase or with the entire set of missing PPP enzymes, 
respectively. In-gel activity staining and proteomics confirmed the functional expression of 
the heterologous genes. Growth and fermentation profile analyses showed that introduction 
of merely the oxPPP enzymes is sufficient to replace RuMP as a source of pentose 
phosphates. H2 production levels were significantly higher in both strains, especially in the 
early exponential phase where a 96% and 50% increase in the H2/OD600, and 42% and 33% 
increase in the H2/acetate ratio was observed for strains SKS001 and SKS002, respectively. 
Moreover, the elevated H2/acetate ratios in the early exponential phase suggested that 
NADPH was responsible for the increase in H2 formation. Unexpectedly, significantly higher 
growth rates and final OD600-values were observed for the mutant strains, which together 
with the higher specific H2 production values (H2/OD600), resulted in a substantially higher 
overall H2 productivity. The higher growth rates could be a result of an increased supply of 
NADPH, but improved growth of the parental strain upon addition of nucleosides and 
proteomics suggested that this could also be due to an enhanced supply of ribulose-5-
phosphate. 
In chapter 4, some puzzling and contradicting results observed during the engineering of the 
strains discussed in chapter 3 were further investigated. While genomic modifications are 
generally relatively easily obtained in T. kodakarensis, obtaining strain SKS001 and SKS002 
proved rather difficult. Not only was it very difficult to obtain desired “double crossover 
mutants”, but it appeared that different chromosome versions co-existed within the same 
culture. Although the latter observation may potentially be explained by cross-
contamination, the difficulty in obtaining homozygous recombinant cultures, as well as the 
repeated observation of this phenomenon among different engineering attempts, suggested 
that T. kodakarensis may possess multiple copies of its chromosome. This prompted us to 
investigate the chromosome copy number of T. kodakarensis KOD1. In this chapter, we 
clearly showed that T. kodakarensis is indeed polyploid and that its chromosome copy 
number varies between 7 and 19 copies, depending on the growth phase. The finding of 
polyploidy in T. kodakarensis explains the observed difficulty in obtaining homozygous 
recombinant cultures of strain SKS001 and SKS002, as it entails that the desired strain is only 
 
acquired when the modification is incorporated in all chromosome copies. Moreover, an 
apparent correlation between the presence of histones and polyploidy in Archaea was 
observed. The histones may assist in efficient DNA packaging which is required for fitting 
multiple chromosomes in a single cell. 
As shown in Table 1.1, hyperthermophilic bacteria and archaea are better H2 producers than 
thermophilic or mesophilic ones. Therefore, it is interesting to understand how these 
hyperthermophilic microbes are able to thrive at such high temperatures, so that these 
characteristics might be transferred to other H2 producers as well. One of the factors 
thought to contribute to this thermal resistance in archaea is the incorporation of tetraether 
(GDGT) lipids in their membrane. However, it is currently unclear how these lipids are 
synthesized. In Chapter 5, we set out to identify the enzyme(s) involved in the synthesis of 
tetraether lipids in Thermococcus kodakarensis, more specifically the one(s) responsible for 
the condensation of two C20 isoprenyl chains, i.e. the putative tetraether synthase(s). To do 
this, a list of genes that are potentially involved in tetraether lipid synthesis was composed, 
and prioritized based on a couple of characteristics assumed to be important for a tetraether 
synthase. This ultimately resulted in the selection of 12 genes, which were targeted for 
overexpression and disruption. Subsequent diether/tetraether lipid analysis of the mutant 
strains strongly suggested that at least three of these genes are indeed involved in the 
tetraether synthesis pathway. Moreover, disruption of various candidate genes turned out 
to be non-viable, which is an interesting result as disruption of a tetraether synthase may 
very well be lethal. However, though interesting results have been obtained, the data did 
not allow for the establishment of the exact functions of the candidate genes. Future 
research is thus needed to get a better understanding of the tetraether synthesis pathway 
and to identify the tetraether synthase(s).   
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acquired when the modification is incorporated in all chromosome copies. Moreover, an 
apparent correlation between the presence of histones and polyploidy in Archaea was 
observed. The histones may assist in efficient DNA packaging which is required for fitting 
multiple chromosomes in a single cell. 
As shown in Table 1.1, hyperthermophilic bacteria and archaea are better H2 producers than 
thermophilic or mesophilic ones. Therefore, it is interesting to understand how these 
hyperthermophilic microbes are able to thrive at such high temperatures, so that these 
characteristics might be transferred to other H2 producers as well. One of the factors 
thought to contribute to this thermal resistance in archaea is the incorporation of tetraether 
(GDGT) lipids in their membrane. However, it is currently unclear how these lipids are 
synthesized. In Chapter 5, we set out to identify the enzyme(s) involved in the synthesis of 
tetraether lipids in Thermococcus kodakarensis, more specifically the one(s) responsible for 
the condensation of two C20 isoprenyl chains, i.e. the putative tetraether synthase(s). To do 
this, a list of genes that are potentially involved in tetraether lipid synthesis was composed, 
and prioritized based on a couple of characteristics assumed to be important for a tetraether 
synthase. This ultimately resulted in the selection of 12 genes, which were targeted for 
overexpression and disruption. Subsequent diether/tetraether lipid analysis of the mutant 
strains strongly suggested that at least three of these genes are indeed involved in the 
tetraether synthesis pathway. Moreover, disruption of various candidate genes turned out 
to be non-viable, which is an interesting result as disruption of a tetraether synthase may 
very well be lethal. However, though interesting results have been obtained, the data did 
not allow for the establishment of the exact functions of the candidate genes. Future 
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General discussion  
Hydrogen production beyond current limits, continued 
To enhance the economy of the microbial dark fermentation it is necessary to improve the 
sugar-to-H2 yield beyond the current limit of 4 mole H2/hexose (i.e. the “Thauer limit). To 
show that this is possible, we introduced extra substrate oxidation (or reducing-equivalent 
generating) steps in the hyperthermophilic archaeon Thermococcus kodakarensis, creating 
strain SKS001 and SKS002. As shown in chapter 3, H2 production levels were significantly 
higher in both strains. Moreover, the elevated H2/acetate ratios in the early exponential 
phase (~1.9 versus ~2.7/2.5 for the parental strain TS559 and the mutants SKS001/SKS002, 
respectively) suggested that NADPH was indeed responsible for (part of) the increase in H2 
formation. Although these results are very promising, the obtained increases in the 
H2/acetate ratios are not large enough to be absolutely certain that the H2/hexose yield has 
broken the “Thauer limit”, especially since the parental strain TS559 also reached a 
H2/acetate ratio of ~2.5 when growth approached the stationary phase. Therefore, to obtain 
absolute prove, we need to reach either significantly higher H2/acetate yields or, ideally, 
determine the exact amount of converted sugar to ultimately obtain H2/glucose yields. This 
might be realized in several ways, which is discussed in the following sections. 
 
Improving the H2/acetate ratio further 
Bioenergetic analyses showed that a H2/acetate ratio of 8 should be possible by microbial 
dark fermentation as sufficient ATP might be obtained by SLP under non-standard 
conditions, especially at elevated temperatures and when partial H2 pressures can be kept 
low (Table 3.1). This implies that there is still sufficient room for improving the H2/acetate 
ratio further. To attempt this, several options are available, which can be divided into those 
that require extra engineering steps and those that do not. For example, one might try to 
reach higher H2/acetate ratios by simply repeating the fermentation analysis performed in 
chapter 3, but by changing one important feature. The experiments described in chapter 3 
were performed in batch, without any control over the fermentation characteristics. This 
implies that partial H2 pressures rapidly increased along with increasing cell densities, which 
 
from a H2-production point of view is thermodynamically unfavorable. Especially, in the case 
of H2 production from NAD(P)H (Figure 6.1). Thus, by repeating the fermentation analysis 
and implementing control over the partial H2 pressures, to keep the H2 concentration 
experienced by the cells as low as possible, H2/acetate (and H2/glucose) ratios may be 
increased further. This can be realized by using either batch or continuous cultures, in which 
evolved gas metabolites are continuously flushed out and measured, using N2 and 
continuous gas chromatography, respectively.   
In addition, one might try to increase the H2/acetate ratio further by increasing the fraction 
of the sugar catabolism directed through the introduced Pentose Phosphate Pathway (PPP). 
This might be realized, without the need of extra engineering steps, by culturing the cells in a 
pentose-free medium. The ASW-YT medium used in this study is a very rich medium 
containing large amounts of tryptone and yeast extract. It is thus likely that the medium 
contains considerable amounts of pentoses or pentose-containing molecules, such as AMP, 
CMP, UMP or nucleosides. These molecules may be taken up by the cell [592], which 
decreases the need for novel pentose biosynthesis via the introduced PPP. Therefore, by 
removing pentoses and pentose-containing molecules from the medium, cells might be 
forced to direct a larger fraction of their sugar catabolism via the PPP.    
 
Figure 6.1 Effect of H2 concentration and temperature on the Gibbs energy of H2 formation from NAD(P)H 
(dotted line) and reduced ferredoxin (dashed line) at 25°C and 85°C. The figure was adapted from [48] 
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Figure 6.1 Effect of H2 concentration and temperature on the Gibbs energy of H2 formation from NAD(P)H 
(dotted line) and reduced ferredoxin (dashed line) at 25°C and 85°C. The figure was adapted from [48] 
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Similarly, one could go even further and attempt to direct sugar catabolism completely 
through the introduced PPP. Theoretically, this should result in a H2/acetate (and 
H2/glucose) ratio of 8 (Table 3.1). To realize this, hexoses need to be prevented to follow the 
modified EM pathway naturally present in T. kodakarensis, while keeping the 
phosphoglucose isomerase (PGI; TK1111) and the carbon-three part of the EM-pathway 
intact to enable conversion of the PPP products fructose-6-phosphate and glyceraldehyde-3-
phosphate. This can be done by disrupting the ADP-dependent phosphofructokinase (PFK; 
TK0376) which, in contrast to the examples given above, thus requires some additional 
metabolic engineering (Figure 6.2). However, since the EM-pathway is normally required for 
survival of T. kodakarensis under glycolytic conditions, disruption of PFK might be extremely 
challenging or even lethal, despite the introduction of the PPP. Therefore, it would be 
desirable to additionally gain control over the expression of PFK-encoding gene TK0376. To 
do this, its natural promoter should be exchanged for a controllable one that can be either 
switched on/off via specific activators or repressors, or that allows transcriptional tuning via 
specific inducers in a dose-response fashion [593-596]. Unfortunately, to the best of our 
knowledge, such controllable promoters are not (yet) available for T. kodakarensis.  
Interestingly, the transcription of the PFK-encoding gene, as well as that of other glycolytic 
and gluconeogenic enzyme-encoding genes, is naturally regulated in a similar manner. Both 
glycolytic and gluconeogenic promoters contain a palindromic sequence, called the 
Thermococcales-Glycolytic Motif (TGM), that is present in many sugar-metabolizing 
Thermococcales [597]. This motif is recognized by a global transcriptional regulator, called 
the Thermococcales-Glycolytic regulator (Tgr), that specifically binds the TGM and that is 
only released when maltotriose is present. In glycolytic promoters, the TGM is positioned 
downstream of the Transcription factor B-responsive element (BRE)/TATA sequence, which 
means that binding of the Tgr to the TGM (i.e. gluconeogenic conditions) structurally blocks 
RNA polymerase recruitment and thus inhibits transcription. When maltodextrins are 
available in the medium (i.e. glycolytic conditions), the intermediate maltotriose binds to the 
Tgr protein, leading to displacement of Tgr from TGM, enabling RNA polymerase recruitment 
and hence transcription. In gluconeogenic promoters, the TGM is positioned upstream of the 
 
BRE/TATA sequence and binding of the Tgr to the TGM (i.e. gluconeogenic conditions) is 
thought to stimulate RNA polymerase recruitment and hence transcription. Displacement of 
the Tgr from the TGM upon the presence of maltotriose (i.e. glycolytic conditions), 
diminishes this activating effect and hence inhibits transcription. Thus, Tgr simultaneously 
controls, in response to sugar availability, both glycolytic and gluconeogenic metabolism in 
T. kodakarensis via its direct binding to the TGM [88], i.e. transcription of glycolytic enzyme-
encoding genes is “switched off” under gluconeogenic conditions and “switched on” under 
glycolytic conditions, while transcription of gluconeogenic enzyme-encoding genes is 
“switched off” under glycolytic conditions and “switched on” under gluconeogenic 
conditions. This suggests that it should be possible to obtain a PFK-disruption mutant under 
gluconeogenic conditions. 
 
Figure 6.2 Schematic representation of the proposed hydrogen production metabolism. The enzymes already 
introduced (red arrows) and disrupted in strain SKS002 are numbered 1-6. The proposed additional PFK-
disruption is shown as number 7. The numbers represent: 1, glucose-6-phosphate dehydrogenase; 2, 6-
phosphogluconolactonase; 3, 6-phosphogluconate dehydrogenase; 4, ribulose-phosphate 3-epimerase; 5, 
transaldolase; 6, 3-hexulose-6-phosphate synthase (hps) - 6-phospho-3-hexuloisomerase (phi) fusion enzyme; 
7, phosphofructokinase    
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To do this, a similar engineering strategy as used for the creation of strain SKS001 and 
SKS002 can be applied (Figure 6.3). Especially, since the selection/counter-selection 
procedure utilized was designed to be performed under gluconeogenic conditions, i.e. on 
ASW-YT plates supplemented with polysulfide [60, 61, 486]. To create a PFK-disruption, 
strain SKS002 should be used as a parent as a complete PPP is required to enable growth 
under glycolytic conditions. Transforming strain SKS002 with the disruption vector shown in 
Figure 6.3, should result in agmatine prototrophs that can easily be selected for on ASW-YT 
plates containing polysulfide [60, 61, 486]. These agmatine prototrophs are the result of 
separate integration events at either the up- or downstream flanking region, resulting in the 
incorporation of the entire vector to the chromosome of T. kodakarensis. Next, an internal 
recombination event can be stimulated by plating the transformants on plates containing 
6MP and agmatine, to either restore the original genome or produce the desired PFK-
disruption strain (Figure 6.3).     
Once a PFK-disruption mutant has been obtained, the strain can be tested for growth under 
glycolytic conditions by using the starch-containing ASW-YT-SA2 medium. If successful, the 
fermentation analysis, as performed on strain SKS001 and SKS002, should be repeated using 
the newly developed mutant strain SKS003. Ideally, the analysis should be performed in such 
a way that partial H2 pressures can be controlled, to keep the H2 concentration experienced 
by the cells as low as possible (see above). All of this may ultimately result in higher H2 and 
alanine levels as observed for strain SKS001 and SKS002. In addition to H2 and alanine, the 
fermentation analysis may reveal other unwanted reduced end products (e.g. formate or 
lactate), which could suggest additional gene-disruption targets. Moreover, one may 
attempt to reveal bottlenecks in the metabolism by using metabolome measurements and 
13C-metabolic flux analysis [598, 599]. Finally, as growth of the engineered SKS003 strain is 
dependent on a functional PPP, a random optimization approach can be conducted in 
chemostats to improve the fermentation kinetics under sugar limited conditions. Such an 
evolutionary engineering approach has for example successfully been applied for the 
optimization of xylose utilization in yeast [600]. 
 
 
Figure 6.3 Disruption strategy for the PFK-encoding gene TK0376 of T. kodakarensis strain SKS002. The initial 
single crossover insertion (step 1) can occur at either the upstream homologous region (in blue, shown above) 
or at the downstream homologous region (in yellow, not shown). Both integration events yields agmatine-
prototrophic intermediate strains, that contain direct repeats flanking the target locus. Dependent on 
recombination responsible for excision upon counter-selection with 6MP (step 2), either the original SKS002 
genome can be restored or the desired deletion genome SKS003 can be generated.  
 
Determining the exact H2/glucose ratio 
Another way to determine if the H2/glucose yield has breached the “Thauer limit”, is by 
determining the exact amount of converted sugar. Unfortunately, the outcome of the 
glucose consumption analysis performed in chapter 3, with soluble starch as C-source, was 
not consistently accurate enough to allow precise calculation of H2/glucose yields. Therefore, 
It would be desirable to repeat the fermentation analysis and to replace starch with sugars 
that can be quantified by HPLC directly, such as glucose, maltose or maltotriose. 
Unfortunately, however, T. kodakarensis is not able to grow on mono- and disaccharides as 
their respective transporters are missing [59]. Growth on maltotriose, on the other hand, 
should be possible, as has also been shown for the wild-type strain KOD1 [72]. However, 
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when we tried to cultivate strain SKS001 and SKS002 in ASW-YT medium supplemented with 
maltotriose, no growth was observed. Moreover, growth was also not observed in a control 
inoculated with the parent strain TS559, but was observed in a control containing the wild-
type strain KOD1 (data not shown). These results show that the wild-type strain KOD1 is 
indeed able to grow on maltotriose, but that this ability has somehow been lost by strain 
TS559, and hence strain SKS001 and SKS002.   
Therefore, it would be desirable to either restore the ability to grow on maltotriose in strain 
SKS001 and SKS002, or to introduce transporters that enable growth on mono- and/or 
disaccharides. To restore the ability to grow on maltotriose, it is needed to establish the 
cause of the perturbation. At first, an unwanted mutation in the maltooligo/maltodextrin 
transporter (MalEFGK, TK1771-1773, TK1775, Figure 1.3) seems likely as this might disable 
maltotriose uptake. However, since this transporter is the only sugar transporter identified 
in T. kodakarensis [59, 72] and growth on starch is still possible, a disrupted 
maltooligo/maltodextrin transporter seems unlikely. Alternatively, a mutation in the 
amylopullulanase (TK1774) might be responsible as a previously developed TK1774-
disruption strain retained the ability to grow on larger maltooligosaccharides, but was 
unable to grow on maltotriose [72]. To establish if undesired mutations in the genes 
described above are indeed responsible for the loss of growth in maltotriose-containing 
medium, the corresponding chromosomal regions could be PCR amplified (using a high 
fidelity polymerase) and analyzed by sequencing.   
Alternatively, a transport system that enables the uptake of mono- and/or disaccharides and 
that is functional at 85°C can be introduced into T. kodakarensis. Although most enzyme 
complexes are not thermostable, such a transporter system can be found in the closely 
related species T. sibiricus (optimal growth temperature of 78°C), T. litoralis (85-88°C), and 
Pyrococcus furiosus (100°C). All of these species contain a maltose/trehalose-specific 
transporter that is closely related to the maltooligo/maltodextrin transporter present in T. 
kodakarensis [601-604]. Like the maltooligo/maltodextrin transporter, the 
maltose/trehalose transporter is encoded by four genes designated MalEFGK. However, 
where the malE-gene of the maltooligo/maltodextrin transporter encodes a periplasmic 
 
binding protein specific for maltooligosaccharides longer than a trimer, the one of the 
maltose/trehalose transporter encodes a binding protein specific for maltose and trehalose. 
Therefore, replacing the natural MalE-gene of T. kodakarensis with the one encoding the 
maltose/trehalose-specific binding protein, might enable growth on these quantifiable 
sugars. However, as this will result in the loss of the ability to grow on maltooligosaccharides 
longer than a trimer, it might be more desirable to just introduce all four of the heterologous 
MalEFGK genes. This will most likely result in a T. kodakarensis strain that, in addition to 
growth on longer maltooligosaccharides, is also able to grow on the disaccharides maltose 
and trehalose.          
Another, more radical, approach to determine if the proposed hydrogen production 
pathway (Figure 6.2) is able to break the “Thauer limit”, is by starting all over and selecting a 
H2-producing hyperthermophilic organism that is already able to grow on mono- and/or 
disaccharides. At the start of this thesis, T. kodakarensis was the only H2-producing 
hyperthermophilic organism that was genetically accessible. However, today, other 
(hyper)thermophilic organisms have become genetically accessible as well. For example, the 
closely related and excellent H2-producer Pyrococcus furiosus now has an efficient toolbox 
and has become one of the model organisms in archaeal research [442, 605]. Like T. 
kodakarensis, P. furiosus already produces H2 near the current limit of 4 mole/hexose (Table 
1.1), contains NADPH-dependent hydrogenases (in contrast to T. kodakarensis, P. furiosus 
contains not one but two NADPH-dependent hydrogenases; SHI and SHII), and is missing 
many of the classical PPP-enzymes [29, 78, 103]. However, in contrast to T. kodakarensis, P. 
furiosus is naturally able to utilize the disaccharides maltose and trehalose. In addition, P. 
furiosus has an even higher optimal growth temperature (i.e. 100°C instead of 85°C), which, 
provided that the heterologous PPP enzymes are still stable, might be beneficial for H2-
production (Figure 6.1).  
Similarly, the hyperthermophilic bacterium Thermotoga maritima (optimum growth 
temperature 80°C) has recently been reported to be transformable, though the efficiency 
was extremely low (~0.25 transformants per µg of DNA) [606]. Moreover, the Thermotoga 
species RQ2 and RQ7, which are both closely related to T. maritima, have been reported to 
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be transformable as well and strain RQ2 has even been used for the heterologous expression 
of cellulases from Caldicellulosiruptor saccharolyticus [607, 608]. This is interesting as T. 
maritima is known as one of the best H2-producers, capable of producing 4 mole H2 per mole 
of glucose (Table 1.1), and naturally contains the PPP, but lacks a NADPH-dependent 
hydrogenase. Thus, Introducing the NADPH-dependent hydrogenase from either T. 
kodakarensis or P. furiosus, might enable H2 production above current limits.   
When successful, the various options described above may result in a H2/glucose yield of 
maximally 8 (Table 3.1). This means that in addition to the 8 moles of H2 and 4 moles of CO2, 
1 mole of acetate is still produced per glucose. As explained in chapter 1 and 3, further 
oxidation of this fermentation-end product to CO2 and H2 by dark fermentation is not 
possible. Especially, as this conversion requires a substantial input of energy (Eq. 1.7). 
However, to increase the H2/glucose yield to its theoretical limit of 12, and thus to extract 
the remaining 4 moles of H2 that is still “locked” in the acetate, a subsequent photo-
fermentation or microbial electrolysis may be performed [11, 42, 53]. In these methods, the 
energy barrier associated with the conversion of acetate (Eq. 1.7) can be overcome by 
utilizing the energy from solar light or by applying an external potential, respectively. 
Nevertheless, although technically feasible, such combined systems are too expensive from 
an economical point of view.  
 
Confirming the physiological role of non-phosphorylating glyceraldehyde 3-
phosphate  dehydrogenase (GAPN) 
As discussed in chapter 1, T. kodakarensis contains a modified Embden-Meyerhof (EM) 
pathway (Figure 1.3, box A and B). This modified EM pathway is also present in other 
Thermococcales and differs from the classical EM pathway present in, for example, 
Escherichia coli in some key aspects. One of these aspects is the mode of conversion of 
glyceraldehyde-3-phosphate (GAP) to 3-phosphoglycerate (3-PG). In the classical EM 
pathway, GAP is converted to 3-PG via 1,3-bisphosphoglycerate by the consecutive functions 
of phosphorylating NAD+-dependent GAP dehydrogenase (GAPDH) and ATP-generating 3-PG 
kinase (PGK) (Figure 6.4). Together, these two enzymes play a crucial role in conserving 
 
energy in the classical glycolysis by generating NADH and ATP. Although GAPDH and PGK 
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Surprisingly, both GAPOR and GAPN have been shown by gene disruption experiments to be 
essential under glycolytic conditions [77]. These results were rather unexpected as both 
catalyze the conversion of GAP to 3-PG, which suggest that they should be able to 
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oxidoreductase (POR) (Figure 1.3). The authors discussed that a feasible explanation for the 
necessity of GAPOR under glycolytic conditions may have to do with the metabolic flux 
through both enzymes. The capacity of GAPOR in terms of metabolic flux can be considered 
relatively high as its co-substrate Fdox is readily regenerated by the function of the 
membrane-bound hydrogenase (Figure 1.3) [30, 82, 83]. In contrast, however, the 
regeneration rate of NADP+ by anabolic processes is expected to be relatively low and might 
therefore not allow a sufficient turnover of GAPN to complement the absence of GAPOR.  
At present, the reason why GAPN is essential under glycolytic conditions is most likely due to 
its role in generating NADPH [77]. T. kodakarensis does not contain many sites for NADPH 
generation, especially not under glycolytic growth conditions. For example, the wild-type 
strain does not possess the oxidative PPP (chapter 2 and 3) and the transcription of the 
glutamate dehydrogenase (GDH) gene is strongly repressed under glycolytic conditions [88]. 
Alternatively, the authors suggested that the disruption of GAPN may lead to an 
accumulation of intracellular GAP, which in turn may lead to a shutdown of the GAPOR 
route. This alternative explanation to why GAPN is essential under glycolytic conditions is 
based on the observation that the GAPOR of P. furiosus is significantly inhibited by GAP 
concentrations of 0.5 mM or higher [77, 609]. 
Interestingly, the strains created in chapter 3, i.e. SKS001 and SKS002, can be used to clarify 
why GAPN is essential under glycolytic conditions. This is because the introduction of the 
oxidative PPP in these strains provides two additional NADPH generation sites (i.e. G6PDH 
and 6PGDH) which, in case the first theory is correct (essential role in NADPH generation), 
should enable a GAPN-disruption strain to survive under glycolytic conditions. Thus, a viable 
GAPN-disruption mutant, in an SKS001 or SKS002 background, would confirm GAPN as an 
essential NADPH generator, whereas a non-viable mutant would suggest that the alternative 
theory (inhibitory effect of GAP on GAPOR) might be true. To test this, various approaches 
are possible, but the most straight-forward one would be to use either strain SKS001 or 
SKS002 as a parent and to slightly adapt the previously developed pUD2-ΔgapN disruption 
vector to make the selection procedure compatible with the genetic background of these 
strains; selection of recombinants after transformation with the pUD2-ΔgapN disruption 
 
vector is based on the integration of the PyrF marker, that confers uracil prototrophy [62, 
63, 77], whereas the genetic background of SKS001/SKS002 only allows for selection based 
on tryptophan and/or agmatine prototrophy, and not on uracil prototrophy [60, 61, 486]. 
To make the pUD2-ΔgapN disruption vector compatible with the strains developed in 
chapter 3, the PyrF marker can be replaced by the TK0149-TK0664 selection/counter-
selection cassette (selection based on agmatine prototrophy and counterselection based on 
6-methyl purine resistance), which would allow for a GAPN-disruption strategy similar to the 
one shown in Figure 6.3. Alternatively, a disruption strategy based on tryptophan selection 
can be applied. For practical reasons not further discussed here, it was decided to attempt to 
obtain a GAPN-disruption strain using the second strategy. To do this, the disruption vector 
was adapted such that it directly targets the GAPN gene locus, so that its integration into the 
genome of strain SKS001/SKS002 will result in a GAPN disruption. Unfortunately, though the 
procedure was performed under gluconeogenic conditions, no tryptophan prototrophs were 
obtained, even not after several transformation attempts. Therefore, a rather different 
approach was attempted as well, in which the strategy was basically turned around: instead 
of starting with the SKS001/SKS002 strain and trying to disrupt GAPN, it was decided to start 
with the previously developed GAPN disruption mutant [77] and to try to introduce the PPP. 
Like done in chapter 3, two different vectors were created that should ultimately result in 
the simultaneous disruption of the ribulose monophosphate pathway (RuMP) and the 
introduction of either the oxPPP enzymes glucose-6-phosphate dehydrogenase (G6PDH), 6-
phosphogluconolactonase (6PGLase), and 6-phosphogluconate dehydrogenase (6PGDH), or 
of all five of the missing PPP enzymes. The difference with the vectors created in chapter 3 is 
that the selection of transformants is based on uracil prototrophy rather than agmatine 
prototrophy, and that the first vector introduces all three of the oxPPP enzymes instead of 
just G6PDH and 6PGDH. In theory, the simultaneous disruption of the RuMP and the 
introduction of just the oxPPP should be enough to complement the loss of GAPN. 
Nevertheless, in accordance with chapter 3, it was decided to include the introduction of the 
entire PPP as well. Unfortunately, however, no desired mutants have been obtained yet. 
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Polyploidy in Thermococcus kodakarensis  
Correlation does not imply causation 
In chapter 4, we showed that T. kodakarensis is polyploid and that its chromosome copy 
number is growth-phase-dependent. (i.e. a chromosome copy number as high as 19.4 ± 4.9 
was observed in the early exponential phase, whereas the ploidy level in the stationary 
phase was only 7.5 ± 2.8). Moreover, we observed an apparent correlation between the 
presence of histones and polyploidy in archaea (Table 4.1). Though it is tempting to 
speculate that histones play an important role in enabling polyploidy, statistics tells us that 
correlation does not necessarily imply causation. Therefore, to confirm a causal relationship, 
further research is needed.  
To test if there is an actual causal relationship between the presence of histones and 
polyploidy in archaea, more species need to be tested for their ploidy level. Especially, those 
that diverge from the apparent dichotomy between Euryarchaeota/Crenarchaeota: all 
Euryarchaeal species tested to date encode archaeal histone homologs and are polyploid, 
while all Crenarchaeal species tested do not encode archaeal histone homologs and were 
found to be monoploid. In this respect, Table 4.1 clearly reveals several candidate species. 
For instance, Thermoplasma acidophilum, T. volcanium and Ferroplasma acidarmanus, are 
all Euryarchaeotes, and therefore believed to be polyploid, but none of these species 
encodes archaeal histones. It should be mentioned, however, that these species do encode 
homologs of the bacterial histone-like proteins (HU-proteins) that have been proposed to 
have a similar function [525]. Similarly, the Crenarchaeota Thermofilum pendens, Caldivirga 
maquilingensis and Vulcanisaeta distributa are interesting as they are among the few 
Crenarchaeota known to encode archaeal histones. Moreover, determining the chromosome 
copy number of species belonging to the archaeal phyla Thaumarchaeota, Korarchaeota and 
Nanoarchaeota, which are all known to encode histones, may be valuable as well in 
strengthening the polyploidy/histone dichotomy hypothesis. 
Another, perhaps more direct way to test if there is a causal relationship between the 
presence of histones and polyploidy in archaea is to disrupt the archaeal histone encoding 
gene(s) and to determine its effect on the ploidy level. However, since histones can play an 
 
important role in DNA packaging and the regulation of gene expression, disruption of 
histone encoding genes might be expected to perturb cell growth and/or metabolism. Yet, 
examples of Euryarchaeal species in which histone encoding genes were successfully deleted 
have been reported. For instance, Methanococcus voltae and T. kodakarensis both contain 
two archaeal histones and though the respective double mutants could not be obtained, 
single disruption mutants for each of the genes have shown to be viable [529, 610]. 
Moreover, a viable histone disruption strain of Methanosarcina mazei Göl has been reported 
as well [611]. The latter is of special interest as this species contains only one histone 
encoding gene and the disruption strain thus lacks any histone proteins. Comparing the 
ploidy level of this mutant strain to that of the wild-type would thus be very interesting.  
Although the polyploidy/histone correlation may hold for archaea, it is for sure not a general 
trait.  For example, polyploidy has been observed in many bacteria as well, while this domain 
is well known not to encode any histones. Instead, bacteria generally encode different DNA-
binding proteins for DNA packaging, such as HU, IHF, Fis or Lrp, some of which have also 
been found in Archaea [524, 525, 529]. Thus, other systems or proteins may exist that 
contribute to polyploidy. Moreover, it might be that it is not histones per se, but rather their 
function (i.e. condensating DNA by wrapping) that enables polyploidy in archaea. If so, a 
correlation between polyploidy and other wrapping proteins might exist in bacteria and/or 
archaea as well. 
Another interesting observation done in chapter 4 was that the chromosome copy number 
of T. kodakarensis is growth-phase-dependent. The observation of a growth-phase-
dependent ploidy level has been reported for many other prokaryotes as well, including the 
majority of the investigated Euryarchaeal species [503, 504, 506, 514]. Unfortunately, no 
common pattern has emerged from the characterized prokaryotic species. Where some 
species have a higher chromosomal copy number in the exponential phase (including T. 
kodakarensis), others have a higher chromosomal copy number in the stationary phase [506, 
515]. Nevertheless, the observation of a growth-phase-dependent ploidy level in itself is 
quite interesting and one may wonder what is causing this effect.  
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A possible explanation for the observation that the ploidy level of T. kodakarensis is 
decreasing towards the stationary phase might be that chromosomal replication cannot 
keep up with cell division. If this is the case, it would suggest that there is a phase of cell 
division independent chromosomal replication, to prepare the cells for rapid growth. This 
would imply that the ploidy levels observed in the exponential phase are an overestimation 
of the true ploidy level of T. kodakarensis (of non-growing cells) and that the ones observed 
in the stationary phase are more accurate. Moreover, it also implies that, through 
chromosomal replication and cell division, ploidy levels are somehow regulated. In this 
regard, it is interesting that in species that contain more than one histone encoding gene, 
differences in their expression levels have been reported to correlate with differences in 
laboratory growth rates and/or growth phases [610, 612, 613]. Nevertheless, although 
interesting, there is currently no data in support of any of the above and other explanations 
may exist as well.  
Potential solutions for polyploidy based engineering problems in T. kodakarensis 
As discussed in chapter 4, the existence of multiple chromosome copies can readily explain 
the difficulty observed in obtaining strain SKS001 and SKS002, as it entails that the desired 
strain is only obtained when the modification is incorporated in all chromosome copies. The 
co-existence of different chromosome variants, i.e. double crossover recombinants, single 
crossover integrations or wild type chromosomes, in the majority of the transformants 
obtained in this chapter may have indicated that the desired modification is harmful and 
possibly lethal. Especially, since genetic modifications are normally relatively easily obtained. 
However, since desired homozygous recombinants were eventually obtained by successive 
cycles of re-plating and screening, this is not necessarily always the case. Nevertheless, 
acquiring homozygous recombinants via this approach can be rather laborious and time-
consuming. The knowledge that T. kodakarensis is polyploid may therefore be quite valuable 
as it allows for the development of more efficient approaches. For example, the observation 
that the chromosome copy number of T. kodakarensis is growth-phase dependent, suggests 
that re-plating cells that are in the stationary phase might be more effective than the 
typically used exponentially growing cells. Moreover, using cells that are in the late 
 
stationary phase might be even better as it is likely that their copy number is even lower 
than the one described in chapter 4 (cells in this chapter were harvested in the early 
stationary phase). 
Similarly, other approaches resulting in a reduced ploidy level might also be applied. One 
could for example try to lower the chromosome copy number by reducing the growth rate 
by using suboptimal growth conditions such as a reduced incubation temperature or the 
usage of suboptimal growth media (see effect of doubling time in Table 4.1). Interestingly, 
we indeed observed that genome modifications involving two independent homologous 
recombinations were often more successful when using plates containing defined ASW-AA 
medium rather than nutrient-rich ASW-YT medium. In addition, the recent discovery that 
Haloferax volcanii uses DNA as a phosphate storage polymer and that its ploidy level is 
severely reduced under phosphate-limiting conditions might also be interesting for T. 
kodakarensis [522]. Even if T. kodakarensis does not use DNA as phosphate storage, 
culturing under phosphate-limited conditions is likely to be effective.  
All of these alternative approaches aiming at improving double recombination efficiency 
have in common that they aim at a reduction of the ploidy level of the cell. However, 
strategies for improving the success rate that are independent of the reduction of ploidy 
levels might also be possible. One could for example apply a selection based on antibiotic 
resistance. To promote the presence of the desired genome only, one could place the 
antibiotic resistance marker under the control of a weak promoter. In theory, gradually 
increasing the concentration of the antibiotic in the selection medium entails that only those 
cells that increase the copy number of the resistance marker accordingly, are able to survive. 
The availability of thermostable antibiotics, such as mevinolin, is, however, crucial for this 
strategy [60, 486].  
Perhaps the most interesting strategy would be one that eliminates the need for 
optimization procedures, such as the recently developed CRISPR-Cas9 system. The CRISPR-
Cas system is regarded as an immune system of bacteria and archaea. It has, however, been 
shown that it can be easily adapted and applied as an efficient, marker-independent, 
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crossover integrations or wild type chromosomes, in the majority of the transformants 
obtained in this chapter may have indicated that the desired modification is harmful and 
possibly lethal. Especially, since genetic modifications are normally relatively easily obtained. 
However, since desired homozygous recombinants were eventually obtained by successive 
cycles of re-plating and screening, this is not necessarily always the case. Nevertheless, 
acquiring homozygous recombinants via this approach can be rather laborious and time-
consuming. The knowledge that T. kodakarensis is polyploid may therefore be quite valuable 
as it allows for the development of more efficient approaches. For example, the observation 
that the chromosome copy number of T. kodakarensis is growth-phase dependent, suggests 
that re-plating cells that are in the stationary phase might be more effective than the 
typically used exponentially growing cells. Moreover, using cells that are in the late 
 
stationary phase might be even better as it is likely that their copy number is even lower 
than the one described in chapter 4 (cells in this chapter were harvested in the early 
stationary phase). 
Similarly, other approaches resulting in a reduced ploidy level might also be applied. One 
could for example try to lower the chromosome copy number by reducing the growth rate 
by using suboptimal growth conditions such as a reduced incubation temperature or the 
usage of suboptimal growth media (see effect of doubling time in Table 4.1). Interestingly, 
we indeed observed that genome modifications involving two independent homologous 
recombinations were often more successful when using plates containing defined ASW-AA 
medium rather than nutrient-rich ASW-YT medium. In addition, the recent discovery that 
Haloferax volcanii uses DNA as a phosphate storage polymer and that its ploidy level is 
severely reduced under phosphate-limiting conditions might also be interesting for T. 
kodakarensis [522]. Even if T. kodakarensis does not use DNA as phosphate storage, 
culturing under phosphate-limited conditions is likely to be effective.  
All of these alternative approaches aiming at improving double recombination efficiency 
have in common that they aim at a reduction of the ploidy level of the cell. However, 
strategies for improving the success rate that are independent of the reduction of ploidy 
levels might also be possible. One could for example apply a selection based on antibiotic 
resistance. To promote the presence of the desired genome only, one could place the 
antibiotic resistance marker under the control of a weak promoter. In theory, gradually 
increasing the concentration of the antibiotic in the selection medium entails that only those 
cells that increase the copy number of the resistance marker accordingly, are able to survive. 
The availability of thermostable antibiotics, such as mevinolin, is, however, crucial for this 
strategy [60, 486].  
Perhaps the most interesting strategy would be one that eliminates the need for 
optimization procedures, such as the recently developed CRISPR-Cas9 system. The CRISPR-
Cas system is regarded as an immune system of bacteria and archaea. It has, however, been 
shown that it can be easily adapted and applied as an efficient, marker-independent, 
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genome editing system. CRISPR assisted editing induces recombination at a desired target 
locus and kills non-edited cells leading to a recovery of close to a 100% of edited cells [614]. 
In theory, the same principle should be true for non-edited chromosomes. Only those 
chromosome copies that contain the desired modification should be able to survive the 
constant CRISPR attack. Unfortunately, applying this system in T. kodakarensis is not possible 
as a thermostable CRISPR-Cas9 system is not (yet) available.   
 
Continuing the search for a tetraether synthase 
In chapter 5 we set out to identify the enzyme(s) responsible for the synthesis of tetraether 
lipids. Especially, the one(s) responsible for the condensation of two C20 isoprenyl chains, i.e. 
the putative tetraether synthase(s). Though interesting results have been obtained, the data 
did not allow for the establishment of the exact functions of the candidate genes. Future 
research is thus needed to get a better understanding of the tetraether synthesis pathway 
and to identify the tetraether synthase(s). To do this, several approaches may be followed. 
First of all, one may repeat the lipid analysis. The reason for this is that in the analysis 
performed in chapter 5, we used HPLC–APCI/MS with selected ion monitoring, aimed to 
detect only the most prevalent lipids in the membrane which are represented by the core 
lipid species archaeol (diether) and GDGT-0 (tetraether). However, the amount of diether 
and tetraether lipids obtained for some of the mutant strains was so low (Figure 5.3) that 
either the cellular integrity of the mutant strains must have been compromised or that lipids 
other than archaeol and GDGT-0 must have been produced. To test this, thin cross-sections 
of the mutant strain showing the lowest amount of diether and tetraether lipids, i.e. 
OE1324, were prepared and analyzed by Transmission Electron Microscopy (TEM). The 
results obtained (Figure 5.5) clearly showed that the cellular integrity of this mutant strain 
has not been compromised, strongly suggesting that other lipids must have been produced. 
Repeating the lipid analysis with a total ion monitoring, or with a selected ion monitoring 
aimed to detect additional lipid species, could therefore provide new insights into the lipid 
biosynthesis pathway and the membrane composition of T. kodakarensis. 
 
To help the identification of the tetraether synthase, some additional experiments may be 
performed. For example, from literature it seems that as a response to various stress 
conditions, many archaea increase the tetraether lipid content of their membrane [546, 550, 
551, 553]. Therefore, exposing T. kodakarensis to various stress conditions (e.g. high/low pH, 
temperature, or salinity) and subsequently analyzing its membrane composition, might 
reveal growth conditions that lead to an increased tetraether lipid content. Once such a 
growth condition has been identified, a differential proteome analysis may be performed 
which might help in identifying the tetraether synthase.           
Moreover, to establish the exact functions of various candidate genes, and to identify the 
tetraether synthase, it would be desirable to be able to perform in vitro enzyme activity 
assays. However, given the complicated nature of these reactions, performing such in vitro 
assays may not be easy to realize. For example, not only is the exact substrate of the 
tetraether synthase still unknown, but the enzyme itself may need to be embedded in a 
membrane to be active. Moreover, real-time monitoring of the reaction, as for instance is 
done in a colorimetric assay in a spectrophotometer, might not be possible. Nevertheless, 
developing an in vitro enzyme assay may ultimately be required to confirm promising 
candidate genes as the tetraether synthase.                                                                                                                  
 
Hydrogen: a clean fuel of the future? 
Future energy scenarios will mainly be based on a mix of renewable primary energy sources 
(e.g. solar-, wind-, or geothermal energy, and biomass), in combination with energy carriers 
that are able to address environmental and security issues posed by current fuels. As 
discussed in chapter 1 and 3, one of the promising fuels in this respect is H2. Hydrogen is 
readily available (though it may take some work to access), can be produced locally, is non-
toxic, can be burned without harmful emissions (no CO2 and little or no NOx), has the highest 
energy density per unit fuel mass (which is why H2 is already used as a propellant in space 
industry), and can be renewable. Moreover, the energy stored in H2 can relatively easily be 
converted to electricity using H2 fuel cells, that can also be applied to power vehicles and are 
in fact more efficient than combustion processes (e.g. H2 fuel cells can reach efficiencies up 
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readily available (though it may take some work to access), can be produced locally, is non-
toxic, can be burned without harmful emissions (no CO2 and little or no NOx), has the highest 
energy density per unit fuel mass (which is why H2 is already used as a propellant in space 
industry), and can be renewable. Moreover, the energy stored in H2 can relatively easily be 
converted to electricity using H2 fuel cells, that can also be applied to power vehicles and are 
in fact more efficient than combustion processes (e.g. H2 fuel cells can reach efficiencies up 
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to 60% whereas conventional gasoline powered combustion engines only have an efficiency 
of less than 20% [615]). In addition, H2 fuel cell powered vehicles (FCVs) have several 
benefits compared to the already more general available battery electric vehicles (BEVs). For 
instance, FCVs show a better mileage, can be refueled a lot faster, and are more scalable, 
which makes them more suitable for heavy transportation. Finally, when compared to 
electricity (the other clean energy carrier), H2 has the major advantage that it can be used for 
long-term renewable energy storage.       
Nevertheless, though very promising, several barriers still need to be overcome to realize 
the huge potential of H2 as a true clean fuel [17]. For example, as H2 is only a means for 
transmitting energy from primary energy sources to end-users, it has to be produced from 
primary energy sources. Unfortunately, the far majority of the H2 produced today still relies 
on fossil fuels. Therefore, to become a true clean fuel, H2 has to be produced exclusively 
from clean renewable primary energy sources, which from an economically point of view is 
still too expensive. Moreover, in contrast to the current fuels, the required H2 infrastructure 
to make it a practical fuel is virtually non-existing. This means that huge investments are 
needed to build the necessary pipelines and fueling stations, and that, until this is realized, 
H2-powered vehicles remain unattractive for consumers. In addition, though FCVs recently 
became available on the market, they are currently still too expensive to be attractive to the 
general public. Finally, another major barrier that needs to be overcome is storage.  
Though H2 has the highest energy density per unit fuel mass, it also has the lowest energy 
density per unit fuel volume. This means that in order to store sufficient H2 to power FCVs, 
extremely large storage tanks would be required under standard conditions. Therefore, to 
store H2 more efficiently and compactly, it must be compressed or cryogenically liquefied. 
However, even in a compressed form, H2 still has a very low energy density per unit fuel 
volume, which severely limits its practicality as a fuel for FCVs. Similarly, though better than 
pressurized H2, liquid H2 still only has about a third of the volumetric value compared to 
gasoline [616]. Moreover, liquid H2 also has some challenges in terms of efficiency. This is 
because a substantial part of its energy content is lost during the liquefaction process and, 
when finally stored as a liquid, H2 must be allowed to bleed off to avoid pressure build-up 
 
[17]. So for now, though major improvements have been accomplished in the last decade, H2 
still remains just a very promising alternative to current fuels. Future research and 
development is required to unlock its potential and to implement H2 as a widespread and 
practical transportation fuel. 
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